data_2jub_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jub _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.26 -49.81 76.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.3 m -60.38 -50.07 75.06 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.054 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -68.44 -49.19 61.71 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.312 -1.492 . . . . 0.0 111.019 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.12 -49.26 78.01 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 112.888 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.66 -45.81 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.554 -1.341 . . . . 0.0 111.892 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -59.93 -42.84 90.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.449 -1.407 . . . . 0.0 108.776 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -57.66 -39.26 76.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -55.19 19.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.835 -1.166 . . . . 0.0 109.005 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.0 m120 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 179.787 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.542 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.542 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 38.3 Cg_endo -101.1 128.03 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 123.364 2.71 . . . . 0.0 109.839 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.8 ttt -126.18 128.97 48.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.997 -1.064 . . . . 0.0 110.053 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -110.0 130.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.544 -0.723 . . . . 0.0 109.376 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 t -93.87 103.58 15.68 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -7.83 12.12 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.12 -43.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -134.4 13.97 3.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.31 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -151.81 145.81 25.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.725 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.12 125.95 33.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mt -123.11 73.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.728 -0.607 . . . . 0.0 109.398 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -69.22 109.37 4.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.007 -1.058 . . . . 0.0 109.361 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.2 21.64 0.95 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -140.83 147.82 39.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.51 101.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 0.0 108.708 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 51.4 28.46 4.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 109.138 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.5 tt -92.34 139.45 30.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.86 18.6 63.08 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -127.16 -54.51 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.72 -0.87 . . . . 0.0 109.187 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.97 33.05 0.02 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -50.31 138.99 15.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -1.222 . . . . 0.0 109.858 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.6 t -151.08 135.5 16.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.92 178.18 10.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.323 -1.486 . . . . 0.0 109.969 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -150.58 161.11 43.2 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -100.0 117.34 34.07 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.905 -1.122 . . . . 0.0 109.988 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 60.6 t0 -94.51 -12.49 27.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.128 -0.983 . . . . 0.0 109.373 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 45' ' ' ALA . . . 93.81 98.24 1.55 Allowed Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.175 -0.953 . . . . 0.0 110.814 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 44' ' ' GLY . . . 85.55 1.1 0.7 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.983 -0.716 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -167.31 117.81 0.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -90.78 142.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.954 -1.091 . . . . 0.0 110.572 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.78 125.29 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.89 144.09 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.4 m -110.44 124.46 33.19 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -37.48 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.87 1.713 . . . . 0.0 111.7 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -101.82 -47.32 4.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.024 -1.048 . . . . 0.0 109.828 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 68.9 mt-10 -161.81 -165.84 1.34 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -168.11 114.66 0.69 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 57' ' ' LEU . 2.6 p -122.4 44.53 2.59 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.244 -0.91 . . . . 0.0 111.115 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 68.32 -16.74 0.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.024 -1.048 . . . . 0.0 110.38 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 55' ' ' THR . 12.6 mt -95.13 -0.77 53.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -134.04 -156.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.09 164.19 35.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.828 -1.17 . . . . 0.0 111.381 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.33 174.96 9.56 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.449 0.642 . . . . 0.0 109.525 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -133.36 133.34 42.35 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -82.76 164.43 20.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.842 -1.161 . . . . 0.0 110.358 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.93 119.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.2 m -64.8 151.13 46.13 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.61 69.9 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.603 -1.31 . . . . 0.0 108.403 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.64 80.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.599 -1.313 . . . . 0.0 109.436 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -60.99 -34.21 74.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 108.981 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.75 -33.1 71.22 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -60.6 -41.47 94.81 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 70' ' ' ILE . 52.8 mt -60.15 -39.22 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.725 . . . . 0.0 110.727 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.72 -46.56 93.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 118.304 -1.359 . . . . 0.0 109.821 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.28 73.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.545 -1.347 . . . . 0.0 109.672 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -62.65 -40.01 95.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.833 -1.167 . . . . 0.0 109.607 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -59.94 -51.35 70.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.431 -0.793 . . . . 0.0 111.631 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.35 -46.82 78.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.177 . . . . 0.0 109.893 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.589 ' HG1' ' N ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 121.696 0.76 . . . . 0.0 109.088 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.589 ' N ' ' HG1' ' A' ' 2' ' ' THR . 8.6 tp -60.16 -45.43 93.1 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.4 m -70.04 -51.84 28.85 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.202 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -73.44 -57.56 3.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.31 -40.34 95.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.388 -1.445 . . . . 0.0 112.361 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.6 t -70.32 -47.95 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.589 -1.319 . . . . 0.0 112.341 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 11' ' ' ASN . 53.4 mt -68.24 -42.55 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.862 -1.149 . . . . 0.0 111.195 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -60.3 -41.7 93.96 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.47 91.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.886 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 8' ' ' ILE . 8.0 m120 . . . . . 0 N--CA 1.499 1.997 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.715 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 36.6 mtmt . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.715 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 80.2 Cg_endo -96.46 123.68 0.25 Allowed 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.554 2.169 . . . . 0.0 113.629 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.3 OUTLIER -122.29 140.95 52.04 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.574 -0.704 . . . . 0.0 109.746 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 76.6 mt -110.53 131.39 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.412 -0.805 . . . . 0.0 110.296 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.6 m -94.59 101.11 12.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.742 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -8.44 22.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.372 -0.83 . . . . 0.0 109.528 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.97 -42.4 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 9.3 t70 -131.54 8.02 4.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.41 87.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -144.68 137.21 26.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -1.138 . . . . 0.0 109.233 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -83.43 122.97 29.21 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -120.06 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.376 -0.827 . . . . 0.0 110.319 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -66.01 107.53 1.91 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.837 -1.164 . . . . 0.0 109.011 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.4 19.16 0.77 Allowed Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 137.25 49.06 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 34' ' ' LEU . 3.1 m -118.03 98.89 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 44.6 17.07 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 32' ' ' VAL . 85.1 mt -72.12 142.01 49.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 108.473 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -21.58 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -73.07 -35.45 66.66 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 123.53 31.8 0.94 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -47.52 139.54 6.77 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.285 1.04 . . . . 0.0 111.314 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -154.62 135.08 13.38 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.23 7.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.653 -1.28 . . . . 0.0 111.583 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -156.76 139.4 15.04 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -94.2 123.55 37.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.29 -1.506 . . . . 0.0 109.523 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 52.0 t0 -102.19 -5.6 24.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.354 -0.841 . . . . 0.0 110.201 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -112.07 0.54 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.9 -6.63 53.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -1.194 . . . . 0.0 109.956 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -125.1 119.95 30.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.981 -1.075 . . . . 0.0 108.88 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -88.97 140.14 16.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.488 -0.758 . . . . 0.0 110.828 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.44 114.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 pt -118.78 172.35 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.023 -1.048 . . . . 0.0 109.917 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 51' ' ' PRO . 63.8 m -135.35 102.37 10.74 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 50' ' ' SER . 0.5 OUTLIER -28.9 -99.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.614 2.209 . . . . 0.0 112.083 -177.036 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -78.29 -44.29 25.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 68.2 mt-10 -160.92 -163.87 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' OE1' ' C ' ' A' ' 59' ' ' LYS . 10.0 tp10 -171.0 103.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.627 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 57' ' ' LEU . 73.1 p -130.81 152.59 49.98 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -26.8 -29.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.4 mp -84.11 -3.11 57.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.712 -1.243 . . . . 0.0 111.004 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 55' ' ' THR . 88.4 m-85 -129.27 -161.07 1.08 Allowed 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.461 -0.774 . . . . 0.0 109.702 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' C ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -140.08 155.68 46.92 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.156 -0.965 . . . . 0.0 111.197 -179.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.71 175.5 10.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.688 -0.633 . . . . 0.0 109.819 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -132.17 153.82 50.16 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -109.28 161.09 15.59 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.331 -0.856 . . . . 0.0 109.978 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -153.06 117.45 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.429 ' HB2' ' HD1' ' A' ' 67' ' ' HIS . 58.7 m -61.74 149.26 40.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.61 -46.03 48.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.775 -1.203 . . . . 0.0 109.581 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.16 -41.73 65.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.186 -1.571 . . . . 0.0 110.241 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.429 ' HD1' ' HB2' ' A' ' 64' ' ' SER . 35.4 m80 -65.75 -29.91 70.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.766 -1.209 . . . . 0.0 109.765 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.63 -36.39 76.27 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -59.17 -39.23 81.85 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 mt -60.17 -32.65 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.053 -1.029 . . . . 0.0 110.184 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.14 -44.37 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.242 -1.536 . . . . 0.0 110.51 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.61 62.09 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.024 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -64.37 -56.54 13.67 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.142 -0.974 . . . . 0.0 110.224 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -51.92 -49.69 62.57 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.622 -0.674 . . . . 0.0 109.331 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -67.6 -23.94 65.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.052 -1.03 . . . . 0.0 110.626 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.825 -1.083 . . . . 0.0 108.962 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.682 0.753 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.76 -40.13 94.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.671 -0.643 . . . . 0.0 111.022 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.447 ' OG1' ' OE2' ' A' ' 53' ' ' GLU . 41.7 m -59.94 -52.39 65.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.927 . . . . 0.0 110.642 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t -68.62 -41.27 79.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.702 -1.249 . . . . 0.0 111.744 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.77 -40.52 76.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.784 -1.197 . . . . 0.0 112.919 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.21 -50.09 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.486 -1.383 . . . . 0.0 111.254 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.455 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.3 mp -60.27 -49.34 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.097 -1.002 . . . . 0.0 110.162 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -60.39 -40.02 89.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.058 -1.027 . . . . 0.0 110.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.64 80.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.961 -1.087 . . . . 0.0 109.459 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 109.439 179.154 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.576 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.3 tttm . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.576 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 78.9 Cg_endo -95.54 130.25 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.748 2.299 . . . . 0.0 110.341 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.6 ttt -116.46 129.67 56.34 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.302 -0.874 . . . . 0.0 111.253 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -106.14 119.85 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 25' ' ' GLY . 26.2 p -100.82 98.86 9.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 0.0 109.057 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.721 ' H ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.08 -10.71 59.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.374 -0.828 . . . . 0.0 109.825 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.03 -41.73 87.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 108.493 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.48 1.29 4.53 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 60.04 82.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -145.28 137.69 25.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.359 -1.083 . . . . 0.0 109.472 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -84.56 128.97 34.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.92 77.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.714 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -71.94 109.99 6.14 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.68 20.36 0.54 Allowed Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.4 p -142.33 149.08 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -1.124 . . . . 0.0 108.372 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.86 85.32 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.67 0.748 . . . . 0.0 109.301 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 53.54 34.29 18.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.435 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 tp -85.67 137.07 33.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.541 -0.724 . . . . 0.0 109.069 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.71 66.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -121.42 -41.98 2.47 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 145.71 26.69 0.1 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -51.26 136.99 23.69 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.163 -1.198 . . . . 0.0 109.294 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 p -152.42 142.31 22.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.13 178.96 9.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.229 -1.544 . . . . 0.0 110.461 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -158.65 146.59 18.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -96.66 123.28 40.29 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.644 -1.285 . . . . 0.0 109.155 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.6 -4.26 22.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -121.87 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.72 -9.96 59.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.217 . . . . 0.0 109.591 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.6 m -120.13 134.59 55.21 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.4 mm -104.69 130.02 56.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.676 -0.64 . . . . 0.0 109.873 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.82 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.064 -1.022 . . . . 0.0 108.354 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.63 141.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.188 -0.945 . . . . 0.0 110.601 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -109.9 118.69 49.38 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -36.77 -76.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.916 1.744 . . . . 0.0 112.211 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -94.96 -50.75 4.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 0.0 108.562 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' OE2' ' OG1' ' A' ' 4' ' ' THR . 15.5 pt-20 -173.22 -161.0 0.13 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.533 -0.729 . . . . 0.0 109.057 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -166.26 115.39 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.034 -1.041 . . . . 0.0 108.935 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.53 ' C ' ' H ' ' A' ' 57' ' ' LEU . 11.8 p -117.09 40.26 3.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.226 -0.921 . . . . 0.0 109.705 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.99 -16.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.663 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.53 ' H ' ' C ' ' A' ' 55' ' ' THR . 4.6 mm? -90.0 -1.75 58.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -136.27 -159.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -144.59 159.99 41.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.971 -1.081 . . . . 0.0 111.339 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 175.74 5.12 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -132.52 124.84 29.26 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -93.07 110.94 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.452 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.4 tt -108.92 124.4 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.7 m -55.63 157.72 3.9 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.339 -0.85 . . . . 0.0 110.687 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.324 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.92 -41.37 61.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.551 -1.343 . . . . 0.0 108.748 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -63.04 -24.21 67.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -59.87 -38.79 83.18 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.07 -35.64 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.77 -39.86 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.859 -1.151 . . . . 0.0 108.888 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 71' ' ' ILE . 55.8 mt -56.45 -38.09 54.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.749 -1.22 . . . . 0.0 108.659 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -69.9 -38.13 76.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.91 -50.47 41.88 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.657 -1.277 . . . . 0.0 111.71 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -59.87 -47.37 86.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 111.457 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.549 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 5.3 mp -69.95 -44.3 69.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.922 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.98 -49.32 78.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 109.739 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.415 ' OG1' ' OE1' ' A' ' 53' ' ' GLU . 89.5 m -64.92 -53.69 42.55 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.298 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.5 p -61.65 -45.26 94.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.718 -1.239 . . . . 0.0 111.751 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.99 -40.97 74.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.914 -1.117 . . . . 0.0 112.65 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 80.8 t -68.6 -47.97 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.393 -1.442 . . . . 0.0 111.216 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.05 -49.16 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.877 -1.139 . . . . 0.0 110.437 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.97 -41.85 92.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.161 -0.962 . . . . 0.0 111.057 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.92 92.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.533 -1.354 . . . . 0.0 110.427 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.939 -179.416 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -95.46 113.31 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.659 2.239 . . . . 0.0 112.231 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.575 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.06 135.26 50.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.337 -0.852 . . . . 0.0 109.748 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.575 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.8 mm -106.22 129.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.754 . . . . 0.0 109.105 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 23' ' ' VAL . 79.5 p -113.58 100.24 8.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.521 -0.737 . . . . 0.0 109.629 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -1.4 3.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 21' ' ' SER . 95.1 t -60.03 -44.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -140.81 15.76 2.31 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.11 85.27 0.03 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 106.63 -2.588 . . . . 0.0 106.63 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -145.7 134.3 22.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.459 -1.024 . . . . 0.0 109.729 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.63 128.67 34.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mt -127.56 75.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.87 109.25 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 109.248 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.89 26.4 1.13 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.8 m -141.74 148.45 39.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 32' ' ' VAL . 22.8 m -127.15 106.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 23.5 m-85 42.06 34.78 0.49 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.83 134.78 34.18 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 109.682 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.39 16.02 23.8 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.582 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 23.5 p30 -131.7 -100.97 0.29 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.38 -1.07 . . . . 0.0 109.276 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -143.72 30.48 1.94 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -46.97 140.02 5.14 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.248 -1.148 . . . . 0.0 110.959 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 t -146.66 149.08 32.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.78 169.92 18.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.084 -1.635 . . . . 0.0 109.184 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -158.94 143.67 15.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -98.92 120.07 38.75 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.606 -1.309 . . . . 0.0 110.584 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 32.3 t0 -97.81 -7.29 30.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.284 -0.885 . . . . 0.0 109.621 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.14 64.47 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -163.03 -57.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.121 . . . . 0.0 108.639 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -118.09 121.49 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.48 135.12 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 t -98.63 103.92 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.84 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.42 -0.8 . . . . 0.0 110.304 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.518 ' HG ' ' C ' ' A' ' 53' ' ' GLU . 3.2 p -111.93 127.75 26.43 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.59 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.233 1.289 . . . . 0.0 111.455 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.73 -48.94 5.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 109.592 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' C ' ' HG ' ' A' ' 50' ' ' SER . 91.9 mt-10 -156.69 -169.98 3.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.122 -0.987 . . . . 0.0 109.882 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 15.6 tm-20 -155.62 96.72 1.79 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.589 ' O ' ' N ' ' A' ' 57' ' ' LEU . 1.7 p -131.49 147.75 52.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.373 -0.83 . . . . 0.0 108.816 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -28.61 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.1 mp -85.4 0.57 51.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.605 -1.31 . . . . 0.0 110.222 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.5 m-85 -136.87 -160.88 1.1 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 108.935 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -150.08 160.19 43.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 0.0 111.612 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.28 173.5 12.53 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -136.18 128.7 30.49 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.32 109.51 22.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.969 -1.082 . . . . 0.0 110.789 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.83 138.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 m -74.43 162.61 28.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.94 . . . . 0.0 108.852 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.05 83.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.883 -1.136 . . . . 0.0 109.44 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.0 -41.7 83.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.628 -1.295 . . . . 0.0 109.995 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -59.95 -32.61 70.96 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 108.633 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.91 -34.77 73.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.86 -37.67 77.04 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.03 -1.044 . . . . 0.0 108.38 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 70' ' ' ILE . 81.6 mt -59.97 -39.85 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.975 . . . . 0.0 109.364 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.474 ' CD1' ' N ' ' A' ' 71' ' ' ILE . 1.4 mp -59.92 -40.11 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 108.267 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.23 96.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 111.055 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.12 -40.0 95.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.672 -1.267 . . . . 0.0 109.489 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -66.7 -71.33 0.2 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.313 0.578 . . . . 0.0 111.883 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 6.4 mp -63.01 -44.55 95.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 111.466 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 120.752 -1.217 . . . . 0.0 109.371 -179.757 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.498 1.946 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.05 -49.92 75.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.304 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 5' ' ' SER . 6.4 t -63.59 -48.46 77.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.311 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.464 ' N ' ' CG2' ' A' ' 4' ' ' THR . 14.5 p -65.19 -43.21 92.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.76 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -40.81 74.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.058 . . . . 0.0 112.122 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.96 -43.82 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.852 -1.155 . . . . 0.0 110.836 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -59.43 -49.11 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.821 . . . . 0.0 109.452 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.09 -36.15 76.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.808 -1.183 . . . . 0.0 109.755 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.24 -20.02 64.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.973 -1.079 . . . . 0.0 110.593 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.9 m120 . . . . . 0 N--CA 1.5 2.025 0 O-C-N 120.772 -1.205 . . . . 0.0 110.715 -179.094 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.958 0 CA-C-O 121.278 0.561 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 38.0 Cg_endo -66.52 156.13 66.93 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.02 1.813 . . . . 0.0 108.668 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.484 ' SD ' ' OD2' ' A' ' 36' ' ' ASP . 35.3 ttp -138.16 125.6 21.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.78 -1.2 . . . . 0.0 110.996 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.439 HD12 HG22 ' A' ' 20' ' ' ILE . 90.3 mt -102.38 128.96 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.7 p -86.61 99.18 11.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.697 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -62.66 -14.44 43.54 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.86 -41.79 90.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -131.7 2.03 4.06 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 59.23 81.15 0.08 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -140.07 130.29 25.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.257 -1.143 . . . . 0.0 109.329 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 51.2 mp0 -77.44 134.91 38.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.289 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.471 ' C ' ' H ' ' A' ' 30' ' ' GLY . 34.5 mt -130.8 60.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -71.94 47.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.862 0.839 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -153.51 26.05 0.76 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 106.846 -2.502 . . . . 0.0 106.846 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m -145.81 150.43 36.17 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 34' ' ' LEU . 18.6 m -114.81 94.62 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' VAL . 26.0 m-85 36.38 25.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.294 0.569 . . . . 0.0 110.538 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 32' ' ' VAL . 4.2 tt -97.68 129.12 44.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 109.207 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.442 ' O ' ' OD1' ' A' ' 36' ' ' ASP . . . 118.01 25.77 2.93 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' SD ' ' A' ' 19' ' ' MET . 90.9 m-20 -143.76 -61.84 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.302 -1.116 . . . . 0.0 109.638 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -170.96 23.79 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -35.23 135.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.021 0.915 . . . . 0.0 112.503 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 t -146.94 135.31 21.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.96 169.31 23.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.822 -1.798 . . . . 0.0 110.064 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -160.5 138.69 9.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -101.59 126.27 48.38 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.686 -1.259 . . . . 0.0 111.176 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 59.2 t0 -95.49 -12.47 25.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.735 -0.603 . . . . 0.0 109.491 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 45' ' ' ALA . . . 94.87 105.05 1.95 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 44' ' ' GLY . . . 84.63 -10.71 0.84 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.984 -0.715 . . . . 0.0 109.773 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.9 m -158.01 114.4 2.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -91.9 140.81 15.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 111.247 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.12 120.05 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.25 146.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.609 -1.307 . . . . 0.0 110.347 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 18.9 t -109.72 120.06 46.04 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -38.05 -77.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 122.082 1.854 . . . . 0.0 113.55 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -85.01 -58.8 2.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.862 -1.148 . . . . 0.0 111.082 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' OG ' ' A' ' 50' ' ' SER . 40.5 mt-10 -161.25 -167.15 1.7 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.835 . . . . 0.0 109.616 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -167.43 113.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.525 ' C ' ' H ' ' A' ' 57' ' ' LEU . 1.4 p -127.87 45.12 2.8 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.36 -0.837 . . . . 0.0 110.198 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 71.8 -22.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' H ' ' C ' ' A' ' 55' ' ' THR . 11.3 mt -90.09 -7.15 54.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.045 -1.034 . . . . 0.0 108.929 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -128.79 -160.53 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -145.8 158.96 43.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.724 -1.235 . . . . 0.0 111.075 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.15 173.52 8.43 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -127.98 140.27 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -85.05 155.54 21.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.0 mt -151.89 112.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.482 ' H ' ' HD1' ' A' ' 67' ' ' HIS . 13.0 p -64.23 154.71 34.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.57 62.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.69 86.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.653 -1.279 . . . . 0.0 109.707 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.482 ' HD1' ' H ' ' A' ' 64' ' ' SER . 46.3 m170 -59.92 -39.16 84.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.108 -0.995 . . . . 0.0 109.331 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 1.8 tm? -59.01 -37.09 76.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.877 -1.14 . . . . 0.0 108.757 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -58.97 -35.01 72.45 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.87 -38.65 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 71' ' ' ILE . 1.5 mp -57.89 -40.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.63 -1.294 . . . . 0.0 108.796 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.0 96.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 110.904 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . 94.0 mttt -68.08 -44.47 76.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.874 -1.141 . . . . 0.0 110.501 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -59.74 -58.26 9.36 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 112.12 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 4.5 mp -68.01 -39.9 83.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.595 -1.316 . . . . 0.0 110.234 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.034 -1.041 . . . . 0.0 109.951 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.95 -49.41 77.78 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 m -65.64 -49.09 69.92 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.956 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -72.36 -57.3 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 112.538 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 2' ' ' THR . 69.9 mm-40 -65.03 -44.33 89.49 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.569 -1.332 . . . . 0.0 113.129 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.0 -45.32 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.526 -1.359 . . . . 0.0 111.107 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.1 -39.4 80.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.001 -1.062 . . . . 0.0 109.144 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.81 -44.0 94.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.802 -1.186 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.69 74.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.886 -1.133 . . . . 0.0 109.986 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.632 HD22 ' CG1' ' A' ' 20' ' ' ILE . 23.5 m120 . . . . . 0 N--CA 1.5 2.063 0 O-C-N 121.135 -0.978 . . . . 0.0 109.567 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.652 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 7.8 mtpt . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 120.469 0.176 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.652 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 63.0 Cg_endo -101.14 130.18 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.151 2.568 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.7 ttp -112.2 143.26 43.56 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.632 ' CG1' HD22 ' A' ' 11' ' ' ASN . 4.5 mm -103.4 129.58 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.299 -0.876 . . . . 0.0 108.989 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 23' ' ' VAL . 11.1 m -100.56 98.49 9.07 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -3.04 6.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 21' ' ' SER . 74.6 t -60.05 -44.27 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.8 t0 -125.01 -5.82 7.34 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.8 11.24 85.61 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -75.88 140.05 41.98 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.651 -0.911 . . . . 0.0 110.399 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.03 133.48 33.58 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.7 mt -123.45 73.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.223 -0.923 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -65.93 109.23 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.528 -1.357 . . . . 0.0 108.834 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.9 23.67 0.85 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 17' ' ' LYS . 87.8 m -133.26 137.26 45.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 34' ' ' LEU . 9.8 m -120.1 102.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.432 -0.792 . . . . 0.0 110.022 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.433 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m-85 41.65 17.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.868 -0.52 . . . . 0.0 109.94 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 32' ' ' VAL . 43.7 tp -93.9 134.56 36.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.673 -1.267 . . . . 0.0 109.68 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.82 17.01 10.74 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 17.5 p-10 -139.37 -69.96 0.41 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -1.119 . . . . 0.0 110.121 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.542 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 173.1 32.08 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -51.54 155.65 1.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.434 -1.039 . . . . 0.0 110.324 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 t -153.39 131.97 12.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.86 177.32 10.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.339 -1.476 . . . . 0.0 109.57 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -159.7 160.05 33.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -99.48 114.76 27.91 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.88 -1.137 . . . . 0.0 109.649 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 38.4 t0 -96.74 -7.7 33.21 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.783 -1.198 . . . . 0.0 109.685 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.97 -113.56 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.84 -5.22 58.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -1.23 . . . . 0.0 109.273 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 m -122.91 132.85 54.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.335 -0.853 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.1 mm -96.36 142.61 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.586 -0.696 . . . . 0.0 110.838 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -109.26 120.01 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.8 mt -131.73 144.16 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.583 -0.698 . . . . 0.0 110.518 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' PRO . 74.1 m -118.29 120.84 31.78 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' SER . 53.9 Cg_exo -33.34 -87.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.137 1.891 . . . . 0.0 111.961 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -99.9 -36.59 9.35 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -165.73 -163.21 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.708 0.766 . . . . 0.0 109.965 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -174.28 117.26 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 57' ' ' LEU . 20.9 p -128.98 40.43 3.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 74.46 -26.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 55' ' ' THR . 8.8 mp -90.02 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.362 -0.836 . . . . 0.0 108.828 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.27 -157.19 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -140.46 158.36 44.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.001 -1.062 . . . . 0.0 111.075 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.04 173.77 9.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -138.99 120.03 14.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -84.76 171.32 12.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.69 118.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -60.18 153.89 21.0 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.694 -1.254 . . . . 0.0 108.13 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.95 -44.32 70.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.784 -1.197 . . . . 0.0 108.245 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.59 -44.05 69.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.041 -1.662 . . . . 0.0 109.309 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.88 -27.14 68.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.687 -1.258 . . . . 0.0 108.96 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -59.91 -32.88 71.17 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.92 -39.77 86.59 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.7 mt -58.28 -34.83 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.988 -1.07 . . . . 0.0 109.998 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.02 -40.16 82.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.23 -1.544 . . . . 0.0 109.675 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -75.39 -28.81 59.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' LEU . 1.6 tmtp? -69.77 -55.11 10.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -58.06 -50.06 74.74 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.857 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 4.6 mp -68.11 -39.85 82.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.355 -1.466 . . . . 0.0 109.744 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 73' ' ' LYS . 1.5 pp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.138 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.507 2.383 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 tp -59.83 -42.99 94.76 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -78.59 -50.01 12.26 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.857 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -65.72 -52.05 54.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.909 -1.119 . . . . 0.0 111.74 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.01 -47.12 63.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 112.836 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.81 -39.93 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.504 -1.372 . . . . 0.0 111.367 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.62 -45.47 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 108.372 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -59.05 -40.06 83.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.604 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 11' ' ' ASN . . . -59.97 -42.04 93.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.975 -1.078 . . . . 0.0 110.35 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 10' ' ' ALA . 89.7 m-20 . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.94 . . . . 0.0 110.068 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.596 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 32.2 ttpt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 119.783 -0.151 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.596 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 98.2 Cg_endo -96.98 108.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 122.432 2.088 . . . . 0.0 113.836 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.439 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -122.74 131.63 53.87 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.574 -0.704 . . . . 0.0 109.101 178.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.19 131.89 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 110.154 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 23' ' ' VAL . 35.4 m -95.76 101.96 13.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.43 0.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.587 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' A' ' 21' ' ' SER . 71.3 t -60.03 -45.43 95.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.911 -1.118 . . . . 0.0 108.272 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -138.47 10.34 2.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.72 89.12 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -146.08 137.84 24.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.107 -1.231 . . . . 0.0 109.81 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.39 129.8 35.32 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.553 ' C ' ' H ' ' A' ' 30' ' ' GLY . 53.6 mt -124.96 77.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.387 -0.821 . . . . 0.0 110.365 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -69.1 40.63 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 109.754 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -151.15 24.03 0.99 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.079 -2.409 . . . . 0.0 107.079 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 m -146.99 150.3 34.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 122.001 -0.705 . . . . 0.0 109.746 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 34' ' ' LEU . 35.5 m -134.67 104.71 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 41.0 p90 39.93 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.86 -0.525 . . . . 0.0 110.865 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.569 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 tt -103.33 118.45 36.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.127 -0.983 . . . . 0.0 108.484 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 36' ' ' ASP . . . 134.03 28.86 0.48 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 70.4 m-20 -155.74 -50.08 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.546 -0.973 . . . . 0.0 109.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 176.16 31.83 0.04 OUTLIER Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.4 ' C ' ' O ' ' A' ' 37' ' ' GLY . 55.4 p-90 -43.4 144.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.2 m -149.16 134.07 17.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.01 170.59 7.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.24 -1.538 . . . . 0.0 109.546 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -151.41 148.27 27.89 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -95.13 134.62 37.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.551 -1.343 . . . . 0.0 109.432 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -109.66 -8.51 14.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.476 -0.765 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 45' ' ' ALA . . . 89.86 103.9 1.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 44' ' ' GLY . . . 86.46 0.57 0.59 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.094 -0.651 . . . . 0.0 110.163 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 45' ' ' ALA . 72.2 m -171.59 116.33 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 108.365 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -91.17 136.28 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.097 -1.002 . . . . 0.0 110.395 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.02 120.7 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.3 147.8 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.651 -1.281 . . . . 0.0 111.559 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.2 m -119.49 147.13 42.8 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.51 -84.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.631 1.554 . . . . 0.0 111.941 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -94.34 -39.44 10.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.011 -1.056 . . . . 0.0 109.921 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -159.4 -164.04 1.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 108.787 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -165.82 100.1 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 110.354 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 57' ' ' LEU . 23.6 p -130.27 151.15 51.1 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.88 -29.15 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.9 mp -84.17 1.29 45.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.701 -1.25 . . . . 0.0 110.041 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.7 m-85 -136.96 -161.03 1.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -151.18 169.29 22.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.839 -1.163 . . . . 0.0 111.58 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.92 175.58 6.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.43 0.633 . . . . 0.0 109.328 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -137.8 134.52 35.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -96.56 108.86 21.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.932 -1.105 . . . . 0.0 111.694 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.5 mt -89.84 131.41 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.636 ' HG ' ' H ' ' A' ' 67' ' ' HIS . 67.1 p -72.63 159.32 34.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.998 -1.064 . . . . 0.0 108.357 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 -50.13 74.99 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.947 -1.095 . . . . 0.0 108.874 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.98 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.301 -1.499 . . . . 0.0 108.55 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.636 ' H ' ' HG ' ' A' ' 64' ' ' SER . 22.7 m170 -60.07 -33.69 72.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.967 -1.083 . . . . 0.0 108.988 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.03 -36.86 78.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.114 -0.991 . . . . 0.0 108.443 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -58.99 -37.38 76.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.85 -39.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 109.348 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.89 -40.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.049 -1.032 . . . . 0.0 109.488 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -64.31 -40.0 95.05 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.659 -1.275 . . . . 0.0 109.74 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -59.9 -44.66 94.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.267 -1.52 . . . . 0.0 109.169 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.28 -71.86 0.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 111.84 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.7 mp -61.9 -41.68 98.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.02 -1.05 . . . . 0.0 111.93 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ALA . 39.1 tp . . . . . 0 N--CA 1.502 2.135 0 O-C-N 120.913 -1.117 . . . . 0.0 109.434 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -60.54 -50.11 74.85 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.054 0.93 . . . . 0.0 108.67 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.8 m -61.02 -52.25 65.79 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.404 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.3 t -67.08 -43.35 82.8 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.853 -1.155 . . . . 0.0 111.786 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -69.73 -40.33 76.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 112.633 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -74.73 -43.08 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.352 -1.468 . . . . 0.0 111.81 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.99 -52.63 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.864 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -63.61 -38.71 92.15 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.865 -1.147 . . . . 0.0 110.502 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.5 91.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.301 -0.874 . . . . 0.0 111.407 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.0 p30 . . . . . 0 N--CA 1.499 1.991 0 O-C-N 120.53 -1.356 . . . . 0.0 111.287 -178.246 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.583 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.583 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 27.3 Cg_endo -101.25 132.24 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.934 2.423 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.535 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 25.5 ttt -125.9 127.76 46.51 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.07 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.8 mt -109.31 133.58 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.825 0.822 . . . . 0.0 109.829 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.4 p -93.81 101.41 13.51 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.539 -0.726 . . . . 0.0 109.243 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.689 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.88 -10.89 23.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.76 -1.213 . . . . 0.0 109.676 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.32 -40.25 83.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 108.641 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -137.16 5.18 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 57.23 88.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -143.68 137.35 28.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.46 -1.024 . . . . 0.0 108.772 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.23 128.61 33.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.22 74.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.346 -0.846 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -70.32 108.34 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.334 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.74 24.55 0.66 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p -143.64 148.43 35.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 34' ' ' LEU . 36.0 m -128.72 110.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.5 m-85 42.58 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.635 -0.665 . . . . 0.0 109.539 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 32' ' ' VAL . 49.0 tp -91.22 133.36 35.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.448 -0.783 . . . . 0.0 109.828 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.88 19.37 13.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.429 -1.869 . . . . 0.0 108.429 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -143.36 -65.05 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.063 . . . . 0.0 109.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 173.12 66.65 0.05 OUTLIER Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -74.33 154.15 39.01 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.286 -1.126 . . . . 0.0 109.633 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -156.36 150.13 24.91 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.89 170.68 15.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.764 -1.21 . . . . 0.0 109.831 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -165.62 109.06 0.82 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -89.95 126.27 35.67 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.546 -1.347 . . . . 0.0 110.364 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -109.2 0.73 19.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.594 -0.691 . . . . 0.0 110.724 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.06 -117.35 0.96 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.41 -8.6 57.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.312 . . . . 0.0 109.657 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.7 m -120.11 128.26 53.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.332 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -93.2 140.63 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.942 0.877 . . . . 0.0 111.315 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 t -109.37 120.13 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 50' ' ' SER . 56.2 mt -121.48 169.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.389 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.481 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 54.8 m -142.33 99.53 5.87 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 50' ' ' SER . 9.3 Cg_exo -32.25 -79.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.307 2.004 . . . . 0.0 112.156 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -103.0 -41.57 6.08 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -155.55 -165.49 2.0 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -171.95 104.8 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.586 -0.696 . . . . 0.0 109.67 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 58' ' ' PHE . 19.2 p -129.65 148.48 51.54 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -33.15 -25.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.139 -0.35 . . . . 0.0 111.655 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 2.4 mt -81.47 2.09 30.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.634 -1.291 . . . . 0.0 109.187 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 55' ' ' THR . 55.0 m-85 -139.73 -160.7 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 156.07 41.95 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.747 -1.221 . . . . 0.0 110.882 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.25 177.29 9.06 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 109.309 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -126.78 131.37 51.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -88.24 170.09 11.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.587 -1.32 . . . . 0.0 110.277 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -164.95 122.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.7 m -59.5 153.18 20.08 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.381 -1.449 . . . . 0.0 108.324 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.8 -48.63 66.75 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.811 -1.181 . . . . 0.0 109.058 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.94 84.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.347 -1.47 . . . . 0.0 108.775 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -59.78 -27.32 66.46 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.72 -1.192 . . . . 0.0 107.847 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.92 -31.32 69.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.445 -1.409 . . . . 0.0 107.641 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.34 -38.43 83.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.808 -1.183 . . . . 0.0 108.71 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.13 -38.88 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.016 -1.053 . . . . 0.0 109.236 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.62 -40.5 86.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.391 -0.818 . . . . 0.0 110.629 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.06 35.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 111.437 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.45 -37.74 81.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.085 -1.634 . . . . 0.0 111.069 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -62.96 -64.72 0.83 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.113 -0.992 . . . . 0.0 111.685 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 5.9 mp -67.83 -47.1 69.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.101 -0.999 . . . . 0.0 110.821 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.597 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 121.646 0.736 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.02 -41.59 92.51 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.447 ' CG2' ' N ' ' A' ' 5' ' ' SER . 6.5 t -79.66 -44.23 21.3 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.897 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.447 ' N ' ' CG2' ' A' ' 4' ' ' THR . 17.6 t -60.31 -53.68 54.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.034 . . . . 0.0 111.307 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.08 -43.16 71.71 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.098 -1.001 . . . . 0.0 112.545 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.99 -43.42 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.698 -1.251 . . . . 0.0 111.67 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.85 -52.24 63.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.773 -1.204 . . . . 0.0 109.201 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.18 -39.99 73.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 110.359 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.04 -47.36 85.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.685 -1.259 . . . . 0.0 109.694 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 . . . . . 0 N--CA 1.496 1.833 0 O-C-N 120.918 -1.113 . . . . 0.0 109.212 -179.861 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.715 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 67.3 mttt . . . . . 0 N--CA 1.5 2.032 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.715 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 66.9 Cg_endo -98.16 140.27 0.47 Allowed 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 122.272 1.981 . . . . 0.0 113.296 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 4.6 ttt -121.32 138.4 54.27 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 20' ' ' ILE . 87.9 mt -107.29 131.78 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.446 -0.784 . . . . 0.0 109.51 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.9 t -93.54 100.32 12.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -10.05 38.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.43 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.76 -40.69 83.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -132.22 -2.79 3.52 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 64.65 85.61 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -143.07 136.29 28.19 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.233 -1.157 . . . . 0.0 110.08 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 58.3 mp0 -82.6 124.63 30.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.1 mt -123.0 73.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.337 -0.852 . . . . 0.0 110.151 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.73 116.78 3.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.204 -0.935 . . . . 0.0 110.261 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.93 26.25 1.74 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.515 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.8 p -135.91 140.25 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.774 -0.839 . . . . 0.0 109.387 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 27.0 m -122.98 98.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 12.8 p90 40.1 26.57 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -96.22 135.24 38.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.661 -0.65 . . . . 0.0 110.692 -178.251 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.44 36.26 1.21 Allowed Glycine 0 N--CA 1.501 2.998 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.37 -85.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.185 . . . . 0.0 110.265 -178.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -147.37 26.28 1.54 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -44.54 148.13 0.52 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.378 -1.072 . . . . 0.0 110.471 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.0 m -148.24 146.95 28.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.07 165.35 27.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.239 -1.538 . . . . 0.0 109.543 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -154.16 130.88 10.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -101.69 125.56 48.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.227 -1.546 . . . . 0.0 110.057 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -99.39 -0.87 40.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 0.0 108.967 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.41 16.39 66.64 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.326 -0.94 . . . . 0.0 110.914 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -161.7 -57.08 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.3 m -122.32 131.73 54.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -92.68 132.91 35.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.292 -0.88 . . . . 0.0 111.137 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.95 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.4 mt -128.19 155.41 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.432 -0.792 . . . . 0.0 109.794 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.8 m -124.97 120.57 25.46 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 22.4 Cg_exo -33.5 -85.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.096 1.864 . . . . 0.0 111.157 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -105.07 -36.97 7.11 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 73.7 mt-10 -164.52 -163.28 0.72 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -169.14 114.78 0.58 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.566 ' C ' ' H ' ' A' ' 57' ' ' LEU . 7.4 p -127.67 41.98 3.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.083 -1.01 . . . . 0.0 109.492 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 70.65 -29.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.566 ' H ' ' C ' ' A' ' 55' ' ' THR . 7.2 mt -82.59 -4.87 58.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.3 -0.875 . . . . 0.0 108.726 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.73 -151.23 0.47 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -150.85 161.89 41.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.799 -1.188 . . . . 0.0 111.329 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.89 173.13 11.48 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' NZ ' ' CE2' ' A' ' 33' ' ' TYR . 36.5 ttpt -134.02 157.9 44.92 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.48 171.18 8.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -165.87 126.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.727 ' HG ' ' H ' ' A' ' 67' ' ' HIS . 59.5 p -57.97 150.11 21.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.225 -1.547 . . . . 0.0 107.033 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.38 -44.9 68.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.746 -1.221 . . . . 0.0 109.131 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.4 -42.52 96.13 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.656 -1.277 . . . . 0.0 109.677 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.727 ' H ' ' HG ' ' A' ' 64' ' ' SER . 12.9 m-70 -54.77 -27.01 38.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.548 -1.345 . . . . 0.0 107.798 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -30.16 68.25 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 107.799 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.57 -33.17 75.07 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.982 -1.074 . . . . 0.0 109.057 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.8 tt -59.92 -32.08 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.675 -1.266 . . . . 0.0 108.886 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.7 -41.16 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.93 75.93 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.948 -1.095 . . . . 0.0 110.846 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -59.85 -50.2 74.74 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.046 -1.034 . . . . 0.0 109.445 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -68.25 -71.33 0.22 Allowed 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 111.309 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 6.6 mp -61.18 -47.92 83.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.506 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 N--CA 1.505 2.308 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.293 179.812 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 tp -60.15 -41.86 93.67 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.2 m -69.05 -51.44 38.91 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.667 -0.646 . . . . 0.0 110.657 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.0 m -69.59 -48.31 60.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.267 -1.52 . . . . 0.0 112.72 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.97 -44.5 72.8 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.595 -1.315 . . . . 0.0 113.115 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.24 -46.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.694 -1.254 . . . . 0.0 111.57 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.537 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -61.0 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 121.146 -0.971 . . . . 0.0 109.1 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.62 -39.49 80.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.77 -40.51 69.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.043 -1.036 . . . . 0.0 109.399 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.597 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.585 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 5.6 tttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.585 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 86.3 Cg_endo -101.74 118.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 123.436 2.757 . . . . 0.0 112.068 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.6 ttt -121.65 130.44 53.47 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.205 -0.934 . . . . 0.0 109.741 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.4 mt -108.37 130.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.3 t -94.38 99.7 11.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 108.931 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -59.72 -12.57 7.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.6 -41.33 84.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -117.33 -16.11 10.32 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.67 8.72 87.56 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -78.98 158.03 28.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -1.033 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -94.91 128.72 41.9 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.95 78.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.539 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.5 101.46 3.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.861 -1.15 . . . . 0.0 108.977 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.4 24.47 0.3 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -141.61 147.09 37.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -1.022 . . . . 0.0 108.41 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 34' ' ' LEU . 33.0 m -129.38 108.75 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 44.37 23.31 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.379 -0.826 . . . . 0.0 109.305 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' VAL . 29.2 tp -90.39 145.05 25.25 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.472 0.653 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.48 17.22 59.02 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -134.35 -48.06 0.77 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.508 -0.995 . . . . 0.0 110.127 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.81 37.39 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -51.36 139.73 18.74 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.133 -1.216 . . . . 0.0 109.92 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -146.52 137.69 24.32 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.58 166.82 13.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.116 -1.615 . . . . 0.0 108.982 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -141.34 154.51 45.72 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -103.11 134.84 45.87 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.73 -1.231 . . . . 0.0 109.514 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -104.77 -5.52 21.17 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.448 -0.782 . . . . 0.0 110.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.4 56.9 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -169.17 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -1.113 . . . . 0.0 109.409 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.9 m -143.62 119.0 10.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 mm -76.91 138.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.848 -1.157 . . . . 0.0 110.878 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.19 117.12 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 53.7 mt -127.73 139.53 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.357 -0.84 . . . . 0.0 111.735 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.414 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 75.1 m -120.08 121.96 29.23 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' SER . 49.6 Cg_exo -36.21 -78.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 121.886 1.724 . . . . 0.0 111.845 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.15 -40.9 5.71 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.194 -0.941 . . . . 0.0 110.073 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.59 -162.83 0.41 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.144 -0.973 . . . . 0.0 111.296 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' OE2' ' OG ' ' A' ' 50' ' ' SER . 80.7 mt-10 -152.09 104.63 2.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.896 -0.503 . . . . 0.0 111.198 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -107.67 114.34 28.25 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.626 -1.296 . . . . 0.0 109.222 178.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.66 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.884 0.85 . . . . 0.0 110.05 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -64.62 43.39 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 111.025 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 56' ' ' ALA . 55.4 p90 -93.41 -178.17 4.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.38 1.086 . . . . 0.0 111.698 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -137.51 119.75 15.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.895 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.27 177.26 8.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.098 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -131.2 127.27 37.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -101.09 108.04 19.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.935 -1.103 . . . . 0.0 110.966 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.03 140.68 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -69.89 157.98 36.4 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.383 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.36 83.8 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.049 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.81 85.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.44 -1.413 . . . . 0.0 110.516 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -59.5 -24.12 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.85 -39.14 84.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -55.75 -32.55 63.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 70' ' ' ILE . 71.8 mt -60.0 -41.26 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.692 -1.255 . . . . 0.0 108.392 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 71' ' ' ILE . 1.6 mp -64.28 -40.31 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.79 93.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 111.236 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -37.72 58.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.453 -1.405 . . . . 0.0 111.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.86 -49.68 60.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.161 -0.962 . . . . 0.0 112.0 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 9.0 mp -80.33 -55.62 4.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.639 -1.288 . . . . 0.0 110.929 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--N 1.298 -1.67 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.777 -179.325 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.07 -47.74 84.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 m -61.02 -50.04 74.96 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.054 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m -75.0 -54.21 7.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.865 -1.147 . . . . 0.0 112.907 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 2' ' ' THR . 61.7 mm-40 -64.77 -41.21 96.03 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.624 -1.298 . . . . 0.0 112.928 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.562 ' CG1' ' CH2' ' A' ' 38' ' ' TRP . 94.0 t -69.91 -47.79 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.341 -1.474 . . . . 0.0 111.373 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.2 mp -61.71 -42.91 96.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.283 -0.886 . . . . 0.0 110.626 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -65.78 -41.4 92.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.653 -1.279 . . . . 0.0 109.782 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.11 -22.43 66.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.055 -1.028 . . . . 0.0 109.329 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.573 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 7.5 tttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.573 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 80.5 Cg_endo -99.88 115.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 123.328 2.685 . . . . 0.0 111.714 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -111.46 141.88 44.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.378 -0.826 . . . . 0.0 109.696 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.602 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.5 mm -110.61 133.19 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 25' ' ' GLY . 20.3 m -105.92 100.48 10.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.449 -0.782 . . . . 0.0 109.067 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.433 HD11 ' H ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.84 -15.99 63.65 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.07 -46.5 94.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -124.9 2.21 8.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.627 -0.671 . . . . 0.0 109.228 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 56.47 78.99 0.1 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.33 135.4 28.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.267 -1.137 . . . . 0.0 109.283 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.45 126.81 32.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 0.0 108.637 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.458 HG21 ' H ' ' A' ' 30' ' ' GLY . 55.3 mt -113.02 162.6 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -147.7 36.19 0.87 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' H ' HG21 ' A' ' 28' ' ' ILE . . . -155.42 30.03 0.63 Allowed Glycine 0 C--N 1.293 -1.818 0 N-CA-C 106.289 -2.724 . . . . 0.0 106.289 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.437 ' OG1' ' CG2' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -133.41 138.09 46.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.524 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -131.87 102.65 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER 44.62 54.66 6.37 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.67 117.91 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.868 -1.145 . . . . 0.0 109.498 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.472 ' N ' ' CD1' ' A' ' 38' ' ' TRP . . . 142.21 22.18 0.23 Allowed Glycine 0 N--CA 1.501 3.016 0 O-C-N 120.995 -1.066 . . . . 0.0 110.887 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.682 ' N ' ' HE1' ' A' ' 38' ' ' TRP . 65.0 m-20 -157.81 -85.86 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.785 -1.421 . . . . 0.0 110.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -142.21 22.08 2.43 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.682 ' HE1' ' N ' ' A' ' 36' ' ' ASP . 2.3 m95 -57.6 147.59 26.7 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.586 0.707 . . . . 0.0 110.633 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 t -156.35 154.1 30.04 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.53 166.68 24.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.597 -1.315 . . . . 0.0 109.049 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -144.91 155.04 43.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -100.64 133.05 45.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.706 -1.246 . . . . 0.0 108.694 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.08 -11.86 15.54 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.418 -0.802 . . . . 0.0 109.98 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 45' ' ' ALA . . . 95.89 107.35 2.27 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 44' ' ' GLY . . . 80.3 -4.24 1.87 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.787 -0.831 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.2 m -166.16 120.59 1.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 mm -95.69 137.87 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.8 t -109.38 123.29 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.156 -0.965 . . . . 0.0 110.801 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.679 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -106.12 120.8 47.65 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 177.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.679 ' O ' ' O ' ' A' ' 50' ' ' SER . 31.1 Cg_exo -36.9 -112.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.144 1.896 . . . . 0.0 111.184 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -76.89 -31.61 56.86 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -171.79 -161.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.008 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -156.4 110.33 2.73 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.763 -0.585 . . . . 0.0 109.513 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.532 ' O ' ' C ' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -111.1 116.3 30.89 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.816 -1.177 . . . . 0.0 109.38 179.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.532 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 26.2 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.966 0.888 . . . . 0.0 110.497 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.2 43.61 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.871 -0.518 . . . . 0.0 111.247 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.445 ' HB3' ' N ' ' A' ' 55' ' ' THR . 47.2 p90 -92.34 178.7 5.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.839 -1.163 . . . . 0.0 111.467 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 102.92 6.81 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 173.39 3.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 109.795 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -144.21 131.31 20.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -111.49 117.23 32.44 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.201 -0.937 . . . . 0.0 111.081 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.25 138.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -73.16 160.0 32.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.726 -1.233 . . . . 0.0 108.601 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.78 91.69 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.809 -1.182 . . . . 0.0 110.0 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.88 92.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.8 -1.188 . . . . 0.0 109.361 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -60.33 -25.21 65.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.35 -40.23 77.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -58.16 -28.63 64.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 109.227 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 70' ' ' ILE . 72.2 mt -60.06 -39.86 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.703 -1.248 . . . . 0.0 108.556 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.423 HG23 HD13 ' A' ' 71' ' ' ILE . 82.5 mt -59.93 -39.94 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 108.997 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.53 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.986 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -60.0 -46.57 89.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.724 -1.235 . . . . 0.0 109.227 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -68.38 -74.22 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.866 -0.521 . . . . 0.0 111.166 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 2.8 mp -61.21 -46.59 89.8 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.705 -1.247 . . . . 0.0 111.226 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.014 -1.054 . . . . 0.0 109.127 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.503 2.208 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.17 -50.15 74.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.0 m -61.42 -49.55 76.4 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.434 ' HG ' ' H ' ' A' ' 6' ' ' GLU . 87.8 p -70.39 -48.04 58.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.911 -1.118 . . . . 0.0 112.384 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.434 ' H ' ' HG ' ' A' ' 5' ' ' SER . 69.8 mm-40 -69.6 -42.25 74.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 112.617 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.76 -45.77 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.558 -1.338 . . . . 0.0 110.576 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mp -60.42 -45.31 96.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.414 ' HZ1' ' CB ' ' A' ' 9' ' ' LYS . 10.0 mtpm? -60.64 -40.49 92.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.641 -1.287 . . . . 0.0 111.441 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -27.93 67.77 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.569 -1.332 . . . . 0.0 109.425 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.633 ' ND2' ' CZ ' ' A' ' 33' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.026 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.759 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.759 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 90.3 Cg_endo -88.8 110.21 0.54 Allowed 'Trans proline' 0 N--CA 1.485 1.02 0 CA-C-N 121.251 1.483 . . . . 0.0 112.203 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.9 ttt -102.74 147.29 27.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.718 -0.614 . . . . 0.0 109.708 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.88 120.99 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.616 -0.678 . . . . 0.0 109.546 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 p -98.24 96.23 7.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.516 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.46 -17.84 64.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.2 t -59.68 -42.87 89.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -128.76 2.82 5.43 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.24 79.66 0.08 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.9 138.53 28.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.29 -1.123 . . . . 0.0 109.759 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 4.1 tm-20 -81.31 120.93 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.95 67.99 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 109.71 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 46.0 pttt -60.24 102.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.442 1.115 . . . . 0.0 110.308 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.627 ' C ' HD22 ' A' ' 74' ' ' ASN . . . 136.45 25.49 0.46 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 98.7 m -138.48 140.96 39.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.507 -0.996 . . . . 0.0 108.5 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -118.55 80.5 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.459 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CZ ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER 42.37 25.6 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' VAL . 54.9 tp -85.12 129.87 34.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.872 . . . . 0.0 109.79 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 36' ' ' ASP . . . 124.83 -75.24 0.4 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' GLY . 78.4 m-20 -31.59 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.866 -0.785 . . . . 0.0 111.498 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . -134.87 16.44 4.24 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.47 ' C ' ' O ' ' A' ' 37' ' ' GLY . 3.7 t90 -26.34 138.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.969 0.414 . . . . 0.0 111.793 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -159.46 144.51 15.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.852 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.05 168.59 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.525 -1.359 . . . . 0.0 109.195 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -153.73 159.54 42.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -104.97 120.97 42.77 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.026 -1.046 . . . . 0.0 110.409 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -100.9 -2.81 31.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.12 -0.988 . . . . 0.0 110.71 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.5 -114.56 1.24 Allowed Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.44 -9.8 59.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -1.027 . . . . 0.0 110.546 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.9 m -129.15 140.12 51.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.3 mm -108.09 139.85 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 110.104 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.2 120.28 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.557 -0.715 . . . . 0.0 109.278 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.66 141.29 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.817 -1.177 . . . . 0.0 110.802 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 51' ' ' PRO . 95.0 p -111.77 127.09 27.37 Favored Pre-proline 0 N--CA 1.482 1.129 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 50' ' ' SER . 52.6 Cg_exo -34.83 -81.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.961 1.774 . . . . 0.0 112.619 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -106.03 -41.64 5.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 79.3 mt-10 -158.62 -165.42 1.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.066 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -172.25 113.27 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 57' ' ' LEU . 19.0 p -126.94 38.46 4.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.293 -0.879 . . . . 0.0 110.415 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 73.85 -24.92 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.93 -1.106 . . . . 0.0 109.57 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 55' ' ' THR . 6.4 mt -87.8 -3.29 58.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -132.47 -156.47 0.75 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -150.74 158.57 44.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.449 -1.407 . . . . 0.0 111.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.23 174.46 8.74 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.19 128.25 33.63 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -81.55 167.05 19.7 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.98 -1.075 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.2 tt -169.69 118.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.699 ' HG ' ' HD1' ' A' ' 67' ' ' HIS . 60.1 p -58.54 151.19 20.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 110.913 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -53.81 -41.44 67.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.98 94.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.5 -1.375 . . . . 0.0 109.267 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.699 ' HD1' ' HG ' ' A' ' 64' ' ' SER . 18.6 m80 -61.52 -25.1 67.06 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.404 ' CB ' ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -57.04 -28.45 62.55 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.34 -34.64 74.91 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.875 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.6 tt -59.56 -36.51 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.479 -1.289 . . . . 0.0 108.427 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.1 mt -60.32 -45.19 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.87 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.82 67.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.055 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -62.26 -39.33 92.53 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.478 -1.389 . . . . 0.0 108.663 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.627 HD22 ' C ' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -69.59 -68.14 0.43 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.697 -0.627 . . . . 0.0 110.761 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.1 -51.2 70.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 0.0 111.221 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.3 -1.58 0 O-C-N 120.799 -1.188 . . . . 0.0 109.219 -179.334 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.5 tp -59.92 -48.88 79.9 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.9 m -64.01 -51.82 62.45 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.329 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 t -70.95 -52.39 20.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.801 -1.187 . . . . 0.0 111.489 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 2' ' ' THR . 36.4 tp10 -61.01 -46.09 92.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.972 -1.08 . . . . 0.0 112.665 -177.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.431 ' O ' ' OD1' ' A' ' 11' ' ' ASN . 64.3 t -67.91 -49.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 112.078 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.01 -45.63 95.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 110.693 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.99 -40.11 88.03 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.981 -1.074 . . . . 0.0 110.931 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -19.93 65.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.83 -1.169 . . . . 0.0 111.769 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.549 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.507 2.404 0 O-C-N 120.996 -1.065 . . . . 0.0 111.263 -178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 72.0 Cg_endo -90.57 128.6 1.42 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.31 2.007 . . . . 0.0 111.675 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -123.02 128.7 50.53 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.463 ' N ' ' SD ' ' A' ' 19' ' ' MET . 87.1 mt -110.49 130.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.067 -1.021 . . . . 0.0 109.465 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' GLY . 67.6 m -88.72 99.78 12.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.721 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -61.95 -13.05 21.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.35 -0.844 . . . . 0.0 109.151 -179.23 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.11 -47.64 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 108.604 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 52.7 t0 -123.42 7.56 9.0 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.93 84.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -142.39 135.5 28.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.476 -1.014 . . . . 0.0 109.936 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -77.13 121.08 23.09 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.8 mt -119.99 69.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -61.64 106.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.989 -1.069 . . . . 0.0 108.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.08 18.75 0.93 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.642 ' N ' HD22 ' A' ' 74' ' ' ASN . 0.5 OUTLIER -141.66 146.8 36.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -1.046 . . . . 0.0 108.437 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -131.23 111.46 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 44.63 21.63 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 0.0 109.224 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' VAL . 34.5 tp -85.82 149.34 25.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.83 79.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.47 -63.37 1.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.618 -0.93 . . . . 0.0 109.355 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.69 39.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -59.74 155.38 16.06 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.499 -1.0 . . . . 0.0 110.507 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -146.43 149.68 34.18 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.93 169.39 17.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.238 -1.539 . . . . 0.0 109.782 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -159.95 136.2 8.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -109.03 122.85 48.13 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.657 -1.277 . . . . 0.0 111.469 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 10.7 t70 -96.69 -6.84 35.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.658 -0.651 . . . . 0.0 110.687 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.61 15.66 42.49 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.743 -1.223 . . . . 0.0 110.813 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -171.12 -55.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.305 . . . . 0.0 108.647 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.3 m -120.12 129.99 54.42 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -91.34 140.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.8 . . . . 0.0 111.959 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 t -103.61 111.58 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -129.67 140.17 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.5 m -112.66 121.58 38.36 Favored Pre-proline 0 N--CA 1.483 1.222 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 50' ' ' SER . 30.8 Cg_exo -35.27 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 122.263 1.975 . . . . 0.0 112.154 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -107.98 -41.52 4.93 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -166.43 -163.41 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.609 0.719 . . . . 0.0 109.943 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 56' ' ' ALA . 3.9 tm-20 -172.05 116.27 0.36 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 57' ' ' LEU . 6.6 p -122.15 38.1 4.22 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.155 -0.966 . . . . 0.0 110.338 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 73.66 -18.68 0.37 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.95 . . . . 0.0 109.383 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 55' ' ' THR . 14.0 mt -93.51 0.09 56.56 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -130.13 -153.34 0.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -145.34 159.62 42.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.998 -1.064 . . . . 0.0 110.818 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.47 174.65 11.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -136.46 106.95 6.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -73.29 175.86 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.431 HG22 HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -166.7 122.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.705 ' HG ' ' HD1' ' A' ' 67' ' ' HIS . 76.9 p -54.67 148.42 12.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.568 -1.332 . . . . 0.0 108.229 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.01 -44.92 64.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.99 -1.069 . . . . 0.0 109.158 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.11 79.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 119.992 -1.693 . . . . 0.0 109.967 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.705 ' HD1' ' HG ' ' A' ' 64' ' ' SER . 31.6 m80 -61.67 -23.57 66.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.558 -1.339 . . . . 0.0 108.668 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.95 -33.47 71.97 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -62.59 -37.18 85.23 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 70' ' ' ILE . 46.8 mt -60.03 -38.86 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.099 -1.001 . . . . 0.0 109.724 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.9 mt -59.92 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.824 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.76 76.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.728 -1.232 . . . . 0.0 110.478 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -61.62 -41.91 98.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.448 -1.408 . . . . 0.0 109.597 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.642 HD22 ' N ' ' A' ' 31' ' ' THR . 57.1 t30 -60.71 -61.62 2.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.715 -0.616 . . . . 0.0 111.194 -177.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -60.25 -40.04 88.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.629 -1.295 . . . . 0.0 110.361 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--N 1.297 -1.682 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.789 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.416 0.627 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.51 -54.71 31.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.3 m -62.49 -50.31 71.93 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -70.31 -43.67 69.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.123 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -70.05 -41.75 73.77 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.698 -1.252 . . . . 0.0 112.131 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.09 -50.3 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.531 -1.356 . . . . 0.0 111.087 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.4 mp -60.05 -48.08 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.019 -1.051 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.01 -39.04 84.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.32 -22.18 63.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.2 t30 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.732 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.439 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.439 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 18.4 Cg_endo -103.62 130.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.568 2.845 . . . . 0.0 110.678 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 ttt -132.06 126.23 33.33 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.878 -1.139 . . . . 0.0 110.012 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.79 129.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.717 0.77 . . . . 0.0 109.925 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 25' ' ' GLY . 13.6 p -87.82 100.7 13.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.73 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.39 -13.82 6.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.9 t -59.99 -44.98 95.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -125.64 0.26 7.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 66.61 13.33 60.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -75.89 137.18 40.23 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.22 138.34 31.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.475 -0.766 . . . . 0.0 110.274 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 28' ' ' ILE . 63.8 mt -122.45 158.1 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -140.83 36.6 1.79 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.083 -1.636 . . . . 0.0 107.576 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.63 28.46 0.54 Allowed Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.0 p -135.51 142.26 45.41 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.054 0.93 . . . . 0.0 110.146 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 34' ' ' LEU . 16.4 m -121.0 88.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 35.4 p90 40.08 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.538 0.685 . . . . 0.0 109.238 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 32' ' ' VAL . 47.1 tp -73.26 135.15 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.675 -0.64 . . . . 0.0 109.572 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . 73.1 147.28 0.85 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 6.5 m-20 95.92 19.95 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 123.295 0.638 . . . . 0.0 110.129 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 123.71 -11.38 8.38 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 37' ' ' GLY . 5.8 p-90 -32.26 126.14 0.28 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.39 0.614 . . . . 0.0 111.013 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 t -152.93 140.23 19.53 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.52 175.02 11.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.157 -1.589 . . . . 0.0 109.868 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -161.19 159.9 29.41 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -110.41 121.47 45.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.995 -1.066 . . . . 0.0 109.708 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 43' ' ' ASP . 4.4 p30 -100.66 -1.02 36.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.56 -120.04 1.36 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.41 -7.75 59.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -1.112 . . . . 0.0 110.317 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.7 m -123.47 130.82 53.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.82 141.93 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.14 119.63 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mt -131.66 146.96 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.287 -0.883 . . . . 0.0 110.917 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 15.8 m -118.12 111.49 38.68 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 102.467 -3.161 . . . . 0.0 102.467 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.1 Cg_exo -33.34 -75.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.023 1.815 . . . . 0.0 111.386 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -106.15 -47.07 3.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.71 -165.99 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.497 ' OE2' ' N ' ' A' ' 60' ' ' ALA . 62.2 tt0 -175.11 114.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.572 ' C ' ' H ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -118.19 36.47 4.34 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.069 -1.019 . . . . 0.0 109.879 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 72.59 -21.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 0.0 109.042 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.572 ' H ' ' C ' ' A' ' 55' ' ' THR . 40.9 mt -91.03 0.02 57.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -128.51 -135.95 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -155.28 155.1 33.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.708 -1.245 . . . . 0.0 111.789 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.497 ' N ' ' OE2' ' A' ' 54' ' ' GLU . . . -86.37 177.44 7.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -139.51 150.77 45.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -115.77 173.16 6.7 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.228 -0.92 . . . . 0.0 108.995 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -168.41 111.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -48.42 155.1 0.55 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.08 -1.013 . . . . 0.0 109.068 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.82 -48.15 78.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.052 -1.03 . . . . 0.0 108.603 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.98 87.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.16 -1.588 . . . . 0.0 108.767 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -59.24 -28.11 66.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.866 -1.146 . . . . 0.0 108.32 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.83 -30.06 68.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -60.39 -37.14 79.85 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.09 -38.74 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.394 -0.816 . . . . 0.0 109.391 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 71' ' ' ILE . 1.4 mp -58.35 -39.9 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 108.281 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.445 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -66.1 -40.03 90.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 111.096 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.13 -48.07 72.05 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.625 -1.297 . . . . 0.0 111.174 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -59.98 -52.67 64.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 112.029 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 4.4 mp -69.91 -42.1 73.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.302 -1.498 . . . . 0.0 110.459 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' OXT' ' O ' ' A' ' 72' ' ' ALA . 2.3 pp . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.7 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.16 -45.74 92.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.015 0.912 . . . . 0.0 108.78 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.4 m -61.2 -54.41 44.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 110.847 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.3 t -70.19 -48.34 57.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.834 -1.166 . . . . 0.0 112.067 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.15 -46.63 86.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.804 -1.185 . . . . 0.0 112.98 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.3 -48.12 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 112.155 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.463 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.4 mp -61.32 -47.78 91.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.667 -1.271 . . . . 0.0 109.934 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.3 -40.12 89.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.889 -1.132 . . . . 0.0 110.755 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.92 86.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.827 -1.171 . . . . 0.0 109.039 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.474 ' CG ' ' H ' ' A' ' 20' ' ' ILE . 35.2 m120 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 110.081 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 2.0 mtmt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD2' ' H ' ' A' ' 17' ' ' LYS . 35.1 Cg_endo -95.12 126.2 0.39 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.313 2.009 . . . . 0.0 110.595 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.66 136.86 54.27 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 110.942 -178.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.499 ' O ' ' SD ' ' A' ' 19' ' ' MET . 27.7 mm -100.09 128.1 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.8 t -102.52 103.92 14.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.419 -0.8 . . . . 0.0 108.88 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.405 ' H ' HD11 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -69.4 -7.28 36.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -47.55 91.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -128.73 11.59 6.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.99 83.27 0.04 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -150.36 139.72 21.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -1.014 . . . . 0.0 109.519 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -84.83 139.09 32.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 109.08 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.0 mt -122.78 158.56 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -144.61 42.46 1.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.3 32.41 0.19 Allowed Glycine 0 C--N 1.294 -1.801 0 N-CA-C 106.313 -2.715 . . . . 0.0 106.313 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 m -136.79 142.64 42.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.784 0.802 . . . . 0.0 109.879 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.55 73.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 53.84 23.27 3.72 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.75 123.71 24.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . 78.64 158.49 12.22 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 10.2 m-20 93.94 7.09 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 C-N-CA 123.105 0.562 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 130.53 -3.77 5.81 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.462 ' C ' ' O ' ' A' ' 37' ' ' GLY . 10.1 p-90 -29.92 138.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.423 0.63 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.8 m -151.01 139.88 20.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.99 167.53 21.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.566 -1.334 . . . . 0.0 109.867 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -161.41 125.82 3.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -102.93 130.11 49.88 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.748 -1.22 . . . . 0.0 110.885 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -107.52 -11.31 15.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.645 -0.659 . . . . 0.0 109.716 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.03 2.32 89.5 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.97 -31.24 0.5 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -1.127 . . . . 0.0 109.433 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.4 m -157.22 118.66 3.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.18 122.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.346 -0.846 . . . . 0.0 111.535 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 t -95.61 99.16 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 142.32 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.426 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.1 p -117.11 149.57 44.55 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.56 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.408 1.405 . . . . 0.0 112.077 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -90.61 -45.85 8.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.884 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -167.44 1.17 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.273 -1.517 . . . . 0.0 111.486 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 28.2 mp0 -150.44 98.48 2.66 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 57' ' ' LEU . 4.1 p -129.99 144.29 51.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -25.13 -29.21 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.8 mp -83.61 -10.2 58.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.62 -1.3 . . . . 0.0 110.242 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CG ' ' N ' ' A' ' 59' ' ' LYS . 23.1 t80 -138.46 -164.55 1.65 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.282 -0.886 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -154.9 170.79 20.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.998 -1.064 . . . . 0.0 110.904 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.68 175.34 8.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.501 0.667 . . . . 0.0 110.404 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -128.77 141.77 51.21 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -86.71 169.29 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.046 -1.034 . . . . 0.0 110.592 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -162.91 127.87 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.091 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.8 m -61.19 154.9 22.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.277 -1.514 . . . . 0.0 108.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.75 68.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.654 -1.278 . . . . 0.0 109.401 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.93 87.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.695 -1.253 . . . . 0.0 109.153 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -55.04 -27.26 43.19 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.889 -1.132 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -33.67 72.19 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -59.95 -35.4 74.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.405 HD12 HG23 ' A' ' 70' ' ' ILE . 82.0 mt -59.64 -39.75 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.91 . . . . 0.0 108.929 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.88 -39.94 78.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.216 -0.927 . . . . 0.0 108.997 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.82 -41.56 99.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 111.106 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . 6.4 mtmp? -65.94 -50.04 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.047 -1.033 . . . . 0.0 111.011 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.87 -43.63 94.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.462 -0.773 . . . . 0.0 111.987 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 5.7 mp -80.92 -22.51 39.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.43 -1.419 . . . . 0.0 110.326 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.11 -0.994 . . . . 0.0 109.96 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.222 0.534 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.99 -45.15 95.95 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.41 ' OG1' ' OE1' ' A' ' 53' ' ' GLU . 22.5 m -62.26 -54.88 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.855 -0.528 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -71.95 -48.65 43.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.574 -1.329 . . . . 0.0 112.0 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.81 -42.58 90.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.02 -1.05 . . . . 0.0 112.791 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.7 t -69.81 -48.36 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.323 -1.486 . . . . 0.0 111.225 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.437 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.4 mp -60.24 -47.91 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -63.71 -40.23 96.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.032 -1.042 . . . . 0.0 110.091 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.22 72.28 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.093 -1.005 . . . . 0.0 108.384 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.42 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 61.2 Cg_endo -95.95 129.7 0.4 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.001 1.8 . . . . 0.0 111.349 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 124.82 46.75 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -109.41 128.09 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.79 . . . . 0.0 109.037 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 23' ' ' VAL . 8.8 t -91.67 99.27 12.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.703 ' H ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -59.13 -8.59 1.59 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 21' ' ' SER . 54.4 t -60.83 -41.12 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -123.28 -14.35 7.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.56 15.58 79.41 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -83.16 150.3 26.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -1.106 . . . . 0.0 111.776 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -91.66 130.99 37.37 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.73 74.39 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.53 -0.731 . . . . 0.0 109.864 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -68.5 108.48 3.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.853 -1.154 . . . . 0.0 108.925 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.91 21.77 0.87 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.3 p -143.62 150.92 39.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -1.068 . . . . 0.0 108.316 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 32' ' ' VAL . 32.7 m -127.1 89.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.448 -0.783 . . . . 0.0 109.178 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 57.78 19.94 6.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.112 -0.993 . . . . 0.0 109.918 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.1 tp -73.15 141.19 47.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 108.908 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.16 58.84 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.15 -138.51 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -102.22 24.32 31.5 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' GLY . 10.9 t90 -38.57 128.33 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.729 0.775 . . . . 0.0 110.891 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.5 t -151.09 137.71 18.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.11 173.12 17.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.304 -1.497 . . . . 0.0 110.208 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -151.97 153.79 34.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -101.26 120.79 40.78 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.707 -1.245 . . . . 0.0 109.131 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 49.1 t0 -100.69 -6.62 24.83 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.84 -117.33 0.97 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.029 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.9 17.94 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.961 . . . . 0.0 109.358 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.1 m -150.91 116.08 5.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.79 140.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 111.144 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.91 129.28 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.2 147.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.441 -1.412 . . . . 0.0 111.274 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -112.3 121.32 39.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 177.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -36.06 -75.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.032 1.821 . . . . 0.0 111.731 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -104.83 -47.97 3.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.207 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.41 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 5.0 mt-10 -160.75 -166.48 1.62 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.361 -0.837 . . . . 0.0 109.953 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -173.14 116.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 4.9 p -89.88 -78.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.927 -1.108 . . . . 0.0 108.886 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.604 ' C ' ' H ' ' A' ' 58' ' ' PHE . . . -149.12 -76.03 0.16 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.467 ' CD2' ' H ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -64.86 22.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.394 -0.816 . . . . 0.0 109.871 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.604 ' H ' ' C ' ' A' ' 56' ' ' ALA . 22.7 m-85 -99.04 -175.67 3.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.783 -1.198 . . . . 0.0 108.366 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 138.94 53.89 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.964 0.888 . . . . 0.0 111.829 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.32 177.75 7.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -136.67 126.27 25.33 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.856 -1.153 . . . . 0.0 108.542 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -84.04 162.16 20.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mt -151.08 112.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 67' ' ' HIS . 79.7 p -62.81 152.18 36.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.755 -1.215 . . . . 0.0 108.358 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.59 69.17 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.773 -1.205 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.04 82.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.426 -1.422 . . . . 0.0 108.774 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.619 ' H ' ' HG ' ' A' ' 64' ' ' SER . 32.8 t-80 -60.2 -35.34 75.18 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.841 -1.162 . . . . 0.0 109.507 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.19 -34.45 66.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -60.53 -40.05 90.06 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mt -61.43 -32.01 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.33 -39.72 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.047 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 76' ' ' LEU . . . -68.27 -36.23 79.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.994 -1.066 . . . . 0.0 109.732 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.07 -46.58 89.09 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.036 -1.04 . . . . 0.0 108.855 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -76.26 -74.19 0.24 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.7 -0.625 . . . . 0.0 110.835 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.508 ' CD1' ' H ' ' A' ' 75' ' ' LEU . 6.7 mp -60.22 -44.58 95.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.952 -1.093 . . . . 0.0 111.309 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 72' ' ' ALA . 21.9 mt . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.602 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.503 2.185 0 CA-C-O 121.051 0.453 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 3.8 tt -60.11 -48.34 82.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.836 -1.165 . . . . 0.0 109.253 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m -78.67 -50.52 11.3 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.494 0.664 . . . . 0.0 110.579 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -66.35 -52.86 42.69 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 112.561 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.55 -42.04 78.93 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.346 -1.471 . . . . 0.0 112.785 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 3' ' ' LEU . 95.7 t -61.15 -48.94 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.128 -0.983 . . . . 0.0 111.451 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.87 -40.34 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.411 -0.805 . . . . 0.0 109.905 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -58.68 -45.18 90.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.1 -1.0 . . . . 0.0 110.831 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 -47.04 87.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.746 -1.221 . . . . 0.0 111.087 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 5.3 p-10 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 120.672 -1.268 . . . . 0.0 110.681 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.632 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 15.8 mttt . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 111.013 0.005 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.632 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 75.5 Cg_endo -92.98 120.66 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.742 2.294 . . . . 0.0 113.513 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.0 tpt -121.5 123.41 41.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.542 -0.724 . . . . 0.0 110.544 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.2 mt -118.21 129.6 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLY . 29.9 t -91.13 99.14 12.2 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.733 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.19 -7.33 8.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.11 -45.85 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -128.95 8.58 5.69 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.27 91.25 0.01 OUTLIER Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -143.56 137.15 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.372 -1.075 . . . . 0.0 109.042 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 57.9 mp0 -81.71 123.47 28.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.098 -1.001 . . . . 0.0 108.887 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.448 ' C ' ' H ' ' A' ' 30' ' ' GLY . 50.1 mt -127.44 75.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.183 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -74.06 45.42 0.21 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.69 -1.256 . . . . 0.0 108.961 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -147.99 22.3 1.43 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -152.38 158.92 43.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 34' ' ' LEU . 14.4 m -133.44 112.6 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.321 -0.862 . . . . 0.0 108.974 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 32.5 p90 39.85 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.528 0.68 . . . . 0.0 109.369 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -81.93 129.01 34.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -178.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 36' ' ' ASP . . . 127.35 -83.47 0.34 Allowed Glycine 0 N--CA 1.499 2.884 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 17.0 p-10 -32.92 -106.82 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.668 0.747 . . . . 0.0 111.895 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -123.23 30.11 5.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' GLY . 21.0 p-90 -31.71 132.68 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.872 0.844 . . . . 0.0 111.183 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -153.86 146.34 24.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 173.36 11.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.277 -1.514 . . . . 0.0 109.36 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -163.49 135.21 4.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -110.95 123.7 50.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.854 -1.154 . . . . 0.0 108.417 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 10.3 t70 -106.3 -10.05 16.55 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.362 -0.836 . . . . 0.0 111.305 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.45 -122.27 1.37 Allowed Glycine 0 N--CA 1.503 3.101 0 O-C-N 120.607 -1.308 . . . . 0.0 109.886 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.11 22.93 1.33 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -1.166 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 m -154.75 113.42 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mm -88.24 136.23 23.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.332 -0.855 . . . . 0.0 111.998 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.4 t -112.91 120.11 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.51 147.95 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 34.4 t -115.9 129.11 25.44 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.83 -76.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.597 1.531 . . . . 0.0 112.229 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.93 -49.99 4.58 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.023 -1.048 . . . . 0.0 112.318 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' O ' ' OG ' ' A' ' 50' ' ' SER . 2.6 mm-40 -165.51 -163.89 0.7 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.002 -1.686 . . . . 0.0 109.771 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -156.26 107.05 2.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.681 -0.637 . . . . 0.0 111.469 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.536 ' O ' ' C ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -110.81 118.02 35.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.621 -1.299 . . . . 0.0 108.288 178.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.27 -90.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.269 1.033 . . . . 0.0 110.287 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.28 43.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.305 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 56' ' ' ALA . 54.9 p90 -91.88 -174.48 3.82 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.773 -1.204 . . . . 0.0 111.251 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HZ1' ' CB ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -138.79 110.77 7.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.713 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.74 174.07 9.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.555 -1.34 . . . . 0.0 109.234 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -126.83 129.51 48.42 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -80.63 159.66 25.3 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.681 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mt -153.34 114.57 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -66.87 159.84 27.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.29 -44.27 64.92 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.738 -1.185 . . . . 0.0 107.865 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.9 93.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.6 -0.688 . . . . 0.0 109.802 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -60.27 -24.79 65.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.17 -45.02 92.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.197 -1.564 . . . . 0.0 106.946 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -54.51 -29.71 51.3 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -0.965 . . . . 0.0 109.014 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.4 -39.67 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.727 -1.233 . . . . 0.0 108.507 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.92 -40.36 80.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.88 -31.49 69.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.363 -1.461 . . . . 0.0 110.528 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -69.84 -55.28 10.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.132 -1.605 . . . . 0.0 111.33 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 17' ' ' LYS . 28.0 t-20 -60.55 -44.66 95.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.229 -0.919 . . . . 0.0 111.334 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -63.78 -53.21 54.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 110.461 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 1.3 mm? . . . . . 0 C--N 1.294 -1.836 0 CA-C-O 117.892 -1.051 . . . . 0.0 108.374 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.36 -49.47 73.77 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 121.359 -0.838 . . . . 0.0 109.656 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 93.9 m -59.58 -48.79 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.072 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -69.01 -41.04 78.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.15 -1.594 . . . . 0.0 111.737 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -68.4 -50.32 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.042 -1.037 . . . . 0.0 112.329 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.495 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 97.6 t -69.37 -40.56 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.396 -0.815 . . . . 0.0 111.728 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 4' ' ' THR . 7.0 mm -59.95 -47.37 91.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.843 -1.16 . . . . 0.0 109.8 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.24 -30.96 70.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.921 -1.112 . . . . 0.0 109.798 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.78 -34.13 77.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.287 -0.883 . . . . 0.0 110.908 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 7' ' ' VAL . 21.7 p30 . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.084 -1.01 . . . . 0.0 111.079 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.558 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 ttmt . . . . . 0 N--CA 1.5 2.035 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.558 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 55.3 Cg_endo -98.47 136.29 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.109 2.54 . . . . 0.0 110.862 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.8 ttt -122.96 136.95 55.05 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.904 -1.123 . . . . 0.0 111.32 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -105.26 133.15 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.4 t -109.28 102.81 11.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.746 . . . . 0.0 109.583 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.575 ' CD2' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.18 -19.38 65.29 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.556 -0.858 . . . . 0.0 108.829 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.01 -43.55 92.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -125.71 1.65 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.3 81.07 0.06 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -150.6 144.62 25.38 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.122 -1.223 . . . . 0.0 110.191 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -81.77 133.54 35.35 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -129.02 72.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.914 . . . . 0.0 110.853 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -65.57 115.52 5.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.678 -1.264 . . . . 0.0 109.296 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.36 21.05 2.32 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.5 m -142.25 148.56 38.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 34' ' ' LEU . 29.3 m -130.67 103.16 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.21 -0.931 . . . . 0.0 108.862 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.6 p90 33.31 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.616 -0.677 . . . . 0.0 110.93 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -93.18 129.96 39.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' O ' ' OD1' ' A' ' 36' ' ' ASP . . . 96.41 40.82 3.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 77.4 m-20 -147.85 -40.12 0.18 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.745 -0.856 . . . . 0.0 108.703 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 153.63 33.26 0.03 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -49.86 145.51 5.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.911 -1.347 . . . . 0.0 111.41 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.2 p -145.64 133.24 20.92 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.53 171.04 17.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.063 -1.648 . . . . 0.0 109.821 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -165.63 132.88 2.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -93.04 120.77 33.69 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.675 -1.265 . . . . 0.0 109.479 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -99.07 -0.85 41.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 110.059 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.54 -118.93 1.49 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.67 -4.69 55.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.7 m -132.21 131.34 42.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.6 143.75 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.356 -0.84 . . . . 0.0 110.774 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.5 120.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.37 144.33 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.869 -1.144 . . . . 0.0 110.491 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 21.2 t -111.99 120.7 41.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -37.34 -78.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.019 0 C-N-CA 122.321 2.014 . . . . 0.0 113.508 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -84.05 -57.92 2.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.737 -1.227 . . . . 0.0 111.442 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.453 ' O ' ' OG ' ' A' ' 50' ' ' SER . 92.7 mt-10 -158.58 -168.92 2.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.015 -1.053 . . . . 0.0 109.545 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -169.71 115.5 0.55 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 56' ' ' ALA . 6.1 p -128.75 40.63 3.61 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.376 -0.828 . . . . 0.0 110.105 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 75.83 -24.88 0.21 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.682 -0.636 . . . . 0.0 110.386 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 55' ' ' THR . 10.4 mp -92.53 1.02 57.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.6 -0.687 . . . . 0.0 109.556 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -126.59 -160.98 1.03 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -134.97 149.67 50.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.084 -1.01 . . . . 0.0 111.555 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.08 175.64 8.89 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -132.76 141.95 48.78 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -101.94 107.8 19.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.2 -0.937 . . . . 0.0 109.721 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mt -100.82 104.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -51.37 164.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.849 -1.157 . . . . 0.0 108.899 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.01 82.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.071 . . . . 0.0 109.53 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.16 85.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.128 -1.608 . . . . 0.0 109.891 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -60.62 -38.18 83.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.389 -1.444 . . . . 0.0 108.679 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.96 -34.73 65.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.997 -1.064 . . . . 0.0 108.371 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -59.89 -33.82 72.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 108.817 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.09 -40.57 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.58 -41.16 91.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.096 -1.003 . . . . 0.0 109.795 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.03 91.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 112.389 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -69.96 -36.95 75.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.868 -1.77 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.53 -66.83 0.49 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 110.849 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.8 mp -66.77 -46.78 74.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.079 . . . . 0.0 111.323 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 120.881 -1.137 . . . . 0.0 109.865 -178.762 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.504 2.268 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.99 -41.59 92.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 m -77.79 -49.42 14.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.393 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.0 m -71.28 -57.11 4.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.927 -1.108 . . . . 0.0 111.647 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -60.32 -43.75 96.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.605 -1.309 . . . . 0.0 112.986 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.5 t -67.19 -42.28 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.158 -1.589 . . . . 0.0 112.024 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.56 -43.77 95.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.948 -1.095 . . . . 0.0 110.406 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -69.26 -49.31 57.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.738 -1.226 . . . . 0.0 111.204 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -18.87 65.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.871 -1.143 . . . . 0.0 109.759 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 -179.02 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.13 111.65 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.924 2.416 . . . . 0.0 113.645 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.9 OUTLIER -123.04 133.37 54.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.094 -1.004 . . . . 0.0 108.841 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -106.64 135.11 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.141 -0.974 . . . . 0.0 109.936 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -87.49 98.41 11.37 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.536 ' CD2' ' H ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -66.23 -13.5 60.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.12 -42.49 93.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.66 -17.4 5.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 82.94 74.44 1.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -138.59 131.86 30.13 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.209 -1.171 . . . . 0.0 109.468 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -82.06 122.57 27.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.869 -1.145 . . . . 0.0 109.824 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.504 HG23 ' H ' ' A' ' 30' ' ' GLY . 67.7 mt -108.66 166.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -150.49 31.54 0.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 28' ' ' ILE . . . -151.33 27.47 0.98 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.1 p -137.82 144.27 41.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.887 -0.772 . . . . 0.0 109.461 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.12 84.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER 58.9 39.15 24.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.561 -1.337 . . . . 0.0 109.489 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 36' ' ' ASP . 55.3 tp -80.38 137.32 36.52 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.12 -17.34 4.92 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 34' ' ' LEU . 83.9 m-20 -70.69 -32.23 69.39 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.345 -1.091 . . . . 0.0 108.663 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 129.13 19.73 1.53 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' GLY . 7.8 t90 -36.19 130.51 0.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.59 0.71 . . . . 0.0 110.955 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.9 t -150.56 131.99 14.69 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.37 179.97 7.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.012 -1.68 . . . . 0.0 111.079 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.93 157.75 43.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.06 -1.025 . . . . 0.0 108.297 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -96.72 113.51 25.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.528 -1.357 . . . . 0.0 108.827 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 46.1 t0 -100.62 -0.69 37.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.919 -1.113 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.99 -106.89 0.59 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.75 -14.04 30.59 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.491 -1.005 . . . . 0.0 110.279 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.7 m -120.7 125.36 47.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.775 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.7 135.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.551 -0.718 . . . . 0.0 110.46 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.61 106.58 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.46 140.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.567 -0.708 . . . . 0.0 111.634 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 51' ' ' PRO . 11.6 m -111.08 111.2 56.17 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.9 Cg_exo -33.49 -76.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 122.264 1.976 . . . . 0.0 112.07 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.87 -49.37 4.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.167 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -165.57 -163.85 0.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -167.91 117.1 0.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.146 -0.972 . . . . 0.0 109.508 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.605 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 8.6 p -88.15 -73.51 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.797 -1.189 . . . . 0.0 108.089 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.605 ' C ' ' H ' ' A' ' 58' ' ' PHE . . . -155.56 -77.28 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.549 ' CD2' ' H ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.45 26.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.505 -0.747 . . . . 0.0 111.092 -179.331 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.605 ' H ' ' C ' ' A' ' 56' ' ' ALA . 19.2 m-85 -103.71 -166.94 1.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 149.97 46.65 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.828 -1.17 . . . . 0.0 110.989 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.65 179.24 6.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -125.92 122.51 36.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -94.09 101.1 13.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.28 132.62 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.783 0.802 . . . . 0.0 109.421 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -65.9 149.44 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.83 -39.74 65.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 109.543 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.7 -41.39 90.65 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.426 -1.421 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -59.84 -34.74 73.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.435 -1.415 . . . . 0.0 108.567 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.33 -29.96 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -60.11 -37.19 79.25 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.56 -39.91 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.206 -0.934 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.16 -39.72 79.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 108.679 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -66.28 -38.77 88.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 110.392 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -62.06 -40.8 97.03 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.595 -1.315 . . . . 0.0 110.42 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -73.99 -69.17 0.46 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.674 -0.641 . . . . 0.0 111.577 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.6 mp -60.03 -45.78 91.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.503 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.12 -43.84 95.33 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.8 m -60.13 -57.82 11.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.642 -0.661 . . . . 0.0 111.187 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.587 ' HG ' ' N ' ' A' ' 6' ' ' GLU . 71.1 p -70.4 -45.79 65.25 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.788 -1.195 . . . . 0.0 111.771 -177.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' HG ' ' A' ' 5' ' ' SER . 51.7 mt-10 -64.86 -49.89 68.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.094 . . . . 0.0 112.733 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.8 t -69.82 -47.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 120.642 -1.286 . . . . 0.0 112.331 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.3 mm -60.09 -48.58 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.876 -1.14 . . . . 0.0 109.547 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -60.05 -39.3 85.48 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.477 -0.764 . . . . 0.0 110.357 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.12 85.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.928 -1.108 . . . . 0.0 110.654 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.1 179.571 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.704 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 32.3 pttt . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.704 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 45.1 Cg_endo -95.56 108.75 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.657 1.571 . . . . 0.0 112.696 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.79 133.75 54.91 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.0 mt -110.6 130.67 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 t -90.39 100.73 13.51 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -7.14 12.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 108.854 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.8 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 24' ' ' ASP . 42.8 t0 -135.34 3.54 3.1 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.31 86.72 0.04 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.19 134.61 29.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.375 -1.073 . . . . 0.0 109.724 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -82.82 121.99 27.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.3 mt -119.99 76.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 110.701 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -70.18 107.13 3.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.679 -1.263 . . . . 0.0 109.959 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.99 23.74 1.03 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -134.97 139.2 44.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.554 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 33.4 m -124.38 111.35 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.554 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 4.4 p90 32.0 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.002 -0.436 . . . . 0.0 111.405 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -92.82 135.92 33.7 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.874 -1.141 . . . . 0.0 109.926 -179.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.73 18.26 21.12 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -129.99 -99.94 0.32 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -1.062 . . . . 0.0 109.521 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -153.41 25.24 0.77 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -50.04 149.59 2.7 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.77 -0.841 . . . . 0.0 111.093 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.3 m -149.68 151.66 34.06 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.79 10.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.234 -1.542 . . . . 0.0 109.474 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -158.78 160.35 36.2 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -97.48 121.79 39.78 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.89 -1.131 . . . . 0.0 109.861 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -100.04 -1.83 35.96 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.152 -0.967 . . . . 0.0 110.306 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 45' ' ' ALA . . . 83.75 95.23 0.63 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.782 -1.199 . . . . 0.0 110.51 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 44' ' ' GLY . . . 84.22 4.76 0.71 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.938 -0.742 . . . . 0.0 109.887 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -165.94 143.77 5.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.99 128.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.468 -0.77 . . . . 0.0 110.371 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.6 t -101.2 109.83 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.36 140.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 p -112.09 120.51 41.65 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -36.61 -79.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.006 1.804 . . . . 0.0 113.097 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -93.53 -48.85 6.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.794 -1.191 . . . . 0.0 109.203 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -160.85 -165.83 1.47 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.535 -1.353 . . . . 0.0 109.568 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -157.5 100.86 1.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.152 -0.967 . . . . 0.0 109.607 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.651 ' O ' ' N ' ' A' ' 57' ' ' LEU . 26.7 p -131.22 145.57 51.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.849 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.82 -27.07 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.8 mp -79.61 -10.14 59.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.649 -1.282 . . . . 0.0 109.461 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -137.5 -161.84 1.22 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.59 166.58 28.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.738 -1.227 . . . . 0.0 111.506 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.62 176.1 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -134.1 127.66 32.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -96.43 110.14 22.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.131 -0.981 . . . . 0.0 110.871 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -110.76 144.99 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.302 0.572 . . . . 0.0 109.812 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -73.4 163.59 27.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.099 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.9 95.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.405 -0.81 . . . . 0.0 111.345 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -49.98 72.62 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.267 -1.521 . . . . 0.0 111.426 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -60.21 -35.57 75.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.262 -1.524 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 3.1 tm? -59.7 -35.43 74.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 108.37 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -59.93 -34.48 73.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.969 -1.082 . . . . 0.0 109.296 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.2 mt -58.19 -38.7 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.88 -1.137 . . . . 0.0 108.77 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.6 mt -59.99 -39.92 81.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.759 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -62.45 -40.05 95.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.083 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -67.23 -50.56 60.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.736 -1.227 . . . . 0.0 110.53 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -59.97 -63.41 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.925 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.7 mp -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.884 -1.135 . . . . 0.0 111.028 -177.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 109.581 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.1 p -109.32 0.24 19.42 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.26 -49.81 76.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.3 m -60.38 -50.07 75.06 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.054 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -68.44 -49.19 61.71 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.312 -1.492 . . . . 0.0 111.019 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.12 -49.26 78.01 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 112.888 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.66 -45.81 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.554 -1.341 . . . . 0.0 111.892 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -59.93 -42.84 90.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.449 -1.407 . . . . 0.0 108.776 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -57.66 -39.26 76.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -55.19 19.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.835 -1.166 . . . . 0.0 109.005 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.424 ' ND2' ' CZ ' ' A' ' 14' ' ' ARG . 15.0 m120 -140.4 139.59 35.31 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -151.38 104.85 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.314 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.649 ' H ' ' HZ3' ' A' ' 61' ' ' LYS . . . 75.05 17.6 80.24 Favored Glycine 0 N--CA 1.496 2.64 0 O-C-N 121.274 -0.891 . . . . 0.0 111.099 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.424 ' CZ ' ' ND2' ' A' ' 11' ' ' ASN . 56.3 ttp180 -94.38 69.65 3.65 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.704 -1.468 . . . . 0.0 110.138 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' ARG . 99.0 mt-10 36.35 75.43 0.06 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.33 -0.856 . . . . 0.0 111.469 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' GLU . . . -36.25 102.16 0.01 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.542 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -162.52 -46.19 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.542 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 38.3 Cg_endo -101.1 128.03 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 123.364 2.71 . . . . 0.0 109.839 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.8 ttt -126.18 128.97 48.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.997 -1.064 . . . . 0.0 110.053 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -110.0 130.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.544 -0.723 . . . . 0.0 109.376 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 t -93.87 103.58 15.68 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -7.83 12.12 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.12 -43.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -134.4 13.97 3.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.31 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -151.81 145.81 25.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.725 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.12 125.95 33.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mt -123.11 73.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.728 -0.607 . . . . 0.0 109.398 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -69.22 109.37 4.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.007 -1.058 . . . . 0.0 109.361 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.2 21.64 0.95 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -140.83 147.82 39.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.51 101.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 0.0 108.708 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 51.4 28.46 4.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 109.138 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.5 tt -92.34 139.45 30.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.86 18.6 63.08 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -127.16 -54.51 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.72 -0.87 . . . . 0.0 109.187 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.97 33.05 0.02 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -50.31 138.99 15.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -1.222 . . . . 0.0 109.858 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.6 t -151.08 135.5 16.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.92 178.18 10.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.323 -1.486 . . . . 0.0 109.969 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -150.58 161.11 43.2 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -100.0 117.34 34.07 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.905 -1.122 . . . . 0.0 109.988 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 60.6 t0 -94.51 -12.49 27.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.128 -0.983 . . . . 0.0 109.373 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 45' ' ' ALA . . . 93.81 98.24 1.55 Allowed Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.175 -0.953 . . . . 0.0 110.814 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 44' ' ' GLY . . . 85.55 1.1 0.7 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.983 -0.716 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -167.31 117.81 0.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -90.78 142.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.954 -1.091 . . . . 0.0 110.572 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.78 125.29 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.89 144.09 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.4 m -110.44 124.46 33.19 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -37.48 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.87 1.713 . . . . 0.0 111.7 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -101.82 -47.32 4.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.024 -1.048 . . . . 0.0 109.828 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 68.9 mt-10 -161.81 -165.84 1.34 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -168.11 114.66 0.69 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 57' ' ' LEU . 2.6 p -122.4 44.53 2.59 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.244 -0.91 . . . . 0.0 111.115 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 68.32 -16.74 0.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.024 -1.048 . . . . 0.0 110.38 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 55' ' ' THR . 12.6 mt -95.13 -0.77 53.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -134.04 -156.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.09 164.19 35.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.828 -1.17 . . . . 0.0 111.381 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.33 174.96 9.56 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.449 0.642 . . . . 0.0 109.525 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.649 ' HZ3' ' H ' ' A' ' 13' ' ' GLY . 86.5 tttt -133.36 133.34 42.35 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -82.76 164.43 20.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.842 -1.161 . . . . 0.0 110.358 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.93 119.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.2 m -64.8 151.13 46.13 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.61 69.9 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.603 -1.31 . . . . 0.0 108.403 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.64 80.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.599 -1.313 . . . . 0.0 109.436 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -60.99 -34.21 74.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 108.981 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.75 -33.1 71.22 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -60.6 -41.47 94.81 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 70' ' ' ILE . 52.8 mt -60.15 -39.22 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.725 . . . . 0.0 110.727 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.72 -46.56 93.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 118.304 -1.359 . . . . 0.0 109.821 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.28 73.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.545 -1.347 . . . . 0.0 109.672 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -62.65 -40.01 95.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.833 -1.167 . . . . 0.0 109.607 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -59.94 -51.35 70.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.431 -0.793 . . . . 0.0 111.631 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.35 -46.82 78.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.177 . . . . 0.0 109.893 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.429 ' C ' ' CG2' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.571 0.7 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.589 ' HG1' ' N ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER 167.99 -74.91 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.696 0.76 . . . . 0.0 109.088 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.589 ' N ' ' HG1' ' A' ' 2' ' ' THR . 8.6 tp -60.16 -45.43 93.1 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.4 m -70.04 -51.84 28.85 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.202 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -73.44 -57.56 3.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.31 -40.34 95.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.388 -1.445 . . . . 0.0 112.361 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.6 t -70.32 -47.95 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.589 -1.319 . . . . 0.0 112.341 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 11' ' ' ASN . 53.4 mt -68.24 -42.55 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.862 -1.149 . . . . 0.0 111.195 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -60.3 -41.7 93.96 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.47 91.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.886 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 8' ' ' ILE . 8.0 m120 -125.44 123.85 40.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -154.37 74.28 0.95 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 0.0 108.873 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.75 37.17 0.04 OUTLIER Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.434 HH21 ' HG2' ' A' ' 18' ' ' PRO . 17.8 mmm180 -81.73 159.96 23.75 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.514 -0.992 . . . . 0.0 110.03 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -70.43 -40.44 73.79 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.792 -0.567 . . . . 0.0 110.058 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.15 27.55 0.57 Allowed Glycine 0 N--CA 1.503 3.106 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.715 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 36.6 mtmt -151.33 -35.17 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.228 -1.16 . . . . 0.0 111.984 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.715 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 80.2 Cg_endo -96.46 123.68 0.25 Allowed 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.554 2.169 . . . . 0.0 113.629 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.3 OUTLIER -122.29 140.95 52.04 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.574 -0.704 . . . . 0.0 109.746 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 76.6 mt -110.53 131.39 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.412 -0.805 . . . . 0.0 110.296 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.6 m -94.59 101.11 12.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.742 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -8.44 22.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.372 -0.83 . . . . 0.0 109.528 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.97 -42.4 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 9.3 t70 -131.54 8.02 4.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.41 87.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -144.68 137.21 26.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -1.138 . . . . 0.0 109.233 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -83.43 122.97 29.21 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -120.06 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.376 -0.827 . . . . 0.0 110.319 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -66.01 107.53 1.91 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.837 -1.164 . . . . 0.0 109.011 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.4 19.16 0.77 Allowed Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 137.25 49.06 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 34' ' ' LEU . 3.1 m -118.03 98.89 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 44.6 17.07 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 32' ' ' VAL . 85.1 mt -72.12 142.01 49.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 108.473 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -21.58 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -73.07 -35.45 66.66 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 123.53 31.8 0.94 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -47.52 139.54 6.77 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.285 1.04 . . . . 0.0 111.314 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -154.62 135.08 13.38 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.23 7.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.653 -1.28 . . . . 0.0 111.583 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -156.76 139.4 15.04 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -94.2 123.55 37.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.29 -1.506 . . . . 0.0 109.523 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 52.0 t0 -102.19 -5.6 24.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.354 -0.841 . . . . 0.0 110.201 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -112.07 0.54 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.9 -6.63 53.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -1.194 . . . . 0.0 109.956 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -125.1 119.95 30.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.981 -1.075 . . . . 0.0 108.88 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -88.97 140.14 16.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.488 -0.758 . . . . 0.0 110.828 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.44 114.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 pt -118.78 172.35 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.023 -1.048 . . . . 0.0 109.917 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 51' ' ' PRO . 63.8 m -135.35 102.37 10.74 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 50' ' ' SER . 0.5 OUTLIER -28.9 -99.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.614 2.209 . . . . 0.0 112.083 -177.036 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -78.29 -44.29 25.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 68.2 mt-10 -160.92 -163.87 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' OE1' ' C ' ' A' ' 59' ' ' LYS . 10.0 tp10 -171.0 103.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.627 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 57' ' ' LEU . 73.1 p -130.81 152.59 49.98 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -26.8 -29.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.4 mp -84.11 -3.11 57.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.712 -1.243 . . . . 0.0 111.004 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 55' ' ' THR . 88.4 m-85 -129.27 -161.07 1.08 Allowed 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.461 -0.774 . . . . 0.0 109.702 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' C ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -140.08 155.68 46.92 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.156 -0.965 . . . . 0.0 111.197 -179.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.71 175.5 10.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.688 -0.633 . . . . 0.0 109.819 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -132.17 153.82 50.16 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -109.28 161.09 15.59 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.331 -0.856 . . . . 0.0 109.978 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -153.06 117.45 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.429 ' HB2' ' HD1' ' A' ' 67' ' ' HIS . 58.7 m -61.74 149.26 40.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.61 -46.03 48.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.775 -1.203 . . . . 0.0 109.581 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.16 -41.73 65.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.186 -1.571 . . . . 0.0 110.241 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.429 ' HD1' ' HB2' ' A' ' 64' ' ' SER . 35.4 m80 -65.75 -29.91 70.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.766 -1.209 . . . . 0.0 109.765 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.63 -36.39 76.27 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -59.17 -39.23 81.85 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 mt -60.17 -32.65 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.053 -1.029 . . . . 0.0 110.184 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.14 -44.37 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.242 -1.536 . . . . 0.0 110.51 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.61 62.09 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.024 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -64.37 -56.54 13.67 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.142 -0.974 . . . . 0.0 110.224 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -51.92 -49.69 62.57 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.622 -0.674 . . . . 0.0 109.331 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -67.6 -23.94 65.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.052 -1.03 . . . . 0.0 110.626 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.825 -1.083 . . . . 0.0 108.962 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.452 ' O ' ' OG1' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 1' ' ' ALA . 71.4 p 50.55 97.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 109.417 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.76 -40.13 94.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.671 -0.643 . . . . 0.0 111.022 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.447 ' OG1' ' OE2' ' A' ' 53' ' ' GLU . 41.7 m -59.94 -52.39 65.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.927 . . . . 0.0 110.642 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t -68.62 -41.27 79.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.702 -1.249 . . . . 0.0 111.744 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.77 -40.52 76.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.784 -1.197 . . . . 0.0 112.919 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.21 -50.09 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.486 -1.383 . . . . 0.0 111.254 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.3 mp -60.27 -49.34 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.097 -1.002 . . . . 0.0 110.162 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -60.39 -40.02 89.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.058 -1.027 . . . . 0.0 110.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.64 80.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.961 -1.087 . . . . 0.0 109.459 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -144.64 115.61 7.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 109.439 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.6 ' C ' ' H ' ' A' ' 14' ' ' ARG . 72.6 tttt -78.3 169.88 17.54 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 15' ' ' GLU . . . -59.18 11.16 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 O-C-N 120.686 -1.259 . . . . 0.0 110.803 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.6 ' H ' ' C ' ' A' ' 12' ' ' LYS . 9.7 ptm180 -50.99 88.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.928 -1.337 . . . . 0.0 109.349 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 13' ' ' GLY . 46.3 tp10 47.93 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 0.0 109.562 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.04 101.41 0.31 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.576 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.3 tttm -154.85 -45.25 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.49 -1.006 . . . . 0.0 109.335 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.576 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 78.9 Cg_endo -95.54 130.25 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.748 2.299 . . . . 0.0 110.341 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.6 ttt -116.46 129.67 56.34 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.302 -0.874 . . . . 0.0 111.253 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -106.14 119.85 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 25' ' ' GLY . 26.2 p -100.82 98.86 9.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 0.0 109.057 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.721 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.08 -10.71 59.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.374 -0.828 . . . . 0.0 109.825 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.03 -41.73 87.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 108.493 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.48 1.29 4.53 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 60.04 82.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -145.28 137.69 25.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.359 -1.083 . . . . 0.0 109.472 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -84.56 128.97 34.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.92 77.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.714 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -71.94 109.99 6.14 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.68 20.36 0.54 Allowed Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.4 p -142.33 149.08 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -1.124 . . . . 0.0 108.372 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.86 85.32 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.67 0.748 . . . . 0.0 109.301 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 53.54 34.29 18.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.435 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 tp -85.67 137.07 33.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.541 -0.724 . . . . 0.0 109.069 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.71 66.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -121.42 -41.98 2.47 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 145.71 26.69 0.1 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -51.26 136.99 23.69 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.163 -1.198 . . . . 0.0 109.294 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 p -152.42 142.31 22.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.13 178.96 9.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.229 -1.544 . . . . 0.0 110.461 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -158.65 146.59 18.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -96.66 123.28 40.29 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.644 -1.285 . . . . 0.0 109.155 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.6 -4.26 22.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -121.87 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.72 -9.96 59.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.217 . . . . 0.0 109.591 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.6 m -120.13 134.59 55.21 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.4 mm -104.69 130.02 56.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.676 -0.64 . . . . 0.0 109.873 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.82 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.064 -1.022 . . . . 0.0 108.354 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.63 141.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.188 -0.945 . . . . 0.0 110.601 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -109.9 118.69 49.38 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -36.77 -76.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.916 1.744 . . . . 0.0 112.211 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -94.96 -50.75 4.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 0.0 108.562 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' OE2' ' OG1' ' A' ' 4' ' ' THR . 15.5 pt-20 -173.22 -161.0 0.13 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.533 -0.729 . . . . 0.0 109.057 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -166.26 115.39 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.034 -1.041 . . . . 0.0 108.935 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.53 ' C ' ' H ' ' A' ' 57' ' ' LEU . 11.8 p -117.09 40.26 3.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.226 -0.921 . . . . 0.0 109.705 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.99 -16.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.663 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.53 ' H ' ' C ' ' A' ' 55' ' ' THR . 4.6 mm? -90.0 -1.75 58.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -136.27 -159.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -144.59 159.99 41.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.971 -1.081 . . . . 0.0 111.339 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 175.74 5.12 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -132.52 124.84 29.26 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -93.07 110.94 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.452 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.4 tt -108.92 124.4 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.7 m -55.63 157.72 3.9 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.339 -0.85 . . . . 0.0 110.687 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.324 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.92 -41.37 61.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.551 -1.343 . . . . 0.0 108.748 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -63.04 -24.21 67.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -59.87 -38.79 83.18 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.07 -35.64 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.77 -39.86 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.859 -1.151 . . . . 0.0 108.888 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 71' ' ' ILE . 55.8 mt -56.45 -38.09 54.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.749 -1.22 . . . . 0.0 108.659 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -69.9 -38.13 76.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.91 -50.47 41.88 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.657 -1.277 . . . . 0.0 111.71 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -59.87 -47.37 86.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 111.457 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.549 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 5.3 mp -69.95 -44.3 69.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.438 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.922 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.0 p -105.02 -1.51 25.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.504 -0.748 . . . . 0.0 109.52 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.98 -49.32 78.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 109.739 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.415 ' OG1' ' OE1' ' A' ' 53' ' ' GLU . 89.5 m -64.92 -53.69 42.55 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.298 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.5 p -61.65 -45.26 94.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.718 -1.239 . . . . 0.0 111.751 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.99 -40.97 74.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.914 -1.117 . . . . 0.0 112.65 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 80.8 t -68.6 -47.97 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.393 -1.442 . . . . 0.0 111.216 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.05 -49.16 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.877 -1.139 . . . . 0.0 110.437 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.97 -41.85 92.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.161 -0.962 . . . . 0.0 111.057 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.92 92.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.533 -1.354 . . . . 0.0 110.427 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -60.01 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.939 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.9 tptm 44.87 26.85 0.22 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.852 0.834 . . . . 0.0 109.342 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ARG . . . -167.84 55.63 0.22 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.531 ' CG ' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -37.57 -92.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.144 -0.621 . . . . 0.0 111.162 -178.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 17' ' ' LYS . 40.3 tp10 48.77 51.77 15.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 108.622 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.471 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -16.46 73.81 0.0 OUTLIER Glycine 0 N--CA 1.505 3.247 0 C-N-CA 123.142 0.401 . . . . 0.0 113.399 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 15' ' ' GLU . 1.3 mmmt -167.01 -52.41 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.166 -1.196 . . . . 0.0 109.318 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -95.46 113.31 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.659 2.239 . . . . 0.0 112.231 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.575 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.06 135.26 50.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.337 -0.852 . . . . 0.0 109.748 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.575 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.8 mm -106.22 129.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.754 . . . . 0.0 109.105 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 23' ' ' VAL . 79.5 p -113.58 100.24 8.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.521 -0.737 . . . . 0.0 109.629 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -1.4 3.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 21' ' ' SER . 95.1 t -60.03 -44.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -140.81 15.76 2.31 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.11 85.27 0.03 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 106.63 -2.588 . . . . 0.0 106.63 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -145.7 134.3 22.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.459 -1.024 . . . . 0.0 109.729 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.63 128.67 34.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mt -127.56 75.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.87 109.25 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 109.248 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.89 26.4 1.13 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.8 m -141.74 148.45 39.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 32' ' ' VAL . 22.8 m -127.15 106.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 23.5 m-85 42.06 34.78 0.49 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.83 134.78 34.18 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 109.682 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.39 16.02 23.8 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.582 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 23.5 p30 -131.7 -100.97 0.29 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.38 -1.07 . . . . 0.0 109.276 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -143.72 30.48 1.94 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -46.97 140.02 5.14 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.248 -1.148 . . . . 0.0 110.959 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 t -146.66 149.08 32.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.78 169.92 18.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.084 -1.635 . . . . 0.0 109.184 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -158.94 143.67 15.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -98.92 120.07 38.75 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.606 -1.309 . . . . 0.0 110.584 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 32.3 t0 -97.81 -7.29 30.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.284 -0.885 . . . . 0.0 109.621 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.14 64.47 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -163.03 -57.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.121 . . . . 0.0 108.639 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -118.09 121.49 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.48 135.12 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 t -98.63 103.92 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.84 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.42 -0.8 . . . . 0.0 110.304 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.518 ' HG ' ' C ' ' A' ' 53' ' ' GLU . 3.2 p -111.93 127.75 26.43 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.59 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.233 1.289 . . . . 0.0 111.455 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.73 -48.94 5.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 109.592 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' C ' ' HG ' ' A' ' 50' ' ' SER . 91.9 mt-10 -156.69 -169.98 3.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.122 -0.987 . . . . 0.0 109.882 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 15.6 tm-20 -155.62 96.72 1.79 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.589 ' O ' ' N ' ' A' ' 57' ' ' LEU . 1.7 p -131.49 147.75 52.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.373 -0.83 . . . . 0.0 108.816 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -28.61 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.1 mp -85.4 0.57 51.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.605 -1.31 . . . . 0.0 110.222 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.5 m-85 -136.87 -160.88 1.1 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 108.935 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -150.08 160.19 43.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 0.0 111.612 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.28 173.5 12.53 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -136.18 128.7 30.49 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.32 109.51 22.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.969 -1.082 . . . . 0.0 110.789 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.83 138.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 m -74.43 162.61 28.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.94 . . . . 0.0 108.852 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.05 83.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.883 -1.136 . . . . 0.0 109.44 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.0 -41.7 83.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.628 -1.295 . . . . 0.0 109.995 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -59.95 -32.61 70.96 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 108.633 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.91 -34.77 73.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.86 -37.67 77.04 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.03 -1.044 . . . . 0.0 108.38 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 70' ' ' ILE . 81.6 mt -59.97 -39.85 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.975 . . . . 0.0 109.364 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.474 ' CD1' ' N ' ' A' ' 71' ' ' ILE . 1.4 mp -59.92 -40.11 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 108.267 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.23 96.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 111.055 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.12 -40.0 95.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.672 -1.267 . . . . 0.0 109.489 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 16' ' ' GLY . 82.5 m-20 -66.7 -71.33 0.2 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.313 0.578 . . . . 0.0 111.883 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 6.4 mp -63.01 -44.55 95.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 111.466 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 120.752 -1.217 . . . . 0.0 109.371 -179.757 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p -109.59 -9.08 14.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.395 -0.815 . . . . 0.0 109.044 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.05 -49.92 75.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.304 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 5' ' ' SER . 6.4 t -63.59 -48.46 77.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.311 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.464 ' N ' ' CG2' ' A' ' 4' ' ' THR . 14.5 p -65.19 -43.21 92.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.76 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -40.81 74.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.058 . . . . 0.0 112.122 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.96 -43.82 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.852 -1.155 . . . . 0.0 110.836 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -59.43 -49.11 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.821 . . . . 0.0 109.452 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.09 -36.15 76.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.808 -1.183 . . . . 0.0 109.755 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.24 -20.02 64.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.973 -1.079 . . . . 0.0 110.593 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -76.7 -119.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.772 -1.205 . . . . 0.0 110.715 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 59.26 30.16 19.85 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.757 -0.589 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 14' ' ' ARG . . . -160.35 58.73 0.31 Allowed Glycine 0 N--CA 1.483 1.798 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 13' ' ' GLY . 86.4 mtm-85 -48.99 -109.89 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.722 0.772 . . . . 0.0 110.37 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 48.19 50.11 16.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.86 -1.15 . . . . 0.0 108.819 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.36 -2.33 20.49 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 48.4 53.02 13.68 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.497 -1.002 . . . . 0.0 109.642 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 38.0 Cg_endo -66.52 156.13 66.93 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.02 1.813 . . . . 0.0 108.668 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.484 ' SD ' ' OD2' ' A' ' 36' ' ' ASP . 35.3 ttp -138.16 125.6 21.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.78 -1.2 . . . . 0.0 110.996 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.439 HD12 HG22 ' A' ' 20' ' ' ILE . 90.3 mt -102.38 128.96 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.7 p -86.61 99.18 11.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.697 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -62.66 -14.44 43.54 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.86 -41.79 90.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -131.7 2.03 4.06 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 59.23 81.15 0.08 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -140.07 130.29 25.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.257 -1.143 . . . . 0.0 109.329 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 51.2 mp0 -77.44 134.91 38.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.289 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.471 ' C ' ' H ' ' A' ' 30' ' ' GLY . 34.5 mt -130.8 60.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -71.94 47.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.862 0.839 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -153.51 26.05 0.76 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 106.846 -2.502 . . . . 0.0 106.846 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m -145.81 150.43 36.17 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 34' ' ' LEU . 18.6 m -114.81 94.62 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' VAL . 26.0 m-85 36.38 25.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.294 0.569 . . . . 0.0 110.538 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 32' ' ' VAL . 4.2 tt -97.68 129.12 44.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 109.207 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.442 ' O ' ' OD1' ' A' ' 36' ' ' ASP . . . 118.01 25.77 2.93 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' SD ' ' A' ' 19' ' ' MET . 90.9 m-20 -143.76 -61.84 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.302 -1.116 . . . . 0.0 109.638 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -170.96 23.79 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -35.23 135.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.021 0.915 . . . . 0.0 112.503 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 t -146.94 135.31 21.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.96 169.31 23.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.822 -1.798 . . . . 0.0 110.064 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -160.5 138.69 9.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -101.59 126.27 48.38 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.686 -1.259 . . . . 0.0 111.176 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 59.2 t0 -95.49 -12.47 25.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.735 -0.603 . . . . 0.0 109.491 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 45' ' ' ALA . . . 94.87 105.05 1.95 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 44' ' ' GLY . . . 84.63 -10.71 0.84 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.984 -0.715 . . . . 0.0 109.773 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.9 m -158.01 114.4 2.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -91.9 140.81 15.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 111.247 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.12 120.05 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.25 146.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.609 -1.307 . . . . 0.0 110.347 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 18.9 t -109.72 120.06 46.04 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -38.05 -77.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 122.082 1.854 . . . . 0.0 113.55 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -85.01 -58.8 2.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.862 -1.148 . . . . 0.0 111.082 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' OG ' ' A' ' 50' ' ' SER . 40.5 mt-10 -161.25 -167.15 1.7 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.835 . . . . 0.0 109.616 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -167.43 113.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.525 ' C ' ' H ' ' A' ' 57' ' ' LEU . 1.4 p -127.87 45.12 2.8 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.36 -0.837 . . . . 0.0 110.198 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 71.8 -22.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' H ' ' C ' ' A' ' 55' ' ' THR . 11.3 mt -90.09 -7.15 54.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.045 -1.034 . . . . 0.0 108.929 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -128.79 -160.53 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -145.8 158.96 43.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.724 -1.235 . . . . 0.0 111.075 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.15 173.52 8.43 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -127.98 140.27 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -85.05 155.54 21.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.0 mt -151.89 112.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.482 ' H ' ' HD1' ' A' ' 67' ' ' HIS . 13.0 p -64.23 154.71 34.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.57 62.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.69 86.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.653 -1.279 . . . . 0.0 109.707 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.482 ' HD1' ' H ' ' A' ' 64' ' ' SER . 46.3 m170 -59.92 -39.16 84.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.108 -0.995 . . . . 0.0 109.331 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 1.8 tm? -59.01 -37.09 76.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.877 -1.14 . . . . 0.0 108.757 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -58.97 -35.01 72.45 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.87 -38.65 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 71' ' ' ILE . 1.5 mp -57.89 -40.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.63 -1.294 . . . . 0.0 108.796 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.0 96.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 110.904 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . 94.0 mttt -68.08 -44.47 76.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.874 -1.141 . . . . 0.0 110.501 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -59.74 -58.26 9.36 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 112.12 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 4.5 mp -68.01 -39.9 83.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.595 -1.316 . . . . 0.0 110.234 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.034 -1.041 . . . . 0.0 109.951 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.677 ' N ' ' HG ' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.19 0.519 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER 169.95 -82.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.794 . . . . 0.0 109.439 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 tp -59.95 -49.41 77.78 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 m -65.64 -49.09 69.92 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.956 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.677 ' HG ' ' N ' ' A' ' 1' ' ' ALA . 6.0 m -72.36 -57.3 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 112.538 -177.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 2' ' ' THR . 69.9 mm-40 -65.03 -44.33 89.49 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.569 -1.332 . . . . 0.0 113.129 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.0 -45.32 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.526 -1.359 . . . . 0.0 111.107 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.1 -39.4 80.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.001 -1.062 . . . . 0.0 109.144 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.81 -44.0 94.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.802 -1.186 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.69 74.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.886 -1.133 . . . . 0.0 109.986 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.632 HD22 ' CG1' ' A' ' 20' ' ' ILE . 23.5 m120 -130.66 122.22 26.98 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.135 -0.978 . . . . 0.0 109.567 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -155.35 51.23 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 108.639 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.51 29.91 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.669 HH21 ' N ' ' A' ' 17' ' ' LYS . 14.9 ptm180 -81.76 165.2 21.14 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.467 -1.019 . . . . 0.0 108.785 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -70.35 -39.94 74.36 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.05 37.76 0.49 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.669 ' N ' HH21 ' A' ' 14' ' ' ARG . 7.8 mtpt -142.77 -43.41 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.559 -0.965 . . . . 0.0 110.701 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.652 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 63.0 Cg_endo -101.14 130.18 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.151 2.568 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.7 ttp -112.2 143.26 43.56 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.632 ' CG1' HD22 ' A' ' 11' ' ' ASN . 4.5 mm -103.4 129.58 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.299 -0.876 . . . . 0.0 108.989 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 23' ' ' VAL . 11.1 m -100.56 98.49 9.07 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -3.04 6.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 21' ' ' SER . 74.6 t -60.05 -44.27 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.8 t0 -125.01 -5.82 7.34 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.8 11.24 85.61 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -75.88 140.05 41.98 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.651 -0.911 . . . . 0.0 110.399 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.03 133.48 33.58 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.7 mt -123.45 73.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.223 -0.923 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -65.93 109.23 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.528 -1.357 . . . . 0.0 108.834 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.9 23.67 0.85 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 17' ' ' LYS . 87.8 m -133.26 137.26 45.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 34' ' ' LEU . 9.8 m -120.1 102.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.432 -0.792 . . . . 0.0 110.022 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.433 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m-85 41.65 17.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.868 -0.52 . . . . 0.0 109.94 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 32' ' ' VAL . 43.7 tp -93.9 134.56 36.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.673 -1.267 . . . . 0.0 109.68 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.82 17.01 10.74 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 17.5 p-10 -139.37 -69.96 0.41 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -1.119 . . . . 0.0 110.121 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.542 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 173.1 32.08 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -51.54 155.65 1.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.434 -1.039 . . . . 0.0 110.324 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 t -153.39 131.97 12.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.86 177.32 10.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.339 -1.476 . . . . 0.0 109.57 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -159.7 160.05 33.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -99.48 114.76 27.91 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.88 -1.137 . . . . 0.0 109.649 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 38.4 t0 -96.74 -7.7 33.21 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.783 -1.198 . . . . 0.0 109.685 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.97 -113.56 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.84 -5.22 58.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -1.23 . . . . 0.0 109.273 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 m -122.91 132.85 54.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.335 -0.853 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.1 mm -96.36 142.61 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.586 -0.696 . . . . 0.0 110.838 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -109.26 120.01 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.8 mt -131.73 144.16 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.583 -0.698 . . . . 0.0 110.518 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' PRO . 74.1 m -118.29 120.84 31.78 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' SER . 53.9 Cg_exo -33.34 -87.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.137 1.891 . . . . 0.0 111.961 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -99.9 -36.59 9.35 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -165.73 -163.21 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.708 0.766 . . . . 0.0 109.965 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -174.28 117.26 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 57' ' ' LEU . 20.9 p -128.98 40.43 3.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 74.46 -26.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 55' ' ' THR . 8.8 mp -90.02 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.362 -0.836 . . . . 0.0 108.828 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.27 -157.19 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -140.46 158.36 44.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.001 -1.062 . . . . 0.0 111.075 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.04 173.77 9.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -138.99 120.03 14.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -84.76 171.32 12.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.69 118.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -60.18 153.89 21.0 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.694 -1.254 . . . . 0.0 108.13 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.95 -44.32 70.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.784 -1.197 . . . . 0.0 108.245 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.59 -44.05 69.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.041 -1.662 . . . . 0.0 109.309 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.88 -27.14 68.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.687 -1.258 . . . . 0.0 108.96 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -59.91 -32.88 71.17 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.92 -39.77 86.59 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.7 mt -58.28 -34.83 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.988 -1.07 . . . . 0.0 109.998 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.0 mt -60.02 -40.16 82.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.23 -1.544 . . . . 0.0 109.675 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -75.39 -28.81 59.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' LEU . 1.6 tmtp? -69.77 -55.11 10.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -58.06 -50.06 74.74 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.857 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 4.6 mp -68.11 -39.85 82.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.355 -1.466 . . . . 0.0 109.744 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 73' ' ' LYS . 1.5 pp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.138 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.525 ' O ' ' CG2' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 154.55 -68.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 tp -59.83 -42.99 94.76 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -78.59 -50.01 12.26 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.857 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -65.72 -52.05 54.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.909 -1.119 . . . . 0.0 111.74 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.01 -47.12 63.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 112.836 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.81 -39.93 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.504 -1.372 . . . . 0.0 111.367 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.62 -45.47 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 108.372 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -59.05 -40.06 83.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.604 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 11' ' ' ASN . . . -59.97 -42.04 93.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.975 -1.078 . . . . 0.0 110.35 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' LYS . 89.7 m-20 -49.63 -99.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.94 . . . . 0.0 110.068 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 11' ' ' ASN . 8.4 mmmm 32.83 85.45 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.691 -0.631 . . . . 0.0 110.602 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.02 -7.63 4.79 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -61.07 147.23 44.49 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.745 -0.856 . . . . 0.0 109.146 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -133.57 -5.11 2.9 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' O ' ' OD1' ' A' ' 74' ' ' ASN . . . 113.13 31.23 2.5 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.596 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 32.2 ttpt -171.92 -37.19 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.481 -1.011 . . . . 0.0 111.345 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.596 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 98.2 Cg_endo -96.98 108.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 122.432 2.088 . . . . 0.0 113.836 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.439 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -122.74 131.63 53.87 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.574 -0.704 . . . . 0.0 109.101 178.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.19 131.89 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 110.154 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 23' ' ' VAL . 35.4 m -95.76 101.96 13.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.43 0.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.587 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' A' ' 21' ' ' SER . 71.3 t -60.03 -45.43 95.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.911 -1.118 . . . . 0.0 108.272 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -138.47 10.34 2.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.72 89.12 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -146.08 137.84 24.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.107 -1.231 . . . . 0.0 109.81 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.39 129.8 35.32 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.553 ' C ' ' H ' ' A' ' 30' ' ' GLY . 53.6 mt -124.96 77.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.387 -0.821 . . . . 0.0 110.365 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -69.1 40.63 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 109.754 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -151.15 24.03 0.99 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.079 -2.409 . . . . 0.0 107.079 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 m -146.99 150.3 34.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 122.001 -0.705 . . . . 0.0 109.746 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 34' ' ' LEU . 35.5 m -134.67 104.71 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 41.0 p90 39.93 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.86 -0.525 . . . . 0.0 110.865 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.569 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 tt -103.33 118.45 36.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.127 -0.983 . . . . 0.0 108.484 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 36' ' ' ASP . . . 134.03 28.86 0.48 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 70.4 m-20 -155.74 -50.08 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.546 -0.973 . . . . 0.0 109.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 176.16 31.83 0.04 OUTLIER Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.4 ' C ' ' O ' ' A' ' 37' ' ' GLY . 55.4 p-90 -43.4 144.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.2 m -149.16 134.07 17.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.01 170.59 7.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.24 -1.538 . . . . 0.0 109.546 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -151.41 148.27 27.89 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -95.13 134.62 37.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.551 -1.343 . . . . 0.0 109.432 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -109.66 -8.51 14.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.476 -0.765 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 45' ' ' ALA . . . 89.86 103.9 1.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 44' ' ' GLY . . . 86.46 0.57 0.59 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.094 -0.651 . . . . 0.0 110.163 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 45' ' ' ALA . 72.2 m -171.59 116.33 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 108.365 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -91.17 136.28 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.097 -1.002 . . . . 0.0 110.395 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.02 120.7 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.3 147.8 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.651 -1.281 . . . . 0.0 111.559 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.2 m -119.49 147.13 42.8 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.51 -84.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.631 1.554 . . . . 0.0 111.941 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -94.34 -39.44 10.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.011 -1.056 . . . . 0.0 109.921 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -159.4 -164.04 1.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 108.787 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -165.82 100.1 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 110.354 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 57' ' ' LEU . 23.6 p -130.27 151.15 51.1 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.88 -29.15 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.9 mp -84.17 1.29 45.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.701 -1.25 . . . . 0.0 110.041 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.7 m-85 -136.96 -161.03 1.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -151.18 169.29 22.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.839 -1.163 . . . . 0.0 111.58 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.92 175.58 6.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.43 0.633 . . . . 0.0 109.328 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -137.8 134.52 35.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -96.56 108.86 21.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.932 -1.105 . . . . 0.0 111.694 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.5 mt -89.84 131.41 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.636 ' HG ' ' H ' ' A' ' 67' ' ' HIS . 67.1 p -72.63 159.32 34.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.998 -1.064 . . . . 0.0 108.357 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 -50.13 74.99 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.947 -1.095 . . . . 0.0 108.874 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.98 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.301 -1.499 . . . . 0.0 108.55 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.636 ' H ' ' HG ' ' A' ' 64' ' ' SER . 22.7 m170 -60.07 -33.69 72.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.967 -1.083 . . . . 0.0 108.988 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.03 -36.86 78.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.114 -0.991 . . . . 0.0 108.443 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -58.99 -37.38 76.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.85 -39.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 109.348 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.89 -40.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.049 -1.032 . . . . 0.0 109.488 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -64.31 -40.0 95.05 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.659 -1.275 . . . . 0.0 109.74 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -59.9 -44.66 94.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.267 -1.52 . . . . 0.0 109.169 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 8.1 m120 -76.28 -71.86 0.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 111.84 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.7 mp -61.9 -41.68 98.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.02 -1.05 . . . . 0.0 111.93 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ALA . 39.1 tp . . . . . 0 N--CA 1.502 2.135 0 O-C-N 120.913 -1.117 . . . . 0.0 109.434 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.389 0.614 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p -110.86 -0.88 16.72 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -60.54 -50.11 74.85 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.054 0.93 . . . . 0.0 108.67 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.8 m -61.02 -52.25 65.79 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.404 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.3 t -67.08 -43.35 82.8 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.853 -1.155 . . . . 0.0 111.786 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -69.73 -40.33 76.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 112.633 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -74.73 -43.08 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.352 -1.468 . . . . 0.0 111.81 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.99 -52.63 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.864 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -63.61 -38.71 92.15 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.865 -1.147 . . . . 0.0 110.502 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.5 91.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.301 -0.874 . . . . 0.0 111.407 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -88.99 -9.12 52.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.53 -1.356 . . . . 0.0 111.287 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -66.29 131.99 47.37 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.963 -1.085 . . . . 0.0 109.09 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.94 -48.72 0.25 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' GLU . 34.5 ptt180 -169.0 177.46 4.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.016 -1.285 . . . . 0.0 110.226 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' ARG . 13.6 pt-20 -35.77 138.23 0.18 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.673 0.749 . . . . 0.0 109.945 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.05 97.07 0.1 OUTLIER Glycine 0 C--N 1.288 -2.083 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.6 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.583 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER -138.06 -46.81 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.7 -0.882 . . . . 0.0 109.045 178.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.583 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 27.3 Cg_endo -101.25 132.24 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.934 2.423 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.535 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 25.5 ttt -125.9 127.76 46.51 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.07 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.8 mt -109.31 133.58 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.825 0.822 . . . . 0.0 109.829 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.4 p -93.81 101.41 13.51 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.539 -0.726 . . . . 0.0 109.243 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.689 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.88 -10.89 23.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.76 -1.213 . . . . 0.0 109.676 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.32 -40.25 83.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 108.641 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -137.16 5.18 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 57.23 88.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -143.68 137.35 28.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.46 -1.024 . . . . 0.0 108.772 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.23 128.61 33.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.22 74.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.346 -0.846 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -70.32 108.34 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.334 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.74 24.55 0.66 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p -143.64 148.43 35.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 34' ' ' LEU . 36.0 m -128.72 110.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.5 m-85 42.58 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.635 -0.665 . . . . 0.0 109.539 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 32' ' ' VAL . 49.0 tp -91.22 133.36 35.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.448 -0.783 . . . . 0.0 109.828 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.88 19.37 13.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.429 -1.869 . . . . 0.0 108.429 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -143.36 -65.05 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.063 . . . . 0.0 109.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 173.12 66.65 0.05 OUTLIER Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -74.33 154.15 39.01 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.286 -1.126 . . . . 0.0 109.633 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -156.36 150.13 24.91 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.89 170.68 15.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.764 -1.21 . . . . 0.0 109.831 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -165.62 109.06 0.82 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -89.95 126.27 35.67 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.546 -1.347 . . . . 0.0 110.364 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -109.2 0.73 19.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.594 -0.691 . . . . 0.0 110.724 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.06 -117.35 0.96 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.41 -8.6 57.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.312 . . . . 0.0 109.657 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.7 m -120.11 128.26 53.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.332 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -93.2 140.63 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.942 0.877 . . . . 0.0 111.315 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 t -109.37 120.13 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 50' ' ' SER . 56.2 mt -121.48 169.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.389 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.481 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 54.8 m -142.33 99.53 5.87 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 50' ' ' SER . 9.3 Cg_exo -32.25 -79.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.307 2.004 . . . . 0.0 112.156 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -103.0 -41.57 6.08 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -155.55 -165.49 2.0 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -171.95 104.8 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.586 -0.696 . . . . 0.0 109.67 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 58' ' ' PHE . 19.2 p -129.65 148.48 51.54 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -33.15 -25.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.139 -0.35 . . . . 0.0 111.655 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 2.4 mt -81.47 2.09 30.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.634 -1.291 . . . . 0.0 109.187 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 55' ' ' THR . 55.0 m-85 -139.73 -160.7 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 156.07 41.95 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.747 -1.221 . . . . 0.0 110.882 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.25 177.29 9.06 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 109.309 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -126.78 131.37 51.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -88.24 170.09 11.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.587 -1.32 . . . . 0.0 110.277 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -164.95 122.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.7 m -59.5 153.18 20.08 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.381 -1.449 . . . . 0.0 108.324 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.8 -48.63 66.75 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.811 -1.181 . . . . 0.0 109.058 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.94 84.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.347 -1.47 . . . . 0.0 108.775 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -59.78 -27.32 66.46 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.72 -1.192 . . . . 0.0 107.847 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.92 -31.32 69.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.445 -1.409 . . . . 0.0 107.641 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.34 -38.43 83.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.808 -1.183 . . . . 0.0 108.71 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.13 -38.88 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.016 -1.053 . . . . 0.0 109.236 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.62 -40.5 86.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.391 -0.818 . . . . 0.0 110.629 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.06 35.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 111.437 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.45 -37.74 81.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.085 -1.634 . . . . 0.0 111.069 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -62.96 -64.72 0.83 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.113 -0.992 . . . . 0.0 111.685 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 5.9 mp -67.83 -47.1 69.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.101 -0.999 . . . . 0.0 110.821 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.597 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 t -97.75 -5.83 34.16 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.251 -0.906 . . . . 0.0 109.565 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.02 -41.59 92.51 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.447 ' CG2' ' N ' ' A' ' 5' ' ' SER . 6.5 t -79.66 -44.23 21.3 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.897 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.447 ' N ' ' CG2' ' A' ' 4' ' ' THR . 17.6 t -60.31 -53.68 54.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.034 . . . . 0.0 111.307 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.08 -43.16 71.71 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.098 -1.001 . . . . 0.0 112.545 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.99 -43.42 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.698 -1.251 . . . . 0.0 111.67 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 12' ' ' LYS . 1.4 mp -60.85 -52.24 63.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.773 -1.204 . . . . 0.0 109.201 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.18 -39.99 73.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 110.359 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.04 -47.36 85.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.685 -1.259 . . . . 0.0 109.694 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.504 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 77.6 m-20 -98.79 -69.91 0.75 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.918 -1.113 . . . . 0.0 109.212 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 8' ' ' ILE . 17.7 ttpp 60.26 77.67 0.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.796 -0.565 . . . . 0.0 111.568 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.56 26.74 72.49 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.391 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.504 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 36.8 ttm180 -60.83 -56.23 23.62 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.791 -1.417 . . . . 0.0 108.546 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 50.77 86.22 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.72 -113.25 0.3 Allowed Glycine 0 N--CA 1.48 1.614 0 C-N-CA 119.116 -1.516 . . . . 0.0 111.292 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.715 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 67.3 mttt -150.83 -34.58 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.768 -0.842 . . . . 0.0 112.039 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.715 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 66.9 Cg_endo -98.16 140.27 0.47 Allowed 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 122.272 1.981 . . . . 0.0 113.296 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 4.6 ttt -121.32 138.4 54.27 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 20' ' ' ILE . 87.9 mt -107.29 131.78 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.446 -0.784 . . . . 0.0 109.51 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.9 t -93.54 100.32 12.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -10.05 38.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.43 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.76 -40.69 83.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -132.22 -2.79 3.52 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 64.65 85.61 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -143.07 136.29 28.19 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.233 -1.157 . . . . 0.0 110.08 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 58.3 mp0 -82.6 124.63 30.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.1 mt -123.0 73.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.337 -0.852 . . . . 0.0 110.151 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.73 116.78 3.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.204 -0.935 . . . . 0.0 110.261 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.93 26.25 1.74 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.515 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.8 p -135.91 140.25 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.774 -0.839 . . . . 0.0 109.387 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 27.0 m -122.98 98.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 12.8 p90 40.1 26.57 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -96.22 135.24 38.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.661 -0.65 . . . . 0.0 110.692 -178.251 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.44 36.26 1.21 Allowed Glycine 0 N--CA 1.501 2.998 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.37 -85.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.185 . . . . 0.0 110.265 -178.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -147.37 26.28 1.54 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -44.54 148.13 0.52 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.378 -1.072 . . . . 0.0 110.471 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.0 m -148.24 146.95 28.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.07 165.35 27.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.239 -1.538 . . . . 0.0 109.543 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -154.16 130.88 10.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -101.69 125.56 48.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.227 -1.546 . . . . 0.0 110.057 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -99.39 -0.87 40.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 0.0 108.967 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.41 16.39 66.64 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.326 -0.94 . . . . 0.0 110.914 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -161.7 -57.08 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.3 m -122.32 131.73 54.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -92.68 132.91 35.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.292 -0.88 . . . . 0.0 111.137 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.95 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.4 mt -128.19 155.41 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.432 -0.792 . . . . 0.0 109.794 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.8 m -124.97 120.57 25.46 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 22.4 Cg_exo -33.5 -85.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.096 1.864 . . . . 0.0 111.157 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -105.07 -36.97 7.11 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 73.7 mt-10 -164.52 -163.28 0.72 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -169.14 114.78 0.58 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.566 ' C ' ' H ' ' A' ' 57' ' ' LEU . 7.4 p -127.67 41.98 3.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.083 -1.01 . . . . 0.0 109.492 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 70.65 -29.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.566 ' H ' ' C ' ' A' ' 55' ' ' THR . 7.2 mt -82.59 -4.87 58.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.3 -0.875 . . . . 0.0 108.726 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.73 -151.23 0.47 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -150.85 161.89 41.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.799 -1.188 . . . . 0.0 111.329 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.89 173.13 11.48 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' NZ ' ' CE2' ' A' ' 33' ' ' TYR . 36.5 ttpt -134.02 157.9 44.92 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.48 171.18 8.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -165.87 126.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.727 ' HG ' ' H ' ' A' ' 67' ' ' HIS . 59.5 p -57.97 150.11 21.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.225 -1.547 . . . . 0.0 107.033 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.38 -44.9 68.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.746 -1.221 . . . . 0.0 109.131 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.4 -42.52 96.13 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.656 -1.277 . . . . 0.0 109.677 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.727 ' H ' ' HG ' ' A' ' 64' ' ' SER . 12.9 m-70 -54.77 -27.01 38.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.548 -1.345 . . . . 0.0 107.798 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -30.16 68.25 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 107.799 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.57 -33.17 75.07 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.982 -1.074 . . . . 0.0 109.057 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.8 tt -59.92 -32.08 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.675 -1.266 . . . . 0.0 108.886 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.7 -41.16 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.93 75.93 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.948 -1.095 . . . . 0.0 110.846 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -59.85 -50.2 74.74 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.046 -1.034 . . . . 0.0 109.445 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -68.25 -71.33 0.22 Allowed 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 111.309 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 6.6 mp -61.18 -47.92 83.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.506 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 N--CA 1.505 2.308 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.293 179.812 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 p -103.91 -2.16 26.59 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.497 -0.752 . . . . 0.0 109.166 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 tp -60.15 -41.86 93.67 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.2 m -69.05 -51.44 38.91 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.667 -0.646 . . . . 0.0 110.657 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.0 m -69.59 -48.31 60.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.267 -1.52 . . . . 0.0 112.72 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.97 -44.5 72.8 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.595 -1.315 . . . . 0.0 113.115 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.24 -46.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.694 -1.254 . . . . 0.0 111.57 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.537 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -61.0 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 121.146 -0.971 . . . . 0.0 109.1 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.62 -39.49 80.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.77 -40.51 69.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.043 -1.036 . . . . 0.0 109.399 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.51 142.7 15.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -163.64 124.97 2.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.762 -1.211 . . . . 0.0 111.044 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 44.95 49.82 9.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -130.79 68.82 1.47 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.482 -1.01 . . . . 0.0 109.306 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 17' ' ' LYS . 97.2 mt-10 48.37 76.51 0.11 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.975 -1.078 . . . . 0.0 109.942 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -42.56 92.59 0.01 OUTLIER Glycine 0 N--CA 1.496 2.693 0 O-C-N 121.146 -0.971 . . . . 0.0 110.682 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.585 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 5.6 tttm -153.0 -46.38 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.417 -1.049 . . . . 0.0 108.31 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.585 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 86.3 Cg_endo -101.74 118.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 123.436 2.757 . . . . 0.0 112.068 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.6 ttt -121.65 130.44 53.47 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.205 -0.934 . . . . 0.0 109.741 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.4 mt -108.37 130.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.3 t -94.38 99.7 11.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 108.931 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -59.72 -12.57 7.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.6 -41.33 84.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -117.33 -16.11 10.32 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.67 8.72 87.56 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -78.98 158.03 28.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -1.033 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -94.91 128.72 41.9 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.95 78.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.539 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.5 101.46 3.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.861 -1.15 . . . . 0.0 108.977 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.4 24.47 0.3 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -141.61 147.09 37.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -1.022 . . . . 0.0 108.41 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 34' ' ' LEU . 33.0 m -129.38 108.75 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 44.37 23.31 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.379 -0.826 . . . . 0.0 109.305 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' VAL . 29.2 tp -90.39 145.05 25.25 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.472 0.653 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.48 17.22 59.02 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -134.35 -48.06 0.77 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.508 -0.995 . . . . 0.0 110.127 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.81 37.39 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -51.36 139.73 18.74 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.133 -1.216 . . . . 0.0 109.92 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -146.52 137.69 24.32 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.58 166.82 13.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.116 -1.615 . . . . 0.0 108.982 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -141.34 154.51 45.72 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -103.11 134.84 45.87 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.73 -1.231 . . . . 0.0 109.514 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -104.77 -5.52 21.17 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.448 -0.782 . . . . 0.0 110.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.4 56.9 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -169.17 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -1.113 . . . . 0.0 109.409 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.9 m -143.62 119.0 10.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 mm -76.91 138.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.848 -1.157 . . . . 0.0 110.878 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.19 117.12 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 53.7 mt -127.73 139.53 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.357 -0.84 . . . . 0.0 111.735 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.414 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 75.1 m -120.08 121.96 29.23 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' SER . 49.6 Cg_exo -36.21 -78.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 121.886 1.724 . . . . 0.0 111.845 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.15 -40.9 5.71 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.194 -0.941 . . . . 0.0 110.073 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.59 -162.83 0.41 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.144 -0.973 . . . . 0.0 111.296 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' OE2' ' OG ' ' A' ' 50' ' ' SER . 80.7 mt-10 -152.09 104.63 2.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.896 -0.503 . . . . 0.0 111.198 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -107.67 114.34 28.25 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.626 -1.296 . . . . 0.0 109.222 178.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.66 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.884 0.85 . . . . 0.0 110.05 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -64.62 43.39 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 111.025 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 56' ' ' ALA . 55.4 p90 -93.41 -178.17 4.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.38 1.086 . . . . 0.0 111.698 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -137.51 119.75 15.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.895 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.27 177.26 8.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.098 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -131.2 127.27 37.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -101.09 108.04 19.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.935 -1.103 . . . . 0.0 110.966 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.03 140.68 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -69.89 157.98 36.4 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.383 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.36 83.8 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.049 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.81 85.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.44 -1.413 . . . . 0.0 110.516 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -59.5 -24.12 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.85 -39.14 84.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -55.75 -32.55 63.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 70' ' ' ILE . 71.8 mt -60.0 -41.26 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.692 -1.255 . . . . 0.0 108.392 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 71' ' ' ILE . 1.6 mp -64.28 -40.31 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.79 93.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 111.236 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -37.72 58.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.453 -1.405 . . . . 0.0 111.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.86 -49.68 60.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.161 -0.962 . . . . 0.0 112.0 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 9.0 mp -80.33 -55.62 4.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.639 -1.288 . . . . 0.0 110.929 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--N 1.298 -1.67 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.777 -179.325 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.507 ' O ' ' CG2' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER 157.69 -75.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.07 -47.74 84.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 m -61.02 -50.04 74.96 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.054 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m -75.0 -54.21 7.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.865 -1.147 . . . . 0.0 112.907 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 2' ' ' THR . 61.7 mm-40 -64.77 -41.21 96.03 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.624 -1.298 . . . . 0.0 112.928 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.562 ' CG1' ' CH2' ' A' ' 38' ' ' TRP . 94.0 t -69.91 -47.79 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.341 -1.474 . . . . 0.0 111.373 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.2 mp -61.71 -42.91 96.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.283 -0.886 . . . . 0.0 110.626 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -65.78 -41.4 92.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.653 -1.279 . . . . 0.0 109.782 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.11 -22.43 66.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.36 99.26 3.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.055 -1.028 . . . . 0.0 109.329 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 14' ' ' ARG . 4.6 mmmm -93.45 169.91 10.0 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.89 39.88 0.11 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 12' ' ' LYS . 7.6 ptm180 -90.88 75.02 6.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.133 -1.216 . . . . 0.0 109.322 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ARG . 58.0 mp0 57.88 113.87 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.77 110.37 3.03 Favored Glycine 0 N--CA 1.481 1.656 0 O-C-N 120.994 -1.066 . . . . 0.0 110.613 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.573 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 7.5 tttp -167.12 -43.36 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.769 -0.842 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.573 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 80.5 Cg_endo -99.88 115.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 123.328 2.685 . . . . 0.0 111.714 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -111.46 141.88 44.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.378 -0.826 . . . . 0.0 109.696 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.602 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.5 mm -110.61 133.19 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 25' ' ' GLY . 20.3 m -105.92 100.48 10.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.449 -0.782 . . . . 0.0 109.067 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.433 HD11 ' H ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.84 -15.99 63.65 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.07 -46.5 94.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -124.9 2.21 8.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.627 -0.671 . . . . 0.0 109.228 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 56.47 78.99 0.1 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.33 135.4 28.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.267 -1.137 . . . . 0.0 109.283 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.45 126.81 32.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 0.0 108.637 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.458 HG21 ' H ' ' A' ' 30' ' ' GLY . 55.3 mt -113.02 162.6 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -147.7 36.19 0.87 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' H ' HG21 ' A' ' 28' ' ' ILE . . . -155.42 30.03 0.63 Allowed Glycine 0 C--N 1.293 -1.818 0 N-CA-C 106.289 -2.724 . . . . 0.0 106.289 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.437 ' OG1' ' CG2' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -133.41 138.09 46.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.524 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -131.87 102.65 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER 44.62 54.66 6.37 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.67 117.91 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.868 -1.145 . . . . 0.0 109.498 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.472 ' N ' ' CD1' ' A' ' 38' ' ' TRP . . . 142.21 22.18 0.23 Allowed Glycine 0 N--CA 1.501 3.016 0 O-C-N 120.995 -1.066 . . . . 0.0 110.887 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.682 ' N ' ' HE1' ' A' ' 38' ' ' TRP . 65.0 m-20 -157.81 -85.86 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.785 -1.421 . . . . 0.0 110.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -142.21 22.08 2.43 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.682 ' HE1' ' N ' ' A' ' 36' ' ' ASP . 2.3 m95 -57.6 147.59 26.7 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.586 0.707 . . . . 0.0 110.633 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 t -156.35 154.1 30.04 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.53 166.68 24.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.597 -1.315 . . . . 0.0 109.049 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -144.91 155.04 43.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -100.64 133.05 45.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.706 -1.246 . . . . 0.0 108.694 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.08 -11.86 15.54 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.418 -0.802 . . . . 0.0 109.98 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 45' ' ' ALA . . . 95.89 107.35 2.27 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 44' ' ' GLY . . . 80.3 -4.24 1.87 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.787 -0.831 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.2 m -166.16 120.59 1.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 mm -95.69 137.87 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.8 t -109.38 123.29 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.156 -0.965 . . . . 0.0 110.801 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.679 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -106.12 120.8 47.65 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 177.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.679 ' O ' ' O ' ' A' ' 50' ' ' SER . 31.1 Cg_exo -36.9 -112.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.144 1.896 . . . . 0.0 111.184 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -76.89 -31.61 56.86 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -171.79 -161.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.008 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -156.4 110.33 2.73 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.763 -0.585 . . . . 0.0 109.513 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.532 ' O ' ' C ' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -111.1 116.3 30.89 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.816 -1.177 . . . . 0.0 109.38 179.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.532 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 26.2 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.966 0.888 . . . . 0.0 110.497 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.2 43.61 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.871 -0.518 . . . . 0.0 111.247 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' HB3' ' N ' ' A' ' 55' ' ' THR . 47.2 p90 -92.34 178.7 5.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.839 -1.163 . . . . 0.0 111.467 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 102.92 6.81 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 173.39 3.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 109.795 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -144.21 131.31 20.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -111.49 117.23 32.44 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.201 -0.937 . . . . 0.0 111.081 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.25 138.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -73.16 160.0 32.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.726 -1.233 . . . . 0.0 108.601 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.78 91.69 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.809 -1.182 . . . . 0.0 110.0 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.88 92.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.8 -1.188 . . . . 0.0 109.361 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -60.33 -25.21 65.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.35 -40.23 77.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -58.16 -28.63 64.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 109.227 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 70' ' ' ILE . 72.2 mt -60.06 -39.86 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.703 -1.248 . . . . 0.0 108.556 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.423 HG23 HD13 ' A' ' 71' ' ' ILE . 82.5 mt -59.93 -39.94 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 108.997 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.53 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.986 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -60.0 -46.57 89.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.724 -1.235 . . . . 0.0 109.227 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -68.38 -74.22 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.866 -0.521 . . . . 0.0 111.166 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 2.8 mp -61.21 -46.59 89.8 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.705 -1.247 . . . . 0.0 111.226 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.014 -1.054 . . . . 0.0 109.127 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.519 ' O ' ' CG2' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 156.89 -85.64 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.17 -50.15 74.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.0 m -61.42 -49.55 76.4 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.434 ' HG ' ' H ' ' A' ' 6' ' ' GLU . 87.8 p -70.39 -48.04 58.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.911 -1.118 . . . . 0.0 112.384 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.434 ' H ' ' HG ' ' A' ' 5' ' ' SER . 69.8 mm-40 -69.6 -42.25 74.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 112.617 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.76 -45.77 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.558 -1.338 . . . . 0.0 110.576 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mp -60.42 -45.31 96.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.414 ' HZ1' ' CB ' ' A' ' 9' ' ' LYS . 10.0 mtpm? -60.64 -40.49 92.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.641 -1.287 . . . . 0.0 111.441 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -27.93 67.77 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.569 -1.332 . . . . 0.0 109.425 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.633 ' ND2' ' CZ ' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -160.28 140.26 11.36 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.026 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -160.27 118.6 2.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.1 -1.0 . . . . 0.0 110.227 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.72 35.57 24.9 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' O ' ' OH ' ' A' ' 33' ' ' TYR . 44.2 ttp180 -149.03 44.75 0.99 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.033 -1.275 . . . . 0.0 109.066 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -66.5 105.83 1.6 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.125 -0.984 . . . . 0.0 110.888 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.5 -68.19 0.04 OUTLIER Glycine 0 N--CA 1.498 2.775 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.759 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -174.56 -20.82 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.215 -1.168 . . . . 0.0 112.782 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.759 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 90.3 Cg_endo -88.8 110.21 0.54 Allowed 'Trans proline' 0 N--CA 1.485 1.02 0 CA-C-N 121.251 1.483 . . . . 0.0 112.203 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.9 ttt -102.74 147.29 27.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.718 -0.614 . . . . 0.0 109.708 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.88 120.99 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.616 -0.678 . . . . 0.0 109.546 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 p -98.24 96.23 7.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.46 -17.84 64.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.2 t -59.68 -42.87 89.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -128.76 2.82 5.43 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.24 79.66 0.08 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.9 138.53 28.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.29 -1.123 . . . . 0.0 109.759 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 4.1 tm-20 -81.31 120.93 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.95 67.99 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 109.71 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 46.0 pttt -60.24 102.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.442 1.115 . . . . 0.0 110.308 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.627 ' C ' HD22 ' A' ' 74' ' ' ASN . . . 136.45 25.49 0.46 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 98.7 m -138.48 140.96 39.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.507 -0.996 . . . . 0.0 108.5 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -118.55 80.5 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.459 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CZ ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER 42.37 25.6 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' VAL . 54.9 tp -85.12 129.87 34.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.872 . . . . 0.0 109.79 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 36' ' ' ASP . . . 124.83 -75.24 0.4 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' GLY . 78.4 m-20 -31.59 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.866 -0.785 . . . . 0.0 111.498 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . -134.87 16.44 4.24 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.47 ' C ' ' O ' ' A' ' 37' ' ' GLY . 3.7 t90 -26.34 138.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.969 0.414 . . . . 0.0 111.793 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -159.46 144.51 15.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.852 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.05 168.59 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.525 -1.359 . . . . 0.0 109.195 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -153.73 159.54 42.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -104.97 120.97 42.77 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.026 -1.046 . . . . 0.0 110.409 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -100.9 -2.81 31.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.12 -0.988 . . . . 0.0 110.71 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.5 -114.56 1.24 Allowed Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.44 -9.8 59.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -1.027 . . . . 0.0 110.546 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.9 m -129.15 140.12 51.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.3 mm -108.09 139.85 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 110.104 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.2 120.28 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.557 -0.715 . . . . 0.0 109.278 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.66 141.29 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.817 -1.177 . . . . 0.0 110.802 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 51' ' ' PRO . 95.0 p -111.77 127.09 27.37 Favored Pre-proline 0 N--CA 1.482 1.129 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 50' ' ' SER . 52.6 Cg_exo -34.83 -81.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.961 1.774 . . . . 0.0 112.619 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -106.03 -41.64 5.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 79.3 mt-10 -158.62 -165.42 1.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.066 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -172.25 113.27 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 57' ' ' LEU . 19.0 p -126.94 38.46 4.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.293 -0.879 . . . . 0.0 110.415 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 73.85 -24.92 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.93 -1.106 . . . . 0.0 109.57 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 55' ' ' THR . 6.4 mt -87.8 -3.29 58.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -132.47 -156.47 0.75 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -150.74 158.57 44.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.449 -1.407 . . . . 0.0 111.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.23 174.46 8.74 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.19 128.25 33.63 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -81.55 167.05 19.7 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.98 -1.075 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.2 tt -169.69 118.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.699 ' HG ' ' HD1' ' A' ' 67' ' ' HIS . 60.1 p -58.54 151.19 20.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 110.913 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -53.81 -41.44 67.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.98 94.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.5 -1.375 . . . . 0.0 109.267 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.699 ' HD1' ' HG ' ' A' ' 64' ' ' SER . 18.6 m80 -61.52 -25.1 67.06 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.404 ' CB ' ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -57.04 -28.45 62.55 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.34 -34.64 74.91 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.875 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.6 tt -59.56 -36.51 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.479 -1.289 . . . . 0.0 108.427 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.1 mt -60.32 -45.19 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.87 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.82 67.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.055 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -62.26 -39.33 92.53 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.478 -1.389 . . . . 0.0 108.663 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.627 HD22 ' C ' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -69.59 -68.14 0.43 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.697 -0.627 . . . . 0.0 110.761 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.1 -51.2 70.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 0.0 111.221 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.3 -1.58 0 O-C-N 120.799 -1.188 . . . . 0.0 109.219 -179.334 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.469 ' O ' ' CB ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.469 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER 162.05 -82.73 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.5 tp -59.92 -48.88 79.9 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.9 m -64.01 -51.82 62.45 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.329 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 t -70.95 -52.39 20.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.801 -1.187 . . . . 0.0 111.489 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 2' ' ' THR . 36.4 tp10 -61.01 -46.09 92.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.972 -1.08 . . . . 0.0 112.665 -177.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.431 ' O ' ' OD1' ' A' ' 11' ' ' ASN . 64.3 t -67.91 -49.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 112.078 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.01 -45.63 95.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 110.693 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.99 -40.11 88.03 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.981 -1.074 . . . . 0.0 110.931 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -19.93 65.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.83 -1.169 . . . . 0.0 111.769 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.549 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -124.77 52.5 1.55 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.996 -1.065 . . . . 0.0 111.263 -178.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -86.67 58.95 5.35 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.571 -1.33 . . . . 0.0 110.018 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.18 36.3 0.03 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.522 ' NH2' ' H ' ' A' ' 20' ' ' ILE . 5.6 tpp180 -74.19 138.89 44.06 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.403 -1.057 . . . . 0.0 109.508 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -70.44 -39.9 74.08 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 57.26 0.26 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.517 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -175.59 -46.05 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.412 -1.052 . . . . 0.0 109.463 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 72.0 Cg_endo -90.57 128.6 1.42 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.31 2.007 . . . . 0.0 111.675 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -123.02 128.7 50.53 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.522 ' H ' ' NH2' ' A' ' 14' ' ' ARG . 87.1 mt -110.49 130.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.067 -1.021 . . . . 0.0 109.465 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' GLY . 67.6 m -88.72 99.78 12.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.721 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -61.95 -13.05 21.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.35 -0.844 . . . . 0.0 109.151 -179.23 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.11 -47.64 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 108.604 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 52.7 t0 -123.42 7.56 9.0 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.93 84.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -142.39 135.5 28.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.476 -1.014 . . . . 0.0 109.936 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -77.13 121.08 23.09 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.8 mt -119.99 69.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -61.64 106.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.989 -1.069 . . . . 0.0 108.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.08 18.75 0.93 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.642 ' N ' HD22 ' A' ' 74' ' ' ASN . 0.5 OUTLIER -141.66 146.8 36.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -1.046 . . . . 0.0 108.437 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -131.23 111.46 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 44.63 21.63 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 0.0 109.224 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' VAL . 34.5 tp -85.82 149.34 25.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.83 79.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.47 -63.37 1.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.618 -0.93 . . . . 0.0 109.355 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.69 39.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -59.74 155.38 16.06 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.499 -1.0 . . . . 0.0 110.507 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -146.43 149.68 34.18 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.93 169.39 17.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.238 -1.539 . . . . 0.0 109.782 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -159.95 136.2 8.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -109.03 122.85 48.13 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.657 -1.277 . . . . 0.0 111.469 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 10.7 t70 -96.69 -6.84 35.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.658 -0.651 . . . . 0.0 110.687 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.61 15.66 42.49 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.743 -1.223 . . . . 0.0 110.813 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -171.12 -55.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.305 . . . . 0.0 108.647 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.3 m -120.12 129.99 54.42 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -91.34 140.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.8 . . . . 0.0 111.959 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 t -103.61 111.58 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -129.67 140.17 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.5 m -112.66 121.58 38.36 Favored Pre-proline 0 N--CA 1.483 1.222 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 50' ' ' SER . 30.8 Cg_exo -35.27 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 122.263 1.975 . . . . 0.0 112.154 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -107.98 -41.52 4.93 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -166.43 -163.41 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.609 0.719 . . . . 0.0 109.943 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 56' ' ' ALA . 3.9 tm-20 -172.05 116.27 0.36 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 57' ' ' LEU . 6.6 p -122.15 38.1 4.22 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.155 -0.966 . . . . 0.0 110.338 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 73.66 -18.68 0.37 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.95 . . . . 0.0 109.383 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 55' ' ' THR . 14.0 mt -93.51 0.09 56.56 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -130.13 -153.34 0.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -145.34 159.62 42.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.998 -1.064 . . . . 0.0 110.818 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.47 174.65 11.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -136.46 106.95 6.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -73.29 175.86 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.431 HG22 HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -166.7 122.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.705 ' HG ' ' HD1' ' A' ' 67' ' ' HIS . 76.9 p -54.67 148.42 12.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.568 -1.332 . . . . 0.0 108.229 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.01 -44.92 64.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.99 -1.069 . . . . 0.0 109.158 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.11 79.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 119.992 -1.693 . . . . 0.0 109.967 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.705 ' HD1' ' HG ' ' A' ' 64' ' ' SER . 31.6 m80 -61.67 -23.57 66.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.558 -1.339 . . . . 0.0 108.668 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.95 -33.47 71.97 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -62.59 -37.18 85.23 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 70' ' ' ILE . 46.8 mt -60.03 -38.86 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.099 -1.001 . . . . 0.0 109.724 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.9 mt -59.92 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.824 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.76 76.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.728 -1.232 . . . . 0.0 110.478 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -61.62 -41.91 98.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.448 -1.408 . . . . 0.0 109.597 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.642 HD22 ' N ' ' A' ' 31' ' ' THR . 57.1 t30 -60.71 -61.62 2.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.715 -0.616 . . . . 0.0 111.194 -177.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -60.25 -40.04 88.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.629 -1.295 . . . . 0.0 110.361 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--N 1.297 -1.682 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.789 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.187 0.517 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p -102.56 -5.54 23.82 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.334 -0.854 . . . . 0.0 109.415 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.51 -54.71 31.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.3 m -62.49 -50.31 71.93 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -70.31 -43.67 69.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.123 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -70.05 -41.75 73.77 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.698 -1.252 . . . . 0.0 112.131 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.09 -50.3 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.531 -1.356 . . . . 0.0 111.087 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.4 mp -60.05 -48.08 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.019 -1.051 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.01 -39.04 84.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.32 -22.18 63.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.2 t30 -152.56 126.92 9.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.732 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' A' ' 14' ' ' ARG . 57.1 pttt -175.01 162.17 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.466 -0.771 . . . . 0.0 109.866 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.56 -27.54 1.56 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.499 ' H ' ' C ' ' A' ' 12' ' ' LYS . 54.4 ttm-85 -95.02 127.0 40.75 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -43.95 -64.0 0.75 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.17 0.509 . . . . 0.0 110.321 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.8 83.31 0.05 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.043 -1.551 . . . . 0.0 110.757 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -125.96 -52.2 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.439 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 18.4 Cg_endo -103.62 130.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.568 2.845 . . . . 0.0 110.678 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 ttt -132.06 126.23 33.33 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.878 -1.139 . . . . 0.0 110.012 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.79 129.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.717 0.77 . . . . 0.0 109.925 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 25' ' ' GLY . 13.6 p -87.82 100.7 13.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.73 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.39 -13.82 6.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.9 t -59.99 -44.98 95.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -125.64 0.26 7.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 66.61 13.33 60.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -75.89 137.18 40.23 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.22 138.34 31.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.475 -0.766 . . . . 0.0 110.274 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 28' ' ' ILE . 63.8 mt -122.45 158.1 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -140.83 36.6 1.79 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.083 -1.636 . . . . 0.0 107.576 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.63 28.46 0.54 Allowed Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.0 p -135.51 142.26 45.41 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.054 0.93 . . . . 0.0 110.146 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 34' ' ' LEU . 16.4 m -121.0 88.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 35.4 p90 40.08 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.538 0.685 . . . . 0.0 109.238 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 32' ' ' VAL . 47.1 tp -73.26 135.15 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.675 -0.64 . . . . 0.0 109.572 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . 73.1 147.28 0.85 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 6.5 m-20 95.92 19.95 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 123.295 0.638 . . . . 0.0 110.129 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 123.71 -11.38 8.38 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 37' ' ' GLY . 5.8 p-90 -32.26 126.14 0.28 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.39 0.614 . . . . 0.0 111.013 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 t -152.93 140.23 19.53 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.52 175.02 11.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.157 -1.589 . . . . 0.0 109.868 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -161.19 159.9 29.41 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -110.41 121.47 45.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.995 -1.066 . . . . 0.0 109.708 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 43' ' ' ASP . 4.4 p30 -100.66 -1.02 36.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.56 -120.04 1.36 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.41 -7.75 59.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -1.112 . . . . 0.0 110.317 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.7 m -123.47 130.82 53.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.82 141.93 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.14 119.63 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mt -131.66 146.96 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.287 -0.883 . . . . 0.0 110.917 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 15.8 m -118.12 111.49 38.68 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 102.467 -3.161 . . . . 0.0 102.467 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.1 Cg_exo -33.34 -75.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.023 1.815 . . . . 0.0 111.386 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -106.15 -47.07 3.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.71 -165.99 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.497 ' OE2' ' N ' ' A' ' 60' ' ' ALA . 62.2 tt0 -175.11 114.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.572 ' C ' ' H ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -118.19 36.47 4.34 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.069 -1.019 . . . . 0.0 109.879 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 72.59 -21.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 0.0 109.042 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.572 ' H ' ' C ' ' A' ' 55' ' ' THR . 40.9 mt -91.03 0.02 57.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -128.51 -135.95 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -155.28 155.1 33.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.708 -1.245 . . . . 0.0 111.789 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.497 ' N ' ' OE2' ' A' ' 54' ' ' GLU . . . -86.37 177.44 7.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -139.51 150.77 45.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -115.77 173.16 6.7 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.228 -0.92 . . . . 0.0 108.995 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -168.41 111.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -48.42 155.1 0.55 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.08 -1.013 . . . . 0.0 109.068 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.82 -48.15 78.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.052 -1.03 . . . . 0.0 108.603 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.98 87.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.16 -1.588 . . . . 0.0 108.767 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -59.24 -28.11 66.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.866 -1.146 . . . . 0.0 108.32 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.83 -30.06 68.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -60.39 -37.14 79.85 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.09 -38.74 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.394 -0.816 . . . . 0.0 109.391 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 71' ' ' ILE . 1.4 mp -58.35 -39.9 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 108.281 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.445 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -66.1 -40.03 90.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 111.096 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.13 -48.07 72.05 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.625 -1.297 . . . . 0.0 111.174 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -59.98 -52.67 64.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 112.029 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 4.4 mp -69.91 -42.1 73.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.302 -1.498 . . . . 0.0 110.459 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' OXT' ' O ' ' A' ' 72' ' ' ALA . 2.3 pp . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.7 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p -97.23 -1.42 44.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.281 -0.887 . . . . 0.0 108.853 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.16 -45.74 92.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.015 0.912 . . . . 0.0 108.78 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.4 m -61.2 -54.41 44.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 110.847 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.3 t -70.19 -48.34 57.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.834 -1.166 . . . . 0.0 112.067 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.15 -46.63 86.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.804 -1.185 . . . . 0.0 112.98 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.3 -48.12 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 112.155 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.463 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.4 mp -61.32 -47.78 91.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.667 -1.271 . . . . 0.0 109.934 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.3 -40.12 89.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.889 -1.132 . . . . 0.0 110.755 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.92 86.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.827 -1.171 . . . . 0.0 109.039 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.474 ' CG ' ' H ' ' A' ' 20' ' ' ILE . 35.2 m120 -135.29 114.85 12.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 110.081 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.571 ' C ' ' H ' ' A' ' 14' ' ' ARG . 52.5 tttm -89.71 169.67 11.1 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.79 27.29 0.14 Allowed Glycine 0 N--CA 1.488 2.141 0 O-C-N 120.536 -1.353 . . . . 0.0 110.81 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.571 ' H ' ' C ' ' A' ' 12' ' ' LYS . 11.1 ptm180 -70.19 88.11 0.61 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.647 -1.502 . . . . 0.0 108.305 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 14' ' ' ARG . 44.5 mt-10 48.87 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.959 -1.088 . . . . 0.0 109.244 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.06 101.49 0.27 Allowed Glycine 0 N--CA 1.487 2.051 0 O-C-N 121.056 -1.027 . . . . 0.0 110.701 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 2.0 mtmt -153.89 -52.73 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD2' ' H ' ' A' ' 17' ' ' LYS . 35.1 Cg_endo -95.12 126.2 0.39 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.313 2.009 . . . . 0.0 110.595 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.66 136.86 54.27 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 110.942 -178.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.499 ' O ' ' SD ' ' A' ' 19' ' ' MET . 27.7 mm -100.09 128.1 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.8 t -102.52 103.92 14.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.419 -0.8 . . . . 0.0 108.88 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.405 ' H ' HD11 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -69.4 -7.28 36.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -47.55 91.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -128.73 11.59 6.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.99 83.27 0.04 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -150.36 139.72 21.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -1.014 . . . . 0.0 109.519 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -84.83 139.09 32.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 109.08 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 71.0 mt -122.78 158.56 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -144.61 42.46 1.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.3 32.41 0.19 Allowed Glycine 0 C--N 1.294 -1.801 0 N-CA-C 106.313 -2.715 . . . . 0.0 106.313 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 m -136.79 142.64 42.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.784 0.802 . . . . 0.0 109.879 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.55 73.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 12' ' ' LYS . 14.5 m-85 53.84 23.27 3.72 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.75 123.71 24.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . 78.64 158.49 12.22 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 10.2 m-20 93.94 7.09 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 C-N-CA 123.105 0.562 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 130.53 -3.77 5.81 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.462 ' C ' ' O ' ' A' ' 37' ' ' GLY . 10.1 p-90 -29.92 138.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.423 0.63 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.8 m -151.01 139.88 20.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.99 167.53 21.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.566 -1.334 . . . . 0.0 109.867 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -161.41 125.82 3.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -102.93 130.11 49.88 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.748 -1.22 . . . . 0.0 110.885 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -107.52 -11.31 15.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.645 -0.659 . . . . 0.0 109.716 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.03 2.32 89.5 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.97 -31.24 0.5 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -1.127 . . . . 0.0 109.433 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.4 m -157.22 118.66 3.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.18 122.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.346 -0.846 . . . . 0.0 111.535 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 t -95.61 99.16 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 142.32 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.426 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.1 p -117.11 149.57 44.55 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.56 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.408 1.405 . . . . 0.0 112.077 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -90.61 -45.85 8.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.884 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -167.44 1.17 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.273 -1.517 . . . . 0.0 111.486 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 28.2 mp0 -150.44 98.48 2.66 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 57' ' ' LEU . 4.1 p -129.99 144.29 51.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -25.13 -29.21 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.8 mp -83.61 -10.2 58.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.62 -1.3 . . . . 0.0 110.242 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CG ' ' N ' ' A' ' 59' ' ' LYS . 23.1 t80 -138.46 -164.55 1.65 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.282 -0.886 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -154.9 170.79 20.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.998 -1.064 . . . . 0.0 110.904 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.68 175.34 8.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.501 0.667 . . . . 0.0 110.404 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -128.77 141.77 51.21 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -86.71 169.29 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.046 -1.034 . . . . 0.0 110.592 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -162.91 127.87 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.091 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.8 m -61.19 154.9 22.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.277 -1.514 . . . . 0.0 108.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.75 68.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.654 -1.278 . . . . 0.0 109.401 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.93 87.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.695 -1.253 . . . . 0.0 109.153 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -55.04 -27.26 43.19 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.889 -1.132 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -33.67 72.19 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -59.95 -35.4 74.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.405 HD12 HG23 ' A' ' 70' ' ' ILE . 82.0 mt -59.64 -39.75 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.91 . . . . 0.0 108.929 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.88 -39.94 78.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.216 -0.927 . . . . 0.0 108.997 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.82 -41.56 99.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 111.106 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . 6.4 mtmp? -65.94 -50.04 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.047 -1.033 . . . . 0.0 111.011 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.87 -43.63 94.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.462 -0.773 . . . . 0.0 111.987 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 5.7 mp -80.92 -22.51 39.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.43 -1.419 . . . . 0.0 110.326 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.11 -0.994 . . . . 0.0 109.96 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.9 p -103.67 -6.82 21.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.612 -0.68 . . . . 0.0 109.755 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.99 -45.15 95.95 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.41 ' OG1' ' OE1' ' A' ' 53' ' ' GLU . 22.5 m -62.26 -54.88 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.855 -0.528 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -71.95 -48.65 43.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.574 -1.329 . . . . 0.0 112.0 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.81 -42.58 90.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.02 -1.05 . . . . 0.0 112.791 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 96.7 t -69.81 -48.36 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.323 -1.486 . . . . 0.0 111.225 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.437 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.4 mp -60.24 -47.91 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -63.71 -40.23 96.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.032 -1.042 . . . . 0.0 110.091 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.22 72.28 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.093 -1.005 . . . . 0.0 108.384 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.26 109.45 5.08 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 14' ' ' ARG . 62.1 mttp -77.01 -179.73 5.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.65 40.25 0.95 Allowed Glycine 0 N--CA 1.491 2.304 0 O-C-N 120.877 -1.139 . . . . 0.0 110.375 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 15' ' ' GLU . 7.9 ptm180 -80.53 86.87 5.76 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.371 -1.076 . . . . 0.0 108.29 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' ARG . 52.4 tp10 53.24 105.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.743 . . . . 0.0 109.61 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.32 93.71 0.45 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER -145.32 -51.85 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.346 -1.09 . . . . 0.0 108.996 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 61.2 Cg_endo -95.95 129.7 0.4 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.001 1.8 . . . . 0.0 111.349 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 124.82 46.75 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -109.41 128.09 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.79 . . . . 0.0 109.037 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 23' ' ' VAL . 8.8 t -91.67 99.27 12.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.703 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -59.13 -8.59 1.59 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 21' ' ' SER . 54.4 t -60.83 -41.12 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -123.28 -14.35 7.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.56 15.58 79.41 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -83.16 150.3 26.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -1.106 . . . . 0.0 111.776 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -91.66 130.99 37.37 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.73 74.39 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.53 -0.731 . . . . 0.0 109.864 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -68.5 108.48 3.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.853 -1.154 . . . . 0.0 108.925 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.91 21.77 0.87 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.3 p -143.62 150.92 39.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -1.068 . . . . 0.0 108.316 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 32' ' ' VAL . 32.7 m -127.1 89.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.448 -0.783 . . . . 0.0 109.178 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 57.78 19.94 6.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.112 -0.993 . . . . 0.0 109.918 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.1 tp -73.15 141.19 47.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 108.908 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.16 58.84 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.15 -138.51 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -102.22 24.32 31.5 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' GLY . 10.9 t90 -38.57 128.33 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.729 0.775 . . . . 0.0 110.891 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.5 t -151.09 137.71 18.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.11 173.12 17.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.304 -1.497 . . . . 0.0 110.208 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -151.97 153.79 34.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -101.26 120.79 40.78 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.707 -1.245 . . . . 0.0 109.131 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 49.1 t0 -100.69 -6.62 24.83 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.84 -117.33 0.97 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.029 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.9 17.94 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.961 . . . . 0.0 109.358 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.1 m -150.91 116.08 5.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.79 140.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 111.144 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.91 129.28 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.2 147.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.441 -1.412 . . . . 0.0 111.274 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -112.3 121.32 39.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 177.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -36.06 -75.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.032 1.821 . . . . 0.0 111.731 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -104.83 -47.97 3.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.207 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.41 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 5.0 mt-10 -160.75 -166.48 1.62 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.361 -0.837 . . . . 0.0 109.953 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -173.14 116.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 4.9 p -89.88 -78.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.927 -1.108 . . . . 0.0 108.886 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' C ' ' H ' ' A' ' 58' ' ' PHE . . . -149.12 -76.03 0.16 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.467 ' CD2' ' H ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -64.86 22.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.394 -0.816 . . . . 0.0 109.871 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.604 ' H ' ' C ' ' A' ' 56' ' ' ALA . 22.7 m-85 -99.04 -175.67 3.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.783 -1.198 . . . . 0.0 108.366 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 138.94 53.89 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.964 0.888 . . . . 0.0 111.829 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.32 177.75 7.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -136.67 126.27 25.33 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.856 -1.153 . . . . 0.0 108.542 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -84.04 162.16 20.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mt -151.08 112.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 67' ' ' HIS . 79.7 p -62.81 152.18 36.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.755 -1.215 . . . . 0.0 108.358 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.59 69.17 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.773 -1.205 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.04 82.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.426 -1.422 . . . . 0.0 108.774 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.619 ' H ' ' HG ' ' A' ' 64' ' ' SER . 32.8 t-80 -60.2 -35.34 75.18 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.841 -1.162 . . . . 0.0 109.507 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.19 -34.45 66.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -60.53 -40.05 90.06 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mt -61.43 -32.01 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.33 -39.72 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.047 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 76' ' ' LEU . . . -68.27 -36.23 79.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.994 -1.066 . . . . 0.0 109.732 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.07 -46.58 89.09 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.036 -1.04 . . . . 0.0 108.855 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -76.26 -74.19 0.24 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.7 -0.625 . . . . 0.0 110.835 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.508 ' CD1' ' H ' ' A' ' 75' ' ' LEU . 6.7 mp -60.22 -44.58 95.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.952 -1.093 . . . . 0.0 111.309 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 72' ' ' ALA . 21.9 mt . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.602 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p -102.33 -0.07 33.35 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.283 -0.886 . . . . 0.0 110.282 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 3.8 tt -60.11 -48.34 82.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.836 -1.165 . . . . 0.0 109.253 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m -78.67 -50.52 11.3 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.494 0.664 . . . . 0.0 110.579 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -66.35 -52.86 42.69 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 112.561 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.55 -42.04 78.93 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.346 -1.471 . . . . 0.0 112.785 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 3' ' ' LEU . 95.7 t -61.15 -48.94 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.128 -0.983 . . . . 0.0 111.451 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.87 -40.34 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.411 -0.805 . . . . 0.0 109.905 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -58.68 -45.18 90.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.1 -1.0 . . . . 0.0 110.831 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 -47.04 87.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.746 -1.221 . . . . 0.0 111.087 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 5.3 p-10 -88.81 -76.56 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.672 -1.268 . . . . 0.0 110.681 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt 49.61 48.69 21.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.546 -1.346 . . . . 0.0 108.545 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.37 40.32 0.02 OUTLIER Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 18' ' ' PRO . 6.6 tpt180 -55.56 118.41 4.46 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.945 0.879 . . . . 0.0 109.632 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -76.79 -36.8 56.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.7 23.21 5.12 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.632 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 15.8 mttt -151.71 -41.6 0.01 OUTLIER Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.548 -0.972 . . . . 0.0 111.013 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.632 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 75.5 Cg_endo -92.98 120.66 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.742 2.294 . . . . 0.0 113.513 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.0 tpt -121.5 123.41 41.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.542 -0.724 . . . . 0.0 110.544 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.2 mt -118.21 129.6 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLY . 29.9 t -91.13 99.14 12.2 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.733 ' CD1' ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.19 -7.33 8.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.11 -45.85 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -128.95 8.58 5.69 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.27 91.25 0.01 OUTLIER Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -143.56 137.15 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.372 -1.075 . . . . 0.0 109.042 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 57.9 mp0 -81.71 123.47 28.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.098 -1.001 . . . . 0.0 108.887 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.448 ' C ' ' H ' ' A' ' 30' ' ' GLY . 50.1 mt -127.44 75.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.183 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -74.06 45.42 0.21 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.69 -1.256 . . . . 0.0 108.961 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -147.99 22.3 1.43 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -152.38 158.92 43.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 34' ' ' LEU . 14.4 m -133.44 112.6 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.321 -0.862 . . . . 0.0 108.974 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 32.5 p90 39.85 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.528 0.68 . . . . 0.0 109.369 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -81.93 129.01 34.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -178.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 36' ' ' ASP . . . 127.35 -83.47 0.34 Allowed Glycine 0 N--CA 1.499 2.884 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 17.0 p-10 -32.92 -106.82 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.668 0.747 . . . . 0.0 111.895 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -123.23 30.11 5.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' GLY . 21.0 p-90 -31.71 132.68 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.872 0.844 . . . . 0.0 111.183 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -153.86 146.34 24.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 173.36 11.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.277 -1.514 . . . . 0.0 109.36 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -163.49 135.21 4.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -110.95 123.7 50.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.854 -1.154 . . . . 0.0 108.417 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 10.3 t70 -106.3 -10.05 16.55 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.362 -0.836 . . . . 0.0 111.305 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.45 -122.27 1.37 Allowed Glycine 0 N--CA 1.503 3.101 0 O-C-N 120.607 -1.308 . . . . 0.0 109.886 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.11 22.93 1.33 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -1.166 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 m -154.75 113.42 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mm -88.24 136.23 23.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.332 -0.855 . . . . 0.0 111.998 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.4 t -112.91 120.11 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.51 147.95 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 34.4 t -115.9 129.11 25.44 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.83 -76.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.597 1.531 . . . . 0.0 112.229 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.93 -49.99 4.58 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.023 -1.048 . . . . 0.0 112.318 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' O ' ' OG ' ' A' ' 50' ' ' SER . 2.6 mm-40 -165.51 -163.89 0.7 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.002 -1.686 . . . . 0.0 109.771 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -156.26 107.05 2.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.681 -0.637 . . . . 0.0 111.469 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.536 ' O ' ' C ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -110.81 118.02 35.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.621 -1.299 . . . . 0.0 108.288 178.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.27 -90.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.269 1.033 . . . . 0.0 110.287 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.28 43.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.305 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 56' ' ' ALA . 54.9 p90 -91.88 -174.48 3.82 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.773 -1.204 . . . . 0.0 111.251 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HZ1' ' CB ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -138.79 110.77 7.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.713 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.74 174.07 9.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.555 -1.34 . . . . 0.0 109.234 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.455 ' NZ ' ' CG ' ' A' ' 14' ' ' ARG . 82.1 tttt -126.83 129.51 48.42 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -80.63 159.66 25.3 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.681 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mt -153.34 114.57 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -66.87 159.84 27.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.29 -44.27 64.92 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.738 -1.185 . . . . 0.0 107.865 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.9 93.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.6 -0.688 . . . . 0.0 109.802 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -60.27 -24.79 65.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.17 -45.02 92.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.197 -1.564 . . . . 0.0 106.946 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -54.51 -29.71 51.3 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -0.965 . . . . 0.0 109.014 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.4 -39.67 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.727 -1.233 . . . . 0.0 108.507 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.92 -40.36 80.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.88 -31.49 69.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.363 -1.461 . . . . 0.0 110.528 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -69.84 -55.28 10.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.132 -1.605 . . . . 0.0 111.33 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 17' ' ' LYS . 28.0 t-20 -60.55 -44.66 95.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.229 -0.919 . . . . 0.0 111.334 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -63.78 -53.21 54.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 110.461 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 1.3 mm? . . . . . 0 C--N 1.294 -1.836 0 CA-C-O 117.892 -1.051 . . . . 0.0 108.374 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.726 0.774 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.7 p -114.34 161.8 17.43 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.36 -49.47 73.77 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 121.359 -0.838 . . . . 0.0 109.656 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 93.9 m -59.58 -48.79 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.072 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -69.01 -41.04 78.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.15 -1.594 . . . . 0.0 111.737 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -68.4 -50.32 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.042 -1.037 . . . . 0.0 112.329 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.495 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 97.6 t -69.37 -40.56 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.396 -0.815 . . . . 0.0 111.728 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 4' ' ' THR . 7.0 mm -59.95 -47.37 91.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.843 -1.16 . . . . 0.0 109.8 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.24 -30.96 70.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.921 -1.112 . . . . 0.0 109.798 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.78 -34.13 77.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.287 -0.883 . . . . 0.0 110.908 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 7' ' ' VAL . 21.7 p30 -99.5 -17.33 17.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.084 -1.01 . . . . 0.0 111.079 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -69.33 134.67 49.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.575 -1.328 . . . . 0.0 108.953 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.42 -45.75 0.3 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' GLU . 16.2 ptm180 -168.47 -176.01 2.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.554 -0.968 . . . . 0.0 109.371 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 55.3 mp0 -36.93 138.26 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.602 0.715 . . . . 0.0 109.825 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.08 101.72 0.7 Allowed Glycine 0 C--N 1.291 -1.934 0 C-N-CA 119.46 -1.353 . . . . 0.0 110.239 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.558 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 ttmt -141.75 -48.03 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.52 -0.988 . . . . 0.0 108.991 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 55.3 Cg_endo -98.47 136.29 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.109 2.54 . . . . 0.0 110.862 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.8 ttt -122.96 136.95 55.05 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.904 -1.123 . . . . 0.0 111.32 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -105.26 133.15 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.4 t -109.28 102.81 11.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.746 . . . . 0.0 109.583 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.575 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.18 -19.38 65.29 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.556 -0.858 . . . . 0.0 108.829 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.01 -43.55 92.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -125.71 1.65 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.3 81.07 0.06 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -150.6 144.62 25.38 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.122 -1.223 . . . . 0.0 110.191 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -81.77 133.54 35.35 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -129.02 72.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.914 . . . . 0.0 110.853 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -65.57 115.52 5.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.678 -1.264 . . . . 0.0 109.296 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.36 21.05 2.32 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.5 m -142.25 148.56 38.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 34' ' ' LEU . 29.3 m -130.67 103.16 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.21 -0.931 . . . . 0.0 108.862 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.6 p90 33.31 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.616 -0.677 . . . . 0.0 110.93 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -93.18 129.96 39.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' O ' ' OD1' ' A' ' 36' ' ' ASP . . . 96.41 40.82 3.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 77.4 m-20 -147.85 -40.12 0.18 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.745 -0.856 . . . . 0.0 108.703 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 153.63 33.26 0.03 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -49.86 145.51 5.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.911 -1.347 . . . . 0.0 111.41 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.2 p -145.64 133.24 20.92 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.53 171.04 17.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.063 -1.648 . . . . 0.0 109.821 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -165.63 132.88 2.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -93.04 120.77 33.69 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.675 -1.265 . . . . 0.0 109.479 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -99.07 -0.85 41.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 110.059 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.54 -118.93 1.49 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.67 -4.69 55.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.7 m -132.21 131.34 42.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.6 143.75 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.356 -0.84 . . . . 0.0 110.774 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.5 120.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.37 144.33 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.869 -1.144 . . . . 0.0 110.491 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 21.2 t -111.99 120.7 41.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -37.34 -78.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.019 0 C-N-CA 122.321 2.014 . . . . 0.0 113.508 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -84.05 -57.92 2.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.737 -1.227 . . . . 0.0 111.442 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.453 ' O ' ' OG ' ' A' ' 50' ' ' SER . 92.7 mt-10 -158.58 -168.92 2.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.015 -1.053 . . . . 0.0 109.545 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -169.71 115.5 0.55 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 56' ' ' ALA . 6.1 p -128.75 40.63 3.61 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.376 -0.828 . . . . 0.0 110.105 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 55' ' ' THR . . . 75.83 -24.88 0.21 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.682 -0.636 . . . . 0.0 110.386 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 55' ' ' THR . 10.4 mp -92.53 1.02 57.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.6 -0.687 . . . . 0.0 109.556 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -126.59 -160.98 1.03 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -134.97 149.67 50.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.084 -1.01 . . . . 0.0 111.555 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.08 175.64 8.89 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -132.76 141.95 48.78 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -101.94 107.8 19.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.2 -0.937 . . . . 0.0 109.721 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.0 mt -100.82 104.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -51.37 164.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.849 -1.157 . . . . 0.0 108.899 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.01 82.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.071 . . . . 0.0 109.53 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.16 85.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.128 -1.608 . . . . 0.0 109.891 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -60.62 -38.18 83.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.389 -1.444 . . . . 0.0 108.679 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.96 -34.73 65.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.997 -1.064 . . . . 0.0 108.371 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -59.89 -33.82 72.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 108.817 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.09 -40.57 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.58 -41.16 91.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.096 -1.003 . . . . 0.0 109.795 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.03 91.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 112.389 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -69.96 -36.95 75.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.868 -1.77 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.53 -66.83 0.49 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 110.849 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.8 mp -66.77 -46.78 74.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.079 . . . . 0.0 111.323 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 120.881 -1.137 . . . . 0.0 109.865 -178.762 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.48 ' O ' ' CG2' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER 160.43 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.99 -41.59 92.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 m -77.79 -49.42 14.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.393 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.0 m -71.28 -57.11 4.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.927 -1.108 . . . . 0.0 111.647 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -60.32 -43.75 96.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.605 -1.309 . . . . 0.0 112.986 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.5 t -67.19 -42.28 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.158 -1.589 . . . . 0.0 112.024 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.56 -43.77 95.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.948 -1.095 . . . . 0.0 110.406 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -69.26 -49.31 57.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.738 -1.226 . . . . 0.0 111.204 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -18.87 65.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.871 -1.143 . . . . 0.0 109.759 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -146.2 123.2 11.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.647 ' N ' HH11 ' A' ' 14' ' ' ARG . 16.7 ttmm -151.02 103.4 3.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.277 -0.889 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.572 ' N ' ' NH1' ' A' ' 14' ' ' ARG . . . 72.95 45.34 33.28 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.647 HH11 ' N ' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -62.69 -95.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -1.115 . . . . 0.0 110.852 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 17' ' ' LYS . 78.4 tt0 170.68 83.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 15' ' ' GLU . . . -4.82 70.0 0.0 OUTLIER Glycine 0 N--CA 1.511 3.661 0 C-N-CA 123.464 0.554 . . . . 0.0 113.831 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 15' ' ' GLU . 1.2 mtpp -174.01 -52.51 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.288 . . . . 0.0 109.944 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.13 111.65 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.924 2.416 . . . . 0.0 113.645 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.9 OUTLIER -123.04 133.37 54.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.094 -1.004 . . . . 0.0 108.841 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -106.64 135.11 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.141 -0.974 . . . . 0.0 109.936 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -87.49 98.41 11.37 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.536 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -66.23 -13.5 60.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.12 -42.49 93.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.66 -17.4 5.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 82.94 74.44 1.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -138.59 131.86 30.13 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.209 -1.171 . . . . 0.0 109.468 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -82.06 122.57 27.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.869 -1.145 . . . . 0.0 109.824 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.504 HG23 ' H ' ' A' ' 30' ' ' GLY . 67.7 mt -108.66 166.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -150.49 31.54 0.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 28' ' ' ILE . . . -151.33 27.47 0.98 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.1 p -137.82 144.27 41.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.887 -0.772 . . . . 0.0 109.461 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.12 84.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER 58.9 39.15 24.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.561 -1.337 . . . . 0.0 109.489 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 36' ' ' ASP . 55.3 tp -80.38 137.32 36.52 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.12 -17.34 4.92 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 34' ' ' LEU . 83.9 m-20 -70.69 -32.23 69.39 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.345 -1.091 . . . . 0.0 108.663 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 129.13 19.73 1.53 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' GLY . 7.8 t90 -36.19 130.51 0.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.59 0.71 . . . . 0.0 110.955 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.9 t -150.56 131.99 14.69 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.37 179.97 7.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.012 -1.68 . . . . 0.0 111.079 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.93 157.75 43.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.06 -1.025 . . . . 0.0 108.297 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -96.72 113.51 25.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.528 -1.357 . . . . 0.0 108.827 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 46.1 t0 -100.62 -0.69 37.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.919 -1.113 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.99 -106.89 0.59 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.75 -14.04 30.59 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.491 -1.005 . . . . 0.0 110.279 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.7 m -120.7 125.36 47.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.775 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.7 135.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.551 -0.718 . . . . 0.0 110.46 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.61 106.58 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.46 140.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.567 -0.708 . . . . 0.0 111.634 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 51' ' ' PRO . 11.6 m -111.08 111.2 56.17 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.9 Cg_exo -33.49 -76.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 122.264 1.976 . . . . 0.0 112.07 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.87 -49.37 4.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.167 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -165.57 -163.85 0.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -167.91 117.1 0.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.146 -0.972 . . . . 0.0 109.508 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.605 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 8.6 p -88.15 -73.51 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.797 -1.189 . . . . 0.0 108.089 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.605 ' N ' ' OG1' ' A' ' 55' ' ' THR . . . -155.56 -77.28 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.549 ' H ' ' CD2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.45 26.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.505 -0.747 . . . . 0.0 111.092 -179.331 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.605 ' H ' ' C ' ' A' ' 56' ' ' ALA . 19.2 m-85 -103.71 -166.94 1.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 149.97 46.65 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.828 -1.17 . . . . 0.0 110.989 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.65 179.24 6.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -125.92 122.51 36.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -94.09 101.1 13.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.28 132.62 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.783 0.802 . . . . 0.0 109.421 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -65.9 149.44 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.83 -39.74 65.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 109.543 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.7 -41.39 90.65 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.426 -1.421 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -59.84 -34.74 73.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.435 -1.415 . . . . 0.0 108.567 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.33 -29.96 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -60.11 -37.19 79.25 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.56 -39.91 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.206 -0.934 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.16 -39.72 79.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 108.679 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -66.28 -38.77 88.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 110.392 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -62.06 -40.8 97.03 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.595 -1.315 . . . . 0.0 110.42 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -73.99 -69.17 0.46 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.674 -0.641 . . . . 0.0 111.577 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.6 mp -60.03 -45.78 91.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.503 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.753 0.787 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -133.85 170.9 14.91 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.12 -43.84 95.33 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.8 m -60.13 -57.82 11.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.642 -0.661 . . . . 0.0 111.187 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.587 ' HG ' ' N ' ' A' ' 6' ' ' GLU . 71.1 p -70.4 -45.79 65.25 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.788 -1.195 . . . . 0.0 111.771 -177.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' HG ' ' A' ' 5' ' ' SER . 51.7 mt-10 -64.86 -49.89 68.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.094 . . . . 0.0 112.733 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.8 t -69.82 -47.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 120.642 -1.286 . . . . 0.0 112.331 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.3 mm -60.09 -48.58 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.876 -1.14 . . . . 0.0 109.547 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -60.05 -39.3 85.48 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.477 -0.764 . . . . 0.0 110.357 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.12 85.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.928 -1.108 . . . . 0.0 110.654 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.9 m-20 -71.08 -79.0 0.07 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.1 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 tptp 40.96 26.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.599 -0.688 . . . . 0.0 110.874 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' ASN . . . 171.85 39.05 0.03 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -69.77 110.8 5.12 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.748 -0.854 . . . . 0.0 110.21 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.91 -40.0 72.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 109.101 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.13 25.93 0.25 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.704 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 32.3 pttt -178.42 -22.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.278 -1.13 . . . . 0.0 112.875 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.704 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 45.1 Cg_endo -95.56 108.75 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.657 1.571 . . . . 0.0 112.696 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.79 133.75 54.91 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.0 mt -110.6 130.67 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 t -90.39 100.73 13.51 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -7.14 12.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 108.854 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.8 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 24' ' ' ASP . 42.8 t0 -135.34 3.54 3.1 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.31 86.72 0.04 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.19 134.61 29.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.375 -1.073 . . . . 0.0 109.724 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -82.82 121.99 27.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.3 mt -119.99 76.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 110.701 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -70.18 107.13 3.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.679 -1.263 . . . . 0.0 109.959 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.99 23.74 1.03 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -134.97 139.2 44.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.554 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 33.4 m -124.38 111.35 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.554 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 4.4 p90 32.0 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.002 -0.436 . . . . 0.0 111.405 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -92.82 135.92 33.7 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.874 -1.141 . . . . 0.0 109.926 -179.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.73 18.26 21.12 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -129.99 -99.94 0.32 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -1.062 . . . . 0.0 109.521 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -153.41 25.24 0.77 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -50.04 149.59 2.7 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.77 -0.841 . . . . 0.0 111.093 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.3 m -149.68 151.66 34.06 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.79 10.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.234 -1.542 . . . . 0.0 109.474 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -158.78 160.35 36.2 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -97.48 121.79 39.78 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.89 -1.131 . . . . 0.0 109.861 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -100.04 -1.83 35.96 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.152 -0.967 . . . . 0.0 110.306 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 45' ' ' ALA . . . 83.75 95.23 0.63 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.782 -1.199 . . . . 0.0 110.51 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 44' ' ' GLY . . . 84.22 4.76 0.71 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.938 -0.742 . . . . 0.0 109.887 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -165.94 143.77 5.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.99 128.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.468 -0.77 . . . . 0.0 110.371 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.6 t -101.2 109.83 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.36 140.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 p -112.09 120.51 41.65 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -36.61 -79.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.006 1.804 . . . . 0.0 113.097 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -93.53 -48.85 6.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.794 -1.191 . . . . 0.0 109.203 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -160.85 -165.83 1.47 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.535 -1.353 . . . . 0.0 109.568 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -157.5 100.86 1.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.152 -0.967 . . . . 0.0 109.607 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.651 ' O ' ' N ' ' A' ' 57' ' ' LEU . 26.7 p -131.22 145.57 51.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.849 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.82 -27.07 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.8 mp -79.61 -10.14 59.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.649 -1.282 . . . . 0.0 109.461 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -137.5 -161.84 1.22 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.59 166.58 28.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.738 -1.227 . . . . 0.0 111.506 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.62 176.1 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -134.1 127.66 32.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -96.43 110.14 22.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.131 -0.981 . . . . 0.0 110.871 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -110.76 144.99 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.302 0.572 . . . . 0.0 109.812 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -73.4 163.59 27.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.099 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.9 95.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.405 -0.81 . . . . 0.0 111.345 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -49.98 72.62 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.267 -1.521 . . . . 0.0 111.426 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -60.21 -35.57 75.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.262 -1.524 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 3.1 tm? -59.7 -35.43 74.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 108.37 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -59.93 -34.48 73.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.969 -1.082 . . . . 0.0 109.296 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.2 mt -58.19 -38.7 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.88 -1.137 . . . . 0.0 108.77 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.6 mt -59.99 -39.92 81.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.759 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -62.45 -40.05 95.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.083 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -67.23 -50.56 60.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.736 -1.227 . . . . 0.0 110.53 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -59.97 -63.41 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.925 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.7 mp -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.884 -1.135 . . . . 0.0 111.028 -177.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 109.581 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.26 -49.81 76.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.603 HG21 ' CD1' ' A' ' 58' ' ' PHE . 56.3 m -60.38 -50.07 75.06 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.054 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -68.44 -49.19 61.71 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.312 -1.492 . . . . 0.0 111.019 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.12 -49.26 78.01 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 112.888 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.66 -45.81 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.554 -1.341 . . . . 0.0 111.892 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -59.93 -42.84 90.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.449 -1.407 . . . . 0.0 108.776 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -57.66 -39.26 76.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -55.19 19.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.835 -1.166 . . . . 0.0 109.005 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 179.787 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 38.3 Cg_endo -101.1 128.03 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 123.364 2.71 . . . . 0.0 109.839 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.8 ttt -126.18 128.97 48.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.997 -1.064 . . . . 0.0 110.053 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -110.0 130.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.544 -0.723 . . . . 0.0 109.376 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 t -93.87 103.58 15.68 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.66 -7.83 12.12 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.251 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.12 -43.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -134.4 13.97 3.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.31 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -151.81 145.81 25.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.725 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.12 125.95 33.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mt -123.11 73.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.728 -0.607 . . . . 0.0 109.398 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -69.22 109.37 4.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.007 -1.058 . . . . 0.0 109.361 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.2 21.64 0.95 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -140.83 147.82 39.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.51 101.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 0.0 108.708 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 51.4 28.46 4.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 109.138 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.5 tt -92.34 139.45 30.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.86 18.6 63.08 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -127.16 -54.51 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.72 -0.87 . . . . 0.0 109.187 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.97 33.05 0.02 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -50.31 138.99 15.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -1.222 . . . . 0.0 109.858 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.6 t -151.08 135.5 16.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.92 178.18 10.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.323 -1.486 . . . . 0.0 109.969 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -150.58 161.11 43.2 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -100.0 117.34 34.07 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.905 -1.122 . . . . 0.0 109.988 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 60.6 t0 -94.51 -12.49 27.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.128 -0.983 . . . . 0.0 109.373 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 93.81 98.24 1.55 Allowed Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.175 -0.953 . . . . 0.0 110.814 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 85.55 1.1 0.7 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.983 -0.716 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -167.31 117.81 0.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -90.78 142.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.954 -1.091 . . . . 0.0 110.572 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.78 125.29 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -146.89 144.09 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.4 m -110.44 124.46 33.19 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -37.48 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.87 1.713 . . . . 0.0 111.7 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -101.82 -47.32 4.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.024 -1.048 . . . . 0.0 109.828 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 68.9 mt-10 -161.81 -165.84 1.34 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -168.11 114.66 0.69 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.6 p -122.4 44.53 2.59 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.244 -0.91 . . . . 0.0 111.115 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 68.32 -16.74 0.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.024 -1.048 . . . . 0.0 110.38 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 55' ' ' THR . 12.6 mt -95.13 -0.77 53.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CD1' HG21 ' A' ' 4' ' ' THR . 89.3 m-85 -134.04 -156.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.09 164.19 35.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.828 -1.17 . . . . 0.0 111.381 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.33 174.96 9.56 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.449 0.642 . . . . 0.0 109.525 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -133.36 133.34 42.35 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -82.76 164.43 20.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.842 -1.161 . . . . 0.0 110.358 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -154.93 119.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.2 m -64.8 151.13 46.13 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.61 69.9 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.603 -1.31 . . . . 0.0 108.403 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.64 80.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.599 -1.313 . . . . 0.0 109.436 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -60.99 -34.21 74.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 108.981 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.584 ' O ' HD13 ' A' ' 68' ' ' LEU . 2.9 tm? -59.75 -33.1 71.22 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -60.6 -41.47 94.81 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.8 mt -60.15 -39.22 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.725 . . . . 0.0 110.727 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.59 ' O ' HD22 ' A' ' 75' ' ' LEU . 96.1 mt -59.72 -46.56 93.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 118.304 -1.359 . . . . 0.0 109.821 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.28 73.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.545 -1.347 . . . . 0.0 109.672 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -62.65 -40.01 95.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.833 -1.167 . . . . 0.0 109.607 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -59.94 -51.35 70.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.431 -0.793 . . . . 0.0 111.631 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.615 HD22 ' H ' ' A' ' 75' ' ' LEU . 1.2 mm? -65.35 -46.82 78.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.177 . . . . 0.0 109.893 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.652 HG23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 121.696 0.76 . . . . 0.0 109.088 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.652 ' H ' HG23 ' A' ' 2' ' ' THR . 8.6 tp -60.16 -45.43 93.1 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.4 m -70.04 -51.84 28.85 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.202 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -73.44 -57.56 3.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.31 -40.34 95.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.388 -1.445 . . . . 0.0 112.361 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.6 t -70.32 -47.95 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.589 -1.319 . . . . 0.0 112.341 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 11' ' ' ASN . 53.4 mt -68.24 -42.55 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.862 -1.149 . . . . 0.0 111.195 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -60.3 -41.7 93.96 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.47 91.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.886 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 8' ' ' ILE . 8.0 m120 . . . . . 0 N--CA 1.499 1.997 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.553 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 36.6 mtmt . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 80.2 Cg_endo -96.46 123.68 0.25 Allowed 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.554 2.169 . . . . 0.0 113.629 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.3 OUTLIER -122.29 140.95 52.04 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.574 -0.704 . . . . 0.0 109.746 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 76.6 mt -110.53 131.39 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.412 -0.805 . . . . 0.0 110.296 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.6 m -94.59 101.11 12.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.025 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -8.44 22.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.372 -0.83 . . . . 0.0 109.528 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.97 -42.4 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 9.3 t70 -131.54 8.02 4.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.41 87.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -144.68 137.21 26.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -1.138 . . . . 0.0 109.233 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -83.43 122.97 29.21 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -120.06 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.376 -0.827 . . . . 0.0 110.319 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -66.01 107.53 1.91 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.837 -1.164 . . . . 0.0 109.011 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.4 19.16 0.77 Allowed Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 137.25 49.06 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 34' ' ' LEU . 3.1 m -118.03 98.89 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 44.6 17.07 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 32' ' ' VAL . 85.1 mt -72.12 142.01 49.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 108.473 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -21.58 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -73.07 -35.45 66.66 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 123.53 31.8 0.94 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.45 ' HE1' HD12 ' A' ' 49' ' ' ILE . 16.3 t90 -47.52 139.54 6.77 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.285 1.04 . . . . 0.0 111.314 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -154.62 135.08 13.38 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.23 7.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.653 -1.28 . . . . 0.0 111.583 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -156.76 139.4 15.04 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -94.2 123.55 37.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.29 -1.506 . . . . 0.0 109.523 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 52.0 t0 -102.19 -5.6 24.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.354 -0.841 . . . . 0.0 110.201 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -112.07 0.54 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.752 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -90.9 -6.63 53.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -1.194 . . . . 0.0 109.956 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -125.1 119.95 30.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.981 -1.075 . . . . 0.0 108.88 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -88.97 140.14 16.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.488 -0.758 . . . . 0.0 110.828 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.44 114.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.608 HD13 HD12 ' A' ' 63' ' ' ILE . 4.4 pt -118.78 172.35 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.023 -1.048 . . . . 0.0 109.917 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 51' ' ' PRO . 63.8 m -135.35 102.37 10.74 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 50' ' ' SER . 0.5 OUTLIER -28.9 -99.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.614 2.209 . . . . 0.0 112.083 -177.036 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -78.29 -44.29 25.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.41 ' OE2' HD23 ' A' ' 3' ' ' LEU . 68.2 mt-10 -160.92 -163.87 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' OE1' ' C ' ' A' ' 59' ' ' LYS . 10.0 tp10 -171.0 103.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.627 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 57' ' ' LEU . 73.1 p -130.81 152.59 49.98 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -26.8 -29.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.4 mp -84.11 -3.11 57.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.712 -1.243 . . . . 0.0 111.004 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 55' ' ' THR . 88.4 m-85 -129.27 -161.07 1.08 Allowed 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.461 -0.774 . . . . 0.0 109.702 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -140.08 155.68 46.92 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.156 -0.965 . . . . 0.0 111.197 -179.217 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.71 175.5 10.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.688 -0.633 . . . . 0.0 109.819 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -132.17 153.82 50.16 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -109.28 161.09 15.59 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.331 -0.856 . . . . 0.0 109.978 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.608 HD12 HD13 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -153.06 117.45 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.151 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -61.74 149.26 40.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -49.61 -46.03 48.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.775 -1.203 . . . . 0.0 109.581 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.16 -41.73 65.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.186 -1.571 . . . . 0.0 110.241 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -65.75 -29.91 70.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.766 -1.209 . . . . 0.0 109.765 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 71' ' ' ILE . 3.2 tm? -59.63 -36.39 76.27 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -59.17 -39.23 81.85 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 mt -60.17 -32.65 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.053 -1.029 . . . . 0.0 110.184 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 68' ' ' LEU . 93.4 mt -62.14 -44.37 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.242 -1.536 . . . . 0.0 110.51 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.61 62.09 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.024 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -64.37 -56.54 13.67 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.142 -0.974 . . . . 0.0 110.224 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -51.92 -49.69 62.57 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.622 -0.674 . . . . 0.0 109.331 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -67.6 -23.94 65.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.052 -1.03 . . . . 0.0 110.626 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.825 -1.083 . . . . 0.0 108.962 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.682 0.753 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.76 -40.13 94.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.671 -0.643 . . . . 0.0 111.022 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.428 ' OG1' ' OE2' ' A' ' 53' ' ' GLU . 41.7 m -59.94 -52.39 65.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.927 . . . . 0.0 110.642 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t -68.62 -41.27 79.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.702 -1.249 . . . . 0.0 111.744 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.77 -40.52 76.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.784 -1.197 . . . . 0.0 112.919 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 52' ' ' ALA . 70.7 t -71.21 -50.09 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.486 -1.383 . . . . 0.0 111.254 -178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.3 mp -60.27 -49.34 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.097 -1.002 . . . . 0.0 110.162 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -60.39 -40.02 89.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.058 -1.027 . . . . 0.0 110.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.64 80.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.961 -1.087 . . . . 0.0 109.459 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.425 HD21 HG13 ' A' ' 20' ' ' ILE . 9.5 m120 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 109.439 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.491 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 1.3 tttm . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 78.9 Cg_endo -95.54 130.25 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.748 2.299 . . . . 0.0 110.341 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.6 ttt -116.46 129.67 56.34 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.302 -0.874 . . . . 0.0 111.253 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.425 HG13 HD21 ' A' ' 11' ' ' ASN . 5.2 mm -106.14 119.85 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 25' ' ' GLY . 26.2 p -100.82 98.86 9.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 0.0 109.057 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.031 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.08 -10.71 59.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.374 -0.828 . . . . 0.0 109.825 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.557 ' N ' HD22 ' A' ' 22' ' ' LEU . 72.9 t -60.03 -41.73 87.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 108.493 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.48 1.29 4.53 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 60.04 82.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -145.28 137.69 25.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.359 -1.083 . . . . 0.0 109.472 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -84.56 128.97 34.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.92 77.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.714 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 44.4 pttt -71.94 109.99 6.14 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.68 20.36 0.54 Allowed Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.4 p -142.33 149.08 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -1.124 . . . . 0.0 108.372 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.567 HG22 HD21 ' A' ' 75' ' ' LEU . 19.1 m -122.86 85.32 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.67 0.748 . . . . 0.0 109.301 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 53.54 34.29 18.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.435 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 tp -85.67 137.07 33.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.541 -0.724 . . . . 0.0 109.069 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.71 66.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -121.42 -41.98 2.47 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 145.71 26.69 0.1 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -51.26 136.99 23.69 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.163 -1.198 . . . . 0.0 109.294 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 p -152.42 142.31 22.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.13 178.96 9.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.229 -1.544 . . . . 0.0 110.461 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -158.65 146.59 18.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -96.66 123.28 40.29 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.644 -1.285 . . . . 0.0 109.155 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.6 -4.26 22.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -121.87 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -80.72 -9.96 59.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.217 . . . . 0.0 109.591 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.6 m -120.13 134.59 55.21 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 HD12 ' A' ' 68' ' ' LEU . 33.4 mm -104.69 130.02 56.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.676 -0.64 . . . . 0.0 109.873 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.82 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.064 -1.022 . . . . 0.0 108.354 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.63 141.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.188 -0.945 . . . . 0.0 110.601 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -109.9 118.69 49.38 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -36.77 -76.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.916 1.744 . . . . 0.0 112.211 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -94.96 -50.75 4.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 0.0 108.562 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' OE2' ' OG1' ' A' ' 4' ' ' THR . 15.5 pt-20 -173.22 -161.0 0.13 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.533 -0.729 . . . . 0.0 109.057 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -166.26 115.39 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.034 -1.041 . . . . 0.0 108.935 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 11.8 p -117.09 40.26 3.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.226 -0.921 . . . . 0.0 109.705 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 69.99 -16.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.663 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 55' ' ' THR . 4.6 mm? -90.0 -1.75 58.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 4' ' ' THR . 67.9 m-85 -136.27 -159.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -144.59 159.99 41.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.971 -1.081 . . . . 0.0 111.339 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 175.74 5.12 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -132.52 124.84 29.26 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -93.07 110.94 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.452 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 63' ' ' ILE . 14.4 tt -108.92 124.4 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.7 m -55.63 157.72 3.9 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.339 -0.85 . . . . 0.0 110.687 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.324 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.92 -41.37 61.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.551 -1.343 . . . . 0.0 108.748 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -63.04 -24.21 67.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -59.87 -38.79 83.18 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.07 -35.64 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.77 -39.86 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.859 -1.151 . . . . 0.0 108.888 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.45 -38.09 54.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.749 -1.22 . . . . 0.0 108.659 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -69.9 -38.13 76.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.91 -50.47 41.88 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.657 -1.277 . . . . 0.0 111.71 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -59.87 -47.37 86.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 111.457 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.567 HD21 HG22 ' A' ' 32' ' ' VAL . 5.3 mp -69.95 -44.3 69.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.922 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 7' ' ' VAL . 3.0 tt -59.98 -49.32 78.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 109.739 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.415 ' OG1' ' OE1' ' A' ' 53' ' ' GLU . 89.5 m -64.92 -53.69 42.55 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.298 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.5 p -61.65 -45.26 94.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.718 -1.239 . . . . 0.0 111.751 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.99 -40.97 74.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.914 -1.117 . . . . 0.0 112.65 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 3' ' ' LEU . 80.8 t -68.6 -47.97 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.393 -1.442 . . . . 0.0 111.216 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.05 -49.16 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.877 -1.139 . . . . 0.0 110.437 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.97 -41.85 92.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.161 -0.962 . . . . 0.0 111.057 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.92 92.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.533 -1.354 . . . . 0.0 110.427 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.939 -179.416 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -95.46 113.31 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.659 2.239 . . . . 0.0 112.231 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.575 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.06 135.26 50.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.337 -0.852 . . . . 0.0 109.748 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.575 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.8 mm -106.22 129.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.754 . . . . 0.0 109.105 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' VAL . 79.5 p -113.58 100.24 8.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.521 -0.737 . . . . 0.0 109.629 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -1.4 3.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' SER . 95.1 t -60.03 -44.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -140.81 15.76 2.31 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.11 85.27 0.03 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 106.63 -2.588 . . . . 0.0 106.63 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -145.7 134.3 22.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.459 -1.024 . . . . 0.0 109.729 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.63 128.67 34.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mt -127.56 75.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.87 109.25 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 109.248 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.89 26.4 1.13 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.8 m -141.74 148.45 39.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.731 ' O ' HG23 ' A' ' 32' ' ' VAL . 22.8 m -127.15 106.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 23.5 m-85 42.06 34.78 0.49 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.598 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -90.83 134.78 34.18 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 109.682 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.598 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 102.39 16.02 23.8 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.564 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 23.5 p30 -131.7 -100.97 0.29 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.38 -1.07 . . . . 0.0 109.276 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -143.72 30.48 1.94 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -46.97 140.02 5.14 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.248 -1.148 . . . . 0.0 110.959 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 t -146.66 149.08 32.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.78 169.92 18.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.084 -1.635 . . . . 0.0 109.184 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -158.94 143.67 15.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -98.92 120.07 38.75 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.606 -1.309 . . . . 0.0 110.584 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 32.3 t0 -97.81 -7.29 30.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.284 -0.885 . . . . 0.0 109.621 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.14 64.47 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -163.03 -57.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.121 . . . . 0.0 108.639 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -118.09 121.49 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.48 135.12 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 t -98.63 103.92 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.84 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.42 -0.8 . . . . 0.0 110.304 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -111.93 127.75 26.43 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.59 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.233 1.289 . . . . 0.0 111.455 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.73 -48.94 5.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 109.592 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.415 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 91.9 mt-10 -156.69 -169.98 3.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.122 -0.987 . . . . 0.0 109.882 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 15.6 tm-20 -155.62 96.72 1.79 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 58' ' ' PHE . 1.7 p -131.49 147.75 52.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.373 -0.83 . . . . 0.0 108.816 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -28.61 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.1 mp -85.4 0.57 51.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.605 -1.31 . . . . 0.0 110.222 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.5 m-85 -136.87 -160.88 1.1 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 108.935 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -150.08 160.19 43.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 0.0 111.612 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.28 173.5 12.53 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -136.18 128.7 30.49 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.32 109.51 22.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.969 -1.082 . . . . 0.0 110.789 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.83 138.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 m -74.43 162.61 28.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.94 . . . . 0.0 108.852 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -59.95 -48.05 83.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.883 -1.136 . . . . 0.0 109.44 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.0 -41.7 83.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.628 -1.295 . . . . 0.0 109.995 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -59.95 -32.61 70.96 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 108.633 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.762 HD13 ' O ' ' A' ' 68' ' ' LEU . 2.7 tm? -59.91 -34.77 73.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.86 -37.67 77.04 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.03 -1.044 . . . . 0.0 108.38 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.97 -39.85 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.975 . . . . 0.0 109.364 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.4 mp -59.92 -40.11 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 108.267 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.23 96.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 111.055 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.12 -40.0 95.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.672 -1.267 . . . . 0.0 109.489 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -66.7 -71.33 0.2 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.313 0.578 . . . . 0.0 111.883 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 75' ' ' LEU . 6.4 mp -63.01 -44.55 95.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 111.466 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 120.752 -1.217 . . . . 0.0 109.371 -179.757 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.498 1.946 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.05 -49.92 75.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.304 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.516 HG23 ' N ' ' A' ' 5' ' ' SER . 6.4 t -63.59 -48.46 77.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.311 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 4' ' ' THR . 14.5 p -65.19 -43.21 92.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.76 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -40.81 74.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.058 . . . . 0.0 112.122 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.96 -43.82 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.852 -1.155 . . . . 0.0 110.836 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 52' ' ' ALA . 1.3 mp -59.43 -49.11 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.821 . . . . 0.0 109.452 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.09 -36.15 76.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.808 -1.183 . . . . 0.0 109.755 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.24 -20.02 64.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.973 -1.079 . . . . 0.0 110.593 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.9 m120 . . . . . 0 N--CA 1.5 2.025 0 O-C-N 120.772 -1.205 . . . . 0.0 110.715 -179.094 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.958 0 CA-C-O 121.278 0.561 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 38.0 Cg_endo -66.52 156.13 66.93 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.02 1.813 . . . . 0.0 108.668 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.484 ' SD ' ' OD2' ' A' ' 36' ' ' ASP . 35.3 ttp -138.16 125.6 21.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.78 -1.2 . . . . 0.0 110.996 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.3 mt -102.38 128.96 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.7 p -86.61 99.18 11.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.012 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -62.66 -14.44 43.54 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' H ' HD22 ' A' ' 22' ' ' LEU . 71.6 t -60.86 -41.79 90.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -131.7 2.03 4.06 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 59.23 81.15 0.08 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -140.07 130.29 25.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.257 -1.143 . . . . 0.0 109.329 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 51.2 mp0 -77.44 134.91 38.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.289 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 30' ' ' GLY . 34.5 mt -130.8 60.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -71.94 47.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.862 0.839 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -153.51 26.05 0.76 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 106.846 -2.502 . . . . 0.0 106.846 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m -145.81 150.43 36.17 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 32' ' ' VAL . 18.6 m -114.81 94.62 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' VAL . 26.0 m-85 36.38 25.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.294 0.569 . . . . 0.0 110.538 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 35' ' ' GLY . 4.2 tt -97.68 129.12 44.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 109.207 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.711 ' N ' HD23 ' A' ' 34' ' ' LEU . . . 118.01 25.77 2.93 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' SD ' ' A' ' 19' ' ' MET . 90.9 m-20 -143.76 -61.84 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.302 -1.116 . . . . 0.0 109.638 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -170.96 23.79 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -35.23 135.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.021 0.915 . . . . 0.0 112.503 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 t -146.94 135.31 21.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.96 169.31 23.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.822 -1.798 . . . . 0.0 110.064 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -160.5 138.69 9.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -101.59 126.27 48.38 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.686 -1.259 . . . . 0.0 111.176 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 59.2 t0 -95.49 -12.47 25.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.735 -0.603 . . . . 0.0 109.491 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 94.87 105.05 1.95 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 84.63 -10.71 0.84 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.984 -0.715 . . . . 0.0 109.773 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.9 m -158.01 114.4 2.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -91.9 140.81 15.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 111.247 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.12 120.05 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.487 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -151.25 146.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.609 -1.307 . . . . 0.0 110.347 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 t -109.72 120.06 46.04 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -38.05 -77.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 122.082 1.854 . . . . 0.0 113.55 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -85.01 -58.8 2.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.862 -1.148 . . . . 0.0 111.082 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 40.5 mt-10 -161.25 -167.15 1.7 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.835 . . . . 0.0 109.616 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -167.43 113.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 1.4 p -127.87 45.12 2.8 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.36 -0.837 . . . . 0.0 110.198 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 71.8 -22.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 55' ' ' THR . 11.3 mt -90.09 -7.15 54.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.045 -1.034 . . . . 0.0 108.929 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -128.79 -160.53 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -145.8 158.96 43.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.724 -1.235 . . . . 0.0 111.075 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.15 173.52 8.43 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -127.98 140.27 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -85.05 155.54 21.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.487 HD12 HG21 ' A' ' 49' ' ' ILE . 8.0 mt -151.89 112.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.0 p -64.23 154.71 34.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.57 62.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.69 86.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.653 -1.279 . . . . 0.0 109.707 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -59.92 -39.16 84.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.108 -0.995 . . . . 0.0 109.331 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 68' ' ' LEU . 1.8 tm? -59.01 -37.09 76.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.877 -1.14 . . . . 0.0 108.757 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -58.97 -35.01 72.45 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.87 -38.65 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.5 mp -57.89 -40.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.63 -1.294 . . . . 0.0 108.796 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.0 96.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 110.904 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . 94.0 mttt -68.08 -44.47 76.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.874 -1.141 . . . . 0.0 110.501 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -59.74 -58.26 9.36 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 112.12 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 HG22 ' A' ' 32' ' ' VAL . 4.5 mp -68.01 -39.9 83.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.595 -1.316 . . . . 0.0 110.234 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.78 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.034 -1.041 . . . . 0.0 109.951 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.628 ' H ' HG23 ' A' ' 2' ' ' THR . 10.4 tp -59.95 -49.41 77.78 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 m -65.64 -49.09 69.92 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.956 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -72.36 -57.3 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 112.538 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 2' ' ' THR . 69.9 mm-40 -65.03 -44.33 89.49 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.569 -1.332 . . . . 0.0 113.129 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.0 -45.32 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.526 -1.359 . . . . 0.0 111.107 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.487 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.3 mp -60.1 -39.4 80.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.001 -1.062 . . . . 0.0 109.144 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.81 -44.0 94.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.802 -1.186 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.69 74.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.886 -1.133 . . . . 0.0 109.986 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.669 HD21 ' CG1' ' A' ' 20' ' ' ILE . 23.5 m120 . . . . . 0 N--CA 1.5 2.063 0 O-C-N 121.135 -0.978 . . . . 0.0 109.567 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 7.8 mtpt . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 120.469 0.176 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 63.0 Cg_endo -101.14 130.18 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.151 2.568 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.7 ttp -112.2 143.26 43.56 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.669 ' CG1' HD21 ' A' ' 11' ' ' ASN . 4.5 mm -103.4 129.58 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.299 -0.876 . . . . 0.0 108.989 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 m -100.56 98.49 9.07 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -66.96 -3.04 6.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.563 ' N ' HD12 ' A' ' 22' ' ' LEU . 74.6 t -60.05 -44.27 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.8 t0 -125.01 -5.82 7.34 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.8 11.24 85.61 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -75.88 140.05 41.98 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.651 -0.911 . . . . 0.0 110.399 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.03 133.48 33.58 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.7 mt -123.45 73.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.223 -0.923 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -65.93 109.23 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.528 -1.357 . . . . 0.0 108.834 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.9 23.67 0.85 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 17' ' ' LYS . 87.8 m -133.26 137.26 45.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 34' ' ' LEU . 9.8 m -120.1 102.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.432 -0.792 . . . . 0.0 110.022 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.433 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m-85 41.65 17.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.868 -0.52 . . . . 0.0 109.94 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 32' ' ' VAL . 43.7 tp -93.9 134.56 36.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.673 -1.267 . . . . 0.0 109.68 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.82 17.01 10.74 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 17.5 p-10 -139.37 -69.96 0.41 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -1.119 . . . . 0.0 110.121 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 173.1 32.08 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -51.54 155.65 1.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.434 -1.039 . . . . 0.0 110.324 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 t -153.39 131.97 12.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.86 177.32 10.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.339 -1.476 . . . . 0.0 109.57 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -159.7 160.05 33.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -99.48 114.76 27.91 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.88 -1.137 . . . . 0.0 109.649 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 38.4 t0 -96.74 -7.7 33.21 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.783 -1.198 . . . . 0.0 109.685 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.97 -113.56 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -88.84 -5.22 58.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -1.23 . . . . 0.0 109.273 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 m -122.91 132.85 54.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.335 -0.853 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.1 mm -96.36 142.61 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.586 -0.696 . . . . 0.0 110.838 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -109.26 120.01 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.648 HD12 HD12 ' A' ' 63' ' ' ILE . 45.8 mt -131.73 144.16 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.583 -0.698 . . . . 0.0 110.518 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' PRO . 74.1 m -118.29 120.84 31.78 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' SER . 53.9 Cg_exo -33.34 -87.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.137 1.891 . . . . 0.0 111.961 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -99.9 -36.59 9.35 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -165.73 -163.21 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.708 0.766 . . . . 0.0 109.965 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -174.28 117.26 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.648 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 20.9 p -128.98 40.43 3.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 74.46 -26.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 55' ' ' THR . 8.8 mp -90.02 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.362 -0.836 . . . . 0.0 108.828 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.27 -157.19 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -140.46 158.36 44.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.001 -1.062 . . . . 0.0 111.075 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.04 173.77 9.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -138.99 120.03 14.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -84.76 171.32 12.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.648 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -161.69 118.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -60.18 153.89 21.0 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.694 -1.254 . . . . 0.0 108.13 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.95 -44.32 70.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.784 -1.197 . . . . 0.0 108.245 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.59 -44.05 69.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.041 -1.662 . . . . 0.0 109.309 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.88 -27.14 68.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.687 -1.258 . . . . 0.0 108.96 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.633 HD22 HD12 ' A' ' 71' ' ' ILE . 3.3 tm? -59.91 -32.88 71.17 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.92 -39.77 86.59 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.7 mt -58.28 -34.83 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.988 -1.07 . . . . 0.0 109.998 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.633 HD12 HD22 ' A' ' 68' ' ' LEU . 71.0 mt -60.02 -40.16 82.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.23 -1.544 . . . . 0.0 109.675 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -75.39 -28.81 59.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' LEU . 1.6 tmtp? -69.77 -55.11 10.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -58.06 -50.06 74.74 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.857 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 4.6 mp -68.11 -39.85 82.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.355 -1.466 . . . . 0.0 109.744 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 73' ' ' LYS . 1.5 pp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.138 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.507 2.383 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 tp -59.83 -42.99 94.76 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -78.59 -50.01 12.26 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.857 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -65.72 -52.05 54.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.909 -1.119 . . . . 0.0 111.74 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.01 -47.12 63.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 112.836 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.81 -39.93 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.504 -1.372 . . . . 0.0 111.367 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.62 -45.47 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 108.372 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -59.05 -40.06 83.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.604 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 11' ' ' ASN . . . -59.97 -42.04 93.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.975 -1.078 . . . . 0.0 110.35 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 10' ' ' ALA . 89.7 m-20 . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.94 . . . . 0.0 110.068 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.534 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 32.2 ttpt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 119.783 -0.151 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 98.2 Cg_endo -96.98 108.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 122.432 2.088 . . . . 0.0 113.836 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.439 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -122.74 131.63 53.87 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.574 -0.704 . . . . 0.0 109.101 178.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.19 131.89 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 110.154 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 23' ' ' VAL . 35.4 m -95.76 101.96 13.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -63.43 0.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.587 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.519 ' N ' HD12 ' A' ' 22' ' ' LEU . 71.3 t -60.03 -45.43 95.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.911 -1.118 . . . . 0.0 108.272 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -138.47 10.34 2.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.72 89.12 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -146.08 137.84 24.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.107 -1.231 . . . . 0.0 109.81 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.39 129.8 35.32 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 30' ' ' GLY . 53.6 mt -124.96 77.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.387 -0.821 . . . . 0.0 110.365 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -69.1 40.63 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 109.754 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -151.15 24.03 0.99 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.079 -2.409 . . . . 0.0 107.079 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 m -146.99 150.3 34.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 122.001 -0.705 . . . . 0.0 109.746 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 32' ' ' VAL . 35.5 m -134.67 104.71 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 41.0 p90 39.93 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.86 -0.525 . . . . 0.0 110.865 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.569 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 tt -103.33 118.45 36.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.127 -0.983 . . . . 0.0 108.484 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.546 ' N ' HD23 ' A' ' 34' ' ' LEU . . . 134.03 28.86 0.48 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 70.4 m-20 -155.74 -50.08 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.546 -0.973 . . . . 0.0 109.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 176.16 31.83 0.04 OUTLIER Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.4 ' C ' ' O ' ' A' ' 37' ' ' GLY . 55.4 p-90 -43.4 144.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.2 m -149.16 134.07 17.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.01 170.59 7.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.24 -1.538 . . . . 0.0 109.546 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -151.41 148.27 27.89 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -95.13 134.62 37.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.551 -1.343 . . . . 0.0 109.432 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -109.66 -8.51 14.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.476 -0.765 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.67 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 89.86 103.9 1.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 86.46 0.57 0.59 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.094 -0.651 . . . . 0.0 110.163 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 45' ' ' ALA . 72.2 m -171.59 116.33 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 108.365 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 47' ' ' ILE . 7.2 mm -91.17 136.28 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.097 -1.002 . . . . 0.0 110.395 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.02 120.7 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.655 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -148.3 147.8 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.651 -1.281 . . . . 0.0 111.559 -177.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.2 m -119.49 147.13 42.8 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.51 -84.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.631 1.554 . . . . 0.0 111.941 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -94.34 -39.44 10.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.011 -1.056 . . . . 0.0 109.921 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -159.4 -164.04 1.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 108.787 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.841 ' OE2' ' HB2' ' A' ' 60' ' ' ALA . 77.6 tt0 -165.82 100.1 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 110.354 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 57' ' ' LEU . 23.6 p -130.27 151.15 51.1 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.88 -29.15 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.9 mp -84.17 1.29 45.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.701 -1.25 . . . . 0.0 110.041 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.7 m-85 -136.96 -161.03 1.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -151.18 169.29 22.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.839 -1.163 . . . . 0.0 111.58 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.841 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -93.92 175.58 6.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.43 0.633 . . . . 0.0 109.328 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -137.8 134.52 35.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -96.56 108.86 21.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.932 -1.105 . . . . 0.0 111.694 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.655 HD12 HG21 ' A' ' 49' ' ' ILE . 1.5 mt -89.84 131.41 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 p -72.63 159.32 34.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.998 -1.064 . . . . 0.0 108.357 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 -50.13 74.99 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.947 -1.095 . . . . 0.0 108.874 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.98 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.301 -1.499 . . . . 0.0 108.55 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -60.07 -33.69 72.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.967 -1.083 . . . . 0.0 108.988 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.3 tm? -60.03 -36.86 78.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.114 -0.991 . . . . 0.0 108.443 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -58.99 -37.38 76.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.85 -39.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 109.348 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.89 -40.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.049 -1.032 . . . . 0.0 109.488 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -64.31 -40.0 95.05 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.659 -1.275 . . . . 0.0 109.74 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -59.9 -44.66 94.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.267 -1.52 . . . . 0.0 109.169 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -76.28 -71.86 0.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 111.84 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 75' ' ' LEU . 7.7 mp -61.9 -41.68 98.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.02 -1.05 . . . . 0.0 111.93 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ALA . 39.1 tp . . . . . 0 N--CA 1.502 2.135 0 O-C-N 120.913 -1.117 . . . . 0.0 109.434 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -60.54 -50.11 74.85 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.054 0.93 . . . . 0.0 108.67 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.421 ' O ' HD13 ' A' ' 8' ' ' ILE . 97.8 m -61.02 -52.25 65.79 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.404 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.3 t -67.08 -43.35 82.8 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.853 -1.155 . . . . 0.0 111.786 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -69.73 -40.33 76.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 112.633 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -74.73 -43.08 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.352 -1.468 . . . . 0.0 111.81 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 4' ' ' THR . 1.5 mp -59.99 -52.63 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.864 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -63.61 -38.71 92.15 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.865 -1.147 . . . . 0.0 110.502 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.5 91.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.301 -0.874 . . . . 0.0 111.407 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' A' ' 8' ' ' ILE . 29.0 p30 . . . . . 0 N--CA 1.499 1.991 0 O-C-N 120.53 -1.356 . . . . 0.0 111.287 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 27.3 Cg_endo -101.25 132.24 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.934 2.423 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.535 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 25.5 ttt -125.9 127.76 46.51 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.07 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.8 mt -109.31 133.58 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.825 0.822 . . . . 0.0 109.829 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.4 p -93.81 101.41 13.51 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.539 -0.726 . . . . 0.0 109.243 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.058 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.88 -10.89 23.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.76 -1.213 . . . . 0.0 109.676 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.556 ' N ' HD22 ' A' ' 22' ' ' LEU . 76.2 t -60.32 -40.25 83.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 108.641 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -137.16 5.18 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 57.23 88.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -143.68 137.35 28.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.46 -1.024 . . . . 0.0 108.772 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.23 128.61 33.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.22 74.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.346 -0.846 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -70.32 108.34 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.334 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.74 24.55 0.66 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p -143.64 148.43 35.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 75' ' ' LEU . 36.0 m -128.72 110.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.5 m-85 42.58 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.635 -0.665 . . . . 0.0 109.539 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 32' ' ' VAL . 49.0 tp -91.22 133.36 35.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.448 -0.783 . . . . 0.0 109.828 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.88 19.37 13.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.429 -1.869 . . . . 0.0 108.429 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -143.36 -65.05 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.063 . . . . 0.0 109.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 173.12 66.65 0.05 OUTLIER Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -74.33 154.15 39.01 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.286 -1.126 . . . . 0.0 109.633 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -156.36 150.13 24.91 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.89 170.68 15.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.764 -1.21 . . . . 0.0 109.831 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -165.62 109.06 0.82 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -89.95 126.27 35.67 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.546 -1.347 . . . . 0.0 110.364 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -109.2 0.73 19.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.594 -0.691 . . . . 0.0 110.724 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.06 -117.35 0.96 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -86.41 -8.6 57.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.312 . . . . 0.0 109.657 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.7 m -120.11 128.26 53.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.332 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -93.2 140.63 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.942 0.877 . . . . 0.0 111.315 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 t -109.37 120.13 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.614 HD12 HD12 ' A' ' 63' ' ' ILE . 56.2 mt -121.48 169.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.389 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 49' ' ' ILE . 54.8 m -142.33 99.53 5.87 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 50' ' ' SER . 9.3 Cg_exo -32.25 -79.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.307 2.004 . . . . 0.0 112.156 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -103.0 -41.57 6.08 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -155.55 -165.49 2.0 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -171.95 104.8 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.586 -0.696 . . . . 0.0 109.67 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 58' ' ' PHE . 19.2 p -129.65 148.48 51.54 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -33.15 -25.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.139 -0.35 . . . . 0.0 111.655 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 2.4 mt -81.47 2.09 30.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.634 -1.291 . . . . 0.0 109.187 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 55' ' ' THR . 55.0 m-85 -139.73 -160.7 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 156.07 41.95 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.747 -1.221 . . . . 0.0 110.882 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.25 177.29 9.06 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 109.309 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -126.78 131.37 51.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -88.24 170.09 11.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.587 -1.32 . . . . 0.0 110.277 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.614 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -164.95 122.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.7 m -59.5 153.18 20.08 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.381 -1.449 . . . . 0.0 108.324 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -52.8 -48.63 66.75 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.811 -1.181 . . . . 0.0 109.058 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.94 84.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.347 -1.47 . . . . 0.0 108.775 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -59.78 -27.32 66.46 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.72 -1.192 . . . . 0.0 107.847 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.1 tm? -59.92 -31.32 69.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.445 -1.409 . . . . 0.0 107.641 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.34 -38.43 83.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.808 -1.183 . . . . 0.0 108.71 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.13 -38.88 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.016 -1.053 . . . . 0.0 109.236 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.62 -40.5 86.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.391 -0.818 . . . . 0.0 110.629 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.06 35.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 111.437 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.45 -37.74 81.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.085 -1.634 . . . . 0.0 111.069 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -62.96 -64.72 0.83 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.113 -0.992 . . . . 0.0 111.685 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 32' ' ' VAL . 5.9 mp -67.83 -47.1 69.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.101 -0.999 . . . . 0.0 110.821 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.695 ' N ' HD22 ' A' ' 76' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.597 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 121.646 0.736 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.02 -41.59 92.51 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 5' ' ' SER . 6.5 t -79.66 -44.23 21.3 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.897 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 4' ' ' THR . 17.6 t -60.31 -53.68 54.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.034 . . . . 0.0 111.307 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.08 -43.16 71.71 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.098 -1.001 . . . . 0.0 112.545 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.99 -43.42 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.698 -1.251 . . . . 0.0 111.67 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.85 -52.24 63.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.773 -1.204 . . . . 0.0 109.201 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.18 -39.99 73.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 110.359 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.04 -47.36 85.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.685 -1.259 . . . . 0.0 109.694 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 . . . . . 0 N--CA 1.496 1.833 0 O-C-N 120.918 -1.113 . . . . 0.0 109.212 -179.861 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 67.3 mttt . . . . . 0 N--CA 1.5 2.032 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 66.9 Cg_endo -98.16 140.27 0.47 Allowed 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 122.272 1.981 . . . . 0.0 113.296 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 4.6 ttt -121.32 138.4 54.27 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.9 mt -107.29 131.78 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.446 -0.784 . . . . 0.0 109.51 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.9 t -93.54 100.32 12.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -66.22 -10.05 38.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.43 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.545 ' N ' HD12 ' A' ' 22' ' ' LEU . 73.4 t -59.76 -40.69 83.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -132.22 -2.79 3.52 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 64.65 85.61 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -143.07 136.29 28.19 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.233 -1.157 . . . . 0.0 110.08 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 58.3 mp0 -82.6 124.63 30.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.1 mt -123.0 73.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.337 -0.852 . . . . 0.0 110.151 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.73 116.78 3.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.204 -0.935 . . . . 0.0 110.261 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.93 26.25 1.74 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.515 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.8 p -135.91 140.25 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.774 -0.839 . . . . 0.0 109.387 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.642 HG22 HD21 ' A' ' 75' ' ' LEU . 27.0 m -122.98 98.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 12.8 p90 40.1 26.57 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -96.22 135.24 38.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.661 -0.65 . . . . 0.0 110.692 -178.251 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.595 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 115.44 36.26 1.21 Allowed Glycine 0 N--CA 1.501 2.998 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.37 -85.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.185 . . . . 0.0 110.265 -178.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -147.37 26.28 1.54 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -44.54 148.13 0.52 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.378 -1.072 . . . . 0.0 110.471 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.0 m -148.24 146.95 28.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.07 165.35 27.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.239 -1.538 . . . . 0.0 109.543 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -154.16 130.88 10.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -101.69 125.56 48.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.227 -1.546 . . . . 0.0 110.057 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -99.39 -0.87 40.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 0.0 108.967 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.41 16.39 66.64 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.326 -0.94 . . . . 0.0 110.914 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -161.7 -57.08 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.3 m -122.32 131.73 54.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -92.68 132.91 35.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.292 -0.88 . . . . 0.0 111.137 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.95 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 50' ' ' SER . 63.4 mt -128.19 155.41 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.432 -0.792 . . . . 0.0 109.794 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.8 m -124.97 120.57 25.46 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 22.4 Cg_exo -33.5 -85.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.096 1.864 . . . . 0.0 111.157 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -105.07 -36.97 7.11 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 73.7 mt-10 -164.52 -163.28 0.72 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -169.14 114.78 0.58 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 7.4 p -127.67 41.98 3.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.083 -1.01 . . . . 0.0 109.492 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 70.65 -29.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.536 ' H ' ' C ' ' A' ' 55' ' ' THR . 7.2 mt -82.59 -4.87 58.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.3 -0.875 . . . . 0.0 108.726 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.73 -151.23 0.47 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -150.85 161.89 41.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.799 -1.188 . . . . 0.0 111.329 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.89 173.13 11.48 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' NZ ' ' CE2' ' A' ' 33' ' ' TYR . 36.5 ttpt -134.02 157.9 44.92 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.48 171.18 8.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -165.87 126.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.5 p -57.97 150.11 21.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.225 -1.547 . . . . 0.0 107.033 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.38 -44.9 68.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.746 -1.221 . . . . 0.0 109.131 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.4 -42.52 96.13 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.656 -1.277 . . . . 0.0 109.677 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 70' ' ' ILE . 9.2 m170 -54.77 -27.01 38.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.548 -1.345 . . . . 0.0 107.798 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -59.4 -30.16 68.25 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 107.799 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.57 -33.17 75.07 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.982 -1.074 . . . . 0.0 109.057 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 67' ' ' HIS . 3.8 tt -59.92 -32.08 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.675 -1.266 . . . . 0.0 108.886 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.7 -41.16 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.93 75.93 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.948 -1.095 . . . . 0.0 110.846 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -59.85 -50.2 74.74 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.046 -1.034 . . . . 0.0 109.445 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -68.25 -71.33 0.22 Allowed 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 111.309 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 75' ' ' LEU . 6.6 mp -61.18 -47.92 83.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.506 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.505 2.308 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.293 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 tp -60.15 -41.86 93.67 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.2 m -69.05 -51.44 38.91 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.667 -0.646 . . . . 0.0 110.657 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.0 m -69.59 -48.31 60.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.267 -1.52 . . . . 0.0 112.72 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.97 -44.5 72.8 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.595 -1.315 . . . . 0.0 113.115 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.24 -46.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.694 -1.254 . . . . 0.0 111.57 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.537 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.2 mp -61.0 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 121.146 -0.971 . . . . 0.0 109.1 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.62 -39.49 80.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.77 -40.51 69.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.043 -1.036 . . . . 0.0 109.399 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.597 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 5.6 tttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 86.3 Cg_endo -101.74 118.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 123.436 2.757 . . . . 0.0 112.068 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.6 ttt -121.65 130.44 53.47 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.205 -0.934 . . . . 0.0 109.741 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.4 mt -108.37 130.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.3 t -94.38 99.7 11.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 108.931 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -59.72 -12.57 7.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.6 -41.33 84.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -117.33 -16.11 10.32 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.67 8.72 87.56 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -78.98 158.03 28.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -1.033 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -94.91 128.72 41.9 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.95 78.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.539 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.5 101.46 3.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.861 -1.15 . . . . 0.0 108.977 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.4 24.47 0.3 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -141.61 147.09 37.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -1.022 . . . . 0.0 108.41 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.755 HG22 HD21 ' A' ' 75' ' ' LEU . 33.0 m -129.38 108.75 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 44.37 23.31 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.379 -0.826 . . . . 0.0 109.305 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' VAL . 29.2 tp -90.39 145.05 25.25 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.472 0.653 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.48 17.22 59.02 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -134.35 -48.06 0.77 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.508 -0.995 . . . . 0.0 110.127 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.81 37.39 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -51.36 139.73 18.74 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.133 -1.216 . . . . 0.0 109.92 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -146.52 137.69 24.32 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.58 166.82 13.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.116 -1.615 . . . . 0.0 108.982 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -141.34 154.51 45.72 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -103.11 134.84 45.87 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.73 -1.231 . . . . 0.0 109.514 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -104.77 -5.52 21.17 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.448 -0.782 . . . . 0.0 110.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.4 56.9 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -169.17 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -1.113 . . . . 0.0 109.409 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.9 m -143.62 119.0 10.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 mm -76.91 138.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.848 -1.157 . . . . 0.0 110.878 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.19 117.12 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 63' ' ' ILE . 53.7 mt -127.73 139.53 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.357 -0.84 . . . . 0.0 111.735 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.414 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 75.1 m -120.08 121.96 29.23 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' SER . 49.6 Cg_exo -36.21 -78.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 121.886 1.724 . . . . 0.0 111.845 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.15 -40.9 5.71 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.194 -0.941 . . . . 0.0 110.073 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.59 -162.83 0.41 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.144 -0.973 . . . . 0.0 111.296 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' OE2' ' OG ' ' A' ' 50' ' ' SER . 80.7 mt-10 -152.09 104.63 2.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.896 -0.503 . . . . 0.0 111.198 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -107.67 114.34 28.25 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.626 -1.296 . . . . 0.0 109.222 178.36 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.66 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.884 0.85 . . . . 0.0 110.05 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -64.62 43.39 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 111.025 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' A' ' 56' ' ' ALA . 55.4 p90 -93.41 -178.17 4.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.38 1.086 . . . . 0.0 111.698 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -137.51 119.75 15.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.895 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.27 177.26 8.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.098 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -131.2 127.27 37.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -101.09 108.04 19.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.935 -1.103 . . . . 0.0 110.966 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -104.03 140.68 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -69.89 157.98 36.4 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.383 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.36 83.8 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.049 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.81 85.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.44 -1.413 . . . . 0.0 110.516 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -59.5 -24.12 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.5 tm? -59.85 -39.14 84.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -55.75 -32.55 63.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.0 -41.26 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.692 -1.255 . . . . 0.0 108.392 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.6 mp -64.28 -40.31 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.79 93.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 111.236 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -37.72 58.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.453 -1.405 . . . . 0.0 111.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.86 -49.68 60.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.161 -0.962 . . . . 0.0 112.0 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.755 HD21 HG22 ' A' ' 32' ' ' VAL . 9.0 mp -80.33 -55.62 4.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.639 -1.288 . . . . 0.0 110.929 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--N 1.298 -1.67 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.777 -179.325 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.07 -47.74 84.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 m -61.02 -50.04 74.96 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.054 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m -75.0 -54.21 7.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.865 -1.147 . . . . 0.0 112.907 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.464 ' HB3' HD22 ' A' ' 22' ' ' LEU . 61.7 mm-40 -64.77 -41.21 96.03 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.624 -1.298 . . . . 0.0 112.928 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.562 ' CG1' ' CH2' ' A' ' 38' ' ' TRP . 94.0 t -69.91 -47.79 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.341 -1.474 . . . . 0.0 111.373 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.2 mp -61.71 -42.91 96.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.283 -0.886 . . . . 0.0 110.626 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -65.78 -41.4 92.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.653 -1.279 . . . . 0.0 109.782 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.438 ' HB2' HD21 ' A' ' 22' ' ' LEU . . . -65.11 -22.43 66.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.055 -1.028 . . . . 0.0 109.329 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 7.5 tttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 80.5 Cg_endo -99.88 115.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 123.328 2.685 . . . . 0.0 111.714 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -111.46 141.88 44.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.378 -0.826 . . . . 0.0 109.696 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.602 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.5 mm -110.61 133.19 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 25' ' ' GLY . 20.3 m -105.92 100.48 10.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.449 -0.782 . . . . 0.0 109.067 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.652 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.84 -15.99 63.65 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.07 -46.5 94.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -124.9 2.21 8.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.627 -0.671 . . . . 0.0 109.228 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 56.47 78.99 0.1 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.33 135.4 28.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.267 -1.137 . . . . 0.0 109.283 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.45 126.81 32.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 0.0 108.637 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 30' ' ' GLY . 55.3 mt -113.02 162.6 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -147.7 36.19 0.87 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.513 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -155.42 30.03 0.63 Allowed Glycine 0 C--N 1.293 -1.818 0 N-CA-C 106.289 -2.724 . . . . 0.0 106.289 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.437 ' OG1' ' CG2' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -133.41 138.09 46.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.549 HG12 ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -131.87 102.65 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.549 ' CZ ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER 44.62 54.66 6.37 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.67 117.91 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.868 -1.145 . . . . 0.0 109.498 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' C ' ' HE1' ' A' ' 38' ' ' TRP . . . 142.21 22.18 0.23 Allowed Glycine 0 N--CA 1.501 3.016 0 O-C-N 120.995 -1.066 . . . . 0.0 110.887 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.719 ' N ' ' HE1' ' A' ' 38' ' ' TRP . 65.0 m-20 -157.81 -85.86 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.785 -1.421 . . . . 0.0 110.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -142.21 22.08 2.43 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.719 ' HE1' ' N ' ' A' ' 36' ' ' ASP . 2.3 m95 -57.6 147.59 26.7 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.586 0.707 . . . . 0.0 110.633 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 t -156.35 154.1 30.04 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.53 166.68 24.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.597 -1.315 . . . . 0.0 109.049 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -144.91 155.04 43.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -100.64 133.05 45.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.706 -1.246 . . . . 0.0 108.694 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.08 -11.86 15.54 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.418 -0.802 . . . . 0.0 109.98 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 95.89 107.35 2.27 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 80.3 -4.24 1.87 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.787 -0.831 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.2 m -166.16 120.59 1.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 mm -95.69 137.87 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.8 t -109.38 123.29 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.418 ' C ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.156 -0.965 . . . . 0.0 110.801 -179.223 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.679 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -106.12 120.8 47.65 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 177.098 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.679 ' O ' ' O ' ' A' ' 50' ' ' SER . 31.1 Cg_exo -36.9 -112.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.144 1.896 . . . . 0.0 111.184 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -76.89 -31.61 56.86 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -171.79 -161.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.008 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -156.4 110.33 2.73 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.763 -0.585 . . . . 0.0 109.513 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.532 ' O ' ' C ' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -111.1 116.3 30.89 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.816 -1.177 . . . . 0.0 109.38 179.431 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.532 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 26.2 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.966 0.888 . . . . 0.0 110.497 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.2 43.61 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.871 -0.518 . . . . 0.0 111.247 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 56' ' ' ALA . 47.2 p90 -92.34 178.7 5.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.839 -1.163 . . . . 0.0 111.467 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 102.92 6.81 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 173.39 3.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 109.795 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -144.21 131.31 20.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -111.49 117.23 32.44 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.201 -0.937 . . . . 0.0 111.081 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.25 138.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -73.16 160.0 32.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.726 -1.233 . . . . 0.0 108.601 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.78 91.69 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.809 -1.182 . . . . 0.0 110.0 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.88 92.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.8 -1.188 . . . . 0.0 109.361 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -60.33 -25.21 65.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.495 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.1 tt -57.35 -40.23 77.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -58.16 -28.63 64.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 109.227 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.06 -39.86 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.703 -1.248 . . . . 0.0 108.556 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.93 -39.94 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 108.997 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.53 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.986 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -60.0 -46.57 89.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.724 -1.235 . . . . 0.0 109.227 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.463 HD22 HG22 ' A' ' 32' ' ' VAL . 64.2 t30 -68.38 -74.22 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.866 -0.521 . . . . 0.0 111.166 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 2.8 mp -61.21 -46.59 89.8 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.705 -1.247 . . . . 0.0 111.226 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 76' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.014 -1.054 . . . . 0.0 109.127 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.624 ' N ' ' HG ' ' A' ' 5' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.503 2.208 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.17 -50.15 74.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.0 m -61.42 -49.55 76.4 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.624 ' HG ' ' N ' ' A' ' 2' ' ' THR . 87.8 p -70.39 -48.04 58.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.911 -1.118 . . . . 0.0 112.384 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -69.6 -42.25 74.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 112.617 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 52' ' ' ALA . 95.4 t -66.76 -45.77 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.558 -1.338 . . . . 0.0 110.576 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mp -60.42 -45.31 96.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -60.64 -40.49 92.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.641 -1.287 . . . . 0.0 111.441 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -27.93 67.77 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.569 -1.332 . . . . 0.0 109.425 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.633 ' ND2' ' CZ ' ' A' ' 33' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.026 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 90.3 Cg_endo -88.8 110.21 0.54 Allowed 'Trans proline' 0 N--CA 1.485 1.02 0 CA-C-N 121.251 1.483 . . . . 0.0 112.203 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.563 ' SD ' HG21 ' A' ' 31' ' ' THR . 8.9 ttt -102.74 147.29 27.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.718 -0.614 . . . . 0.0 109.708 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.88 120.99 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.616 -0.678 . . . . 0.0 109.546 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 p -98.24 96.23 7.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.63 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.46 -17.84 64.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.2 t -59.68 -42.87 89.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -128.76 2.82 5.43 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.24 79.66 0.08 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.9 138.53 28.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.29 -1.123 . . . . 0.0 109.759 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 4.1 tm-20 -81.31 120.93 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.95 67.99 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 109.71 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 46.0 pttt -60.24 102.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.442 1.115 . . . . 0.0 110.308 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.662 ' C ' HD21 ' A' ' 74' ' ' ASN . . . 136.45 25.49 0.46 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.563 HG21 ' SD ' ' A' ' 19' ' ' MET . 98.7 m -138.48 140.96 39.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.507 -0.996 . . . . 0.0 108.5 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -118.55 80.5 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.459 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CZ ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER 42.37 25.6 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' VAL . 54.9 tp -85.12 129.87 34.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.872 . . . . 0.0 109.79 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 36' ' ' ASP . . . 124.83 -75.24 0.4 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' GLY . 78.4 m-20 -31.59 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.866 -0.785 . . . . 0.0 111.498 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . -134.87 16.44 4.24 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.47 ' C ' ' O ' ' A' ' 37' ' ' GLY . 3.7 t90 -26.34 138.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.969 0.414 . . . . 0.0 111.793 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -159.46 144.51 15.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.852 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.05 168.59 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.525 -1.359 . . . . 0.0 109.195 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -153.73 159.54 42.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -104.97 120.97 42.77 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.026 -1.046 . . . . 0.0 110.409 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -100.9 -2.81 31.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.12 -0.988 . . . . 0.0 110.71 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.5 -114.56 1.24 Allowed Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.44 -9.8 59.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -1.027 . . . . 0.0 110.546 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.9 m -129.15 140.12 51.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.45 HG13 HD12 ' A' ' 68' ' ' LEU . 36.3 mm -108.09 139.85 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 110.104 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.2 120.28 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.557 -0.715 . . . . 0.0 109.278 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.66 141.29 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.817 -1.177 . . . . 0.0 110.802 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 51' ' ' PRO . 95.0 p -111.77 127.09 27.37 Favored Pre-proline 0 N--CA 1.482 1.129 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD3' ' HZ2' ' A' ' 61' ' ' LYS . 52.6 Cg_exo -34.83 -81.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.961 1.774 . . . . 0.0 112.619 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -106.03 -41.64 5.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 79.3 mt-10 -158.62 -165.42 1.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.066 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -172.25 113.27 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.673 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 19.0 p -126.94 38.46 4.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.293 -0.879 . . . . 0.0 110.415 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 73.85 -24.92 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.93 -1.106 . . . . 0.0 109.57 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 55' ' ' THR . 6.4 mt -87.8 -3.29 58.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -132.47 -156.47 0.75 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -150.74 158.57 44.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.449 -1.407 . . . . 0.0 111.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.23 174.46 8.74 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HZ2' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -134.19 128.25 33.63 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -81.55 167.05 19.7 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.98 -1.075 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 63' ' ' ILE . 19.2 tt -169.69 118.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.1 p -58.54 151.19 20.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 110.913 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -53.81 -41.44 67.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.98 94.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.5 -1.375 . . . . 0.0 109.267 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.452 ' O ' HG22 ' A' ' 70' ' ' ILE . 18.6 m80 -61.52 -25.1 67.06 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD12 HG13 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -57.04 -28.45 62.55 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.34 -34.64 74.91 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.875 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 67' ' ' HIS . 4.6 tt -59.56 -36.51 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.479 -1.289 . . . . 0.0 108.427 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.516 ' O ' HD22 ' A' ' 75' ' ' LEU . 67.1 mt -60.32 -45.19 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.87 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.82 67.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.055 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -62.26 -39.33 92.53 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.478 -1.389 . . . . 0.0 108.663 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.662 HD21 ' C ' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -69.59 -68.14 0.43 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.697 -0.627 . . . . 0.0 110.761 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.647 ' H ' HD22 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -60.1 -51.2 70.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 0.0 111.221 -176.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 76' ' ' LEU . 6.3 mt . . . . . 0 C--N 1.3 -1.58 0 O-C-N 120.799 -1.188 . . . . 0.0 109.219 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.5 tp -59.92 -48.88 79.9 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.9 m -64.01 -51.82 62.45 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.329 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 t -70.95 -52.39 20.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.801 -1.187 . . . . 0.0 111.489 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' THR . 36.4 tp10 -61.01 -46.09 92.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.972 -1.08 . . . . 0.0 112.665 -177.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 52' ' ' ALA . 64.3 t -67.91 -49.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 112.078 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.586 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.01 -45.63 95.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 110.693 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.99 -40.11 88.03 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.981 -1.074 . . . . 0.0 110.931 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -19.93 65.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.83 -1.169 . . . . 0.0 111.769 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.549 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.507 2.404 0 O-C-N 120.996 -1.065 . . . . 0.0 111.263 -178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 72.0 Cg_endo -90.57 128.6 1.42 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.31 2.007 . . . . 0.0 111.675 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -123.02 128.7 50.53 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.463 ' N ' ' SD ' ' A' ' 19' ' ' MET . 87.1 mt -110.49 130.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.067 -1.021 . . . . 0.0 109.465 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' GLY . 67.6 m -88.72 99.78 12.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.015 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -61.95 -13.05 21.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.35 -0.844 . . . . 0.0 109.151 -179.23 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.575 ' N ' HD22 ' A' ' 22' ' ' LEU . 70.0 t -60.11 -47.64 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 108.604 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 52.7 t0 -123.42 7.56 9.0 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.93 84.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -142.39 135.5 28.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.476 -1.014 . . . . 0.0 109.936 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -77.13 121.08 23.09 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.8 mt -119.99 69.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -61.64 106.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.989 -1.069 . . . . 0.0 108.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.08 18.75 0.93 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.66 146.8 36.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -1.046 . . . . 0.0 108.437 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG2' HD21 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -131.23 111.46 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 44.63 21.63 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 0.0 109.224 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' VAL . 34.5 tp -85.82 149.34 25.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.83 79.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.47 -63.37 1.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.618 -0.93 . . . . 0.0 109.355 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.69 39.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -59.74 155.38 16.06 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.499 -1.0 . . . . 0.0 110.507 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -146.43 149.68 34.18 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.93 169.39 17.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.238 -1.539 . . . . 0.0 109.782 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -159.95 136.2 8.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -109.03 122.85 48.13 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.657 -1.277 . . . . 0.0 111.469 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 10.7 t70 -96.69 -6.84 35.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.658 -0.651 . . . . 0.0 110.687 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.61 15.66 42.49 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.743 -1.223 . . . . 0.0 110.813 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -171.12 -55.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.305 . . . . 0.0 108.647 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.3 m -120.12 129.99 54.42 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -91.34 140.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.8 . . . . 0.0 111.959 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 t -103.61 111.58 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -129.67 140.17 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.5 m -112.66 121.58 38.36 Favored Pre-proline 0 N--CA 1.483 1.222 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 50' ' ' SER . 30.8 Cg_exo -35.27 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 122.263 1.975 . . . . 0.0 112.154 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.586 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -107.98 -41.52 4.93 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -166.43 -163.41 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.609 0.719 . . . . 0.0 109.943 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 56' ' ' ALA . 3.9 tm-20 -172.05 116.27 0.36 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.667 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 6.6 p -122.15 38.1 4.22 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.155 -0.966 . . . . 0.0 110.338 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 73.66 -18.68 0.37 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.95 . . . . 0.0 109.383 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 55' ' ' THR . 14.0 mt -93.51 0.09 56.56 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -130.13 -153.34 0.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -145.34 159.62 42.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.998 -1.064 . . . . 0.0 110.818 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.47 174.65 11.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -136.46 106.95 6.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -73.29 175.86 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -166.7 122.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.5 ' HG ' ' HD1' ' A' ' 67' ' ' HIS . 76.9 p -54.67 148.42 12.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.568 -1.332 . . . . 0.0 108.229 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -52.01 -44.92 64.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.99 -1.069 . . . . 0.0 109.158 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.11 79.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 119.992 -1.693 . . . . 0.0 109.967 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.5 ' HD1' ' HG ' ' A' ' 64' ' ' SER . 31.6 m80 -61.67 -23.57 66.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.558 -1.339 . . . . 0.0 108.668 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.95 -33.47 71.97 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -62.59 -37.18 85.23 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.03 -38.86 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.099 -1.001 . . . . 0.0 109.724 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.497 ' O ' HD22 ' A' ' 75' ' ' LEU . 57.9 mt -59.92 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.824 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.76 76.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.728 -1.232 . . . . 0.0 110.478 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -61.62 -41.91 98.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.448 -1.408 . . . . 0.0 109.597 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -60.71 -61.62 2.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.715 -0.616 . . . . 0.0 111.194 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.2 mm? -60.25 -40.04 88.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.629 -1.295 . . . . 0.0 110.361 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--N 1.297 -1.682 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.789 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.416 0.627 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.521 HD21 ' O ' ' A' ' 36' ' ' ASP . 10.6 tp -63.51 -54.71 31.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.441 HG21 ' CD2' ' A' ' 58' ' ' PHE . 33.3 m -62.49 -50.31 71.93 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -70.31 -43.67 69.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.123 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -70.05 -41.75 73.77 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.698 -1.252 . . . . 0.0 112.131 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.09 -50.3 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.531 -1.356 . . . . 0.0 111.087 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.571 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.05 -48.08 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.019 -1.051 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.01 -39.04 84.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.32 -22.18 63.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' ILE . 4.9 t-20 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.732 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -103.62 130.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.568 2.845 . . . . 0.0 110.678 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 ttt -132.06 126.23 33.33 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.878 -1.139 . . . . 0.0 110.012 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.79 129.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.717 0.77 . . . . 0.0 109.925 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 25' ' ' GLY . 13.6 p -87.82 100.7 13.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.049 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.39 -13.82 6.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.408 ' H ' HD22 ' A' ' 22' ' ' LEU . 65.9 t -59.99 -44.98 95.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -125.64 0.26 7.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 66.61 13.33 60.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -75.89 137.18 40.23 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.22 138.34 31.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.475 -0.766 . . . . 0.0 110.274 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 30' ' ' GLY . 63.8 mt -122.45 158.1 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -140.83 36.6 1.79 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.083 -1.636 . . . . 0.0 107.576 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -156.63 28.46 0.54 Allowed Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.0 p -135.51 142.26 45.41 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.054 0.93 . . . . 0.0 110.146 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 32' ' ' VAL . 16.4 m -121.0 88.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 35.4 p90 40.08 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.538 0.685 . . . . 0.0 109.238 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 32' ' ' VAL . 47.1 tp -73.26 135.15 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.675 -0.64 . . . . 0.0 109.572 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . 73.1 147.28 0.85 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' HD21 ' A' ' 3' ' ' LEU . 6.5 m-20 95.92 19.95 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 123.295 0.638 . . . . 0.0 110.129 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 123.71 -11.38 8.38 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 37' ' ' GLY . 5.8 p-90 -32.26 126.14 0.28 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.39 0.614 . . . . 0.0 111.013 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 t -152.93 140.23 19.53 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.52 175.02 11.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.157 -1.589 . . . . 0.0 109.868 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -161.19 159.9 29.41 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -110.41 121.47 45.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.995 -1.066 . . . . 0.0 109.708 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 43' ' ' ASP . 4.4 p30 -100.66 -1.02 36.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.56 -120.04 1.36 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.736 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -81.41 -7.75 59.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -1.112 . . . . 0.0 110.317 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.7 m -123.47 130.82 53.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.82 141.93 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.14 119.63 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mt -131.66 146.96 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.287 -0.883 . . . . 0.0 110.917 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 15.8 m -118.12 111.49 38.68 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 102.467 -3.161 . . . . 0.0 102.467 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.1 Cg_exo -33.34 -75.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.023 1.815 . . . . 0.0 111.386 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.571 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -106.15 -47.07 3.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.71 -165.99 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.497 ' OE2' ' N ' ' A' ' 60' ' ' ALA . 62.2 tt0 -175.11 114.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -118.19 36.47 4.34 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.069 -1.019 . . . . 0.0 109.879 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 72.59 -21.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 0.0 109.042 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 55' ' ' THR . 40.9 mt -91.03 0.02 57.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CD2' HG21 ' A' ' 4' ' ' THR . 92.6 m-85 -128.51 -135.95 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -155.28 155.1 33.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.708 -1.245 . . . . 0.0 111.789 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.497 ' N ' ' OE2' ' A' ' 54' ' ' GLU . . . -86.37 177.44 7.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -139.51 150.77 45.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -115.77 173.16 6.7 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.228 -0.92 . . . . 0.0 108.995 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -168.41 111.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -48.42 155.1 0.55 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.08 -1.013 . . . . 0.0 109.068 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -56.82 -48.15 78.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.052 -1.03 . . . . 0.0 108.603 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.98 87.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.16 -1.588 . . . . 0.0 108.767 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -59.24 -28.11 66.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.866 -1.146 . . . . 0.0 108.32 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.692 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.2 tm? -59.83 -30.06 68.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -60.39 -37.14 79.85 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.09 -38.74 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.394 -0.816 . . . . 0.0 109.391 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.4 mp -58.35 -39.9 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 108.281 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.445 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -66.1 -40.03 90.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 111.096 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.13 -48.07 72.05 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.625 -1.297 . . . . 0.0 111.174 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -59.98 -52.67 64.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 112.029 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.587 HD11 HG13 ' A' ' 32' ' ' VAL . 4.4 mp -69.91 -42.1 73.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.302 -1.498 . . . . 0.0 110.459 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' OXT' ' O ' ' A' ' 72' ' ' ALA . 2.3 pp . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.7 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.16 -45.74 92.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.015 0.912 . . . . 0.0 108.78 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.4 m -61.2 -54.41 44.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 110.847 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.3 t -70.19 -48.34 57.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.834 -1.166 . . . . 0.0 112.067 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.15 -46.63 86.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.804 -1.185 . . . . 0.0 112.98 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.3 -48.12 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 112.155 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.463 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.4 mp -61.32 -47.78 91.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.667 -1.271 . . . . 0.0 109.934 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.3 -40.12 89.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.889 -1.132 . . . . 0.0 110.755 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.92 86.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.827 -1.171 . . . . 0.0 109.039 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 20' ' ' ILE . 35.2 m120 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 110.081 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -95.12 126.2 0.39 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.313 2.009 . . . . 0.0 110.595 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.66 136.86 54.27 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 110.942 -178.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.509 ' H ' ' CG ' ' A' ' 11' ' ' ASN . 27.7 mm -100.09 128.1 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.8 t -102.52 103.92 14.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.419 -0.8 . . . . 0.0 108.88 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.63 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -69.4 -7.28 36.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -47.55 91.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -128.73 11.59 6.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.99 83.27 0.04 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -150.36 139.72 21.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -1.014 . . . . 0.0 109.519 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -84.83 139.09 32.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 109.08 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 30' ' ' GLY . 71.0 mt -122.78 158.56 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -144.61 42.46 1.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -168.3 32.41 0.19 Allowed Glycine 0 C--N 1.294 -1.801 0 N-CA-C 106.313 -2.715 . . . . 0.0 106.313 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.463 ' OG1' HG21 ' A' ' 28' ' ' ILE . 12.7 m -136.79 142.64 42.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.784 0.802 . . . . 0.0 109.879 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.537 HG22 HD21 ' A' ' 75' ' ' LEU . 16.7 m -128.55 73.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 53.84 23.27 3.72 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.651 HD13 ' N ' ' A' ' 35' ' ' GLY . 1.7 tm? -73.75 123.71 24.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.651 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 78.64 158.49 12.22 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 10.2 m-20 93.94 7.09 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 C-N-CA 123.105 0.562 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 130.53 -3.77 5.81 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.473 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 10.1 p-90 -29.92 138.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.423 0.63 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.8 m -151.01 139.88 20.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.99 167.53 21.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.566 -1.334 . . . . 0.0 109.867 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -161.41 125.82 3.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -102.93 130.11 49.88 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.748 -1.22 . . . . 0.0 110.885 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -107.52 -11.31 15.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.645 -0.659 . . . . 0.0 109.716 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.03 2.32 89.5 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.97 -31.24 0.5 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -1.127 . . . . 0.0 109.433 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.4 m -157.22 118.66 3.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.18 122.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.346 -0.846 . . . . 0.0 111.535 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 t -95.61 99.16 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 142.32 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.407 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.1 p -117.11 149.57 44.55 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.56 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.408 1.405 . . . . 0.0 112.077 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -90.61 -45.85 8.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.884 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -167.44 1.17 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.273 -1.517 . . . . 0.0 111.486 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 28.2 mp0 -150.44 98.48 2.66 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 57' ' ' LEU . 4.1 p -129.99 144.29 51.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -25.13 -29.21 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.8 mp -83.61 -10.2 58.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.62 -1.3 . . . . 0.0 110.242 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 55' ' ' THR . 23.1 t80 -138.46 -164.55 1.65 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.282 -0.886 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -154.9 170.79 20.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.998 -1.064 . . . . 0.0 110.904 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.68 175.34 8.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.501 0.667 . . . . 0.0 110.404 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -128.77 141.77 51.21 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -86.71 169.29 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.046 -1.034 . . . . 0.0 110.592 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -162.91 127.87 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.8 m -61.19 154.9 22.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.277 -1.514 . . . . 0.0 108.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.75 68.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.654 -1.278 . . . . 0.0 109.401 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.93 87.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.695 -1.253 . . . . 0.0 109.153 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -55.04 -27.26 43.19 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.889 -1.132 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.445 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -59.91 -33.67 72.19 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -59.95 -35.4 74.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.0 mt -59.64 -39.75 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.91 . . . . 0.0 108.929 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.425 HG23 HG21 ' A' ' 32' ' ' VAL . 48.1 mt -58.88 -39.94 78.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.216 -0.927 . . . . 0.0 108.997 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.82 -41.56 99.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 111.106 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . 6.4 mtmp? -65.94 -50.04 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.047 -1.033 . . . . 0.0 111.011 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.87 -43.63 94.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.462 -0.773 . . . . 0.0 111.987 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 75' ' ' LEU . 5.7 mp -80.92 -22.51 39.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.43 -1.419 . . . . 0.0 110.326 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.11 -0.994 . . . . 0.0 109.96 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.222 0.534 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.99 -45.15 95.95 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.496 HG22 ' CE2' ' A' ' 58' ' ' PHE . 22.5 m -62.26 -54.88 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.855 -0.528 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -71.95 -48.65 43.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.574 -1.329 . . . . 0.0 112.0 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.81 -42.58 90.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.02 -1.05 . . . . 0.0 112.791 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 52' ' ' ALA . 96.7 t -69.81 -48.36 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.323 -1.486 . . . . 0.0 111.225 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.583 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.24 -47.91 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -63.71 -40.23 96.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.032 -1.042 . . . . 0.0 110.091 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.519 ' CB ' HD12 ' A' ' 22' ' ' LEU . . . -56.81 -38.22 72.28 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.093 -1.005 . . . . 0.0 108.384 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -95.95 129.7 0.4 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.001 1.8 . . . . 0.0 111.349 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 124.82 46.75 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -109.41 128.09 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.79 . . . . 0.0 109.037 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 23' ' ' VAL . 8.8 t -91.67 99.27 12.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.09 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -59.13 -8.59 1.59 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.59 ' N ' HD22 ' A' ' 22' ' ' LEU . 54.4 t -60.83 -41.12 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -123.28 -14.35 7.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.56 15.58 79.41 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -83.16 150.3 26.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -1.106 . . . . 0.0 111.776 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -91.66 130.99 37.37 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.73 74.39 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.53 -0.731 . . . . 0.0 109.864 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -68.5 108.48 3.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.853 -1.154 . . . . 0.0 108.925 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.91 21.77 0.87 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.3 p -143.62 150.92 39.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -1.068 . . . . 0.0 108.316 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 32' ' ' VAL . 32.7 m -127.1 89.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.448 -0.783 . . . . 0.0 109.178 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 57.78 19.94 6.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.112 -0.993 . . . . 0.0 109.918 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.1 tp -73.15 141.19 47.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 108.908 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.16 58.84 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.15 -138.51 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -102.22 24.32 31.5 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' GLY . 10.9 t90 -38.57 128.33 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.729 0.775 . . . . 0.0 110.891 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.5 t -151.09 137.71 18.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.11 173.12 17.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.304 -1.497 . . . . 0.0 110.208 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -151.97 153.79 34.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -101.26 120.79 40.78 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.707 -1.245 . . . . 0.0 109.131 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 49.1 t0 -100.69 -6.62 24.83 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.84 -117.33 0.97 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.029 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.9 17.94 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.961 . . . . 0.0 109.358 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.1 m -150.91 116.08 5.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.79 140.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 111.144 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.91 129.28 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.509 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -151.2 147.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.441 -1.412 . . . . 0.0 111.274 -178.036 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -112.3 121.32 39.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 177.211 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -36.06 -75.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.032 1.821 . . . . 0.0 111.731 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.583 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -104.83 -47.97 3.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.207 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.41 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 5.0 mt-10 -160.75 -166.48 1.62 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.361 -0.837 . . . . 0.0 109.953 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -173.14 116.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 4.9 p -89.88 -78.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.927 -1.108 . . . . 0.0 108.886 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.587 ' N ' ' OG1' ' A' ' 55' ' ' THR . . . -149.12 -76.03 0.16 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -64.86 22.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.394 -0.816 . . . . 0.0 109.871 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' H ' ' C ' ' A' ' 56' ' ' ALA . 22.7 m-85 -99.04 -175.67 3.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.783 -1.198 . . . . 0.0 108.366 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 138.94 53.89 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.964 0.888 . . . . 0.0 111.829 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.32 177.75 7.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -136.67 126.27 25.33 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.856 -1.153 . . . . 0.0 108.542 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -84.04 162.16 20.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.509 HD12 HG21 ' A' ' 49' ' ' ILE . 1.9 mt -151.08 112.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.7 p -62.81 152.18 36.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.755 -1.215 . . . . 0.0 108.358 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.59 69.17 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.773 -1.205 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.04 82.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.426 -1.422 . . . . 0.0 108.774 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -60.2 -35.34 75.18 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.841 -1.162 . . . . 0.0 109.507 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 71' ' ' ILE . 3.4 tm? -56.19 -34.45 66.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -60.53 -40.05 90.06 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mt -61.43 -32.01 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.667 HD12 HD22 ' A' ' 68' ' ' LEU . 79.7 mt -60.33 -39.72 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.047 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 76' ' ' LEU . . . -68.27 -36.23 79.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.994 -1.066 . . . . 0.0 109.732 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.07 -46.58 89.09 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.036 -1.04 . . . . 0.0 108.855 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -76.26 -74.19 0.24 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.7 -0.625 . . . . 0.0 110.835 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.696 HD12 ' N ' ' A' ' 75' ' ' LEU . 6.7 mp -60.22 -44.58 95.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.952 -1.093 . . . . 0.0 111.309 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 72' ' ' ALA . 21.9 mt . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.602 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.503 2.185 0 CA-C-O 121.051 0.453 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 3.8 tt -60.11 -48.34 82.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.836 -1.165 . . . . 0.0 109.253 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m -78.67 -50.52 11.3 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.494 0.664 . . . . 0.0 110.579 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -66.35 -52.86 42.69 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 112.561 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.55 -42.04 78.93 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.346 -1.471 . . . . 0.0 112.785 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 3' ' ' LEU . 95.7 t -61.15 -48.94 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.128 -0.983 . . . . 0.0 111.451 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.87 -40.34 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.411 -0.805 . . . . 0.0 109.905 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -58.68 -45.18 90.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.1 -1.0 . . . . 0.0 110.831 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 22' ' ' LEU . . . -60.12 -47.04 87.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.746 -1.221 . . . . 0.0 111.087 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 11' ' ' ASN . 5.3 p-10 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 120.672 -1.268 . . . . 0.0 110.681 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.539 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 15.8 mttt . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 111.013 0.005 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 75.5 Cg_endo -92.98 120.66 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.742 2.294 . . . . 0.0 113.513 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.0 tpt -121.5 123.41 41.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.542 -0.724 . . . . 0.0 110.544 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.2 mt -118.21 129.6 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLY . 29.9 t -91.13 99.14 12.2 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.136 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.19 -7.33 8.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.559 ' N ' HD22 ' A' ' 22' ' ' LEU . 78.2 t -61.11 -45.85 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -128.95 8.58 5.69 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.27 91.25 0.01 OUTLIER Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -143.56 137.15 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.372 -1.075 . . . . 0.0 109.042 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 57.9 mp0 -81.71 123.47 28.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.098 -1.001 . . . . 0.0 108.887 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' GLY . 50.1 mt -127.44 75.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.183 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -74.06 45.42 0.21 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.69 -1.256 . . . . 0.0 108.961 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -147.99 22.3 1.43 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -152.38 158.92 43.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 34' ' ' LEU . 14.4 m -133.44 112.6 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.321 -0.862 . . . . 0.0 108.974 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 32.5 p90 39.85 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.528 0.68 . . . . 0.0 109.369 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -81.93 129.01 34.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -178.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.65 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 127.35 -83.47 0.34 Allowed Glycine 0 N--CA 1.499 2.884 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 17.0 p-10 -32.92 -106.82 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.668 0.747 . . . . 0.0 111.895 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -123.23 30.11 5.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' GLY . 21.0 p-90 -31.71 132.68 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.872 0.844 . . . . 0.0 111.183 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -153.86 146.34 24.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 173.36 11.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.277 -1.514 . . . . 0.0 109.36 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -163.49 135.21 4.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -110.95 123.7 50.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.854 -1.154 . . . . 0.0 108.417 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 10.3 t70 -106.3 -10.05 16.55 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.362 -0.836 . . . . 0.0 111.305 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.45 -122.27 1.37 Allowed Glycine 0 N--CA 1.503 3.101 0 O-C-N 120.607 -1.308 . . . . 0.0 109.886 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.11 22.93 1.33 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -1.166 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 m -154.75 113.42 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mm -88.24 136.23 23.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.332 -0.855 . . . . 0.0 111.998 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.4 t -112.91 120.11 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.519 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -142.51 147.95 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.63 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.4 t -115.9 129.11 25.44 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.83 -76.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.597 1.531 . . . . 0.0 112.229 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.93 -49.99 4.58 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.023 -1.048 . . . . 0.0 112.318 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -165.51 -163.89 0.7 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.002 -1.686 . . . . 0.0 109.771 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -156.26 107.05 2.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.681 -0.637 . . . . 0.0 111.469 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.536 ' O ' ' C ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -110.81 118.02 35.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.621 -1.299 . . . . 0.0 108.288 178.166 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.27 -90.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.269 1.033 . . . . 0.0 110.287 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.28 43.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.305 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' A' ' 56' ' ' ALA . 54.9 p90 -91.88 -174.48 3.82 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.773 -1.204 . . . . 0.0 111.251 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.79 110.77 7.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.713 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.74 174.07 9.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.555 -1.34 . . . . 0.0 109.234 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -126.83 129.51 48.42 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -80.63 159.66 25.3 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.681 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.519 HD12 HG21 ' A' ' 49' ' ' ILE . 3.3 mt -153.34 114.57 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -66.87 159.84 27.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.29 -44.27 64.92 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.738 -1.185 . . . . 0.0 107.865 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.9 93.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.6 -0.688 . . . . 0.0 109.802 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -60.27 -24.79 65.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.17 -45.02 92.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.197 -1.564 . . . . 0.0 106.946 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -54.51 -29.71 51.3 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -0.965 . . . . 0.0 109.014 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.4 -39.67 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.727 -1.233 . . . . 0.0 108.507 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.92 -40.36 80.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.88 -31.49 69.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.363 -1.461 . . . . 0.0 110.528 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -69.84 -55.28 10.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.132 -1.605 . . . . 0.0 111.33 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 17' ' ' LYS . 28.0 t-20 -60.55 -44.66 95.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.229 -0.919 . . . . 0.0 111.334 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -63.78 -53.21 54.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 110.461 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 1.3 mm? . . . . . 0 C--N 1.294 -1.836 0 CA-C-O 117.892 -1.051 . . . . 0.0 108.374 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.36 -49.47 73.77 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 121.359 -0.838 . . . . 0.0 109.656 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.449 HG21 ' CE2' ' A' ' 58' ' ' PHE . 93.9 m -59.58 -48.79 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.072 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -69.01 -41.04 78.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.15 -1.594 . . . . 0.0 111.737 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -68.4 -50.32 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.042 -1.037 . . . . 0.0 112.329 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.495 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 97.6 t -69.37 -40.56 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.396 -0.815 . . . . 0.0 111.728 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 53' ' ' GLU . 7.0 mm -59.95 -47.37 91.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.843 -1.16 . . . . 0.0 109.8 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.24 -30.96 70.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.921 -1.112 . . . . 0.0 109.798 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 20' ' ' ILE . . . -66.78 -34.13 77.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.287 -0.883 . . . . 0.0 110.908 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 7' ' ' VAL . 21.7 p30 . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.084 -1.01 . . . . 0.0 111.079 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 ttmt . . . . . 0 N--CA 1.5 2.035 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 55.3 Cg_endo -98.47 136.29 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.109 2.54 . . . . 0.0 110.862 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.439 ' SD ' HG22 ' A' ' 31' ' ' THR . 11.8 ttt -122.96 136.95 55.05 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.904 -1.123 . . . . 0.0 111.32 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 10' ' ' ALA . 5.2 mm -105.26 133.15 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.4 t -109.28 102.81 11.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.746 . . . . 0.0 109.583 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.838 ' H ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.18 -19.38 65.29 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.556 -0.858 . . . . 0.0 108.829 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.01 -43.55 92.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -125.71 1.65 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.3 81.07 0.06 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -150.6 144.62 25.38 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.122 -1.223 . . . . 0.0 110.191 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -81.77 133.54 35.35 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -129.02 72.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.914 . . . . 0.0 110.853 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -65.57 115.52 5.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.678 -1.264 . . . . 0.0 109.296 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.36 21.05 2.32 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.439 HG22 ' SD ' ' A' ' 19' ' ' MET . 34.5 m -142.25 148.56 38.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.718 HG22 HD21 ' A' ' 75' ' ' LEU . 29.3 m -130.67 103.16 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.21 -0.931 . . . . 0.0 108.862 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.6 p90 33.31 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.616 -0.677 . . . . 0.0 110.93 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -93.18 129.96 39.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.606 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 96.41 40.82 3.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 77.4 m-20 -147.85 -40.12 0.18 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.745 -0.856 . . . . 0.0 108.703 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 153.63 33.26 0.03 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -49.86 145.51 5.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.911 -1.347 . . . . 0.0 111.41 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.2 p -145.64 133.24 20.92 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.53 171.04 17.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.063 -1.648 . . . . 0.0 109.821 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -165.63 132.88 2.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -93.04 120.77 33.69 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.675 -1.265 . . . . 0.0 109.479 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -99.07 -0.85 41.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 110.059 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.54 -118.93 1.49 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.67 -4.69 55.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.7 m -132.21 131.34 42.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.6 143.75 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.356 -0.84 . . . . 0.0 110.774 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.5 120.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.492 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -154.37 144.33 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.869 -1.144 . . . . 0.0 110.491 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.2 t -111.99 120.7 41.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -37.34 -78.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.019 0 C-N-CA 122.321 2.014 . . . . 0.0 113.508 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -84.05 -57.92 2.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.737 -1.227 . . . . 0.0 111.442 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' H ' HD11 ' A' ' 8' ' ' ILE . 92.7 mt-10 -158.58 -168.92 2.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.015 -1.053 . . . . 0.0 109.545 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -169.71 115.5 0.55 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.642 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 6.1 p -128.75 40.63 3.61 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.376 -0.828 . . . . 0.0 110.105 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 75.83 -24.88 0.21 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.682 -0.636 . . . . 0.0 110.386 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 57' ' ' LEU . 10.4 mp -92.53 1.02 57.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.6 -0.687 . . . . 0.0 109.556 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CE2' HG21 ' A' ' 4' ' ' THR . 98.1 m-85 -126.59 -160.98 1.03 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -134.97 149.67 50.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.084 -1.01 . . . . 0.0 111.555 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.08 175.64 8.89 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -132.76 141.95 48.78 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -101.94 107.8 19.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.2 -0.937 . . . . 0.0 109.721 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 49' ' ' ILE . 48.0 mt -100.82 104.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -51.37 164.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.849 -1.157 . . . . 0.0 108.899 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.01 82.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.071 . . . . 0.0 109.53 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.16 85.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.128 -1.608 . . . . 0.0 109.891 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -60.62 -38.18 83.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.389 -1.444 . . . . 0.0 108.679 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.4 tm? -55.96 -34.73 65.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.997 -1.064 . . . . 0.0 108.371 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -59.89 -33.82 72.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 108.817 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.47 HG22 ' ND2' ' A' ' 74' ' ' ASN . 77.2 mt -60.09 -40.57 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.58 -41.16 91.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.096 -1.003 . . . . 0.0 109.795 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.03 91.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 112.389 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -69.96 -36.95 75.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.868 -1.77 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.47 ' ND2' HG22 ' A' ' 70' ' ' ILE . 95.8 m-20 -63.53 -66.83 0.49 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 110.849 -178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.718 HD21 HG22 ' A' ' 32' ' ' VAL . 7.8 mp -66.77 -46.78 74.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.079 . . . . 0.0 111.323 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 120.881 -1.137 . . . . 0.0 109.865 -178.762 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.504 2.268 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.99 -41.59 92.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 m -77.79 -49.42 14.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.393 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.0 m -71.28 -57.11 4.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.927 -1.108 . . . . 0.0 111.647 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -60.32 -43.75 96.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.605 -1.309 . . . . 0.0 112.986 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 52' ' ' ALA . 94.5 t -67.19 -42.28 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.158 -1.589 . . . . 0.0 112.024 -177.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.56 -43.77 95.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.948 -1.095 . . . . 0.0 110.406 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -69.26 -49.31 57.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.738 -1.226 . . . . 0.0 111.204 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -18.87 65.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.871 -1.143 . . . . 0.0 109.759 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 -179.02 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.13 111.65 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.924 2.416 . . . . 0.0 113.645 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.9 OUTLIER -123.04 133.37 54.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.094 -1.004 . . . . 0.0 108.841 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -106.64 135.11 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.141 -0.974 . . . . 0.0 109.936 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -87.49 98.41 11.37 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -66.23 -13.5 60.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.12 -42.49 93.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.66 -17.4 5.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 82.94 74.44 1.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -138.59 131.86 30.13 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.209 -1.171 . . . . 0.0 109.468 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -82.06 122.57 27.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.869 -1.145 . . . . 0.0 109.824 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 30' ' ' GLY . 67.7 mt -108.66 166.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' N ' HG22 ' A' ' 28' ' ' ILE . 52.5 tttp -150.49 31.54 0.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.628 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -151.33 27.47 0.98 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 28' ' ' ILE . 6.1 p -137.82 144.27 41.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.887 -0.772 . . . . 0.0 109.461 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 32' ' ' VAL . 31.5 m -123.12 84.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER 58.9 39.15 24.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.561 -1.337 . . . . 0.0 109.489 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 36' ' ' ASP . 55.3 tp -80.38 137.32 36.52 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.12 -17.34 4.92 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 34' ' ' LEU . 83.9 m-20 -70.69 -32.23 69.39 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.345 -1.091 . . . . 0.0 108.663 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 129.13 19.73 1.53 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' GLY . 7.8 t90 -36.19 130.51 0.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.59 0.71 . . . . 0.0 110.955 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.9 t -150.56 131.99 14.69 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.37 179.97 7.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.012 -1.68 . . . . 0.0 111.079 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.93 157.75 43.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.06 -1.025 . . . . 0.0 108.297 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -96.72 113.51 25.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.528 -1.357 . . . . 0.0 108.827 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 46.1 t0 -100.62 -0.69 37.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.919 -1.113 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.99 -106.89 0.59 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.715 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -91.75 -14.04 30.59 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.491 -1.005 . . . . 0.0 110.279 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.7 m -120.7 125.36 47.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.775 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.7 135.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.551 -0.718 . . . . 0.0 110.46 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.61 106.58 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.46 140.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.567 -0.708 . . . . 0.0 111.634 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 51' ' ' PRO . 11.6 m -111.08 111.2 56.17 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.9 Cg_exo -33.49 -76.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 122.264 1.976 . . . . 0.0 112.07 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -97.87 -49.37 4.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.167 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -165.57 -163.85 0.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -167.91 117.1 0.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.146 -0.972 . . . . 0.0 109.508 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.605 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 8.6 p -88.15 -73.51 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.797 -1.189 . . . . 0.0 108.089 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.605 ' N ' ' OG1' ' A' ' 55' ' ' THR . . . -155.56 -77.28 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.45 26.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.505 -0.747 . . . . 0.0 111.092 -179.331 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.582 ' H ' ' C ' ' A' ' 56' ' ' ALA . 19.2 m-85 -103.71 -166.94 1.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 149.97 46.65 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.828 -1.17 . . . . 0.0 110.989 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.65 179.24 6.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -125.92 122.51 36.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -94.09 101.1 13.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.28 132.62 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.783 0.802 . . . . 0.0 109.421 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -65.9 149.44 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.83 -39.74 65.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 109.543 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.7 -41.39 90.65 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.426 -1.421 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -59.84 -34.74 73.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.435 -1.415 . . . . 0.0 108.567 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.772 HD22 HD12 ' A' ' 71' ' ' ILE . 3.2 tm? -58.33 -29.96 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -60.11 -37.19 79.25 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.56 -39.91 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.206 -0.934 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.772 HD12 HD22 ' A' ' 68' ' ' LEU . 78.7 mt -59.16 -39.72 79.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 108.679 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -66.28 -38.77 88.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 110.392 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -62.06 -40.8 97.03 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.595 -1.315 . . . . 0.0 110.42 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -73.99 -69.17 0.46 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.674 -0.641 . . . . 0.0 111.577 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 75' ' ' LEU . 7.6 mp -60.03 -45.78 91.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.503 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.12 -43.84 95.33 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.486 HG22 ' CE1' ' A' ' 58' ' ' PHE . 24.8 m -60.13 -57.82 11.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.642 -0.661 . . . . 0.0 111.187 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 p -70.4 -45.79 65.25 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.788 -1.195 . . . . 0.0 111.771 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.86 -49.89 68.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.094 . . . . 0.0 112.733 -177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.8 t -69.82 -47.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 120.642 -1.286 . . . . 0.0 112.331 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.408 ' CD1' ' H ' ' A' ' 52' ' ' ALA . 47.3 mm -60.09 -48.58 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.876 -1.14 . . . . 0.0 109.547 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -60.05 -39.3 85.48 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.477 -0.764 . . . . 0.0 110.357 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.12 85.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.928 -1.108 . . . . 0.0 110.654 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.1 179.571 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.553 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 32.3 pttt . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 45.1 Cg_endo -95.56 108.75 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.657 1.571 . . . . 0.0 112.696 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.79 133.75 54.91 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.0 mt -110.6 130.67 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 t -90.39 100.73 13.51 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -65.45 -7.14 12.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 108.854 -179.54 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.493 ' N ' HD12 ' A' ' 22' ' ' LEU . 91.8 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 24' ' ' ASP . 42.8 t0 -135.34 3.54 3.1 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.31 86.72 0.04 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.19 134.61 29.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.375 -1.073 . . . . 0.0 109.724 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -82.82 121.99 27.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.3 mt -119.99 76.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 110.701 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -70.18 107.13 3.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.679 -1.263 . . . . 0.0 109.959 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.99 23.74 1.03 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -134.97 139.2 44.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.611 HG22 HD21 ' A' ' 75' ' ' LEU . 33.4 m -124.38 111.35 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.616 ' OH ' HD13 ' A' ' 71' ' ' ILE . 4.4 p90 32.0 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.002 -0.436 . . . . 0.0 111.405 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -92.82 135.92 33.7 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.874 -1.141 . . . . 0.0 109.926 -179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.599 ' H ' HD13 ' A' ' 34' ' ' LEU . . . 100.73 18.26 21.12 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -129.99 -99.94 0.32 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -1.062 . . . . 0.0 109.521 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -153.41 25.24 0.77 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -50.04 149.59 2.7 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.77 -0.841 . . . . 0.0 111.093 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.3 m -149.68 151.66 34.06 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.79 10.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.234 -1.542 . . . . 0.0 109.474 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -158.78 160.35 36.2 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -97.48 121.79 39.78 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.89 -1.131 . . . . 0.0 109.861 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.495 ' OD2' HG23 ' A' ' 48' ' ' VAL . 12.2 m-20 -100.04 -1.83 35.96 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.152 -0.967 . . . . 0.0 110.306 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.664 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 83.75 95.23 0.63 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.782 -1.199 . . . . 0.0 110.51 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 84.22 4.76 0.71 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.938 -0.742 . . . . 0.0 109.887 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -165.94 143.77 5.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.99 128.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.468 -0.77 . . . . 0.0 110.371 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' OD2' ' A' ' 43' ' ' ASP . 89.6 t -101.2 109.83 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.36 140.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 p -112.09 120.51 41.65 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -36.61 -79.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.006 1.804 . . . . 0.0 113.097 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -93.53 -48.85 6.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.794 -1.191 . . . . 0.0 109.203 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -160.85 -165.83 1.47 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.535 -1.353 . . . . 0.0 109.568 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.631 ' OE2' ' HB2' ' A' ' 60' ' ' ALA . 84.8 tt0 -157.5 100.86 1.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.152 -0.967 . . . . 0.0 109.607 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.651 ' O ' ' N ' ' A' ' 57' ' ' LEU . 26.7 p -131.22 145.57 51.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.849 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.82 -27.07 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.8 mp -79.61 -10.14 59.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.649 -1.282 . . . . 0.0 109.461 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 4' ' ' THR . 34.9 m-85 -137.5 -161.84 1.22 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.59 166.58 28.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.738 -1.227 . . . . 0.0 111.506 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.631 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -76.62 176.1 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -134.1 127.66 32.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -96.43 110.14 22.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.131 -0.981 . . . . 0.0 110.871 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -110.76 144.99 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.302 0.572 . . . . 0.0 109.812 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -73.4 163.59 27.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.099 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.9 95.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.405 -0.81 . . . . 0.0 111.345 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -49.98 72.62 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.267 -1.521 . . . . 0.0 111.426 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -60.21 -35.57 75.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.262 -1.524 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.1 tm? -59.7 -35.43 74.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 108.37 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -59.93 -34.48 73.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.969 -1.082 . . . . 0.0 109.296 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.2 mt -58.19 -38.7 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.88 -1.137 . . . . 0.0 108.77 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.63 HD12 HD22 ' A' ' 68' ' ' LEU . 82.6 mt -59.99 -39.92 81.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.759 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -62.45 -40.05 95.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.083 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -67.23 -50.56 60.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.736 -1.227 . . . . 0.0 110.53 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -59.97 -63.41 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.925 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.654 HD12 ' N ' ' A' ' 75' ' ' LEU . 7.7 mp -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.884 -1.135 . . . . 0.0 111.028 -177.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.794 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 109.581 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.1 p -109.32 0.24 19.42 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.26 -49.81 76.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.603 HG21 ' CD1' ' A' ' 58' ' ' PHE . 56.3 m -60.38 -50.07 75.06 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.054 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -68.44 -49.19 61.71 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.312 -1.492 . . . . 0.0 111.019 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.12 -49.26 78.01 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 112.888 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.66 -45.81 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.554 -1.341 . . . . 0.0 111.892 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.2 mp -59.93 -42.84 90.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.449 -1.407 . . . . 0.0 108.776 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -57.66 -39.26 76.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -55.19 19.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.835 -1.166 . . . . 0.0 109.005 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -140.4 139.59 35.31 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -151.38 104.85 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.314 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' H ' ' HZ2' ' A' ' 61' ' ' LYS . . . 75.05 17.6 80.24 Favored Glycine 0 N--CA 1.496 2.64 0 O-C-N 121.274 -0.891 . . . . 0.0 111.099 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 15' ' ' GLU . 56.3 ttp180 -94.38 69.65 3.65 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.704 -1.468 . . . . 0.0 110.138 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' ARG . 99.0 mt-10 36.35 75.43 0.06 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.33 -0.856 . . . . 0.0 111.469 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' GLU . . . -36.25 102.16 0.01 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.631 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -162.52 -46.19 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.631 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 38.3 Cg_endo -101.1 128.03 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 123.364 2.71 . . . . 0.0 109.839 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.8 ttt -126.18 128.97 48.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.997 -1.064 . . . . 0.0 110.053 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -110.0 130.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.544 -0.723 . . . . 0.0 109.376 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 t -93.87 103.58 15.68 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.66 -7.83 12.12 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.251 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.12 -43.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -134.4 13.97 3.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.31 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -151.81 145.81 25.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.725 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.12 125.95 33.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mt -123.11 73.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.728 -0.607 . . . . 0.0 109.398 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -69.22 109.37 4.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.007 -1.058 . . . . 0.0 109.361 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.2 21.64 0.95 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -140.83 147.82 39.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.51 101.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 0.0 108.708 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 51.4 28.46 4.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 109.138 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.5 tt -92.34 139.45 30.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.86 18.6 63.08 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -127.16 -54.51 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.72 -0.87 . . . . 0.0 109.187 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.97 33.05 0.02 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -50.31 138.99 15.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -1.222 . . . . 0.0 109.858 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.6 t -151.08 135.5 16.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.92 178.18 10.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.323 -1.486 . . . . 0.0 109.969 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -150.58 161.11 43.2 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -100.0 117.34 34.07 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.905 -1.122 . . . . 0.0 109.988 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 60.6 t0 -94.51 -12.49 27.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.128 -0.983 . . . . 0.0 109.373 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 93.81 98.24 1.55 Allowed Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.175 -0.953 . . . . 0.0 110.814 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 85.55 1.1 0.7 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.983 -0.716 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -167.31 117.81 0.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -90.78 142.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.954 -1.091 . . . . 0.0 110.572 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.78 125.29 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -146.89 144.09 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.4 m -110.44 124.46 33.19 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -37.48 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.87 1.713 . . . . 0.0 111.7 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -101.82 -47.32 4.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.024 -1.048 . . . . 0.0 109.828 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 68.9 mt-10 -161.81 -165.84 1.34 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -168.11 114.66 0.69 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.6 p -122.4 44.53 2.59 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.244 -0.91 . . . . 0.0 111.115 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 68.32 -16.74 0.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.024 -1.048 . . . . 0.0 110.38 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 55' ' ' THR . 12.6 mt -95.13 -0.77 53.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CD1' HG21 ' A' ' 4' ' ' THR . 89.3 m-85 -134.04 -156.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.09 164.19 35.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.828 -1.17 . . . . 0.0 111.381 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.33 174.96 9.56 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.449 0.642 . . . . 0.0 109.525 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.585 ' HZ2' ' H ' ' A' ' 13' ' ' GLY . 86.5 tttt -133.36 133.34 42.35 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -82.76 164.43 20.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.842 -1.161 . . . . 0.0 110.358 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -154.93 119.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.2 m -64.8 151.13 46.13 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.61 69.9 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.603 -1.31 . . . . 0.0 108.403 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.64 80.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.599 -1.313 . . . . 0.0 109.436 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -60.99 -34.21 74.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 108.981 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.584 HD13 ' O ' ' A' ' 68' ' ' LEU . 2.9 tm? -59.75 -33.1 71.22 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -60.6 -41.47 94.81 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.8 mt -60.15 -39.22 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.725 . . . . 0.0 110.727 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.59 ' O ' HD22 ' A' ' 75' ' ' LEU . 96.1 mt -59.72 -46.56 93.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 118.304 -1.359 . . . . 0.0 109.821 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.28 73.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.545 -1.347 . . . . 0.0 109.672 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -62.65 -40.01 95.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.833 -1.167 . . . . 0.0 109.607 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -59.94 -51.35 70.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.431 -0.793 . . . . 0.0 111.631 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.615 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.2 mm? -65.35 -46.82 78.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.177 . . . . 0.0 109.893 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.648 ' C ' HG22 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.571 0.7 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.652 HG23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER 167.99 -74.91 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.696 0.76 . . . . 0.0 109.088 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.652 ' H ' HG23 ' A' ' 2' ' ' THR . 8.6 tp -60.16 -45.43 93.1 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.4 m -70.04 -51.84 28.85 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.202 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -73.44 -57.56 3.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.31 -40.34 95.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.388 -1.445 . . . . 0.0 112.361 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.6 t -70.32 -47.95 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.589 -1.319 . . . . 0.0 112.341 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 11' ' ' ASN . 53.4 mt -68.24 -42.55 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.862 -1.149 . . . . 0.0 111.195 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -60.3 -41.7 93.96 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.47 91.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.886 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 8' ' ' ILE . 8.0 m120 -125.44 123.85 40.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -154.37 74.28 0.95 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 0.0 108.873 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.75 37.17 0.04 OUTLIER Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.474 HH21 ' HG2' ' A' ' 18' ' ' PRO . 17.8 mmm180 -81.73 159.96 23.75 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.514 -0.992 . . . . 0.0 110.03 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -70.43 -40.44 73.79 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.792 -0.567 . . . . 0.0 110.058 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.15 27.55 0.57 Allowed Glycine 0 N--CA 1.503 3.106 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.817 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 36.6 mtmt -151.33 -35.17 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.228 -1.16 . . . . 0.0 111.984 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.817 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 80.2 Cg_endo -96.46 123.68 0.25 Allowed 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.554 2.169 . . . . 0.0 113.629 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.3 OUTLIER -122.29 140.95 52.04 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.574 -0.704 . . . . 0.0 109.746 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 76.6 mt -110.53 131.39 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.412 -0.805 . . . . 0.0 110.296 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.6 m -94.59 101.11 12.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.025 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -8.44 22.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.372 -0.83 . . . . 0.0 109.528 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.97 -42.4 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 9.3 t70 -131.54 8.02 4.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.41 87.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -144.68 137.21 26.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -1.138 . . . . 0.0 109.233 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -83.43 122.97 29.21 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -120.06 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.376 -0.827 . . . . 0.0 110.319 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -66.01 107.53 1.91 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.837 -1.164 . . . . 0.0 109.011 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.4 19.16 0.77 Allowed Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 137.25 49.06 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 34' ' ' LEU . 3.1 m -118.03 98.89 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 44.6 17.07 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 32' ' ' VAL . 85.1 mt -72.12 142.01 49.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 108.473 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -21.58 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -73.07 -35.45 66.66 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 123.53 31.8 0.94 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.45 ' HE1' HD12 ' A' ' 49' ' ' ILE . 16.3 t90 -47.52 139.54 6.77 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.285 1.04 . . . . 0.0 111.314 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -154.62 135.08 13.38 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.23 7.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.653 -1.28 . . . . 0.0 111.583 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -156.76 139.4 15.04 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -94.2 123.55 37.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.29 -1.506 . . . . 0.0 109.523 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 52.0 t0 -102.19 -5.6 24.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.354 -0.841 . . . . 0.0 110.201 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -112.07 0.54 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.752 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -90.9 -6.63 53.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -1.194 . . . . 0.0 109.956 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -125.1 119.95 30.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.981 -1.075 . . . . 0.0 108.88 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -88.97 140.14 16.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.488 -0.758 . . . . 0.0 110.828 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.44 114.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.608 HD13 HD12 ' A' ' 63' ' ' ILE . 4.4 pt -118.78 172.35 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.023 -1.048 . . . . 0.0 109.917 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 51' ' ' PRO . 63.8 m -135.35 102.37 10.74 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 50' ' ' SER . 0.5 OUTLIER -28.9 -99.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.614 2.209 . . . . 0.0 112.083 -177.036 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -78.29 -44.29 25.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.41 ' OE2' HD23 ' A' ' 3' ' ' LEU . 68.2 mt-10 -160.92 -163.87 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' OE1' ' C ' ' A' ' 59' ' ' LYS . 10.0 tp10 -171.0 103.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.627 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 57' ' ' LEU . 73.1 p -130.81 152.59 49.98 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -26.8 -29.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.4 mp -84.11 -3.11 57.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.712 -1.243 . . . . 0.0 111.004 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 55' ' ' THR . 88.4 m-85 -129.27 -161.07 1.08 Allowed 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.461 -0.774 . . . . 0.0 109.702 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -140.08 155.68 46.92 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.156 -0.965 . . . . 0.0 111.197 -179.217 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.71 175.5 10.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.688 -0.633 . . . . 0.0 109.819 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -132.17 153.82 50.16 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -109.28 161.09 15.59 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.331 -0.856 . . . . 0.0 109.978 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.608 HD12 HD13 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -153.06 117.45 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.151 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -61.74 149.26 40.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -49.61 -46.03 48.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.775 -1.203 . . . . 0.0 109.581 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.16 -41.73 65.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.186 -1.571 . . . . 0.0 110.241 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -65.75 -29.91 70.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.766 -1.209 . . . . 0.0 109.765 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 71' ' ' ILE . 3.2 tm? -59.63 -36.39 76.27 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -59.17 -39.23 81.85 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 mt -60.17 -32.65 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.053 -1.029 . . . . 0.0 110.184 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 68' ' ' LEU . 93.4 mt -62.14 -44.37 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.242 -1.536 . . . . 0.0 110.51 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.61 62.09 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.024 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -64.37 -56.54 13.67 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.142 -0.974 . . . . 0.0 110.224 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -51.92 -49.69 62.57 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.622 -0.674 . . . . 0.0 109.331 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -67.6 -23.94 65.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.052 -1.03 . . . . 0.0 110.626 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.825 -1.083 . . . . 0.0 108.962 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 1' ' ' ALA . 71.4 p 50.55 97.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 109.417 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.76 -40.13 94.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.671 -0.643 . . . . 0.0 111.022 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.428 ' OG1' ' OE2' ' A' ' 53' ' ' GLU . 41.7 m -59.94 -52.39 65.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.927 . . . . 0.0 110.642 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t -68.62 -41.27 79.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.702 -1.249 . . . . 0.0 111.744 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.77 -40.52 76.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.784 -1.197 . . . . 0.0 112.919 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 52' ' ' ALA . 70.7 t -71.21 -50.09 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.486 -1.383 . . . . 0.0 111.254 -178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.3 mp -60.27 -49.34 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.097 -1.002 . . . . 0.0 110.162 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -60.39 -40.02 89.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.058 -1.027 . . . . 0.0 110.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.64 80.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.961 -1.087 . . . . 0.0 109.459 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.425 HD21 HG13 ' A' ' 20' ' ' ILE . 9.5 m120 -144.64 115.61 7.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 109.439 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.569 ' C ' ' H ' ' A' ' 14' ' ' ARG . 72.6 tttt -78.3 169.88 17.54 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 15' ' ' GLU . . . -59.18 11.16 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 O-C-N 120.686 -1.259 . . . . 0.0 110.803 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.569 ' H ' ' C ' ' A' ' 12' ' ' LYS . 9.7 ptm180 -50.99 88.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.928 -1.337 . . . . 0.0 109.349 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 13' ' ' GLY . 46.3 tp10 47.93 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 0.0 109.562 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.04 101.41 0.31 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.674 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.3 tttm -154.85 -45.25 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.49 -1.006 . . . . 0.0 109.335 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 78.9 Cg_endo -95.54 130.25 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.748 2.299 . . . . 0.0 110.341 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.6 ttt -116.46 129.67 56.34 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.302 -0.874 . . . . 0.0 111.253 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.425 HG13 HD21 ' A' ' 11' ' ' ASN . 5.2 mm -106.14 119.85 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 25' ' ' GLY . 26.2 p -100.82 98.86 9.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 0.0 109.057 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.031 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.08 -10.71 59.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.374 -0.828 . . . . 0.0 109.825 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.557 ' N ' HD22 ' A' ' 22' ' ' LEU . 72.9 t -60.03 -41.73 87.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 108.493 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.48 1.29 4.53 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 60.04 82.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -145.28 137.69 25.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.359 -1.083 . . . . 0.0 109.472 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -84.56 128.97 34.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.92 77.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.714 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 44.4 pttt -71.94 109.99 6.14 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.68 20.36 0.54 Allowed Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.4 p -142.33 149.08 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -1.124 . . . . 0.0 108.372 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.567 HG22 HD21 ' A' ' 75' ' ' LEU . 19.1 m -122.86 85.32 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.67 0.748 . . . . 0.0 109.301 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 53.54 34.29 18.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.435 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 tp -85.67 137.07 33.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.541 -0.724 . . . . 0.0 109.069 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.71 66.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -121.42 -41.98 2.47 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 145.71 26.69 0.1 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -51.26 136.99 23.69 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.163 -1.198 . . . . 0.0 109.294 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 p -152.42 142.31 22.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.13 178.96 9.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.229 -1.544 . . . . 0.0 110.461 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -158.65 146.59 18.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -96.66 123.28 40.29 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.644 -1.285 . . . . 0.0 109.155 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.6 -4.26 22.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -121.87 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -80.72 -9.96 59.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.217 . . . . 0.0 109.591 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.6 m -120.13 134.59 55.21 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 HD12 ' A' ' 68' ' ' LEU . 33.4 mm -104.69 130.02 56.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.676 -0.64 . . . . 0.0 109.873 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.82 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.064 -1.022 . . . . 0.0 108.354 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.63 141.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.188 -0.945 . . . . 0.0 110.601 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -109.9 118.69 49.38 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -36.77 -76.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.916 1.744 . . . . 0.0 112.211 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -94.96 -50.75 4.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 0.0 108.562 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' OE2' ' OG1' ' A' ' 4' ' ' THR . 15.5 pt-20 -173.22 -161.0 0.13 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.533 -0.729 . . . . 0.0 109.057 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -166.26 115.39 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.034 -1.041 . . . . 0.0 108.935 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 11.8 p -117.09 40.26 3.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.226 -0.921 . . . . 0.0 109.705 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 69.99 -16.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.663 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 55' ' ' THR . 4.6 mm? -90.0 -1.75 58.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 4' ' ' THR . 67.9 m-85 -136.27 -159.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -144.59 159.99 41.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.971 -1.081 . . . . 0.0 111.339 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 175.74 5.12 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -132.52 124.84 29.26 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -93.07 110.94 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.452 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 63' ' ' ILE . 14.4 tt -108.92 124.4 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.7 m -55.63 157.72 3.9 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.339 -0.85 . . . . 0.0 110.687 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.324 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.92 -41.37 61.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.551 -1.343 . . . . 0.0 108.748 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -63.04 -24.21 67.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -59.87 -38.79 83.18 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.07 -35.64 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.77 -39.86 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.859 -1.151 . . . . 0.0 108.888 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.45 -38.09 54.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.749 -1.22 . . . . 0.0 108.659 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -69.9 -38.13 76.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.91 -50.47 41.88 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.657 -1.277 . . . . 0.0 111.71 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -59.87 -47.37 86.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 111.457 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.567 HD21 HG22 ' A' ' 32' ' ' VAL . 5.3 mp -69.95 -44.3 69.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.922 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.0 p -105.02 -1.51 25.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.504 -0.748 . . . . 0.0 109.52 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 7' ' ' VAL . 3.0 tt -59.98 -49.32 78.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 109.739 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.415 ' OG1' ' OE1' ' A' ' 53' ' ' GLU . 89.5 m -64.92 -53.69 42.55 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.298 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.5 p -61.65 -45.26 94.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.718 -1.239 . . . . 0.0 111.751 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.99 -40.97 74.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.914 -1.117 . . . . 0.0 112.65 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 3' ' ' LEU . 80.8 t -68.6 -47.97 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.393 -1.442 . . . . 0.0 111.216 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.05 -49.16 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.877 -1.139 . . . . 0.0 110.437 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.97 -41.85 92.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.161 -0.962 . . . . 0.0 111.057 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.92 92.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.533 -1.354 . . . . 0.0 110.427 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -60.01 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.939 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.9 tptm 44.87 26.85 0.22 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.852 0.834 . . . . 0.0 109.342 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ARG . . . -167.84 55.63 0.22 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.506 ' NE ' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -37.57 -92.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.144 -0.621 . . . . 0.0 111.162 -178.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 17' ' ' LYS . 40.3 tp10 48.77 51.77 15.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 108.622 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.471 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -16.46 73.81 0.0 OUTLIER Glycine 0 N--CA 1.505 3.247 0 C-N-CA 123.142 0.401 . . . . 0.0 113.399 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 15' ' ' GLU . 1.3 mmmt -167.01 -52.41 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.166 -1.196 . . . . 0.0 109.318 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HD2' ' H ' ' A' ' 17' ' ' LYS . 29.6 Cg_endo -95.46 113.31 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.659 2.239 . . . . 0.0 112.231 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.575 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.06 135.26 50.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.337 -0.852 . . . . 0.0 109.748 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.575 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.8 mm -106.22 129.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.754 . . . . 0.0 109.105 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' VAL . 79.5 p -113.58 100.24 8.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.521 -0.737 . . . . 0.0 109.629 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -1.4 3.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' SER . 95.1 t -60.03 -44.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -140.81 15.76 2.31 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.11 85.27 0.03 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 106.63 -2.588 . . . . 0.0 106.63 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -145.7 134.3 22.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.459 -1.024 . . . . 0.0 109.729 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.63 128.67 34.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mt -127.56 75.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.87 109.25 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 109.248 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.89 26.4 1.13 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.8 m -141.74 148.45 39.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.731 ' O ' HG23 ' A' ' 32' ' ' VAL . 22.8 m -127.15 106.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 23.5 m-85 42.06 34.78 0.49 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.598 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -90.83 134.78 34.18 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 109.682 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.598 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 102.39 16.02 23.8 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.564 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 23.5 p30 -131.7 -100.97 0.29 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.38 -1.07 . . . . 0.0 109.276 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -143.72 30.48 1.94 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -46.97 140.02 5.14 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.248 -1.148 . . . . 0.0 110.959 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 t -146.66 149.08 32.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.78 169.92 18.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.084 -1.635 . . . . 0.0 109.184 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -158.94 143.67 15.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -98.92 120.07 38.75 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.606 -1.309 . . . . 0.0 110.584 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 32.3 t0 -97.81 -7.29 30.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.284 -0.885 . . . . 0.0 109.621 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.14 64.47 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -163.03 -57.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.121 . . . . 0.0 108.639 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -118.09 121.49 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.48 135.12 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 t -98.63 103.92 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.84 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.42 -0.8 . . . . 0.0 110.304 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -111.93 127.75 26.43 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.59 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.233 1.289 . . . . 0.0 111.455 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.73 -48.94 5.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 109.592 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.415 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 91.9 mt-10 -156.69 -169.98 3.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.122 -0.987 . . . . 0.0 109.882 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 15.6 tm-20 -155.62 96.72 1.79 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 58' ' ' PHE . 1.7 p -131.49 147.75 52.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.373 -0.83 . . . . 0.0 108.816 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -28.61 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.1 mp -85.4 0.57 51.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.605 -1.31 . . . . 0.0 110.222 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.5 m-85 -136.87 -160.88 1.1 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 108.935 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -150.08 160.19 43.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 0.0 111.612 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.28 173.5 12.53 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -136.18 128.7 30.49 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.32 109.51 22.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.969 -1.082 . . . . 0.0 110.789 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.83 138.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 m -74.43 162.61 28.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.94 . . . . 0.0 108.852 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -59.95 -48.05 83.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.883 -1.136 . . . . 0.0 109.44 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.0 -41.7 83.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.628 -1.295 . . . . 0.0 109.995 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -59.95 -32.61 70.96 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 108.633 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.762 HD13 ' O ' ' A' ' 68' ' ' LEU . 2.7 tm? -59.91 -34.77 73.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.86 -37.67 77.04 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.03 -1.044 . . . . 0.0 108.38 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.97 -39.85 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.975 . . . . 0.0 109.364 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.4 mp -59.92 -40.11 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 108.267 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.23 96.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 111.055 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.12 -40.0 95.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.672 -1.267 . . . . 0.0 109.489 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 16' ' ' GLY . 82.5 m-20 -66.7 -71.33 0.2 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.313 0.578 . . . . 0.0 111.883 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 75' ' ' LEU . 6.4 mp -63.01 -44.55 95.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 111.466 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 120.752 -1.217 . . . . 0.0 109.371 -179.757 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p -109.59 -9.08 14.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.395 -0.815 . . . . 0.0 109.044 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.05 -49.92 75.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.304 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.516 HG23 ' N ' ' A' ' 5' ' ' SER . 6.4 t -63.59 -48.46 77.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.311 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 4' ' ' THR . 14.5 p -65.19 -43.21 92.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.76 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -40.81 74.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.058 . . . . 0.0 112.122 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.96 -43.82 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.852 -1.155 . . . . 0.0 110.836 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 52' ' ' ALA . 1.3 mp -59.43 -49.11 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.821 . . . . 0.0 109.452 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.09 -36.15 76.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.808 -1.183 . . . . 0.0 109.755 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.24 -20.02 64.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.973 -1.079 . . . . 0.0 110.593 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -76.7 -119.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.772 -1.205 . . . . 0.0 110.715 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 59.26 30.16 19.85 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.757 -0.589 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 14' ' ' ARG . . . -160.35 58.73 0.31 Allowed Glycine 0 N--CA 1.483 1.798 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 13' ' ' GLY . 86.4 mtm-85 -48.99 -109.89 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.722 0.772 . . . . 0.0 110.37 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 48.19 50.11 16.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.86 -1.15 . . . . 0.0 108.819 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.36 -2.33 20.49 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 48.4 53.02 13.68 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.497 -1.002 . . . . 0.0 109.642 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 38.0 Cg_endo -66.52 156.13 66.93 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.02 1.813 . . . . 0.0 108.668 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.484 ' SD ' ' OD2' ' A' ' 36' ' ' ASP . 35.3 ttp -138.16 125.6 21.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.78 -1.2 . . . . 0.0 110.996 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.3 mt -102.38 128.96 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.7 p -86.61 99.18 11.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.012 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -62.66 -14.44 43.54 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' H ' HD22 ' A' ' 22' ' ' LEU . 71.6 t -60.86 -41.79 90.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -131.7 2.03 4.06 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 59.23 81.15 0.08 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -140.07 130.29 25.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.257 -1.143 . . . . 0.0 109.329 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 51.2 mp0 -77.44 134.91 38.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.289 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 30' ' ' GLY . 34.5 mt -130.8 60.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -71.94 47.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.862 0.839 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -153.51 26.05 0.76 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 106.846 -2.502 . . . . 0.0 106.846 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m -145.81 150.43 36.17 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 32' ' ' VAL . 18.6 m -114.81 94.62 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' VAL . 26.0 m-85 36.38 25.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.294 0.569 . . . . 0.0 110.538 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 35' ' ' GLY . 4.2 tt -97.68 129.12 44.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 109.207 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.711 ' N ' HD23 ' A' ' 34' ' ' LEU . . . 118.01 25.77 2.93 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' SD ' ' A' ' 19' ' ' MET . 90.9 m-20 -143.76 -61.84 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.302 -1.116 . . . . 0.0 109.638 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -170.96 23.79 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -35.23 135.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.021 0.915 . . . . 0.0 112.503 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 t -146.94 135.31 21.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.96 169.31 23.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.822 -1.798 . . . . 0.0 110.064 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -160.5 138.69 9.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -101.59 126.27 48.38 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.686 -1.259 . . . . 0.0 111.176 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 59.2 t0 -95.49 -12.47 25.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.735 -0.603 . . . . 0.0 109.491 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 94.87 105.05 1.95 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 84.63 -10.71 0.84 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.984 -0.715 . . . . 0.0 109.773 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.9 m -158.01 114.4 2.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -91.9 140.81 15.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 111.247 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.12 120.05 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.487 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -151.25 146.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.609 -1.307 . . . . 0.0 110.347 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 t -109.72 120.06 46.04 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -38.05 -77.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 122.082 1.854 . . . . 0.0 113.55 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -85.01 -58.8 2.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.862 -1.148 . . . . 0.0 111.082 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 40.5 mt-10 -161.25 -167.15 1.7 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.835 . . . . 0.0 109.616 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -167.43 113.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 1.4 p -127.87 45.12 2.8 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.36 -0.837 . . . . 0.0 110.198 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 71.8 -22.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 55' ' ' THR . 11.3 mt -90.09 -7.15 54.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.045 -1.034 . . . . 0.0 108.929 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -128.79 -160.53 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -145.8 158.96 43.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.724 -1.235 . . . . 0.0 111.075 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.15 173.52 8.43 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -127.98 140.27 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -85.05 155.54 21.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.487 HD12 HG21 ' A' ' 49' ' ' ILE . 8.0 mt -151.89 112.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.0 p -64.23 154.71 34.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.57 62.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.69 86.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.653 -1.279 . . . . 0.0 109.707 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -59.92 -39.16 84.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.108 -0.995 . . . . 0.0 109.331 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 68' ' ' LEU . 1.8 tm? -59.01 -37.09 76.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.877 -1.14 . . . . 0.0 108.757 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -58.97 -35.01 72.45 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.87 -38.65 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.5 mp -57.89 -40.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.63 -1.294 . . . . 0.0 108.796 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.0 96.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 110.904 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . 94.0 mttt -68.08 -44.47 76.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.874 -1.141 . . . . 0.0 110.501 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -59.74 -58.26 9.36 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 112.12 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 HG22 ' A' ' 32' ' ' VAL . 4.5 mp -68.01 -39.9 83.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.595 -1.316 . . . . 0.0 110.234 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.78 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.034 -1.041 . . . . 0.0 109.951 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.619 ' C ' HG22 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.19 0.519 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER 169.95 -82.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.794 . . . . 0.0 109.439 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.628 ' H ' HG23 ' A' ' 2' ' ' THR . 10.4 tp -59.95 -49.41 77.78 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 m -65.64 -49.09 69.92 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.956 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -72.36 -57.3 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 112.538 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 2' ' ' THR . 69.9 mm-40 -65.03 -44.33 89.49 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.569 -1.332 . . . . 0.0 113.129 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.0 -45.32 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.526 -1.359 . . . . 0.0 111.107 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.487 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.3 mp -60.1 -39.4 80.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.001 -1.062 . . . . 0.0 109.144 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.81 -44.0 94.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.802 -1.186 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.69 74.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.886 -1.133 . . . . 0.0 109.986 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.669 HD21 ' CG1' ' A' ' 20' ' ' ILE . 23.5 m120 -130.66 122.22 26.98 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.135 -0.978 . . . . 0.0 109.567 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -155.35 51.23 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 108.639 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.51 29.91 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.689 HH21 ' N ' ' A' ' 17' ' ' LYS . 14.9 ptm180 -81.76 165.2 21.14 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.467 -1.019 . . . . 0.0 108.785 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -70.35 -39.94 74.36 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.05 37.76 0.49 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.745 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 7.8 mtpt -142.77 -43.41 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.559 -0.965 . . . . 0.0 110.701 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.745 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 63.0 Cg_endo -101.14 130.18 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.151 2.568 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.7 ttp -112.2 143.26 43.56 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.669 ' CG1' HD21 ' A' ' 11' ' ' ASN . 4.5 mm -103.4 129.58 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.299 -0.876 . . . . 0.0 108.989 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 m -100.56 98.49 9.07 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -66.96 -3.04 6.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.563 ' N ' HD12 ' A' ' 22' ' ' LEU . 74.6 t -60.05 -44.27 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.8 t0 -125.01 -5.82 7.34 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.8 11.24 85.61 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -75.88 140.05 41.98 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.651 -0.911 . . . . 0.0 110.399 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.03 133.48 33.58 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.7 mt -123.45 73.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.223 -0.923 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -65.93 109.23 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.528 -1.357 . . . . 0.0 108.834 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.9 23.67 0.85 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 17' ' ' LYS . 87.8 m -133.26 137.26 45.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 34' ' ' LEU . 9.8 m -120.1 102.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.432 -0.792 . . . . 0.0 110.022 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.433 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m-85 41.65 17.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.868 -0.52 . . . . 0.0 109.94 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 32' ' ' VAL . 43.7 tp -93.9 134.56 36.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.673 -1.267 . . . . 0.0 109.68 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.82 17.01 10.74 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 17.5 p-10 -139.37 -69.96 0.41 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -1.119 . . . . 0.0 110.121 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 173.1 32.08 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -51.54 155.65 1.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.434 -1.039 . . . . 0.0 110.324 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 t -153.39 131.97 12.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.86 177.32 10.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.339 -1.476 . . . . 0.0 109.57 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -159.7 160.05 33.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -99.48 114.76 27.91 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.88 -1.137 . . . . 0.0 109.649 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 38.4 t0 -96.74 -7.7 33.21 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.783 -1.198 . . . . 0.0 109.685 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.97 -113.56 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -88.84 -5.22 58.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -1.23 . . . . 0.0 109.273 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 m -122.91 132.85 54.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.335 -0.853 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.1 mm -96.36 142.61 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.586 -0.696 . . . . 0.0 110.838 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -109.26 120.01 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.648 HD12 HD12 ' A' ' 63' ' ' ILE . 45.8 mt -131.73 144.16 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.583 -0.698 . . . . 0.0 110.518 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' PRO . 74.1 m -118.29 120.84 31.78 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' SER . 53.9 Cg_exo -33.34 -87.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.137 1.891 . . . . 0.0 111.961 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -99.9 -36.59 9.35 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -165.73 -163.21 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.708 0.766 . . . . 0.0 109.965 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -174.28 117.26 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.648 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 20.9 p -128.98 40.43 3.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 74.46 -26.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 55' ' ' THR . 8.8 mp -90.02 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.362 -0.836 . . . . 0.0 108.828 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.27 -157.19 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -140.46 158.36 44.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.001 -1.062 . . . . 0.0 111.075 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.04 173.77 9.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -138.99 120.03 14.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -84.76 171.32 12.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.648 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -161.69 118.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -60.18 153.89 21.0 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.694 -1.254 . . . . 0.0 108.13 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.95 -44.32 70.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.784 -1.197 . . . . 0.0 108.245 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.59 -44.05 69.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.041 -1.662 . . . . 0.0 109.309 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.88 -27.14 68.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.687 -1.258 . . . . 0.0 108.96 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.633 HD22 HD12 ' A' ' 71' ' ' ILE . 3.3 tm? -59.91 -32.88 71.17 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.92 -39.77 86.59 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.7 mt -58.28 -34.83 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.988 -1.07 . . . . 0.0 109.998 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.633 HD12 HD22 ' A' ' 68' ' ' LEU . 71.0 mt -60.02 -40.16 82.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.23 -1.544 . . . . 0.0 109.675 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -75.39 -28.81 59.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' LEU . 1.6 tmtp? -69.77 -55.11 10.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -58.06 -50.06 74.74 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.857 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 4.6 mp -68.11 -39.85 82.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.355 -1.466 . . . . 0.0 109.744 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 73' ' ' LYS . 1.5 pp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.138 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.731 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 154.55 -68.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 tp -59.83 -42.99 94.76 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -78.59 -50.01 12.26 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.857 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -65.72 -52.05 54.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.909 -1.119 . . . . 0.0 111.74 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.01 -47.12 63.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 112.836 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.81 -39.93 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.504 -1.372 . . . . 0.0 111.367 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.62 -45.47 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 108.372 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -59.05 -40.06 83.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.604 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 11' ' ' ASN . . . -59.97 -42.04 93.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.975 -1.078 . . . . 0.0 110.35 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' LYS . 89.7 m-20 -49.63 -99.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.94 . . . . 0.0 110.068 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 11' ' ' ASN . 8.4 mmmm 32.83 85.45 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.691 -0.631 . . . . 0.0 110.602 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.02 -7.63 4.79 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -61.07 147.23 44.49 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.745 -0.856 . . . . 0.0 109.146 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 12.0 tm-20 -133.57 -5.11 2.9 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.569 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . 113.13 31.23 2.5 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.674 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 32.2 ttpt -171.92 -37.19 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.481 -1.011 . . . . 0.0 111.345 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 98.2 Cg_endo -96.98 108.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 122.432 2.088 . . . . 0.0 113.836 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.439 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -122.74 131.63 53.87 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.574 -0.704 . . . . 0.0 109.101 178.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.19 131.89 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 110.154 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 23' ' ' VAL . 35.4 m -95.76 101.96 13.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -63.43 0.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.587 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.519 ' N ' HD12 ' A' ' 22' ' ' LEU . 71.3 t -60.03 -45.43 95.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.911 -1.118 . . . . 0.0 108.272 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -138.47 10.34 2.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.72 89.12 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -146.08 137.84 24.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.107 -1.231 . . . . 0.0 109.81 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.39 129.8 35.32 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 30' ' ' GLY . 53.6 mt -124.96 77.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.387 -0.821 . . . . 0.0 110.365 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -69.1 40.63 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 109.754 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -151.15 24.03 0.99 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.079 -2.409 . . . . 0.0 107.079 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 m -146.99 150.3 34.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 122.001 -0.705 . . . . 0.0 109.746 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 32' ' ' VAL . 35.5 m -134.67 104.71 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 41.0 p90 39.93 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.86 -0.525 . . . . 0.0 110.865 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.569 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 tt -103.33 118.45 36.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.127 -0.983 . . . . 0.0 108.484 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.546 ' N ' HD23 ' A' ' 34' ' ' LEU . . . 134.03 28.86 0.48 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 70.4 m-20 -155.74 -50.08 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.546 -0.973 . . . . 0.0 109.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 176.16 31.83 0.04 OUTLIER Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.4 ' C ' ' O ' ' A' ' 37' ' ' GLY . 55.4 p-90 -43.4 144.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.2 m -149.16 134.07 17.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.01 170.59 7.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.24 -1.538 . . . . 0.0 109.546 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -151.41 148.27 27.89 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -95.13 134.62 37.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.551 -1.343 . . . . 0.0 109.432 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -109.66 -8.51 14.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.476 -0.765 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.67 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 89.86 103.9 1.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 86.46 0.57 0.59 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.094 -0.651 . . . . 0.0 110.163 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 45' ' ' ALA . 72.2 m -171.59 116.33 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 108.365 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 47' ' ' ILE . 7.2 mm -91.17 136.28 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.097 -1.002 . . . . 0.0 110.395 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.02 120.7 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.655 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -148.3 147.8 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.651 -1.281 . . . . 0.0 111.559 -177.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.2 m -119.49 147.13 42.8 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.51 -84.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.631 1.554 . . . . 0.0 111.941 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -94.34 -39.44 10.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.011 -1.056 . . . . 0.0 109.921 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -159.4 -164.04 1.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 108.787 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.841 ' OE2' ' HB2' ' A' ' 60' ' ' ALA . 77.6 tt0 -165.82 100.1 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 110.354 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 57' ' ' LEU . 23.6 p -130.27 151.15 51.1 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.88 -29.15 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.9 mp -84.17 1.29 45.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.701 -1.25 . . . . 0.0 110.041 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.7 m-85 -136.96 -161.03 1.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -151.18 169.29 22.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.839 -1.163 . . . . 0.0 111.58 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.841 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -93.92 175.58 6.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.43 0.633 . . . . 0.0 109.328 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -137.8 134.52 35.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -96.56 108.86 21.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.932 -1.105 . . . . 0.0 111.694 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.655 HD12 HG21 ' A' ' 49' ' ' ILE . 1.5 mt -89.84 131.41 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 p -72.63 159.32 34.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.998 -1.064 . . . . 0.0 108.357 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 -50.13 74.99 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.947 -1.095 . . . . 0.0 108.874 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.98 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.301 -1.499 . . . . 0.0 108.55 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -60.07 -33.69 72.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.967 -1.083 . . . . 0.0 108.988 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.3 tm? -60.03 -36.86 78.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.114 -0.991 . . . . 0.0 108.443 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -58.99 -37.38 76.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.85 -39.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 109.348 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.89 -40.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.049 -1.032 . . . . 0.0 109.488 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -64.31 -40.0 95.05 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.659 -1.275 . . . . 0.0 109.74 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -59.9 -44.66 94.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.267 -1.52 . . . . 0.0 109.169 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 16' ' ' GLY . 44.0 m-20 -76.28 -71.86 0.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 111.84 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 75' ' ' LEU . 7.7 mp -61.9 -41.68 98.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.02 -1.05 . . . . 0.0 111.93 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ALA . 39.1 tp . . . . . 0 N--CA 1.502 2.135 0 O-C-N 120.913 -1.117 . . . . 0.0 109.434 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.389 0.614 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p -110.86 -0.88 16.72 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -60.54 -50.11 74.85 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.054 0.93 . . . . 0.0 108.67 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.421 ' O ' HD13 ' A' ' 8' ' ' ILE . 97.8 m -61.02 -52.25 65.79 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.404 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.3 t -67.08 -43.35 82.8 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.853 -1.155 . . . . 0.0 111.786 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -69.73 -40.33 76.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 112.633 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -74.73 -43.08 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.352 -1.468 . . . . 0.0 111.81 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 4' ' ' THR . 1.5 mp -59.99 -52.63 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.864 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -63.61 -38.71 92.15 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.865 -1.147 . . . . 0.0 110.502 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.5 91.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.301 -0.874 . . . . 0.0 111.407 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' A' ' 8' ' ' ILE . 29.0 p30 -88.99 -9.12 52.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.53 -1.356 . . . . 0.0 111.287 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -66.29 131.99 47.37 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.963 -1.085 . . . . 0.0 109.09 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.94 -48.72 0.25 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' GLU . 34.5 ptt180 -169.0 177.46 4.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.016 -1.285 . . . . 0.0 110.226 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' ARG . 13.6 pt-20 -35.77 138.23 0.18 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.673 0.749 . . . . 0.0 109.945 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.05 97.07 0.1 OUTLIER Glycine 0 C--N 1.288 -2.083 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.6 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.681 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER -138.06 -46.81 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.7 -0.882 . . . . 0.0 109.045 178.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.681 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 27.3 Cg_endo -101.25 132.24 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.934 2.423 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.535 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 25.5 ttt -125.9 127.76 46.51 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.07 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.8 mt -109.31 133.58 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.825 0.822 . . . . 0.0 109.829 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.4 p -93.81 101.41 13.51 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.539 -0.726 . . . . 0.0 109.243 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.058 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.88 -10.89 23.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.76 -1.213 . . . . 0.0 109.676 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' N ' HD22 ' A' ' 22' ' ' LEU . 76.2 t -60.32 -40.25 83.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 108.641 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -137.16 5.18 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 57.23 88.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -143.68 137.35 28.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.46 -1.024 . . . . 0.0 108.772 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.23 128.61 33.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.22 74.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.346 -0.846 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -70.32 108.34 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.334 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.74 24.55 0.66 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p -143.64 148.43 35.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 75' ' ' LEU . 36.0 m -128.72 110.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.5 m-85 42.58 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.635 -0.665 . . . . 0.0 109.539 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 32' ' ' VAL . 49.0 tp -91.22 133.36 35.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.448 -0.783 . . . . 0.0 109.828 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.88 19.37 13.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.429 -1.869 . . . . 0.0 108.429 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -143.36 -65.05 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.063 . . . . 0.0 109.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 173.12 66.65 0.05 OUTLIER Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -74.33 154.15 39.01 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.286 -1.126 . . . . 0.0 109.633 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -156.36 150.13 24.91 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.89 170.68 15.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.764 -1.21 . . . . 0.0 109.831 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -165.62 109.06 0.82 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -89.95 126.27 35.67 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.546 -1.347 . . . . 0.0 110.364 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -109.2 0.73 19.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.594 -0.691 . . . . 0.0 110.724 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.06 -117.35 0.96 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -86.41 -8.6 57.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.312 . . . . 0.0 109.657 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.7 m -120.11 128.26 53.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.332 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -93.2 140.63 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.942 0.877 . . . . 0.0 111.315 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 t -109.37 120.13 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.614 HD12 HD12 ' A' ' 63' ' ' ILE . 56.2 mt -121.48 169.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.389 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 49' ' ' ILE . 54.8 m -142.33 99.53 5.87 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 50' ' ' SER . 9.3 Cg_exo -32.25 -79.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.307 2.004 . . . . 0.0 112.156 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -103.0 -41.57 6.08 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -155.55 -165.49 2.0 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -171.95 104.8 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.586 -0.696 . . . . 0.0 109.67 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 58' ' ' PHE . 19.2 p -129.65 148.48 51.54 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -33.15 -25.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.139 -0.35 . . . . 0.0 111.655 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 2.4 mt -81.47 2.09 30.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.634 -1.291 . . . . 0.0 109.187 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 55' ' ' THR . 55.0 m-85 -139.73 -160.7 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 156.07 41.95 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.747 -1.221 . . . . 0.0 110.882 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.25 177.29 9.06 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 109.309 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -126.78 131.37 51.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -88.24 170.09 11.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.587 -1.32 . . . . 0.0 110.277 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.614 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -164.95 122.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.7 m -59.5 153.18 20.08 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.381 -1.449 . . . . 0.0 108.324 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -52.8 -48.63 66.75 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.811 -1.181 . . . . 0.0 109.058 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.94 84.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.347 -1.47 . . . . 0.0 108.775 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -59.78 -27.32 66.46 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.72 -1.192 . . . . 0.0 107.847 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.1 tm? -59.92 -31.32 69.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.445 -1.409 . . . . 0.0 107.641 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.34 -38.43 83.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.808 -1.183 . . . . 0.0 108.71 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.13 -38.88 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.016 -1.053 . . . . 0.0 109.236 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.62 -40.5 86.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.391 -0.818 . . . . 0.0 110.629 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.06 35.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 111.437 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.45 -37.74 81.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.085 -1.634 . . . . 0.0 111.069 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -62.96 -64.72 0.83 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.113 -0.992 . . . . 0.0 111.685 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 32' ' ' VAL . 5.9 mp -67.83 -47.1 69.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.101 -0.999 . . . . 0.0 110.821 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.695 ' N ' HD22 ' A' ' 76' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.597 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 t -97.75 -5.83 34.16 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.251 -0.906 . . . . 0.0 109.565 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.02 -41.59 92.51 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 5' ' ' SER . 6.5 t -79.66 -44.23 21.3 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.897 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 4' ' ' THR . 17.6 t -60.31 -53.68 54.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.034 . . . . 0.0 111.307 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.08 -43.16 71.71 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.098 -1.001 . . . . 0.0 112.545 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.99 -43.42 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.698 -1.251 . . . . 0.0 111.67 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.85 -52.24 63.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.773 -1.204 . . . . 0.0 109.201 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.18 -39.99 73.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 110.359 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.04 -47.36 85.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.685 -1.259 . . . . 0.0 109.694 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.504 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 77.6 m-20 -98.79 -69.91 0.75 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.918 -1.113 . . . . 0.0 109.212 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 8' ' ' ILE . 17.7 ttpp 60.26 77.67 0.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.796 -0.565 . . . . 0.0 111.568 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.56 26.74 72.49 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.391 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.504 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 36.8 ttm180 -60.83 -56.23 23.62 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.791 -1.417 . . . . 0.0 108.546 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.61 ' OE2' HD11 ' A' ' 63' ' ' ILE . 53.3 tp10 50.77 86.22 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.72 -113.25 0.3 Allowed Glycine 0 N--CA 1.48 1.614 0 C-N-CA 119.116 -1.516 . . . . 0.0 111.292 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.817 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 67.3 mttt -150.83 -34.58 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.768 -0.842 . . . . 0.0 112.039 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.817 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 66.9 Cg_endo -98.16 140.27 0.47 Allowed 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 122.272 1.981 . . . . 0.0 113.296 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 4.6 ttt -121.32 138.4 54.27 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.9 mt -107.29 131.78 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.446 -0.784 . . . . 0.0 109.51 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.9 t -93.54 100.32 12.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -66.22 -10.05 38.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.43 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.545 ' N ' HD12 ' A' ' 22' ' ' LEU . 73.4 t -59.76 -40.69 83.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -132.22 -2.79 3.52 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 64.65 85.61 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -143.07 136.29 28.19 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.233 -1.157 . . . . 0.0 110.08 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 58.3 mp0 -82.6 124.63 30.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.1 mt -123.0 73.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.337 -0.852 . . . . 0.0 110.151 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.73 116.78 3.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.204 -0.935 . . . . 0.0 110.261 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.93 26.25 1.74 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.515 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.8 p -135.91 140.25 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.774 -0.839 . . . . 0.0 109.387 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.642 HG22 HD21 ' A' ' 75' ' ' LEU . 27.0 m -122.98 98.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 12.8 p90 40.1 26.57 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -96.22 135.24 38.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.661 -0.65 . . . . 0.0 110.692 -178.251 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.595 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 115.44 36.26 1.21 Allowed Glycine 0 N--CA 1.501 2.998 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.37 -85.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.185 . . . . 0.0 110.265 -178.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -147.37 26.28 1.54 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -44.54 148.13 0.52 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.378 -1.072 . . . . 0.0 110.471 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.0 m -148.24 146.95 28.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.07 165.35 27.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.239 -1.538 . . . . 0.0 109.543 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -154.16 130.88 10.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -101.69 125.56 48.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.227 -1.546 . . . . 0.0 110.057 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -99.39 -0.87 40.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 0.0 108.967 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.41 16.39 66.64 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.326 -0.94 . . . . 0.0 110.914 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -161.7 -57.08 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.3 m -122.32 131.73 54.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -92.68 132.91 35.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.292 -0.88 . . . . 0.0 111.137 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.95 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 50' ' ' SER . 63.4 mt -128.19 155.41 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.432 -0.792 . . . . 0.0 109.794 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.8 m -124.97 120.57 25.46 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 22.4 Cg_exo -33.5 -85.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.096 1.864 . . . . 0.0 111.157 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -105.07 -36.97 7.11 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 73.7 mt-10 -164.52 -163.28 0.72 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -169.14 114.78 0.58 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 7.4 p -127.67 41.98 3.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.083 -1.01 . . . . 0.0 109.492 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 70.65 -29.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.536 ' H ' ' C ' ' A' ' 55' ' ' THR . 7.2 mt -82.59 -4.87 58.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.3 -0.875 . . . . 0.0 108.726 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.73 -151.23 0.47 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -150.85 161.89 41.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.799 -1.188 . . . . 0.0 111.329 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.89 173.13 11.48 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' NZ ' ' CE2' ' A' ' 33' ' ' TYR . 36.5 ttpt -134.02 157.9 44.92 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.48 171.18 8.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.61 HD11 ' OE2' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -165.87 126.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.5 p -57.97 150.11 21.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.225 -1.547 . . . . 0.0 107.033 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.38 -44.9 68.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.746 -1.221 . . . . 0.0 109.131 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.4 -42.52 96.13 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.656 -1.277 . . . . 0.0 109.677 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 70' ' ' ILE . 9.2 m170 -54.77 -27.01 38.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.548 -1.345 . . . . 0.0 107.798 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -59.4 -30.16 68.25 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 107.799 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.57 -33.17 75.07 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.982 -1.074 . . . . 0.0 109.057 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 67' ' ' HIS . 3.8 tt -59.92 -32.08 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.675 -1.266 . . . . 0.0 108.886 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.7 -41.16 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.93 75.93 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.948 -1.095 . . . . 0.0 110.846 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -59.85 -50.2 74.74 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.046 -1.034 . . . . 0.0 109.445 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -68.25 -71.33 0.22 Allowed 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 111.309 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 75' ' ' LEU . 6.6 mp -61.18 -47.92 83.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.506 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.505 2.308 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.293 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 p -103.91 -2.16 26.59 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.497 -0.752 . . . . 0.0 109.166 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 tp -60.15 -41.86 93.67 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.2 m -69.05 -51.44 38.91 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.667 -0.646 . . . . 0.0 110.657 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.0 m -69.59 -48.31 60.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.267 -1.52 . . . . 0.0 112.72 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.97 -44.5 72.8 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.595 -1.315 . . . . 0.0 113.115 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.24 -46.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.694 -1.254 . . . . 0.0 111.57 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.537 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.2 mp -61.0 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 121.146 -0.971 . . . . 0.0 109.1 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.62 -39.49 80.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.77 -40.51 69.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.043 -1.036 . . . . 0.0 109.399 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.51 142.7 15.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -163.64 124.97 2.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.762 -1.211 . . . . 0.0 111.044 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 44.95 49.82 9.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -130.79 68.82 1.47 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.482 -1.01 . . . . 0.0 109.306 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 17' ' ' LYS . 97.2 mt-10 48.37 76.51 0.11 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.975 -1.078 . . . . 0.0 109.942 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -42.56 92.59 0.01 OUTLIER Glycine 0 N--CA 1.496 2.693 0 O-C-N 121.146 -0.971 . . . . 0.0 110.682 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.677 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 5.6 tttm -153.0 -46.38 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.417 -1.049 . . . . 0.0 108.31 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.677 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 86.3 Cg_endo -101.74 118.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 123.436 2.757 . . . . 0.0 112.068 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.6 ttt -121.65 130.44 53.47 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.205 -0.934 . . . . 0.0 109.741 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.4 mt -108.37 130.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.3 t -94.38 99.7 11.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 108.931 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -59.72 -12.57 7.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.6 -41.33 84.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -117.33 -16.11 10.32 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.67 8.72 87.56 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -78.98 158.03 28.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -1.033 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -94.91 128.72 41.9 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.95 78.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.539 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.5 101.46 3.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.861 -1.15 . . . . 0.0 108.977 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.4 24.47 0.3 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -141.61 147.09 37.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -1.022 . . . . 0.0 108.41 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.755 HG22 HD21 ' A' ' 75' ' ' LEU . 33.0 m -129.38 108.75 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 44.37 23.31 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.379 -0.826 . . . . 0.0 109.305 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' VAL . 29.2 tp -90.39 145.05 25.25 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.472 0.653 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.48 17.22 59.02 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -134.35 -48.06 0.77 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.508 -0.995 . . . . 0.0 110.127 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.81 37.39 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -51.36 139.73 18.74 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.133 -1.216 . . . . 0.0 109.92 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -146.52 137.69 24.32 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.58 166.82 13.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.116 -1.615 . . . . 0.0 108.982 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -141.34 154.51 45.72 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -103.11 134.84 45.87 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.73 -1.231 . . . . 0.0 109.514 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -104.77 -5.52 21.17 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.448 -0.782 . . . . 0.0 110.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.4 56.9 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -169.17 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -1.113 . . . . 0.0 109.409 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.9 m -143.62 119.0 10.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 mm -76.91 138.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.848 -1.157 . . . . 0.0 110.878 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.19 117.12 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 63' ' ' ILE . 53.7 mt -127.73 139.53 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.357 -0.84 . . . . 0.0 111.735 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.414 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 75.1 m -120.08 121.96 29.23 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' SER . 49.6 Cg_exo -36.21 -78.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 121.886 1.724 . . . . 0.0 111.845 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.15 -40.9 5.71 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.194 -0.941 . . . . 0.0 110.073 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.59 -162.83 0.41 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.144 -0.973 . . . . 0.0 111.296 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' OE2' ' OG ' ' A' ' 50' ' ' SER . 80.7 mt-10 -152.09 104.63 2.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.896 -0.503 . . . . 0.0 111.198 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -107.67 114.34 28.25 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.626 -1.296 . . . . 0.0 109.222 178.36 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.66 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.884 0.85 . . . . 0.0 110.05 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -64.62 43.39 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 111.025 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' A' ' 56' ' ' ALA . 55.4 p90 -93.41 -178.17 4.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.38 1.086 . . . . 0.0 111.698 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -137.51 119.75 15.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.895 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.27 177.26 8.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.098 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -131.2 127.27 37.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -101.09 108.04 19.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.935 -1.103 . . . . 0.0 110.966 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -104.03 140.68 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -69.89 157.98 36.4 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.383 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.36 83.8 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.049 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.81 85.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.44 -1.413 . . . . 0.0 110.516 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -59.5 -24.12 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.5 tm? -59.85 -39.14 84.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -55.75 -32.55 63.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.0 -41.26 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.692 -1.255 . . . . 0.0 108.392 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.6 mp -64.28 -40.31 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.79 93.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 111.236 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -37.72 58.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.453 -1.405 . . . . 0.0 111.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.86 -49.68 60.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.161 -0.962 . . . . 0.0 112.0 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.755 HD21 HG22 ' A' ' 32' ' ' VAL . 9.0 mp -80.33 -55.62 4.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.639 -1.288 . . . . 0.0 110.929 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--N 1.298 -1.67 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.777 -179.325 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.721 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER 157.69 -75.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.07 -47.74 84.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 m -61.02 -50.04 74.96 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.054 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m -75.0 -54.21 7.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.865 -1.147 . . . . 0.0 112.907 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.464 ' HB3' HD22 ' A' ' 22' ' ' LEU . 61.7 mm-40 -64.77 -41.21 96.03 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.624 -1.298 . . . . 0.0 112.928 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.562 ' CG1' ' CH2' ' A' ' 38' ' ' TRP . 94.0 t -69.91 -47.79 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.341 -1.474 . . . . 0.0 111.373 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.2 mp -61.71 -42.91 96.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.283 -0.886 . . . . 0.0 110.626 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -65.78 -41.4 92.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.653 -1.279 . . . . 0.0 109.782 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.438 ' HB2' HD21 ' A' ' 22' ' ' LEU . . . -65.11 -22.43 66.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.36 99.26 3.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.055 -1.028 . . . . 0.0 109.329 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 14' ' ' ARG . 4.6 mmmm -93.45 169.91 10.0 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.89 39.88 0.11 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' LYS . 7.6 ptm180 -90.88 75.02 6.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.133 -1.216 . . . . 0.0 109.322 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ARG . 58.0 mp0 57.88 113.87 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.77 110.37 3.03 Favored Glycine 0 N--CA 1.481 1.656 0 O-C-N 120.994 -1.066 . . . . 0.0 110.613 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.668 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 7.5 tttp -167.12 -43.36 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.769 -0.842 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 80.5 Cg_endo -99.88 115.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 123.328 2.685 . . . . 0.0 111.714 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -111.46 141.88 44.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.378 -0.826 . . . . 0.0 109.696 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.602 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.5 mm -110.61 133.19 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 25' ' ' GLY . 20.3 m -105.92 100.48 10.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.449 -0.782 . . . . 0.0 109.067 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.652 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.84 -15.99 63.65 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.07 -46.5 94.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -124.9 2.21 8.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.627 -0.671 . . . . 0.0 109.228 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 56.47 78.99 0.1 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.33 135.4 28.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.267 -1.137 . . . . 0.0 109.283 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.45 126.81 32.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 0.0 108.637 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 30' ' ' GLY . 55.3 mt -113.02 162.6 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -147.7 36.19 0.87 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.513 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -155.42 30.03 0.63 Allowed Glycine 0 C--N 1.293 -1.818 0 N-CA-C 106.289 -2.724 . . . . 0.0 106.289 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.437 ' OG1' ' CG2' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -133.41 138.09 46.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.549 HG12 ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -131.87 102.65 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.549 ' CZ ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER 44.62 54.66 6.37 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.67 117.91 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.868 -1.145 . . . . 0.0 109.498 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' C ' ' HE1' ' A' ' 38' ' ' TRP . . . 142.21 22.18 0.23 Allowed Glycine 0 N--CA 1.501 3.016 0 O-C-N 120.995 -1.066 . . . . 0.0 110.887 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.719 ' N ' ' HE1' ' A' ' 38' ' ' TRP . 65.0 m-20 -157.81 -85.86 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.785 -1.421 . . . . 0.0 110.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -142.21 22.08 2.43 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.719 ' HE1' ' N ' ' A' ' 36' ' ' ASP . 2.3 m95 -57.6 147.59 26.7 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.586 0.707 . . . . 0.0 110.633 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 t -156.35 154.1 30.04 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.53 166.68 24.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.597 -1.315 . . . . 0.0 109.049 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -144.91 155.04 43.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -100.64 133.05 45.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.706 -1.246 . . . . 0.0 108.694 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.08 -11.86 15.54 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.418 -0.802 . . . . 0.0 109.98 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 95.89 107.35 2.27 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 80.3 -4.24 1.87 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.787 -0.831 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.2 m -166.16 120.59 1.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 mm -95.69 137.87 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.8 t -109.38 123.29 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.418 ' C ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.156 -0.965 . . . . 0.0 110.801 -179.223 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.679 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -106.12 120.8 47.65 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 177.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.679 ' O ' ' O ' ' A' ' 50' ' ' SER . 31.1 Cg_exo -36.9 -112.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.144 1.896 . . . . 0.0 111.184 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -76.89 -31.61 56.86 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -171.79 -161.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.008 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -156.4 110.33 2.73 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.763 -0.585 . . . . 0.0 109.513 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.532 ' O ' ' C ' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -111.1 116.3 30.89 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.816 -1.177 . . . . 0.0 109.38 179.431 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.532 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 26.2 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.966 0.888 . . . . 0.0 110.497 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.2 43.61 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.871 -0.518 . . . . 0.0 111.247 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 56' ' ' ALA . 47.2 p90 -92.34 178.7 5.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.839 -1.163 . . . . 0.0 111.467 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 102.92 6.81 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 173.39 3.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 109.795 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -144.21 131.31 20.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -111.49 117.23 32.44 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.201 -0.937 . . . . 0.0 111.081 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.25 138.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -73.16 160.0 32.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.726 -1.233 . . . . 0.0 108.601 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.78 91.69 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.809 -1.182 . . . . 0.0 110.0 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.88 92.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.8 -1.188 . . . . 0.0 109.361 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -60.33 -25.21 65.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.495 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.1 tt -57.35 -40.23 77.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -58.16 -28.63 64.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 109.227 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.06 -39.86 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.703 -1.248 . . . . 0.0 108.556 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.93 -39.94 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 108.997 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.53 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.986 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -60.0 -46.57 89.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.724 -1.235 . . . . 0.0 109.227 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.463 HD22 HG22 ' A' ' 32' ' ' VAL . 64.2 t30 -68.38 -74.22 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.866 -0.521 . . . . 0.0 111.166 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 2.8 mp -61.21 -46.59 89.8 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.705 -1.247 . . . . 0.0 111.226 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 76' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.014 -1.054 . . . . 0.0 109.127 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.733 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 156.89 -85.64 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.17 -50.15 74.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.0 m -61.42 -49.55 76.4 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.8 p -70.39 -48.04 58.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.911 -1.118 . . . . 0.0 112.384 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -69.6 -42.25 74.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 112.617 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 52' ' ' ALA . 95.4 t -66.76 -45.77 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.558 -1.338 . . . . 0.0 110.576 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mp -60.42 -45.31 96.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -60.64 -40.49 92.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.641 -1.287 . . . . 0.0 111.441 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -27.93 67.77 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.569 -1.332 . . . . 0.0 109.425 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.633 ' ND2' ' CZ ' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -160.28 140.26 11.36 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.026 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -160.27 118.6 2.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.1 -1.0 . . . . 0.0 110.227 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.72 35.57 24.9 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' O ' ' OH ' ' A' ' 33' ' ' TYR . 44.2 ttp180 -149.03 44.75 0.99 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.033 -1.275 . . . . 0.0 109.066 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -66.5 105.83 1.6 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.125 -0.984 . . . . 0.0 110.888 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.5 -68.19 0.04 OUTLIER Glycine 0 N--CA 1.498 2.775 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.849 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -174.56 -20.82 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.215 -1.168 . . . . 0.0 112.782 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.849 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 90.3 Cg_endo -88.8 110.21 0.54 Allowed 'Trans proline' 0 N--CA 1.485 1.02 0 CA-C-N 121.251 1.483 . . . . 0.0 112.203 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.563 ' SD ' HG21 ' A' ' 31' ' ' THR . 8.9 ttt -102.74 147.29 27.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.718 -0.614 . . . . 0.0 109.708 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.88 120.99 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.616 -0.678 . . . . 0.0 109.546 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 p -98.24 96.23 7.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.63 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.46 -17.84 64.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.2 t -59.68 -42.87 89.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -128.76 2.82 5.43 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.24 79.66 0.08 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.9 138.53 28.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.29 -1.123 . . . . 0.0 109.759 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 4.1 tm-20 -81.31 120.93 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.95 67.99 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 109.71 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 46.0 pttt -60.24 102.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.442 1.115 . . . . 0.0 110.308 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.662 ' C ' HD21 ' A' ' 74' ' ' ASN . . . 136.45 25.49 0.46 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.563 HG21 ' SD ' ' A' ' 19' ' ' MET . 98.7 m -138.48 140.96 39.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.507 -0.996 . . . . 0.0 108.5 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -118.55 80.5 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.459 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CZ ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER 42.37 25.6 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' VAL . 54.9 tp -85.12 129.87 34.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.872 . . . . 0.0 109.79 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 36' ' ' ASP . . . 124.83 -75.24 0.4 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' GLY . 78.4 m-20 -31.59 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.866 -0.785 . . . . 0.0 111.498 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . -134.87 16.44 4.24 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.47 ' C ' ' O ' ' A' ' 37' ' ' GLY . 3.7 t90 -26.34 138.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.969 0.414 . . . . 0.0 111.793 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -159.46 144.51 15.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.852 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.05 168.59 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.525 -1.359 . . . . 0.0 109.195 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -153.73 159.54 42.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -104.97 120.97 42.77 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.026 -1.046 . . . . 0.0 110.409 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -100.9 -2.81 31.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.12 -0.988 . . . . 0.0 110.71 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.5 -114.56 1.24 Allowed Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.44 -9.8 59.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -1.027 . . . . 0.0 110.546 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.9 m -129.15 140.12 51.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.45 HG13 HD12 ' A' ' 68' ' ' LEU . 36.3 mm -108.09 139.85 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 110.104 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.2 120.28 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.557 -0.715 . . . . 0.0 109.278 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.66 141.29 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.817 -1.177 . . . . 0.0 110.802 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 51' ' ' PRO . 95.0 p -111.77 127.09 27.37 Favored Pre-proline 0 N--CA 1.482 1.129 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD3' ' HZ2' ' A' ' 61' ' ' LYS . 52.6 Cg_exo -34.83 -81.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.961 1.774 . . . . 0.0 112.619 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -106.03 -41.64 5.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 79.3 mt-10 -158.62 -165.42 1.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.066 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -172.25 113.27 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.673 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 19.0 p -126.94 38.46 4.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.293 -0.879 . . . . 0.0 110.415 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 73.85 -24.92 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.93 -1.106 . . . . 0.0 109.57 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 55' ' ' THR . 6.4 mt -87.8 -3.29 58.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -132.47 -156.47 0.75 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -150.74 158.57 44.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.449 -1.407 . . . . 0.0 111.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.23 174.46 8.74 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HZ2' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -134.19 128.25 33.63 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -81.55 167.05 19.7 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.98 -1.075 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 63' ' ' ILE . 19.2 tt -169.69 118.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.1 p -58.54 151.19 20.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 110.913 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -53.81 -41.44 67.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.98 94.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.5 -1.375 . . . . 0.0 109.267 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.452 ' O ' HG22 ' A' ' 70' ' ' ILE . 18.6 m80 -61.52 -25.1 67.06 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.45 HD12 HG13 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -57.04 -28.45 62.55 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.34 -34.64 74.91 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.875 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 67' ' ' HIS . 4.6 tt -59.56 -36.51 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.479 -1.289 . . . . 0.0 108.427 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.516 ' O ' HD22 ' A' ' 75' ' ' LEU . 67.1 mt -60.32 -45.19 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.87 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.82 67.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.055 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -62.26 -39.33 92.53 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.478 -1.389 . . . . 0.0 108.663 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.662 HD21 ' C ' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -69.59 -68.14 0.43 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.697 -0.627 . . . . 0.0 110.761 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.647 ' H ' HD22 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -60.1 -51.2 70.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 0.0 111.221 -176.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 76' ' ' LEU . 6.3 mt . . . . . 0 C--N 1.3 -1.58 0 O-C-N 120.799 -1.188 . . . . 0.0 109.219 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER 162.05 -82.73 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.5 tp -59.92 -48.88 79.9 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.9 m -64.01 -51.82 62.45 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.329 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 t -70.95 -52.39 20.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.801 -1.187 . . . . 0.0 111.489 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' THR . 36.4 tp10 -61.01 -46.09 92.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.972 -1.08 . . . . 0.0 112.665 -177.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 52' ' ' ALA . 64.3 t -67.91 -49.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 112.078 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.586 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.01 -45.63 95.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 110.693 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.99 -40.11 88.03 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.981 -1.074 . . . . 0.0 110.931 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -19.93 65.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.83 -1.169 . . . . 0.0 111.769 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.549 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -124.77 52.5 1.55 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.996 -1.065 . . . . 0.0 111.263 -178.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -86.67 58.95 5.35 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.571 -1.33 . . . . 0.0 110.018 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.18 36.3 0.03 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.561 HH22 ' H ' ' A' ' 20' ' ' ILE . 5.6 tpp180 -74.19 138.89 44.06 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.403 -1.057 . . . . 0.0 109.508 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -70.44 -39.9 74.08 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 57.26 0.26 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.535 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -175.59 -46.05 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.412 -1.052 . . . . 0.0 109.463 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' ' H ' ' A' ' 17' ' ' LYS . 72.0 Cg_endo -90.57 128.6 1.42 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.31 2.007 . . . . 0.0 111.675 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -123.02 128.7 50.53 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.561 ' H ' HH22 ' A' ' 14' ' ' ARG . 87.1 mt -110.49 130.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.067 -1.021 . . . . 0.0 109.465 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' GLY . 67.6 m -88.72 99.78 12.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.015 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -61.95 -13.05 21.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.35 -0.844 . . . . 0.0 109.151 -179.23 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.575 ' N ' HD22 ' A' ' 22' ' ' LEU . 70.0 t -60.11 -47.64 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 108.604 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 52.7 t0 -123.42 7.56 9.0 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.93 84.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -142.39 135.5 28.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.476 -1.014 . . . . 0.0 109.936 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -77.13 121.08 23.09 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.8 mt -119.99 69.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -61.64 106.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.989 -1.069 . . . . 0.0 108.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.08 18.75 0.93 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.66 146.8 36.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -1.046 . . . . 0.0 108.437 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG2' HD21 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -131.23 111.46 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 44.63 21.63 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 0.0 109.224 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' VAL . 34.5 tp -85.82 149.34 25.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.83 79.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.47 -63.37 1.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.618 -0.93 . . . . 0.0 109.355 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.69 39.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -59.74 155.38 16.06 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.499 -1.0 . . . . 0.0 110.507 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -146.43 149.68 34.18 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.93 169.39 17.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.238 -1.539 . . . . 0.0 109.782 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -159.95 136.2 8.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -109.03 122.85 48.13 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.657 -1.277 . . . . 0.0 111.469 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 10.7 t70 -96.69 -6.84 35.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.658 -0.651 . . . . 0.0 110.687 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.61 15.66 42.49 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.743 -1.223 . . . . 0.0 110.813 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -171.12 -55.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.305 . . . . 0.0 108.647 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.3 m -120.12 129.99 54.42 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -91.34 140.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.8 . . . . 0.0 111.959 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 t -103.61 111.58 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -129.67 140.17 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.5 m -112.66 121.58 38.36 Favored Pre-proline 0 N--CA 1.483 1.222 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 50' ' ' SER . 30.8 Cg_exo -35.27 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 122.263 1.975 . . . . 0.0 112.154 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.586 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -107.98 -41.52 4.93 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -166.43 -163.41 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.609 0.719 . . . . 0.0 109.943 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 56' ' ' ALA . 3.9 tm-20 -172.05 116.27 0.36 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.667 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 6.6 p -122.15 38.1 4.22 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.155 -0.966 . . . . 0.0 110.338 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 73.66 -18.68 0.37 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.95 . . . . 0.0 109.383 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 55' ' ' THR . 14.0 mt -93.51 0.09 56.56 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -130.13 -153.34 0.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -145.34 159.62 42.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.998 -1.064 . . . . 0.0 110.818 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.47 174.65 11.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -136.46 106.95 6.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -73.29 175.86 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -166.7 122.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.5 ' HG ' ' HD1' ' A' ' 67' ' ' HIS . 76.9 p -54.67 148.42 12.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.568 -1.332 . . . . 0.0 108.229 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -52.01 -44.92 64.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.99 -1.069 . . . . 0.0 109.158 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.11 79.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 119.992 -1.693 . . . . 0.0 109.967 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.5 ' HD1' ' HG ' ' A' ' 64' ' ' SER . 31.6 m80 -61.67 -23.57 66.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.558 -1.339 . . . . 0.0 108.668 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.95 -33.47 71.97 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -62.59 -37.18 85.23 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.03 -38.86 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.099 -1.001 . . . . 0.0 109.724 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.497 ' O ' HD22 ' A' ' 75' ' ' LEU . 57.9 mt -59.92 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.824 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.76 76.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.728 -1.232 . . . . 0.0 110.478 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -61.62 -41.91 98.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.448 -1.408 . . . . 0.0 109.597 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -60.71 -61.62 2.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.715 -0.616 . . . . 0.0 111.194 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.2 mm? -60.25 -40.04 88.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.629 -1.295 . . . . 0.0 110.361 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--N 1.297 -1.682 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.789 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.187 0.517 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p -102.56 -5.54 23.82 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.334 -0.854 . . . . 0.0 109.415 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.521 HD21 ' O ' ' A' ' 36' ' ' ASP . 10.6 tp -63.51 -54.71 31.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.441 HG21 ' CD2' ' A' ' 58' ' ' PHE . 33.3 m -62.49 -50.31 71.93 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -70.31 -43.67 69.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.123 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -70.05 -41.75 73.77 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.698 -1.252 . . . . 0.0 112.131 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.09 -50.3 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.531 -1.356 . . . . 0.0 111.087 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.571 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.05 -48.08 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.019 -1.051 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.01 -39.04 84.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.32 -22.18 63.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' ILE . 4.9 t-20 -152.56 126.92 9.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.732 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 14' ' ' ARG . 57.1 pttt -175.01 162.17 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.466 -0.771 . . . . 0.0 109.866 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.56 -27.54 1.56 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 12' ' ' LYS . 54.4 ttm-85 -95.02 127.0 40.75 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HA ' ' HZ1' ' A' ' 61' ' ' LYS . 91.3 mt-10 -43.95 -64.0 0.75 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.17 0.509 . . . . 0.0 110.321 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.8 83.31 0.05 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.043 -1.551 . . . . 0.0 110.757 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.536 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -125.96 -52.2 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 18.4 Cg_endo -103.62 130.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.568 2.845 . . . . 0.0 110.678 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 ttt -132.06 126.23 33.33 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.878 -1.139 . . . . 0.0 110.012 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.79 129.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.717 0.77 . . . . 0.0 109.925 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 25' ' ' GLY . 13.6 p -87.82 100.7 13.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.049 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.39 -13.82 6.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' H ' HD22 ' A' ' 22' ' ' LEU . 65.9 t -59.99 -44.98 95.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -125.64 0.26 7.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 66.61 13.33 60.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -75.89 137.18 40.23 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.22 138.34 31.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.475 -0.766 . . . . 0.0 110.274 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 30' ' ' GLY . 63.8 mt -122.45 158.1 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -140.83 36.6 1.79 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.083 -1.636 . . . . 0.0 107.576 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -156.63 28.46 0.54 Allowed Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.0 p -135.51 142.26 45.41 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.054 0.93 . . . . 0.0 110.146 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 32' ' ' VAL . 16.4 m -121.0 88.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 35.4 p90 40.08 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.538 0.685 . . . . 0.0 109.238 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 32' ' ' VAL . 47.1 tp -73.26 135.15 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.675 -0.64 . . . . 0.0 109.572 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . 73.1 147.28 0.85 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' HD21 ' A' ' 3' ' ' LEU . 6.5 m-20 95.92 19.95 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 123.295 0.638 . . . . 0.0 110.129 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 123.71 -11.38 8.38 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 37' ' ' GLY . 5.8 p-90 -32.26 126.14 0.28 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.39 0.614 . . . . 0.0 111.013 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 t -152.93 140.23 19.53 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.52 175.02 11.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.157 -1.589 . . . . 0.0 109.868 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -161.19 159.9 29.41 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -110.41 121.47 45.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.995 -1.066 . . . . 0.0 109.708 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 43' ' ' ASP . 4.4 p30 -100.66 -1.02 36.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.56 -120.04 1.36 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.736 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -81.41 -7.75 59.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -1.112 . . . . 0.0 110.317 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.7 m -123.47 130.82 53.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.82 141.93 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.14 119.63 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mt -131.66 146.96 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.287 -0.883 . . . . 0.0 110.917 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 15.8 m -118.12 111.49 38.68 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 102.467 -3.161 . . . . 0.0 102.467 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.1 Cg_exo -33.34 -75.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.023 1.815 . . . . 0.0 111.386 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.571 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -106.15 -47.07 3.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.71 -165.99 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.497 ' OE2' ' N ' ' A' ' 60' ' ' ALA . 62.2 tt0 -175.11 114.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -118.19 36.47 4.34 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.069 -1.019 . . . . 0.0 109.879 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 72.59 -21.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 0.0 109.042 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 55' ' ' THR . 40.9 mt -91.03 0.02 57.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CD2' HG21 ' A' ' 4' ' ' THR . 92.6 m-85 -128.51 -135.95 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -155.28 155.1 33.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.708 -1.245 . . . . 0.0 111.789 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.497 ' N ' ' OE2' ' A' ' 54' ' ' GLU . . . -86.37 177.44 7.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HZ1' ' HA ' ' A' ' 15' ' ' GLU . 53.5 tttm -139.51 150.77 45.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -115.77 173.16 6.7 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.228 -0.92 . . . . 0.0 108.995 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -168.41 111.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -48.42 155.1 0.55 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.08 -1.013 . . . . 0.0 109.068 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -56.82 -48.15 78.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.052 -1.03 . . . . 0.0 108.603 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.98 87.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.16 -1.588 . . . . 0.0 108.767 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -59.24 -28.11 66.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.866 -1.146 . . . . 0.0 108.32 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.692 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.2 tm? -59.83 -30.06 68.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -60.39 -37.14 79.85 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.09 -38.74 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.394 -0.816 . . . . 0.0 109.391 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.4 mp -58.35 -39.9 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 108.281 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.445 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -66.1 -40.03 90.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 111.096 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.13 -48.07 72.05 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.625 -1.297 . . . . 0.0 111.174 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -59.98 -52.67 64.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 112.029 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.587 HD11 HG13 ' A' ' 32' ' ' VAL . 4.4 mp -69.91 -42.1 73.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.302 -1.498 . . . . 0.0 110.459 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' OXT' ' O ' ' A' ' 72' ' ' ALA . 2.3 pp . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.7 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p -97.23 -1.42 44.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.281 -0.887 . . . . 0.0 108.853 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.16 -45.74 92.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.015 0.912 . . . . 0.0 108.78 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.4 m -61.2 -54.41 44.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 110.847 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.3 t -70.19 -48.34 57.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.834 -1.166 . . . . 0.0 112.067 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.15 -46.63 86.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.804 -1.185 . . . . 0.0 112.98 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.3 -48.12 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 112.155 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.463 ' CD1' ' N ' ' A' ' 8' ' ' ILE . 1.4 mp -61.32 -47.78 91.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.667 -1.271 . . . . 0.0 109.934 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.3 -40.12 89.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.889 -1.132 . . . . 0.0 110.755 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.92 86.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.827 -1.171 . . . . 0.0 109.039 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 20' ' ' ILE . 35.2 m120 -135.29 114.85 12.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 110.081 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 14' ' ' ARG . 52.5 tttm -89.71 169.67 11.1 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.79 27.29 0.14 Allowed Glycine 0 N--CA 1.488 2.141 0 O-C-N 120.536 -1.353 . . . . 0.0 110.81 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' LYS . 11.1 ptm180 -70.19 88.11 0.61 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.647 -1.502 . . . . 0.0 108.305 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 14' ' ' ARG . 44.5 mt-10 48.87 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.959 -1.088 . . . . 0.0 109.244 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.06 101.49 0.27 Allowed Glycine 0 N--CA 1.487 2.051 0 O-C-N 121.056 -1.027 . . . . 0.0 110.701 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 2.0 mtmt -153.89 -52.73 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 17' ' ' LYS . 35.1 Cg_endo -95.12 126.2 0.39 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.313 2.009 . . . . 0.0 110.595 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.66 136.86 54.27 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 110.942 -178.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.509 ' H ' ' CG ' ' A' ' 11' ' ' ASN . 27.7 mm -100.09 128.1 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.8 t -102.52 103.92 14.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.419 -0.8 . . . . 0.0 108.88 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.63 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -69.4 -7.28 36.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -47.55 91.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -128.73 11.59 6.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.99 83.27 0.04 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -150.36 139.72 21.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -1.014 . . . . 0.0 109.519 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -84.83 139.09 32.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 109.08 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 30' ' ' GLY . 71.0 mt -122.78 158.56 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -144.61 42.46 1.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -168.3 32.41 0.19 Allowed Glycine 0 C--N 1.294 -1.801 0 N-CA-C 106.313 -2.715 . . . . 0.0 106.313 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.463 ' OG1' HG21 ' A' ' 28' ' ' ILE . 12.7 m -136.79 142.64 42.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.784 0.802 . . . . 0.0 109.879 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.537 HG22 HD21 ' A' ' 75' ' ' LEU . 16.7 m -128.55 73.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.407 ' OH ' ' O ' ' A' ' 12' ' ' LYS . 14.5 m-85 53.84 23.27 3.72 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.651 HD13 ' N ' ' A' ' 35' ' ' GLY . 1.7 tm? -73.75 123.71 24.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.651 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 78.64 158.49 12.22 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 10.2 m-20 93.94 7.09 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 C-N-CA 123.105 0.562 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 130.53 -3.77 5.81 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.473 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 10.1 p-90 -29.92 138.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.423 0.63 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.8 m -151.01 139.88 20.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.99 167.53 21.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.566 -1.334 . . . . 0.0 109.867 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -161.41 125.82 3.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -102.93 130.11 49.88 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.748 -1.22 . . . . 0.0 110.885 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -107.52 -11.31 15.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.645 -0.659 . . . . 0.0 109.716 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.03 2.32 89.5 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.97 -31.24 0.5 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -1.127 . . . . 0.0 109.433 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.4 m -157.22 118.66 3.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.18 122.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.346 -0.846 . . . . 0.0 111.535 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 t -95.61 99.16 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 142.32 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.407 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.1 p -117.11 149.57 44.55 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.56 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.408 1.405 . . . . 0.0 112.077 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -90.61 -45.85 8.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.884 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -167.44 1.17 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.273 -1.517 . . . . 0.0 111.486 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 28.2 mp0 -150.44 98.48 2.66 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 57' ' ' LEU . 4.1 p -129.99 144.29 51.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -25.13 -29.21 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.8 mp -83.61 -10.2 58.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.62 -1.3 . . . . 0.0 110.242 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 55' ' ' THR . 23.1 t80 -138.46 -164.55 1.65 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.282 -0.886 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -154.9 170.79 20.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.998 -1.064 . . . . 0.0 110.904 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.68 175.34 8.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.501 0.667 . . . . 0.0 110.404 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -128.77 141.77 51.21 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -86.71 169.29 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.046 -1.034 . . . . 0.0 110.592 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -162.91 127.87 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.8 m -61.19 154.9 22.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.277 -1.514 . . . . 0.0 108.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.75 68.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.654 -1.278 . . . . 0.0 109.401 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.93 87.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.695 -1.253 . . . . 0.0 109.153 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -55.04 -27.26 43.19 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.889 -1.132 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.445 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -59.91 -33.67 72.19 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -59.95 -35.4 74.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.0 mt -59.64 -39.75 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.91 . . . . 0.0 108.929 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.425 HG23 HG21 ' A' ' 32' ' ' VAL . 48.1 mt -58.88 -39.94 78.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.216 -0.927 . . . . 0.0 108.997 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.82 -41.56 99.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 111.106 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . 6.4 mtmp? -65.94 -50.04 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.047 -1.033 . . . . 0.0 111.011 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.87 -43.63 94.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.462 -0.773 . . . . 0.0 111.987 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 75' ' ' LEU . 5.7 mp -80.92 -22.51 39.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.43 -1.419 . . . . 0.0 110.326 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.11 -0.994 . . . . 0.0 109.96 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.9 p -103.67 -6.82 21.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.612 -0.68 . . . . 0.0 109.755 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.99 -45.15 95.95 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.496 HG22 ' CE2' ' A' ' 58' ' ' PHE . 22.5 m -62.26 -54.88 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.855 -0.528 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -71.95 -48.65 43.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.574 -1.329 . . . . 0.0 112.0 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.81 -42.58 90.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.02 -1.05 . . . . 0.0 112.791 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 52' ' ' ALA . 96.7 t -69.81 -48.36 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.323 -1.486 . . . . 0.0 111.225 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.583 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.24 -47.91 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -63.71 -40.23 96.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.032 -1.042 . . . . 0.0 110.091 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.519 ' CB ' HD12 ' A' ' 22' ' ' LEU . . . -56.81 -38.22 72.28 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.093 -1.005 . . . . 0.0 108.384 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.26 109.45 5.08 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 14' ' ' ARG . 62.1 mttp -77.01 -179.73 5.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.65 40.25 0.95 Allowed Glycine 0 N--CA 1.491 2.304 0 O-C-N 120.877 -1.139 . . . . 0.0 110.375 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 15' ' ' GLU . 7.9 ptm180 -80.53 86.87 5.76 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.371 -1.076 . . . . 0.0 108.29 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' ARG . 52.4 tp10 53.24 105.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.743 . . . . 0.0 109.61 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.32 93.71 0.45 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.517 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER -145.32 -51.85 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.346 -1.09 . . . . 0.0 108.996 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 61.2 Cg_endo -95.95 129.7 0.4 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.001 1.8 . . . . 0.0 111.349 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 124.82 46.75 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -109.41 128.09 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.79 . . . . 0.0 109.037 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 23' ' ' VAL . 8.8 t -91.67 99.27 12.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.09 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -59.13 -8.59 1.59 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.59 ' N ' HD22 ' A' ' 22' ' ' LEU . 54.4 t -60.83 -41.12 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -123.28 -14.35 7.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.56 15.58 79.41 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -83.16 150.3 26.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -1.106 . . . . 0.0 111.776 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -91.66 130.99 37.37 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.73 74.39 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.53 -0.731 . . . . 0.0 109.864 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -68.5 108.48 3.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.853 -1.154 . . . . 0.0 108.925 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.91 21.77 0.87 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.3 p -143.62 150.92 39.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -1.068 . . . . 0.0 108.316 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 32' ' ' VAL . 32.7 m -127.1 89.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.448 -0.783 . . . . 0.0 109.178 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 57.78 19.94 6.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.112 -0.993 . . . . 0.0 109.918 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.1 tp -73.15 141.19 47.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 108.908 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.16 58.84 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.15 -138.51 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -102.22 24.32 31.5 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' GLY . 10.9 t90 -38.57 128.33 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.729 0.775 . . . . 0.0 110.891 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.5 t -151.09 137.71 18.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.11 173.12 17.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.304 -1.497 . . . . 0.0 110.208 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -151.97 153.79 34.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -101.26 120.79 40.78 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.707 -1.245 . . . . 0.0 109.131 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 49.1 t0 -100.69 -6.62 24.83 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.84 -117.33 0.97 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.029 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.9 17.94 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.961 . . . . 0.0 109.358 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.1 m -150.91 116.08 5.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.79 140.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 111.144 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.91 129.28 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.509 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -151.2 147.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.441 -1.412 . . . . 0.0 111.274 -178.036 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -112.3 121.32 39.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 177.211 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -36.06 -75.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.032 1.821 . . . . 0.0 111.731 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.583 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -104.83 -47.97 3.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.207 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.41 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 5.0 mt-10 -160.75 -166.48 1.62 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.361 -0.837 . . . . 0.0 109.953 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -173.14 116.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 4.9 p -89.88 -78.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.927 -1.108 . . . . 0.0 108.886 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.587 ' N ' ' OG1' ' A' ' 55' ' ' THR . . . -149.12 -76.03 0.16 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -64.86 22.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.394 -0.816 . . . . 0.0 109.871 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' H ' ' C ' ' A' ' 56' ' ' ALA . 22.7 m-85 -99.04 -175.67 3.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.783 -1.198 . . . . 0.0 108.366 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 138.94 53.89 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.964 0.888 . . . . 0.0 111.829 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.32 177.75 7.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -136.67 126.27 25.33 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.856 -1.153 . . . . 0.0 108.542 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -84.04 162.16 20.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.509 HD12 HG21 ' A' ' 49' ' ' ILE . 1.9 mt -151.08 112.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.7 p -62.81 152.18 36.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.755 -1.215 . . . . 0.0 108.358 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.59 69.17 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.773 -1.205 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.04 82.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.426 -1.422 . . . . 0.0 108.774 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -60.2 -35.34 75.18 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.841 -1.162 . . . . 0.0 109.507 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 71' ' ' ILE . 3.4 tm? -56.19 -34.45 66.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -60.53 -40.05 90.06 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mt -61.43 -32.01 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.667 HD12 HD22 ' A' ' 68' ' ' LEU . 79.7 mt -60.33 -39.72 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.047 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 76' ' ' LEU . . . -68.27 -36.23 79.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.994 -1.066 . . . . 0.0 109.732 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.07 -46.58 89.09 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.036 -1.04 . . . . 0.0 108.855 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -76.26 -74.19 0.24 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.7 -0.625 . . . . 0.0 110.835 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.696 HD12 ' N ' ' A' ' 75' ' ' LEU . 6.7 mp -60.22 -44.58 95.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.952 -1.093 . . . . 0.0 111.309 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 72' ' ' ALA . 21.9 mt . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.602 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p -102.33 -0.07 33.35 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.283 -0.886 . . . . 0.0 110.282 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 3.8 tt -60.11 -48.34 82.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.836 -1.165 . . . . 0.0 109.253 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m -78.67 -50.52 11.3 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.494 0.664 . . . . 0.0 110.579 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -66.35 -52.86 42.69 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 112.561 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.55 -42.04 78.93 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.346 -1.471 . . . . 0.0 112.785 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 3' ' ' LEU . 95.7 t -61.15 -48.94 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.128 -0.983 . . . . 0.0 111.451 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.87 -40.34 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.411 -0.805 . . . . 0.0 109.905 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -58.68 -45.18 90.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.1 -1.0 . . . . 0.0 110.831 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 22' ' ' LEU . . . -60.12 -47.04 87.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.746 -1.221 . . . . 0.0 111.087 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 11' ' ' ASN . 5.3 p-10 -88.81 -76.56 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.672 -1.268 . . . . 0.0 110.681 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt 49.61 48.69 21.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.546 -1.346 . . . . 0.0 108.545 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.37 40.32 0.02 OUTLIER Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.551 ' CG ' ' HZ2' ' A' ' 61' ' ' LYS . 6.6 tpt180 -55.56 118.41 4.46 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.945 0.879 . . . . 0.0 109.632 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -76.79 -36.8 56.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.7 23.21 5.12 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.727 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 15.8 mttt -151.71 -41.6 0.01 OUTLIER Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.548 -0.972 . . . . 0.0 111.013 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.727 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 75.5 Cg_endo -92.98 120.66 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.742 2.294 . . . . 0.0 113.513 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.0 tpt -121.5 123.41 41.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.542 -0.724 . . . . 0.0 110.544 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.2 mt -118.21 129.6 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLY . 29.9 t -91.13 99.14 12.2 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.136 HD13 ' H ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.19 -7.33 8.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.559 ' N ' HD22 ' A' ' 22' ' ' LEU . 78.2 t -61.11 -45.85 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -128.95 8.58 5.69 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.27 91.25 0.01 OUTLIER Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -143.56 137.15 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.372 -1.075 . . . . 0.0 109.042 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 57.9 mp0 -81.71 123.47 28.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.098 -1.001 . . . . 0.0 108.887 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' GLY . 50.1 mt -127.44 75.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.183 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -74.06 45.42 0.21 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.69 -1.256 . . . . 0.0 108.961 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -147.99 22.3 1.43 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -152.38 158.92 43.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 34' ' ' LEU . 14.4 m -133.44 112.6 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.321 -0.862 . . . . 0.0 108.974 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.505 ' H ' ' NH1' ' A' ' 14' ' ' ARG . 32.5 p90 39.85 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.528 0.68 . . . . 0.0 109.369 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -81.93 129.01 34.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -178.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.65 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 127.35 -83.47 0.34 Allowed Glycine 0 N--CA 1.499 2.884 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 17.0 p-10 -32.92 -106.82 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.668 0.747 . . . . 0.0 111.895 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -123.23 30.11 5.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' GLY . 21.0 p-90 -31.71 132.68 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.872 0.844 . . . . 0.0 111.183 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -153.86 146.34 24.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 173.36 11.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.277 -1.514 . . . . 0.0 109.36 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -163.49 135.21 4.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -110.95 123.7 50.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.854 -1.154 . . . . 0.0 108.417 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 10.3 t70 -106.3 -10.05 16.55 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.362 -0.836 . . . . 0.0 111.305 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.45 -122.27 1.37 Allowed Glycine 0 N--CA 1.503 3.101 0 O-C-N 120.607 -1.308 . . . . 0.0 109.886 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.11 22.93 1.33 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -1.166 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 m -154.75 113.42 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mm -88.24 136.23 23.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.332 -0.855 . . . . 0.0 111.998 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.4 t -112.91 120.11 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.519 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -142.51 147.95 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.63 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.4 t -115.9 129.11 25.44 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.83 -76.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.597 1.531 . . . . 0.0 112.229 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.93 -49.99 4.58 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.023 -1.048 . . . . 0.0 112.318 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -165.51 -163.89 0.7 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.002 -1.686 . . . . 0.0 109.771 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -156.26 107.05 2.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.681 -0.637 . . . . 0.0 111.469 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.536 ' O ' ' C ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -110.81 118.02 35.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.621 -1.299 . . . . 0.0 108.288 178.166 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.27 -90.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.269 1.033 . . . . 0.0 110.287 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.28 43.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.305 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' A' ' 56' ' ' ALA . 54.9 p90 -91.88 -174.48 3.82 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.773 -1.204 . . . . 0.0 111.251 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.79 110.77 7.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.713 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.74 174.07 9.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.555 -1.34 . . . . 0.0 109.234 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.551 ' HZ2' ' CG ' ' A' ' 14' ' ' ARG . 82.1 tttt -126.83 129.51 48.42 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -80.63 159.66 25.3 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.681 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.519 HD12 HG21 ' A' ' 49' ' ' ILE . 3.3 mt -153.34 114.57 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -66.87 159.84 27.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.29 -44.27 64.92 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.738 -1.185 . . . . 0.0 107.865 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.9 93.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.6 -0.688 . . . . 0.0 109.802 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -60.27 -24.79 65.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.17 -45.02 92.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.197 -1.564 . . . . 0.0 106.946 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -54.51 -29.71 51.3 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -0.965 . . . . 0.0 109.014 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.4 -39.67 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.727 -1.233 . . . . 0.0 108.507 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.92 -40.36 80.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.88 -31.49 69.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.363 -1.461 . . . . 0.0 110.528 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -69.84 -55.28 10.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.132 -1.605 . . . . 0.0 111.33 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 17' ' ' LYS . 28.0 t-20 -60.55 -44.66 95.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.229 -0.919 . . . . 0.0 111.334 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -63.78 -53.21 54.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 110.461 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 1.3 mm? . . . . . 0 C--N 1.294 -1.836 0 CA-C-O 117.892 -1.051 . . . . 0.0 108.374 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.726 0.774 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.7 p -114.34 161.8 17.43 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.36 -49.47 73.77 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 121.359 -0.838 . . . . 0.0 109.656 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.449 HG21 ' CE2' ' A' ' 58' ' ' PHE . 93.9 m -59.58 -48.79 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.072 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -69.01 -41.04 78.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.15 -1.594 . . . . 0.0 111.737 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -68.4 -50.32 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.042 -1.037 . . . . 0.0 112.329 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.495 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 97.6 t -69.37 -40.56 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.396 -0.815 . . . . 0.0 111.728 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 53' ' ' GLU . 7.0 mm -59.95 -47.37 91.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.843 -1.16 . . . . 0.0 109.8 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.24 -30.96 70.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.921 -1.112 . . . . 0.0 109.798 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 20' ' ' ILE . . . -66.78 -34.13 77.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.287 -0.883 . . . . 0.0 110.908 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 7' ' ' VAL . 21.7 p30 -99.5 -17.33 17.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.084 -1.01 . . . . 0.0 111.079 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -69.33 134.67 49.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.575 -1.328 . . . . 0.0 108.953 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.42 -45.75 0.3 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' GLU . 16.2 ptm180 -168.47 -176.01 2.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.554 -0.968 . . . . 0.0 109.371 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 55.3 mp0 -36.93 138.26 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.602 0.715 . . . . 0.0 109.825 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.08 101.72 0.7 Allowed Glycine 0 C--N 1.291 -1.934 0 C-N-CA 119.46 -1.353 . . . . 0.0 110.239 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.658 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 ttmt -141.75 -48.03 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.52 -0.988 . . . . 0.0 108.991 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.658 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 55.3 Cg_endo -98.47 136.29 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.109 2.54 . . . . 0.0 110.862 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.439 ' SD ' HG22 ' A' ' 31' ' ' THR . 11.8 ttt -122.96 136.95 55.05 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.904 -1.123 . . . . 0.0 111.32 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 10' ' ' ALA . 5.2 mm -105.26 133.15 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.4 t -109.28 102.81 11.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.746 . . . . 0.0 109.583 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.838 ' H ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.18 -19.38 65.29 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.556 -0.858 . . . . 0.0 108.829 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.01 -43.55 92.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -125.71 1.65 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.3 81.07 0.06 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -150.6 144.62 25.38 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.122 -1.223 . . . . 0.0 110.191 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -81.77 133.54 35.35 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -129.02 72.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.914 . . . . 0.0 110.853 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -65.57 115.52 5.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.678 -1.264 . . . . 0.0 109.296 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.36 21.05 2.32 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.439 HG22 ' SD ' ' A' ' 19' ' ' MET . 34.5 m -142.25 148.56 38.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.718 HG22 HD21 ' A' ' 75' ' ' LEU . 29.3 m -130.67 103.16 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.21 -0.931 . . . . 0.0 108.862 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.6 p90 33.31 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.616 -0.677 . . . . 0.0 110.93 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -93.18 129.96 39.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.606 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 96.41 40.82 3.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 77.4 m-20 -147.85 -40.12 0.18 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.745 -0.856 . . . . 0.0 108.703 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 153.63 33.26 0.03 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -49.86 145.51 5.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.911 -1.347 . . . . 0.0 111.41 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.2 p -145.64 133.24 20.92 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.53 171.04 17.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.063 -1.648 . . . . 0.0 109.821 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -165.63 132.88 2.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -93.04 120.77 33.69 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.675 -1.265 . . . . 0.0 109.479 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -99.07 -0.85 41.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 110.059 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.54 -118.93 1.49 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.67 -4.69 55.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.7 m -132.21 131.34 42.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.6 143.75 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.356 -0.84 . . . . 0.0 110.774 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.5 120.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.492 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -154.37 144.33 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.869 -1.144 . . . . 0.0 110.491 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.2 t -111.99 120.7 41.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -37.34 -78.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.019 0 C-N-CA 122.321 2.014 . . . . 0.0 113.508 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -84.05 -57.92 2.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.737 -1.227 . . . . 0.0 111.442 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' H ' HD11 ' A' ' 8' ' ' ILE . 92.7 mt-10 -158.58 -168.92 2.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.015 -1.053 . . . . 0.0 109.545 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -169.71 115.5 0.55 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.642 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 6.1 p -128.75 40.63 3.61 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.376 -0.828 . . . . 0.0 110.105 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 75.83 -24.88 0.21 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.682 -0.636 . . . . 0.0 110.386 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 57' ' ' LEU . 10.4 mp -92.53 1.02 57.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.6 -0.687 . . . . 0.0 109.556 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CE2' HG21 ' A' ' 4' ' ' THR . 98.1 m-85 -126.59 -160.98 1.03 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -134.97 149.67 50.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.084 -1.01 . . . . 0.0 111.555 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.08 175.64 8.89 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -132.76 141.95 48.78 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -101.94 107.8 19.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.2 -0.937 . . . . 0.0 109.721 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 49' ' ' ILE . 48.0 mt -100.82 104.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -51.37 164.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.849 -1.157 . . . . 0.0 108.899 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.01 82.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.071 . . . . 0.0 109.53 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.16 85.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.128 -1.608 . . . . 0.0 109.891 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -60.62 -38.18 83.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.389 -1.444 . . . . 0.0 108.679 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.4 tm? -55.96 -34.73 65.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.997 -1.064 . . . . 0.0 108.371 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -59.89 -33.82 72.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 108.817 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.47 HG22 ' ND2' ' A' ' 74' ' ' ASN . 77.2 mt -60.09 -40.57 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.58 -41.16 91.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.096 -1.003 . . . . 0.0 109.795 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.03 91.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 112.389 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -69.96 -36.95 75.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.868 -1.77 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.47 ' ND2' HG22 ' A' ' 70' ' ' ILE . 95.8 m-20 -63.53 -66.83 0.49 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 110.849 -178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.718 HD21 HG22 ' A' ' 32' ' ' VAL . 7.8 mp -66.77 -46.78 74.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.079 . . . . 0.0 111.323 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 120.881 -1.137 . . . . 0.0 109.865 -178.762 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.688 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER 160.43 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.99 -41.59 92.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 m -77.79 -49.42 14.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.393 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.0 m -71.28 -57.11 4.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.927 -1.108 . . . . 0.0 111.647 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -60.32 -43.75 96.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.605 -1.309 . . . . 0.0 112.986 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 52' ' ' ALA . 94.5 t -67.19 -42.28 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.158 -1.589 . . . . 0.0 112.024 -177.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.56 -43.77 95.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.948 -1.095 . . . . 0.0 110.406 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -69.26 -49.31 57.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.738 -1.226 . . . . 0.0 111.204 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -18.87 65.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.871 -1.143 . . . . 0.0 109.759 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -146.2 123.2 11.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.66 ' N ' HH11 ' A' ' 14' ' ' ARG . 16.7 ttmm -151.02 103.4 3.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.277 -0.889 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.572 ' N ' ' NH1' ' A' ' 14' ' ' ARG . . . 72.95 45.34 33.28 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.66 HH11 ' N ' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -62.69 -95.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -1.115 . . . . 0.0 110.852 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 17' ' ' LYS . 78.4 tt0 170.68 83.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 15' ' ' GLU . . . -4.82 70.0 0.0 OUTLIER Glycine 0 N--CA 1.511 3.661 0 C-N-CA 123.464 0.554 . . . . 0.0 113.831 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 15' ' ' GLU . 1.2 mtpp -174.01 -52.51 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.288 . . . . 0.0 109.944 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.13 111.65 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.924 2.416 . . . . 0.0 113.645 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 19' ' ' MET . 0.9 OUTLIER -123.04 133.37 54.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.094 -1.004 . . . . 0.0 108.841 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -106.64 135.11 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.141 -0.974 . . . . 0.0 109.936 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -87.49 98.41 11.37 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -66.23 -13.5 60.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.12 -42.49 93.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.66 -17.4 5.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 82.94 74.44 1.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -138.59 131.86 30.13 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.209 -1.171 . . . . 0.0 109.468 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -82.06 122.57 27.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.869 -1.145 . . . . 0.0 109.824 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 30' ' ' GLY . 67.7 mt -108.66 166.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' N ' HG22 ' A' ' 28' ' ' ILE . 52.5 tttp -150.49 31.54 0.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.628 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -151.33 27.47 0.98 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 28' ' ' ILE . 6.1 p -137.82 144.27 41.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.887 -0.772 . . . . 0.0 109.461 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 32' ' ' VAL . 31.5 m -123.12 84.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER 58.9 39.15 24.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.561 -1.337 . . . . 0.0 109.489 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 36' ' ' ASP . 55.3 tp -80.38 137.32 36.52 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.12 -17.34 4.92 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 34' ' ' LEU . 83.9 m-20 -70.69 -32.23 69.39 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.345 -1.091 . . . . 0.0 108.663 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 129.13 19.73 1.53 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' GLY . 7.8 t90 -36.19 130.51 0.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.59 0.71 . . . . 0.0 110.955 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.9 t -150.56 131.99 14.69 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.37 179.97 7.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.012 -1.68 . . . . 0.0 111.079 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.93 157.75 43.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.06 -1.025 . . . . 0.0 108.297 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -96.72 113.51 25.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.528 -1.357 . . . . 0.0 108.827 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 46.1 t0 -100.62 -0.69 37.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.919 -1.113 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.99 -106.89 0.59 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.715 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -91.75 -14.04 30.59 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.491 -1.005 . . . . 0.0 110.279 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.7 m -120.7 125.36 47.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.775 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.7 135.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.551 -0.718 . . . . 0.0 110.46 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.61 106.58 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.46 140.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.567 -0.708 . . . . 0.0 111.634 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 51' ' ' PRO . 11.6 m -111.08 111.2 56.17 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.9 Cg_exo -33.49 -76.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 122.264 1.976 . . . . 0.0 112.07 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -97.87 -49.37 4.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.167 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -165.57 -163.85 0.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -167.91 117.1 0.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.146 -0.972 . . . . 0.0 109.508 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.605 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 8.6 p -88.15 -73.51 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.797 -1.189 . . . . 0.0 108.089 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.605 ' N ' ' OG1' ' A' ' 55' ' ' THR . . . -155.56 -77.28 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.45 26.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.505 -0.747 . . . . 0.0 111.092 -179.331 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.582 ' H ' ' C ' ' A' ' 56' ' ' ALA . 19.2 m-85 -103.71 -166.94 1.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 149.97 46.65 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.828 -1.17 . . . . 0.0 110.989 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.65 179.24 6.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -125.92 122.51 36.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -94.09 101.1 13.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.28 132.62 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.783 0.802 . . . . 0.0 109.421 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -65.9 149.44 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.83 -39.74 65.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 109.543 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.7 -41.39 90.65 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.426 -1.421 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -59.84 -34.74 73.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.435 -1.415 . . . . 0.0 108.567 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.772 HD22 HD12 ' A' ' 71' ' ' ILE . 3.2 tm? -58.33 -29.96 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -60.11 -37.19 79.25 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.56 -39.91 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.206 -0.934 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.772 HD12 HD22 ' A' ' 68' ' ' LEU . 78.7 mt -59.16 -39.72 79.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 108.679 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -66.28 -38.77 88.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 110.392 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -62.06 -40.8 97.03 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.595 -1.315 . . . . 0.0 110.42 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -73.99 -69.17 0.46 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.674 -0.641 . . . . 0.0 111.577 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 75' ' ' LEU . 7.6 mp -60.03 -45.78 91.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.503 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.753 0.787 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -133.85 170.9 14.91 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.12 -43.84 95.33 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.486 HG22 ' CE1' ' A' ' 58' ' ' PHE . 24.8 m -60.13 -57.82 11.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.642 -0.661 . . . . 0.0 111.187 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 p -70.4 -45.79 65.25 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.788 -1.195 . . . . 0.0 111.771 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.86 -49.89 68.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.094 . . . . 0.0 112.733 -177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.8 t -69.82 -47.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 120.642 -1.286 . . . . 0.0 112.331 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.408 ' CD1' ' H ' ' A' ' 52' ' ' ALA . 47.3 mm -60.09 -48.58 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.876 -1.14 . . . . 0.0 109.547 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -60.05 -39.3 85.48 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.477 -0.764 . . . . 0.0 110.357 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.12 85.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.928 -1.108 . . . . 0.0 110.654 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.9 m-20 -71.08 -79.0 0.07 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.1 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 tptp 40.96 26.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.599 -0.688 . . . . 0.0 110.874 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' ASN . . . 171.85 39.05 0.03 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -69.77 110.8 5.12 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.748 -0.854 . . . . 0.0 110.21 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.91 -40.0 72.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 109.101 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.13 25.93 0.25 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.795 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 32.3 pttt -178.42 -22.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.278 -1.13 . . . . 0.0 112.875 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.795 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 45.1 Cg_endo -95.56 108.75 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.657 1.571 . . . . 0.0 112.696 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.79 133.75 54.91 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.0 mt -110.6 130.67 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 t -90.39 100.73 13.51 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -65.45 -7.14 12.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 108.854 -179.54 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.493 ' N ' HD12 ' A' ' 22' ' ' LEU . 91.8 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 24' ' ' ASP . 42.8 t0 -135.34 3.54 3.1 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.31 86.72 0.04 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.19 134.61 29.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.375 -1.073 . . . . 0.0 109.724 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -82.82 121.99 27.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.3 mt -119.99 76.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 110.701 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -70.18 107.13 3.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.679 -1.263 . . . . 0.0 109.959 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.99 23.74 1.03 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -134.97 139.2 44.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.611 HG22 HD21 ' A' ' 75' ' ' LEU . 33.4 m -124.38 111.35 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.616 ' OH ' HD13 ' A' ' 71' ' ' ILE . 4.4 p90 32.0 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.002 -0.436 . . . . 0.0 111.405 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -92.82 135.92 33.7 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.874 -1.141 . . . . 0.0 109.926 -179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.599 ' H ' HD13 ' A' ' 34' ' ' LEU . . . 100.73 18.26 21.12 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -129.99 -99.94 0.32 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -1.062 . . . . 0.0 109.521 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -153.41 25.24 0.77 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -50.04 149.59 2.7 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.77 -0.841 . . . . 0.0 111.093 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.3 m -149.68 151.66 34.06 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.79 10.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.234 -1.542 . . . . 0.0 109.474 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -158.78 160.35 36.2 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -97.48 121.79 39.78 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.89 -1.131 . . . . 0.0 109.861 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.495 ' OD2' HG23 ' A' ' 48' ' ' VAL . 12.2 m-20 -100.04 -1.83 35.96 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.152 -0.967 . . . . 0.0 110.306 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.664 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 83.75 95.23 0.63 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.782 -1.199 . . . . 0.0 110.51 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 84.22 4.76 0.71 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.938 -0.742 . . . . 0.0 109.887 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -165.94 143.77 5.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.99 128.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.468 -0.77 . . . . 0.0 110.371 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' OD2' ' A' ' 43' ' ' ASP . 89.6 t -101.2 109.83 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.36 140.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 p -112.09 120.51 41.65 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -36.61 -79.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.006 1.804 . . . . 0.0 113.097 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -93.53 -48.85 6.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.794 -1.191 . . . . 0.0 109.203 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -160.85 -165.83 1.47 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.535 -1.353 . . . . 0.0 109.568 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.631 ' OE2' ' HB2' ' A' ' 60' ' ' ALA . 84.8 tt0 -157.5 100.86 1.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.152 -0.967 . . . . 0.0 109.607 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.651 ' O ' ' N ' ' A' ' 57' ' ' LEU . 26.7 p -131.22 145.57 51.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.849 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.82 -27.07 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.8 mp -79.61 -10.14 59.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.649 -1.282 . . . . 0.0 109.461 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 4' ' ' THR . 34.9 m-85 -137.5 -161.84 1.22 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.59 166.58 28.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.738 -1.227 . . . . 0.0 111.506 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.631 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -76.62 176.1 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -134.1 127.66 32.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -96.43 110.14 22.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.131 -0.981 . . . . 0.0 110.871 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -110.76 144.99 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.302 0.572 . . . . 0.0 109.812 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -73.4 163.59 27.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.099 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.9 95.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.405 -0.81 . . . . 0.0 111.345 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -49.98 72.62 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.267 -1.521 . . . . 0.0 111.426 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -60.21 -35.57 75.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.262 -1.524 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 68' ' ' LEU . 3.1 tm? -59.7 -35.43 74.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 108.37 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -59.93 -34.48 73.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.969 -1.082 . . . . 0.0 109.296 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.2 mt -58.19 -38.7 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.88 -1.137 . . . . 0.0 108.77 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.63 HD12 HD22 ' A' ' 68' ' ' LEU . 82.6 mt -59.99 -39.92 81.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.759 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -62.45 -40.05 95.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.083 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -67.23 -50.56 60.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.736 -1.227 . . . . 0.0 110.53 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -59.97 -63.41 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.925 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.654 HD12 ' N ' ' A' ' 75' ' ' LEU . 7.7 mp -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.884 -1.135 . . . . 0.0 111.028 -177.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.794 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 109.581 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.26 -49.81 76.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.603 HG21 ' CD1' ' A' ' 58' ' ' PHE . 56.3 m -60.38 -50.07 75.06 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.054 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -68.44 -49.19 61.71 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.312 -1.492 . . . . 0.0 111.019 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.12 -49.26 78.01 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 112.888 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.66 -45.81 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.554 -1.341 . . . . 0.0 111.892 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -59.93 -42.84 90.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.449 -1.407 . . . . 0.0 108.776 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -57.66 -39.26 76.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -55.19 19.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.835 -1.166 . . . . 0.0 109.005 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.0 m120 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 179.787 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 38.3 Cg_endo -101.1 128.03 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 123.364 2.71 . . . . 0.0 109.839 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.8 ttt -126.18 128.97 48.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.997 -1.064 . . . . 0.0 110.053 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -110.0 130.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.544 -0.723 . . . . 0.0 109.376 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 t -93.87 103.58 15.68 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.66 -7.83 12.12 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.12 -43.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -134.4 13.97 3.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.31 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -151.81 145.81 25.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.725 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.12 125.95 33.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mt -123.11 73.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.728 -0.607 . . . . 0.0 109.398 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -69.22 109.37 4.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.007 -1.058 . . . . 0.0 109.361 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.2 21.64 0.95 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -140.83 147.82 39.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.51 101.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 0.0 108.708 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 51.4 28.46 4.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 109.138 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.5 tt -92.34 139.45 30.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.86 18.6 63.08 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -127.16 -54.51 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.72 -0.87 . . . . 0.0 109.187 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.97 33.05 0.02 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -50.31 138.99 15.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -1.222 . . . . 0.0 109.858 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.6 t -151.08 135.5 16.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.92 178.18 10.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.323 -1.486 . . . . 0.0 109.969 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -150.58 161.11 43.2 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -100.0 117.34 34.07 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.905 -1.122 . . . . 0.0 109.988 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 60.6 t0 -94.51 -12.49 27.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.128 -0.983 . . . . 0.0 109.373 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 93.81 98.24 1.55 Allowed Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.175 -0.953 . . . . 0.0 110.814 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 85.55 1.1 0.7 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.983 -0.716 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -167.31 117.81 0.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -90.78 142.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.954 -1.091 . . . . 0.0 110.572 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.78 125.29 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -146.89 144.09 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.4 m -110.44 124.46 33.19 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -37.48 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.87 1.713 . . . . 0.0 111.7 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -101.82 -47.32 4.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.024 -1.048 . . . . 0.0 109.828 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 68.9 mt-10 -161.81 -165.84 1.34 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -168.11 114.66 0.69 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.6 p -122.4 44.53 2.59 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.244 -0.91 . . . . 0.0 111.115 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 68.32 -16.74 0.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.024 -1.048 . . . . 0.0 110.38 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 55' ' ' THR . 12.6 mt -95.13 -0.77 53.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CD1' HG21 ' A' ' 4' ' ' THR . 89.3 m-85 -134.04 -156.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.09 164.19 35.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.828 -1.17 . . . . 0.0 111.381 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.33 174.96 9.56 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.449 0.642 . . . . 0.0 109.525 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -133.36 133.34 42.35 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -82.76 164.43 20.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.842 -1.161 . . . . 0.0 110.358 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -154.93 119.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.2 m -64.8 151.13 46.13 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.61 69.9 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.603 -1.31 . . . . 0.0 108.403 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.64 80.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.599 -1.313 . . . . 0.0 109.436 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -60.99 -34.21 74.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 108.981 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.584 HD13 ' O ' ' A' ' 68' ' ' LEU . 2.9 tm? -59.75 -33.1 71.22 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -60.6 -41.47 94.81 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.8 mt -60.15 -39.22 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.725 . . . . 0.0 110.727 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.59 ' O ' HD22 ' A' ' 75' ' ' LEU . 96.1 mt -59.72 -46.56 93.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 118.304 -1.359 . . . . 0.0 109.821 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.28 73.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.545 -1.347 . . . . 0.0 109.672 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -62.65 -40.01 95.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.833 -1.167 . . . . 0.0 109.607 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -59.94 -51.35 70.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.431 -0.793 . . . . 0.0 111.631 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.615 HD22 ' H ' ' A' ' 75' ' ' LEU . 1.2 mm? -65.35 -46.82 78.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.177 . . . . 0.0 109.893 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.652 HG23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 121.696 0.76 . . . . 0.0 109.088 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.652 ' H ' HG23 ' A' ' 2' ' ' THR . 8.6 tp -60.16 -45.43 93.1 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.4 m -70.04 -51.84 28.85 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.202 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -73.44 -57.56 3.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.31 -40.34 95.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.388 -1.445 . . . . 0.0 112.361 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.6 t -70.32 -47.95 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.589 -1.319 . . . . 0.0 112.341 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 11' ' ' ASN . 53.4 mt -68.24 -42.55 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.862 -1.149 . . . . 0.0 111.195 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -60.3 -41.7 93.96 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.47 91.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.886 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 8' ' ' ILE . 8.0 m120 . . . . . 0 N--CA 1.499 1.997 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.553 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 36.6 mtmt . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 80.2 Cg_endo -96.46 123.68 0.25 Allowed 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.554 2.169 . . . . 0.0 113.629 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 19' ' ' MET . 0.3 OUTLIER -122.29 140.95 52.04 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.574 -0.704 . . . . 0.0 109.746 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 76.6 mt -110.53 131.39 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.412 -0.805 . . . . 0.0 110.296 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.6 m -94.59 101.11 12.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.025 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -8.44 22.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.372 -0.83 . . . . 0.0 109.528 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.97 -42.4 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 9.3 t70 -131.54 8.02 4.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.41 87.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -144.68 137.21 26.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -1.138 . . . . 0.0 109.233 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -83.43 122.97 29.21 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -120.06 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.376 -0.827 . . . . 0.0 110.319 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -66.01 107.53 1.91 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.837 -1.164 . . . . 0.0 109.011 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.4 19.16 0.77 Allowed Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 137.25 49.06 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 34' ' ' LEU . 3.1 m -118.03 98.89 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 44.6 17.07 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 32' ' ' VAL . 85.1 mt -72.12 142.01 49.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 108.473 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -21.58 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -73.07 -35.45 66.66 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 123.53 31.8 0.94 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.45 ' HE1' HD12 ' A' ' 49' ' ' ILE . 16.3 t90 -47.52 139.54 6.77 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.285 1.04 . . . . 0.0 111.314 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -154.62 135.08 13.38 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.23 7.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.653 -1.28 . . . . 0.0 111.583 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -156.76 139.4 15.04 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -94.2 123.55 37.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.29 -1.506 . . . . 0.0 109.523 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 52.0 t0 -102.19 -5.6 24.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.354 -0.841 . . . . 0.0 110.201 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -112.07 0.54 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.752 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -90.9 -6.63 53.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -1.194 . . . . 0.0 109.956 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -125.1 119.95 30.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.981 -1.075 . . . . 0.0 108.88 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -88.97 140.14 16.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.488 -0.758 . . . . 0.0 110.828 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.44 114.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.608 HD13 HD12 ' A' ' 63' ' ' ILE . 4.4 pt -118.78 172.35 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.023 -1.048 . . . . 0.0 109.917 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 51' ' ' PRO . 63.8 m -135.35 102.37 10.74 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 50' ' ' SER . 0.5 OUTLIER -28.9 -99.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.614 2.209 . . . . 0.0 112.083 -177.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -78.29 -44.29 25.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.41 ' OE2' HD23 ' A' ' 3' ' ' LEU . 68.2 mt-10 -160.92 -163.87 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' OE1' ' C ' ' A' ' 59' ' ' LYS . 10.0 tp10 -171.0 103.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.627 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 57' ' ' LEU . 73.1 p -130.81 152.59 49.98 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -26.8 -29.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.4 mp -84.11 -3.11 57.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.712 -1.243 . . . . 0.0 111.004 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 55' ' ' THR . 88.4 m-85 -129.27 -161.07 1.08 Allowed 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.461 -0.774 . . . . 0.0 109.702 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -140.08 155.68 46.92 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.156 -0.965 . . . . 0.0 111.197 -179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.71 175.5 10.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.688 -0.633 . . . . 0.0 109.819 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -132.17 153.82 50.16 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -109.28 161.09 15.59 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.331 -0.856 . . . . 0.0 109.978 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.608 HD12 HD13 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -153.06 117.45 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -61.74 149.26 40.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -49.61 -46.03 48.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.775 -1.203 . . . . 0.0 109.581 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.16 -41.73 65.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.186 -1.571 . . . . 0.0 110.241 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -65.75 -29.91 70.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.766 -1.209 . . . . 0.0 109.765 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 71' ' ' ILE . 3.2 tm? -59.63 -36.39 76.27 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -59.17 -39.23 81.85 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 mt -60.17 -32.65 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.053 -1.029 . . . . 0.0 110.184 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 68' ' ' LEU . 93.4 mt -62.14 -44.37 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.242 -1.536 . . . . 0.0 110.51 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.61 62.09 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.024 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -64.37 -56.54 13.67 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.142 -0.974 . . . . 0.0 110.224 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -51.92 -49.69 62.57 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.622 -0.674 . . . . 0.0 109.331 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -67.6 -23.94 65.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.052 -1.03 . . . . 0.0 110.626 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.825 -1.083 . . . . 0.0 108.962 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.682 0.753 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.76 -40.13 94.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.671 -0.643 . . . . 0.0 111.022 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.428 ' OG1' ' OE2' ' A' ' 53' ' ' GLU . 41.7 m -59.94 -52.39 65.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.927 . . . . 0.0 110.642 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t -68.62 -41.27 79.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.702 -1.249 . . . . 0.0 111.744 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.77 -40.52 76.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.784 -1.197 . . . . 0.0 112.919 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 52' ' ' ALA . 70.7 t -71.21 -50.09 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.486 -1.383 . . . . 0.0 111.254 -178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.455 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.3 mp -60.27 -49.34 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.097 -1.002 . . . . 0.0 110.162 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -60.39 -40.02 89.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.058 -1.027 . . . . 0.0 110.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.64 80.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.961 -1.087 . . . . 0.0 109.459 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.425 HD21 HG13 ' A' ' 20' ' ' ILE . 9.5 m120 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 109.439 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.491 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 1.3 tttm . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 78.9 Cg_endo -95.54 130.25 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.748 2.299 . . . . 0.0 110.341 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.6 ttt -116.46 129.67 56.34 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.302 -0.874 . . . . 0.0 111.253 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.425 HG13 HD21 ' A' ' 11' ' ' ASN . 5.2 mm -106.14 119.85 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 25' ' ' GLY . 26.2 p -100.82 98.86 9.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 0.0 109.057 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.031 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.08 -10.71 59.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.374 -0.828 . . . . 0.0 109.825 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.557 ' N ' HD22 ' A' ' 22' ' ' LEU . 72.9 t -60.03 -41.73 87.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 108.493 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.48 1.29 4.53 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 60.04 82.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -145.28 137.69 25.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.359 -1.083 . . . . 0.0 109.472 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -84.56 128.97 34.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.92 77.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.714 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 44.4 pttt -71.94 109.99 6.14 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.68 20.36 0.54 Allowed Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.4 p -142.33 149.08 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -1.124 . . . . 0.0 108.372 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.567 HG22 HD21 ' A' ' 75' ' ' LEU . 19.1 m -122.86 85.32 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.67 0.748 . . . . 0.0 109.301 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 53.54 34.29 18.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.435 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 tp -85.67 137.07 33.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.541 -0.724 . . . . 0.0 109.069 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.71 66.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -121.42 -41.98 2.47 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 145.71 26.69 0.1 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -51.26 136.99 23.69 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.163 -1.198 . . . . 0.0 109.294 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 p -152.42 142.31 22.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.13 178.96 9.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.229 -1.544 . . . . 0.0 110.461 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -158.65 146.59 18.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -96.66 123.28 40.29 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.644 -1.285 . . . . 0.0 109.155 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.6 -4.26 22.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -121.87 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -80.72 -9.96 59.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.217 . . . . 0.0 109.591 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.6 m -120.13 134.59 55.21 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 HD12 ' A' ' 68' ' ' LEU . 33.4 mm -104.69 130.02 56.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.676 -0.64 . . . . 0.0 109.873 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.82 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.064 -1.022 . . . . 0.0 108.354 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.63 141.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.188 -0.945 . . . . 0.0 110.601 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -109.9 118.69 49.38 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -36.77 -76.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.916 1.744 . . . . 0.0 112.211 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -94.96 -50.75 4.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 0.0 108.562 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' OE2' ' OG1' ' A' ' 4' ' ' THR . 15.5 pt-20 -173.22 -161.0 0.13 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.533 -0.729 . . . . 0.0 109.057 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -166.26 115.39 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.034 -1.041 . . . . 0.0 108.935 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 11.8 p -117.09 40.26 3.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.226 -0.921 . . . . 0.0 109.705 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 69.99 -16.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.663 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 55' ' ' THR . 4.6 mm? -90.0 -1.75 58.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 4' ' ' THR . 67.9 m-85 -136.27 -159.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -144.59 159.99 41.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.971 -1.081 . . . . 0.0 111.339 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 175.74 5.12 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -132.52 124.84 29.26 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -93.07 110.94 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.452 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 63' ' ' ILE . 14.4 tt -108.92 124.4 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.7 m -55.63 157.72 3.9 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.339 -0.85 . . . . 0.0 110.687 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.324 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.92 -41.37 61.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.551 -1.343 . . . . 0.0 108.748 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -63.04 -24.21 67.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -59.87 -38.79 83.18 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.07 -35.64 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.77 -39.86 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.859 -1.151 . . . . 0.0 108.888 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.45 -38.09 54.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.749 -1.22 . . . . 0.0 108.659 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -69.9 -38.13 76.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.91 -50.47 41.88 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.657 -1.277 . . . . 0.0 111.71 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -59.87 -47.37 86.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 111.457 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.567 HD21 HG22 ' A' ' 32' ' ' VAL . 5.3 mp -69.95 -44.3 69.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.922 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 7' ' ' VAL . 3.0 tt -59.98 -49.32 78.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 109.739 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.415 ' OG1' ' OE1' ' A' ' 53' ' ' GLU . 89.5 m -64.92 -53.69 42.55 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.298 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.5 p -61.65 -45.26 94.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.718 -1.239 . . . . 0.0 111.751 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.99 -40.97 74.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.914 -1.117 . . . . 0.0 112.65 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 3' ' ' LEU . 80.8 t -68.6 -47.97 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.393 -1.442 . . . . 0.0 111.216 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.05 -49.16 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.877 -1.139 . . . . 0.0 110.437 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.97 -41.85 92.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.161 -0.962 . . . . 0.0 111.057 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.92 92.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.533 -1.354 . . . . 0.0 110.427 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.939 -179.416 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -95.46 113.31 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.659 2.239 . . . . 0.0 112.231 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.575 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.06 135.26 50.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.337 -0.852 . . . . 0.0 109.748 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.575 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.8 mm -106.22 129.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.754 . . . . 0.0 109.105 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' VAL . 79.5 p -113.58 100.24 8.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.521 -0.737 . . . . 0.0 109.629 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -1.4 3.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' SER . 95.1 t -60.03 -44.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -140.81 15.76 2.31 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.11 85.27 0.03 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 106.63 -2.588 . . . . 0.0 106.63 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -145.7 134.3 22.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.459 -1.024 . . . . 0.0 109.729 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.63 128.67 34.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mt -127.56 75.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.87 109.25 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 109.248 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.89 26.4 1.13 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.8 m -141.74 148.45 39.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 32' ' ' VAL . 22.8 m -127.15 106.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 23.5 m-85 42.06 34.78 0.49 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.598 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -90.83 134.78 34.18 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 109.682 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.598 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 102.39 16.02 23.8 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.564 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 23.5 p30 -131.7 -100.97 0.29 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.38 -1.07 . . . . 0.0 109.276 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -143.72 30.48 1.94 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -46.97 140.02 5.14 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.248 -1.148 . . . . 0.0 110.959 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 t -146.66 149.08 32.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.78 169.92 18.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.084 -1.635 . . . . 0.0 109.184 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -158.94 143.67 15.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -98.92 120.07 38.75 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.606 -1.309 . . . . 0.0 110.584 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 32.3 t0 -97.81 -7.29 30.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.284 -0.885 . . . . 0.0 109.621 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.14 64.47 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -163.03 -57.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.121 . . . . 0.0 108.639 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -118.09 121.49 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.48 135.12 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 t -98.63 103.92 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.84 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.42 -0.8 . . . . 0.0 110.304 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -111.93 127.75 26.43 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.59 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.233 1.289 . . . . 0.0 111.455 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.73 -48.94 5.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 109.592 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.415 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 91.9 mt-10 -156.69 -169.98 3.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.122 -0.987 . . . . 0.0 109.882 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 15.6 tm-20 -155.62 96.72 1.79 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 58' ' ' PHE . 1.7 p -131.49 147.75 52.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.373 -0.83 . . . . 0.0 108.816 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -28.61 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.1 mp -85.4 0.57 51.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.605 -1.31 . . . . 0.0 110.222 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.5 m-85 -136.87 -160.88 1.1 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 108.935 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -150.08 160.19 43.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 0.0 111.612 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.28 173.5 12.53 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -136.18 128.7 30.49 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.32 109.51 22.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.969 -1.082 . . . . 0.0 110.789 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.83 138.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 m -74.43 162.61 28.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.94 . . . . 0.0 108.852 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -59.95 -48.05 83.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.883 -1.136 . . . . 0.0 109.44 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.0 -41.7 83.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.628 -1.295 . . . . 0.0 109.995 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -59.95 -32.61 70.96 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 108.633 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.762 ' O ' HD13 ' A' ' 68' ' ' LEU . 2.7 tm? -59.91 -34.77 73.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.86 -37.67 77.04 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.03 -1.044 . . . . 0.0 108.38 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.97 -39.85 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.975 . . . . 0.0 109.364 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.4 mp -59.92 -40.11 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 108.267 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.23 96.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 111.055 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.12 -40.0 95.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.672 -1.267 . . . . 0.0 109.489 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -66.7 -71.33 0.2 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.313 0.578 . . . . 0.0 111.883 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.697 ' N ' HD12 ' A' ' 75' ' ' LEU . 6.4 mp -63.01 -44.55 95.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 111.466 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 120.752 -1.217 . . . . 0.0 109.371 -179.757 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.498 1.946 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.05 -49.92 75.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.304 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.516 HG23 ' N ' ' A' ' 5' ' ' SER . 6.4 t -63.59 -48.46 77.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.311 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 4' ' ' THR . 14.5 p -65.19 -43.21 92.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.76 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -40.81 74.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.058 . . . . 0.0 112.122 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.96 -43.82 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.852 -1.155 . . . . 0.0 110.836 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 52' ' ' ALA . 1.3 mp -59.43 -49.11 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.821 . . . . 0.0 109.452 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.09 -36.15 76.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.808 -1.183 . . . . 0.0 109.755 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.24 -20.02 64.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.973 -1.079 . . . . 0.0 110.593 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.9 m120 . . . . . 0 N--CA 1.5 2.025 0 O-C-N 120.772 -1.205 . . . . 0.0 110.715 -179.094 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.958 0 CA-C-O 121.278 0.561 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 38.0 Cg_endo -66.52 156.13 66.93 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.02 1.813 . . . . 0.0 108.668 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.484 ' SD ' ' OD2' ' A' ' 36' ' ' ASP . 35.3 ttp -138.16 125.6 21.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.78 -1.2 . . . . 0.0 110.996 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.3 mt -102.38 128.96 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.7 p -86.61 99.18 11.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.012 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -62.66 -14.44 43.54 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' H ' HD22 ' A' ' 22' ' ' LEU . 71.6 t -60.86 -41.79 90.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -131.7 2.03 4.06 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 59.23 81.15 0.08 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -140.07 130.29 25.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.257 -1.143 . . . . 0.0 109.329 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 51.2 mp0 -77.44 134.91 38.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.289 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 30' ' ' GLY . 34.5 mt -130.8 60.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -71.94 47.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.862 0.839 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -153.51 26.05 0.76 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 106.846 -2.502 . . . . 0.0 106.846 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m -145.81 150.43 36.17 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 32' ' ' VAL . 18.6 m -114.81 94.62 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' VAL . 26.0 m-85 36.38 25.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.294 0.569 . . . . 0.0 110.538 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 35' ' ' GLY . 4.2 tt -97.68 129.12 44.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 109.207 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.711 ' N ' HD23 ' A' ' 34' ' ' LEU . . . 118.01 25.77 2.93 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' SD ' ' A' ' 19' ' ' MET . 90.9 m-20 -143.76 -61.84 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.302 -1.116 . . . . 0.0 109.638 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -170.96 23.79 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -35.23 135.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.021 0.915 . . . . 0.0 112.503 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 t -146.94 135.31 21.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.96 169.31 23.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.822 -1.798 . . . . 0.0 110.064 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -160.5 138.69 9.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -101.59 126.27 48.38 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.686 -1.259 . . . . 0.0 111.176 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 59.2 t0 -95.49 -12.47 25.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.735 -0.603 . . . . 0.0 109.491 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 94.87 105.05 1.95 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 84.63 -10.71 0.84 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.984 -0.715 . . . . 0.0 109.773 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.9 m -158.01 114.4 2.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -91.9 140.81 15.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 111.247 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.12 120.05 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.487 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -151.25 146.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.609 -1.307 . . . . 0.0 110.347 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 t -109.72 120.06 46.04 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -38.05 -77.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 122.082 1.854 . . . . 0.0 113.55 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -85.01 -58.8 2.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.862 -1.148 . . . . 0.0 111.082 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 40.5 mt-10 -161.25 -167.15 1.7 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.835 . . . . 0.0 109.616 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -167.43 113.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 1.4 p -127.87 45.12 2.8 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.36 -0.837 . . . . 0.0 110.198 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 71.8 -22.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 55' ' ' THR . 11.3 mt -90.09 -7.15 54.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.045 -1.034 . . . . 0.0 108.929 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -128.79 -160.53 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -145.8 158.96 43.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.724 -1.235 . . . . 0.0 111.075 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.15 173.52 8.43 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -127.98 140.27 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -85.05 155.54 21.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.487 HD12 HG21 ' A' ' 49' ' ' ILE . 8.0 mt -151.89 112.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.0 p -64.23 154.71 34.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.57 62.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.69 86.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.653 -1.279 . . . . 0.0 109.707 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -59.92 -39.16 84.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.108 -0.995 . . . . 0.0 109.331 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 68' ' ' LEU . 1.8 tm? -59.01 -37.09 76.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.877 -1.14 . . . . 0.0 108.757 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -58.97 -35.01 72.45 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.87 -38.65 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.5 mp -57.89 -40.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.63 -1.294 . . . . 0.0 108.796 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.0 96.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 110.904 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . 94.0 mttt -68.08 -44.47 76.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.874 -1.141 . . . . 0.0 110.501 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -59.74 -58.26 9.36 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 112.12 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 HG22 ' A' ' 32' ' ' VAL . 4.5 mp -68.01 -39.9 83.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.595 -1.316 . . . . 0.0 110.234 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.78 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.034 -1.041 . . . . 0.0 109.951 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.628 ' H ' HG23 ' A' ' 2' ' ' THR . 10.4 tp -59.95 -49.41 77.78 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 m -65.64 -49.09 69.92 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.956 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -72.36 -57.3 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 112.538 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 2' ' ' THR . 69.9 mm-40 -65.03 -44.33 89.49 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.569 -1.332 . . . . 0.0 113.129 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.0 -45.32 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.526 -1.359 . . . . 0.0 111.107 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.487 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.3 mp -60.1 -39.4 80.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.001 -1.062 . . . . 0.0 109.144 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.81 -44.0 94.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.802 -1.186 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.69 74.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.886 -1.133 . . . . 0.0 109.986 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.669 HD21 ' CG1' ' A' ' 20' ' ' ILE . 23.5 m120 . . . . . 0 N--CA 1.5 2.063 0 O-C-N 121.135 -0.978 . . . . 0.0 109.567 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 7.8 mtpt . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 120.469 0.176 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 63.0 Cg_endo -101.14 130.18 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.151 2.568 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.7 ttp -112.2 143.26 43.56 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.669 ' CG1' HD21 ' A' ' 11' ' ' ASN . 4.5 mm -103.4 129.58 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.299 -0.876 . . . . 0.0 108.989 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 m -100.56 98.49 9.07 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -66.96 -3.04 6.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.563 ' N ' HD12 ' A' ' 22' ' ' LEU . 74.6 t -60.05 -44.27 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.8 t0 -125.01 -5.82 7.34 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.8 11.24 85.61 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -75.88 140.05 41.98 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.651 -0.911 . . . . 0.0 110.399 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.03 133.48 33.58 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.7 mt -123.45 73.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.223 -0.923 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -65.93 109.23 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.528 -1.357 . . . . 0.0 108.834 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.9 23.67 0.85 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 17' ' ' LYS . 87.8 m -133.26 137.26 45.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 34' ' ' LEU . 9.8 m -120.1 102.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.432 -0.792 . . . . 0.0 110.022 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.433 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m-85 41.65 17.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.868 -0.52 . . . . 0.0 109.94 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 32' ' ' VAL . 43.7 tp -93.9 134.56 36.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.673 -1.267 . . . . 0.0 109.68 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.82 17.01 10.74 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 17.5 p-10 -139.37 -69.96 0.41 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -1.119 . . . . 0.0 110.121 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 173.1 32.08 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -51.54 155.65 1.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.434 -1.039 . . . . 0.0 110.324 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 t -153.39 131.97 12.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.86 177.32 10.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.339 -1.476 . . . . 0.0 109.57 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -159.7 160.05 33.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -99.48 114.76 27.91 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.88 -1.137 . . . . 0.0 109.649 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 38.4 t0 -96.74 -7.7 33.21 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.783 -1.198 . . . . 0.0 109.685 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.97 -113.56 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -88.84 -5.22 58.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -1.23 . . . . 0.0 109.273 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 m -122.91 132.85 54.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.335 -0.853 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.1 mm -96.36 142.61 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.586 -0.696 . . . . 0.0 110.838 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -109.26 120.01 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.648 HD12 HD12 ' A' ' 63' ' ' ILE . 45.8 mt -131.73 144.16 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.583 -0.698 . . . . 0.0 110.518 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' PRO . 74.1 m -118.29 120.84 31.78 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' SER . 53.9 Cg_exo -33.34 -87.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.137 1.891 . . . . 0.0 111.961 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -99.9 -36.59 9.35 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -165.73 -163.21 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.708 0.766 . . . . 0.0 109.965 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -174.28 117.26 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.648 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 20.9 p -128.98 40.43 3.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 74.46 -26.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 55' ' ' THR . 8.8 mp -90.02 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.362 -0.836 . . . . 0.0 108.828 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.27 -157.19 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -140.46 158.36 44.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.001 -1.062 . . . . 0.0 111.075 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.04 173.77 9.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -138.99 120.03 14.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -84.76 171.32 12.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.648 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -161.69 118.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -60.18 153.89 21.0 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.694 -1.254 . . . . 0.0 108.13 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.95 -44.32 70.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.784 -1.197 . . . . 0.0 108.245 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.59 -44.05 69.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.041 -1.662 . . . . 0.0 109.309 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.88 -27.14 68.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.687 -1.258 . . . . 0.0 108.96 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.633 HD22 HD12 ' A' ' 71' ' ' ILE . 3.3 tm? -59.91 -32.88 71.17 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.92 -39.77 86.59 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.7 mt -58.28 -34.83 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.988 -1.07 . . . . 0.0 109.998 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.633 HD12 HD22 ' A' ' 68' ' ' LEU . 71.0 mt -60.02 -40.16 82.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.23 -1.544 . . . . 0.0 109.675 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -75.39 -28.81 59.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' LEU . 1.6 tmtp? -69.77 -55.11 10.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -58.06 -50.06 74.74 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.857 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 75' ' ' LEU . 4.6 mp -68.11 -39.85 82.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.355 -1.466 . . . . 0.0 109.744 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 73' ' ' LYS . 1.5 pp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.138 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.507 2.383 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 tp -59.83 -42.99 94.76 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -78.59 -50.01 12.26 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.857 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -65.72 -52.05 54.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.909 -1.119 . . . . 0.0 111.74 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.01 -47.12 63.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 112.836 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.81 -39.93 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.504 -1.372 . . . . 0.0 111.367 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.62 -45.47 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 108.372 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -59.05 -40.06 83.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.604 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 11' ' ' ASN . . . -59.97 -42.04 93.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.975 -1.078 . . . . 0.0 110.35 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 10' ' ' ALA . 89.7 m-20 . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.94 . . . . 0.0 110.068 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.534 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 32.2 ttpt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 119.783 -0.151 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 98.2 Cg_endo -96.98 108.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 122.432 2.088 . . . . 0.0 113.836 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.439 ' C ' ' SD ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -122.74 131.63 53.87 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.574 -0.704 . . . . 0.0 109.101 178.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.19 131.89 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 110.154 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 23' ' ' VAL . 35.4 m -95.76 101.96 13.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -63.43 0.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.587 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.519 ' N ' HD12 ' A' ' 22' ' ' LEU . 71.3 t -60.03 -45.43 95.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.911 -1.118 . . . . 0.0 108.272 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -138.47 10.34 2.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.72 89.12 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -146.08 137.84 24.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.107 -1.231 . . . . 0.0 109.81 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.39 129.8 35.32 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 30' ' ' GLY . 53.6 mt -124.96 77.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.387 -0.821 . . . . 0.0 110.365 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -69.1 40.63 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 109.754 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -151.15 24.03 0.99 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.079 -2.409 . . . . 0.0 107.079 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 m -146.99 150.3 34.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 122.001 -0.705 . . . . 0.0 109.746 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 32' ' ' VAL . 35.5 m -134.67 104.71 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 41.0 p90 39.93 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.86 -0.525 . . . . 0.0 110.865 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.569 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 tt -103.33 118.45 36.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.127 -0.983 . . . . 0.0 108.484 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.546 ' N ' HD23 ' A' ' 34' ' ' LEU . . . 134.03 28.86 0.48 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 70.4 m-20 -155.74 -50.08 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.546 -0.973 . . . . 0.0 109.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 176.16 31.83 0.04 OUTLIER Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.4 ' C ' ' O ' ' A' ' 37' ' ' GLY . 55.4 p-90 -43.4 144.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.2 m -149.16 134.07 17.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.01 170.59 7.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.24 -1.538 . . . . 0.0 109.546 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -151.41 148.27 27.89 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -95.13 134.62 37.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.551 -1.343 . . . . 0.0 109.432 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -109.66 -8.51 14.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.476 -0.765 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.67 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 89.86 103.9 1.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 86.46 0.57 0.59 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.094 -0.651 . . . . 0.0 110.163 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 45' ' ' ALA . 72.2 m -171.59 116.33 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 108.365 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 47' ' ' ILE . 7.2 mm -91.17 136.28 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.097 -1.002 . . . . 0.0 110.395 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.02 120.7 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.655 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -148.3 147.8 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.651 -1.281 . . . . 0.0 111.559 -177.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.2 m -119.49 147.13 42.8 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.51 -84.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.631 1.554 . . . . 0.0 111.941 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -94.34 -39.44 10.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.011 -1.056 . . . . 0.0 109.921 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -159.4 -164.04 1.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 108.787 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.841 ' OE2' ' HB2' ' A' ' 60' ' ' ALA . 77.6 tt0 -165.82 100.1 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 110.354 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 57' ' ' LEU . 23.6 p -130.27 151.15 51.1 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.88 -29.15 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.9 mp -84.17 1.29 45.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.701 -1.25 . . . . 0.0 110.041 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.7 m-85 -136.96 -161.03 1.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -151.18 169.29 22.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.839 -1.163 . . . . 0.0 111.58 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.841 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -93.92 175.58 6.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.43 0.633 . . . . 0.0 109.328 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -137.8 134.52 35.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -96.56 108.86 21.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.932 -1.105 . . . . 0.0 111.694 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.655 HD12 HG21 ' A' ' 49' ' ' ILE . 1.5 mt -89.84 131.41 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 p -72.63 159.32 34.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.998 -1.064 . . . . 0.0 108.357 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 -50.13 74.99 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.947 -1.095 . . . . 0.0 108.874 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.98 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.301 -1.499 . . . . 0.0 108.55 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -60.07 -33.69 72.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.967 -1.083 . . . . 0.0 108.988 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.688 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.3 tm? -60.03 -36.86 78.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.114 -0.991 . . . . 0.0 108.443 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -58.99 -37.38 76.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.85 -39.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 109.348 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.89 -40.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.049 -1.032 . . . . 0.0 109.488 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -64.31 -40.0 95.05 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.659 -1.275 . . . . 0.0 109.74 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -59.9 -44.66 94.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.267 -1.52 . . . . 0.0 109.169 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.28 -71.86 0.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 111.84 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.7 mp -61.9 -41.68 98.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.02 -1.05 . . . . 0.0 111.93 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ALA . 39.1 tp . . . . . 0 N--CA 1.502 2.135 0 O-C-N 120.913 -1.117 . . . . 0.0 109.434 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -60.54 -50.11 74.85 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.054 0.93 . . . . 0.0 108.67 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.421 ' O ' HD13 ' A' ' 8' ' ' ILE . 97.8 m -61.02 -52.25 65.79 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.404 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.3 t -67.08 -43.35 82.8 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.853 -1.155 . . . . 0.0 111.786 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -69.73 -40.33 76.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 112.633 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -74.73 -43.08 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.352 -1.468 . . . . 0.0 111.81 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 4' ' ' THR . 1.5 mp -59.99 -52.63 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.864 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -63.61 -38.71 92.15 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.865 -1.147 . . . . 0.0 110.502 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.5 91.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.301 -0.874 . . . . 0.0 111.407 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' A' ' 8' ' ' ILE . 29.0 p30 . . . . . 0 N--CA 1.499 1.991 0 O-C-N 120.53 -1.356 . . . . 0.0 111.287 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 27.3 Cg_endo -101.25 132.24 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.934 2.423 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.535 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 25.5 ttt -125.9 127.76 46.51 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.07 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.8 mt -109.31 133.58 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.825 0.822 . . . . 0.0 109.829 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.4 p -93.81 101.41 13.51 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.539 -0.726 . . . . 0.0 109.243 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.058 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.88 -10.89 23.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.76 -1.213 . . . . 0.0 109.676 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.556 ' N ' HD22 ' A' ' 22' ' ' LEU . 76.2 t -60.32 -40.25 83.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 108.641 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -137.16 5.18 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 57.23 88.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -143.68 137.35 28.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.46 -1.024 . . . . 0.0 108.772 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.23 128.61 33.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.22 74.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.346 -0.846 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -70.32 108.34 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.334 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.74 24.55 0.66 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p -143.64 148.43 35.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 75' ' ' LEU . 36.0 m -128.72 110.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.5 m-85 42.58 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.635 -0.665 . . . . 0.0 109.539 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 32' ' ' VAL . 49.0 tp -91.22 133.36 35.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.448 -0.783 . . . . 0.0 109.828 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.88 19.37 13.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.429 -1.869 . . . . 0.0 108.429 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -143.36 -65.05 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.063 . . . . 0.0 109.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 173.12 66.65 0.05 OUTLIER Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -74.33 154.15 39.01 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.286 -1.126 . . . . 0.0 109.633 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -156.36 150.13 24.91 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.89 170.68 15.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.764 -1.21 . . . . 0.0 109.831 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -165.62 109.06 0.82 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -89.95 126.27 35.67 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.546 -1.347 . . . . 0.0 110.364 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -109.2 0.73 19.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.594 -0.691 . . . . 0.0 110.724 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.06 -117.35 0.96 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -86.41 -8.6 57.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.312 . . . . 0.0 109.657 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.7 m -120.11 128.26 53.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.332 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -93.2 140.63 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.942 0.877 . . . . 0.0 111.315 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 t -109.37 120.13 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.614 HD12 HD12 ' A' ' 63' ' ' ILE . 56.2 mt -121.48 169.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.389 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 49' ' ' ILE . 54.8 m -142.33 99.53 5.87 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 50' ' ' SER . 9.3 Cg_exo -32.25 -79.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.307 2.004 . . . . 0.0 112.156 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -103.0 -41.57 6.08 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -155.55 -165.49 2.0 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -171.95 104.8 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.586 -0.696 . . . . 0.0 109.67 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 58' ' ' PHE . 19.2 p -129.65 148.48 51.54 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -33.15 -25.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.139 -0.35 . . . . 0.0 111.655 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 2.4 mt -81.47 2.09 30.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.634 -1.291 . . . . 0.0 109.187 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 55' ' ' THR . 55.0 m-85 -139.73 -160.7 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 156.07 41.95 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.747 -1.221 . . . . 0.0 110.882 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.25 177.29 9.06 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 109.309 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -126.78 131.37 51.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -88.24 170.09 11.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.587 -1.32 . . . . 0.0 110.277 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.614 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -164.95 122.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.7 m -59.5 153.18 20.08 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.381 -1.449 . . . . 0.0 108.324 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -52.8 -48.63 66.75 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.811 -1.181 . . . . 0.0 109.058 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.94 84.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.347 -1.47 . . . . 0.0 108.775 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -59.78 -27.32 66.46 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.72 -1.192 . . . . 0.0 107.847 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.721 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.1 tm? -59.92 -31.32 69.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.445 -1.409 . . . . 0.0 107.641 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.34 -38.43 83.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.808 -1.183 . . . . 0.0 108.71 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.13 -38.88 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.016 -1.053 . . . . 0.0 109.236 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.62 -40.5 86.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.391 -0.818 . . . . 0.0 110.629 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.06 35.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 111.437 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.45 -37.74 81.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.085 -1.634 . . . . 0.0 111.069 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -62.96 -64.72 0.83 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.113 -0.992 . . . . 0.0 111.685 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 32' ' ' VAL . 5.9 mp -67.83 -47.1 69.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.101 -0.999 . . . . 0.0 110.821 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.695 HD22 ' N ' ' A' ' 76' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.597 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 121.646 0.736 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.02 -41.59 92.51 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 5' ' ' SER . 6.5 t -79.66 -44.23 21.3 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.897 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 4' ' ' THR . 17.6 t -60.31 -53.68 54.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.034 . . . . 0.0 111.307 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.08 -43.16 71.71 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.098 -1.001 . . . . 0.0 112.545 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.99 -43.42 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.698 -1.251 . . . . 0.0 111.67 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.85 -52.24 63.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.773 -1.204 . . . . 0.0 109.201 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.18 -39.99 73.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 110.359 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.04 -47.36 85.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.685 -1.259 . . . . 0.0 109.694 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 . . . . . 0 N--CA 1.496 1.833 0 O-C-N 120.918 -1.113 . . . . 0.0 109.212 -179.861 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 67.3 mttt . . . . . 0 N--CA 1.5 2.032 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 66.9 Cg_endo -98.16 140.27 0.47 Allowed 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 122.272 1.981 . . . . 0.0 113.296 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 4.6 ttt -121.32 138.4 54.27 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.9 mt -107.29 131.78 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.446 -0.784 . . . . 0.0 109.51 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.9 t -93.54 100.32 12.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -66.22 -10.05 38.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.43 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.545 ' N ' HD12 ' A' ' 22' ' ' LEU . 73.4 t -59.76 -40.69 83.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -132.22 -2.79 3.52 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 64.65 85.61 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -143.07 136.29 28.19 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.233 -1.157 . . . . 0.0 110.08 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 58.3 mp0 -82.6 124.63 30.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.1 mt -123.0 73.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.337 -0.852 . . . . 0.0 110.151 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.73 116.78 3.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.204 -0.935 . . . . 0.0 110.261 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.93 26.25 1.74 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.515 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.8 p -135.91 140.25 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.774 -0.839 . . . . 0.0 109.387 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.642 HG22 HD21 ' A' ' 75' ' ' LEU . 27.0 m -122.98 98.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 12.8 p90 40.1 26.57 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -96.22 135.24 38.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.661 -0.65 . . . . 0.0 110.692 -178.251 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.595 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 115.44 36.26 1.21 Allowed Glycine 0 N--CA 1.501 2.998 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.37 -85.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.185 . . . . 0.0 110.265 -178.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -147.37 26.28 1.54 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -44.54 148.13 0.52 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.378 -1.072 . . . . 0.0 110.471 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.0 m -148.24 146.95 28.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.07 165.35 27.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.239 -1.538 . . . . 0.0 109.543 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -154.16 130.88 10.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -101.69 125.56 48.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.227 -1.546 . . . . 0.0 110.057 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -99.39 -0.87 40.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 0.0 108.967 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.41 16.39 66.64 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.326 -0.94 . . . . 0.0 110.914 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -161.7 -57.08 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.3 m -122.32 131.73 54.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -92.68 132.91 35.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.292 -0.88 . . . . 0.0 111.137 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.95 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 50' ' ' SER . 63.4 mt -128.19 155.41 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.432 -0.792 . . . . 0.0 109.794 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.8 m -124.97 120.57 25.46 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 22.4 Cg_exo -33.5 -85.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.096 1.864 . . . . 0.0 111.157 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -105.07 -36.97 7.11 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 73.7 mt-10 -164.52 -163.28 0.72 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -169.14 114.78 0.58 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 7.4 p -127.67 41.98 3.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.083 -1.01 . . . . 0.0 109.492 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 70.65 -29.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.536 ' H ' ' C ' ' A' ' 55' ' ' THR . 7.2 mt -82.59 -4.87 58.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.3 -0.875 . . . . 0.0 108.726 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.73 -151.23 0.47 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -150.85 161.89 41.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.799 -1.188 . . . . 0.0 111.329 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.89 173.13 11.48 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' NZ ' ' CE2' ' A' ' 33' ' ' TYR . 36.5 ttpt -134.02 157.9 44.92 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.48 171.18 8.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -165.87 126.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.5 p -57.97 150.11 21.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.225 -1.547 . . . . 0.0 107.033 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.38 -44.9 68.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.746 -1.221 . . . . 0.0 109.131 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.4 -42.52 96.13 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.656 -1.277 . . . . 0.0 109.677 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 70' ' ' ILE . 12.9 m-70 -54.77 -27.01 38.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.548 -1.345 . . . . 0.0 107.798 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -59.4 -30.16 68.25 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 107.799 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.57 -33.17 75.07 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.982 -1.074 . . . . 0.0 109.057 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 67' ' ' HIS . 3.8 tt -59.92 -32.08 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.675 -1.266 . . . . 0.0 108.886 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.7 -41.16 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.93 75.93 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.948 -1.095 . . . . 0.0 110.846 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -59.85 -50.2 74.74 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.046 -1.034 . . . . 0.0 109.445 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -68.25 -71.33 0.22 Allowed 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 111.309 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.687 ' N ' HD12 ' A' ' 75' ' ' LEU . 6.6 mp -61.18 -47.92 83.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.506 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 76' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.505 2.308 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.293 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 tp -60.15 -41.86 93.67 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.2 m -69.05 -51.44 38.91 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.667 -0.646 . . . . 0.0 110.657 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.0 m -69.59 -48.31 60.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.267 -1.52 . . . . 0.0 112.72 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.97 -44.5 72.8 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.595 -1.315 . . . . 0.0 113.115 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.24 -46.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.694 -1.254 . . . . 0.0 111.57 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.537 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -61.0 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 121.146 -0.971 . . . . 0.0 109.1 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.62 -39.49 80.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.77 -40.51 69.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.043 -1.036 . . . . 0.0 109.399 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.597 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 5.6 tttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 86.3 Cg_endo -101.74 118.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 123.436 2.757 . . . . 0.0 112.068 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.6 ttt -121.65 130.44 53.47 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.205 -0.934 . . . . 0.0 109.741 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.4 mt -108.37 130.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.3 t -94.38 99.7 11.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 108.931 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -59.72 -12.57 7.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.6 -41.33 84.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -117.33 -16.11 10.32 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.67 8.72 87.56 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -78.98 158.03 28.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -1.033 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -94.91 128.72 41.9 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.95 78.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.539 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.5 101.46 3.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.861 -1.15 . . . . 0.0 108.977 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.4 24.47 0.3 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -141.61 147.09 37.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -1.022 . . . . 0.0 108.41 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.755 HG22 HD21 ' A' ' 75' ' ' LEU . 33.0 m -129.38 108.75 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 44.37 23.31 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.379 -0.826 . . . . 0.0 109.305 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' VAL . 29.2 tp -90.39 145.05 25.25 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.472 0.653 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.48 17.22 59.02 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -134.35 -48.06 0.77 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.508 -0.995 . . . . 0.0 110.127 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.81 37.39 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -51.36 139.73 18.74 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.133 -1.216 . . . . 0.0 109.92 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -146.52 137.69 24.32 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.58 166.82 13.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.116 -1.615 . . . . 0.0 108.982 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -141.34 154.51 45.72 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -103.11 134.84 45.87 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.73 -1.231 . . . . 0.0 109.514 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -104.77 -5.52 21.17 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.448 -0.782 . . . . 0.0 110.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.4 56.9 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -169.17 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -1.113 . . . . 0.0 109.409 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.9 m -143.62 119.0 10.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 mm -76.91 138.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.848 -1.157 . . . . 0.0 110.878 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.19 117.12 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 63' ' ' ILE . 53.7 mt -127.73 139.53 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.357 -0.84 . . . . 0.0 111.735 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.414 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 75.1 m -120.08 121.96 29.23 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' SER . 49.6 Cg_exo -36.21 -78.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 121.886 1.724 . . . . 0.0 111.845 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.15 -40.9 5.71 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.194 -0.941 . . . . 0.0 110.073 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.59 -162.83 0.41 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.144 -0.973 . . . . 0.0 111.296 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' OE2' ' OG ' ' A' ' 50' ' ' SER . 80.7 mt-10 -152.09 104.63 2.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.896 -0.503 . . . . 0.0 111.198 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -107.67 114.34 28.25 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.626 -1.296 . . . . 0.0 109.222 178.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.66 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.884 0.85 . . . . 0.0 110.05 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -64.62 43.39 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 111.025 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' A' ' 56' ' ' ALA . 55.4 p90 -93.41 -178.17 4.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.38 1.086 . . . . 0.0 111.698 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -137.51 119.75 15.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.895 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.27 177.26 8.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.098 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -131.2 127.27 37.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -101.09 108.04 19.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.935 -1.103 . . . . 0.0 110.966 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -104.03 140.68 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -69.89 157.98 36.4 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.383 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.36 83.8 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.049 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.81 85.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.44 -1.413 . . . . 0.0 110.516 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -59.5 -24.12 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.5 tm? -59.85 -39.14 84.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -55.75 -32.55 63.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.0 -41.26 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.692 -1.255 . . . . 0.0 108.392 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.6 mp -64.28 -40.31 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.79 93.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 111.236 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -37.72 58.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.453 -1.405 . . . . 0.0 111.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.86 -49.68 60.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.161 -0.962 . . . . 0.0 112.0 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.755 HD21 HG22 ' A' ' 32' ' ' VAL . 9.0 mp -80.33 -55.62 4.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.639 -1.288 . . . . 0.0 110.929 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--N 1.298 -1.67 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.777 -179.325 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.07 -47.74 84.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 m -61.02 -50.04 74.96 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.054 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m -75.0 -54.21 7.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.865 -1.147 . . . . 0.0 112.907 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.464 ' HB3' HD22 ' A' ' 22' ' ' LEU . 61.7 mm-40 -64.77 -41.21 96.03 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.624 -1.298 . . . . 0.0 112.928 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.562 ' CG1' ' CH2' ' A' ' 38' ' ' TRP . 94.0 t -69.91 -47.79 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.341 -1.474 . . . . 0.0 111.373 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -61.71 -42.91 96.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.283 -0.886 . . . . 0.0 110.626 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -65.78 -41.4 92.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.653 -1.279 . . . . 0.0 109.782 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.438 ' HB2' HD21 ' A' ' 22' ' ' LEU . . . -65.11 -22.43 66.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.055 -1.028 . . . . 0.0 109.329 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 7.5 tttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 80.5 Cg_endo -99.88 115.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 123.328 2.685 . . . . 0.0 111.714 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -111.46 141.88 44.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.378 -0.826 . . . . 0.0 109.696 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.602 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.5 mm -110.61 133.19 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 25' ' ' GLY . 20.3 m -105.92 100.48 10.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.449 -0.782 . . . . 0.0 109.067 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.652 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.84 -15.99 63.65 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.07 -46.5 94.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -124.9 2.21 8.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.627 -0.671 . . . . 0.0 109.228 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 56.47 78.99 0.1 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.33 135.4 28.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.267 -1.137 . . . . 0.0 109.283 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.45 126.81 32.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 0.0 108.637 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 30' ' ' GLY . 55.3 mt -113.02 162.6 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -147.7 36.19 0.87 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.513 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -155.42 30.03 0.63 Allowed Glycine 0 C--N 1.293 -1.818 0 N-CA-C 106.289 -2.724 . . . . 0.0 106.289 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.437 ' OG1' ' CG2' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -133.41 138.09 46.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.549 HG12 ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -131.87 102.65 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.549 ' CZ ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER 44.62 54.66 6.37 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.67 117.91 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.868 -1.145 . . . . 0.0 109.498 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' C ' ' HE1' ' A' ' 38' ' ' TRP . . . 142.21 22.18 0.23 Allowed Glycine 0 N--CA 1.501 3.016 0 O-C-N 120.995 -1.066 . . . . 0.0 110.887 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.719 ' N ' ' HE1' ' A' ' 38' ' ' TRP . 65.0 m-20 -157.81 -85.86 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.785 -1.421 . . . . 0.0 110.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -142.21 22.08 2.43 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.719 ' HE1' ' N ' ' A' ' 36' ' ' ASP . 2.3 m95 -57.6 147.59 26.7 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.586 0.707 . . . . 0.0 110.633 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 t -156.35 154.1 30.04 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.53 166.68 24.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.597 -1.315 . . . . 0.0 109.049 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -144.91 155.04 43.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -100.64 133.05 45.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.706 -1.246 . . . . 0.0 108.694 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.08 -11.86 15.54 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.418 -0.802 . . . . 0.0 109.98 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 95.89 107.35 2.27 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 80.3 -4.24 1.87 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.787 -0.831 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.2 m -166.16 120.59 1.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 mm -95.69 137.87 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.8 t -109.38 123.29 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.418 ' C ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.156 -0.965 . . . . 0.0 110.801 -179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.679 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -106.12 120.8 47.65 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 177.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.679 ' O ' ' O ' ' A' ' 50' ' ' SER . 31.1 Cg_exo -36.9 -112.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.144 1.896 . . . . 0.0 111.184 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -76.89 -31.61 56.86 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -171.79 -161.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.008 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -156.4 110.33 2.73 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.763 -0.585 . . . . 0.0 109.513 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.532 ' O ' ' C ' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -111.1 116.3 30.89 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.816 -1.177 . . . . 0.0 109.38 179.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.532 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 26.2 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.966 0.888 . . . . 0.0 110.497 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.2 43.61 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.871 -0.518 . . . . 0.0 111.247 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 56' ' ' ALA . 47.2 p90 -92.34 178.7 5.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.839 -1.163 . . . . 0.0 111.467 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 102.92 6.81 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 173.39 3.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 109.795 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -144.21 131.31 20.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -111.49 117.23 32.44 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.201 -0.937 . . . . 0.0 111.081 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.25 138.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -73.16 160.0 32.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.726 -1.233 . . . . 0.0 108.601 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.78 91.69 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.809 -1.182 . . . . 0.0 110.0 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.88 92.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.8 -1.188 . . . . 0.0 109.361 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -60.33 -25.21 65.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 68' ' ' LEU . 1.1 tt -57.35 -40.23 77.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -58.16 -28.63 64.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 109.227 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.06 -39.86 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.703 -1.248 . . . . 0.0 108.556 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.93 -39.94 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 108.997 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.53 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.986 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -60.0 -46.57 89.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.724 -1.235 . . . . 0.0 109.227 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.463 HD22 HG22 ' A' ' 32' ' ' VAL . 64.2 t30 -68.38 -74.22 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.866 -0.521 . . . . 0.0 111.166 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' A' ' 75' ' ' LEU . 2.8 mp -61.21 -46.59 89.8 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.705 -1.247 . . . . 0.0 111.226 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 76' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.014 -1.054 . . . . 0.0 109.127 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.624 ' N ' ' HG ' ' A' ' 5' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.503 2.208 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.17 -50.15 74.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.0 m -61.42 -49.55 76.4 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.624 ' HG ' ' N ' ' A' ' 2' ' ' THR . 87.8 p -70.39 -48.04 58.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.911 -1.118 . . . . 0.0 112.384 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -69.6 -42.25 74.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 112.617 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 52' ' ' ALA . 95.4 t -66.76 -45.77 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.558 -1.338 . . . . 0.0 110.576 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mp -60.42 -45.31 96.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -60.64 -40.49 92.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.641 -1.287 . . . . 0.0 111.441 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -27.93 67.77 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.569 -1.332 . . . . 0.0 109.425 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.633 ' ND2' ' CZ ' ' A' ' 33' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.026 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 90.3 Cg_endo -88.8 110.21 0.54 Allowed 'Trans proline' 0 N--CA 1.485 1.02 0 CA-C-N 121.251 1.483 . . . . 0.0 112.203 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.563 ' SD ' HG21 ' A' ' 31' ' ' THR . 8.9 ttt -102.74 147.29 27.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.718 -0.614 . . . . 0.0 109.708 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.88 120.99 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.616 -0.678 . . . . 0.0 109.546 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 p -98.24 96.23 7.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.63 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.46 -17.84 64.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.2 t -59.68 -42.87 89.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -128.76 2.82 5.43 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.24 79.66 0.08 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.9 138.53 28.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.29 -1.123 . . . . 0.0 109.759 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 4.1 tm-20 -81.31 120.93 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.95 67.99 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 109.71 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 46.0 pttt -60.24 102.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.442 1.115 . . . . 0.0 110.308 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.662 ' C ' HD21 ' A' ' 74' ' ' ASN . . . 136.45 25.49 0.46 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.563 HG21 ' SD ' ' A' ' 19' ' ' MET . 98.7 m -138.48 140.96 39.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.507 -0.996 . . . . 0.0 108.5 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -118.55 80.5 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CZ ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER 42.37 25.6 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' VAL . 54.9 tp -85.12 129.87 34.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.872 . . . . 0.0 109.79 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 36' ' ' ASP . . . 124.83 -75.24 0.4 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' GLY . 78.4 m-20 -31.59 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.866 -0.785 . . . . 0.0 111.498 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . -134.87 16.44 4.24 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.47 ' C ' ' O ' ' A' ' 37' ' ' GLY . 3.7 t90 -26.34 138.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.969 0.414 . . . . 0.0 111.793 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -159.46 144.51 15.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.852 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.05 168.59 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.525 -1.359 . . . . 0.0 109.195 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -153.73 159.54 42.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -104.97 120.97 42.77 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.026 -1.046 . . . . 0.0 110.409 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -100.9 -2.81 31.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.12 -0.988 . . . . 0.0 110.71 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.5 -114.56 1.24 Allowed Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.44 -9.8 59.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -1.027 . . . . 0.0 110.546 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.9 m -129.15 140.12 51.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.45 HG13 HD12 ' A' ' 68' ' ' LEU . 36.3 mm -108.09 139.85 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 110.104 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.2 120.28 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.557 -0.715 . . . . 0.0 109.278 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.66 141.29 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.817 -1.177 . . . . 0.0 110.802 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 51' ' ' PRO . 95.0 p -111.77 127.09 27.37 Favored Pre-proline 0 N--CA 1.482 1.129 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD3' ' HZ2' ' A' ' 61' ' ' LYS . 52.6 Cg_exo -34.83 -81.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.961 1.774 . . . . 0.0 112.619 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -106.03 -41.64 5.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 79.3 mt-10 -158.62 -165.42 1.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.066 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -172.25 113.27 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.673 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 19.0 p -126.94 38.46 4.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.293 -0.879 . . . . 0.0 110.415 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 73.85 -24.92 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.93 -1.106 . . . . 0.0 109.57 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 55' ' ' THR . 6.4 mt -87.8 -3.29 58.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -132.47 -156.47 0.75 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -150.74 158.57 44.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.449 -1.407 . . . . 0.0 111.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.23 174.46 8.74 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HZ2' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -134.19 128.25 33.63 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -81.55 167.05 19.7 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.98 -1.075 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 63' ' ' ILE . 19.2 tt -169.69 118.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.1 p -58.54 151.19 20.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 110.913 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -53.81 -41.44 67.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.98 94.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.5 -1.375 . . . . 0.0 109.267 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.452 ' O ' HG22 ' A' ' 70' ' ' ILE . 18.6 m80 -61.52 -25.1 67.06 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD12 HG13 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -57.04 -28.45 62.55 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.34 -34.64 74.91 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.875 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 67' ' ' HIS . 4.6 tt -59.56 -36.51 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.479 -1.289 . . . . 0.0 108.427 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.516 ' O ' HD22 ' A' ' 75' ' ' LEU . 67.1 mt -60.32 -45.19 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.87 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.82 67.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.055 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -62.26 -39.33 92.53 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.478 -1.389 . . . . 0.0 108.663 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.662 HD21 ' C ' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -69.59 -68.14 0.43 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.697 -0.627 . . . . 0.0 110.761 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.647 ' H ' HD22 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -60.1 -51.2 70.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 0.0 111.221 -176.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 76' ' ' LEU . 6.3 mt . . . . . 0 C--N 1.3 -1.58 0 O-C-N 120.799 -1.188 . . . . 0.0 109.219 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.5 tp -59.92 -48.88 79.9 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.9 m -64.01 -51.82 62.45 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.329 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 t -70.95 -52.39 20.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.801 -1.187 . . . . 0.0 111.489 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' THR . 36.4 tp10 -61.01 -46.09 92.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.972 -1.08 . . . . 0.0 112.665 -177.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 52' ' ' ALA . 64.3 t -67.91 -49.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 112.078 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.586 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.01 -45.63 95.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 110.693 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.99 -40.11 88.03 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.981 -1.074 . . . . 0.0 110.931 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -19.93 65.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.83 -1.169 . . . . 0.0 111.769 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.549 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.507 2.404 0 O-C-N 120.996 -1.065 . . . . 0.0 111.263 -178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 72.0 Cg_endo -90.57 128.6 1.42 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.31 2.007 . . . . 0.0 111.675 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -123.02 128.7 50.53 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.463 ' N ' ' SD ' ' A' ' 19' ' ' MET . 87.1 mt -110.49 130.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.067 -1.021 . . . . 0.0 109.465 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' GLY . 67.6 m -88.72 99.78 12.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.015 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -61.95 -13.05 21.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.35 -0.844 . . . . 0.0 109.151 -179.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.575 ' N ' HD22 ' A' ' 22' ' ' LEU . 70.0 t -60.11 -47.64 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 108.604 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 52.7 t0 -123.42 7.56 9.0 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.93 84.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -142.39 135.5 28.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.476 -1.014 . . . . 0.0 109.936 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -77.13 121.08 23.09 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.8 mt -119.99 69.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -61.64 106.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.989 -1.069 . . . . 0.0 108.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.08 18.75 0.93 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.663 ' N ' HD21 ' A' ' 74' ' ' ASN . 0.5 OUTLIER -141.66 146.8 36.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -1.046 . . . . 0.0 108.437 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG2' HD21 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -131.23 111.46 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 44.63 21.63 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 0.0 109.224 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' VAL . 34.5 tp -85.82 149.34 25.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.83 79.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.47 -63.37 1.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.618 -0.93 . . . . 0.0 109.355 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.69 39.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -59.74 155.38 16.06 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.499 -1.0 . . . . 0.0 110.507 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -146.43 149.68 34.18 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.93 169.39 17.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.238 -1.539 . . . . 0.0 109.782 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -159.95 136.2 8.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -109.03 122.85 48.13 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.657 -1.277 . . . . 0.0 111.469 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 10.7 t70 -96.69 -6.84 35.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.658 -0.651 . . . . 0.0 110.687 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.61 15.66 42.49 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.743 -1.223 . . . . 0.0 110.813 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -171.12 -55.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.305 . . . . 0.0 108.647 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.3 m -120.12 129.99 54.42 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -91.34 140.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.8 . . . . 0.0 111.959 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 t -103.61 111.58 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -129.67 140.17 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.5 m -112.66 121.58 38.36 Favored Pre-proline 0 N--CA 1.483 1.222 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 50' ' ' SER . 30.8 Cg_exo -35.27 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 122.263 1.975 . . . . 0.0 112.154 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.586 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -107.98 -41.52 4.93 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -166.43 -163.41 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.609 0.719 . . . . 0.0 109.943 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 56' ' ' ALA . 3.9 tm-20 -172.05 116.27 0.36 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.667 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 6.6 p -122.15 38.1 4.22 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.155 -0.966 . . . . 0.0 110.338 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 73.66 -18.68 0.37 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.95 . . . . 0.0 109.383 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 55' ' ' THR . 14.0 mt -93.51 0.09 56.56 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -130.13 -153.34 0.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -145.34 159.62 42.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.998 -1.064 . . . . 0.0 110.818 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.47 174.65 11.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -136.46 106.95 6.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -73.29 175.86 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -166.7 122.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.5 ' HG ' ' HD1' ' A' ' 67' ' ' HIS . 76.9 p -54.67 148.42 12.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.568 -1.332 . . . . 0.0 108.229 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -52.01 -44.92 64.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.99 -1.069 . . . . 0.0 109.158 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.11 79.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 119.992 -1.693 . . . . 0.0 109.967 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.5 ' HD1' ' HG ' ' A' ' 64' ' ' SER . 31.6 m80 -61.67 -23.57 66.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.558 -1.339 . . . . 0.0 108.668 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.95 -33.47 71.97 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -62.59 -37.18 85.23 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.03 -38.86 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.099 -1.001 . . . . 0.0 109.724 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.497 ' O ' HD22 ' A' ' 75' ' ' LEU . 57.9 mt -59.92 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.824 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.76 76.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.728 -1.232 . . . . 0.0 110.478 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -61.62 -41.91 98.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.448 -1.408 . . . . 0.0 109.597 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.663 HD21 ' N ' ' A' ' 31' ' ' THR . 57.1 t30 -60.71 -61.62 2.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.715 -0.616 . . . . 0.0 111.194 -177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.2 mm? -60.25 -40.04 88.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.629 -1.295 . . . . 0.0 110.361 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--N 1.297 -1.682 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.789 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.416 0.627 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.521 HD21 ' O ' ' A' ' 36' ' ' ASP . 10.6 tp -63.51 -54.71 31.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.441 HG21 ' CD2' ' A' ' 58' ' ' PHE . 33.3 m -62.49 -50.31 71.93 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -70.31 -43.67 69.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.123 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -70.05 -41.75 73.77 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.698 -1.252 . . . . 0.0 112.131 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.09 -50.3 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.531 -1.356 . . . . 0.0 111.087 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.571 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.05 -48.08 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.019 -1.051 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.01 -39.04 84.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.32 -22.18 63.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.2 t30 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.732 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -103.62 130.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.568 2.845 . . . . 0.0 110.678 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 ttt -132.06 126.23 33.33 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.878 -1.139 . . . . 0.0 110.012 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.79 129.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.717 0.77 . . . . 0.0 109.925 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 25' ' ' GLY . 13.6 p -87.82 100.7 13.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.049 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.39 -13.82 6.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.408 ' H ' HD22 ' A' ' 22' ' ' LEU . 65.9 t -59.99 -44.98 95.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -125.64 0.26 7.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 66.61 13.33 60.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -75.89 137.18 40.23 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.22 138.34 31.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.475 -0.766 . . . . 0.0 110.274 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 30' ' ' GLY . 63.8 mt -122.45 158.1 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -140.83 36.6 1.79 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.083 -1.636 . . . . 0.0 107.576 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -156.63 28.46 0.54 Allowed Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.0 p -135.51 142.26 45.41 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.054 0.93 . . . . 0.0 110.146 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 32' ' ' VAL . 16.4 m -121.0 88.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 35.4 p90 40.08 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.538 0.685 . . . . 0.0 109.238 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 32' ' ' VAL . 47.1 tp -73.26 135.15 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.675 -0.64 . . . . 0.0 109.572 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . 73.1 147.28 0.85 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' HD21 ' A' ' 3' ' ' LEU . 6.5 m-20 95.92 19.95 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 123.295 0.638 . . . . 0.0 110.129 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 123.71 -11.38 8.38 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 37' ' ' GLY . 5.8 p-90 -32.26 126.14 0.28 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.39 0.614 . . . . 0.0 111.013 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 t -152.93 140.23 19.53 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.52 175.02 11.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.157 -1.589 . . . . 0.0 109.868 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -161.19 159.9 29.41 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -110.41 121.47 45.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.995 -1.066 . . . . 0.0 109.708 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.414 ' C ' ' OD1' ' A' ' 43' ' ' ASP . 4.4 p30 -100.66 -1.02 36.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.56 -120.04 1.36 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.736 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -81.41 -7.75 59.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -1.112 . . . . 0.0 110.317 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.7 m -123.47 130.82 53.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.82 141.93 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.14 119.63 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mt -131.66 146.96 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.287 -0.883 . . . . 0.0 110.917 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 15.8 m -118.12 111.49 38.68 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 102.467 -3.161 . . . . 0.0 102.467 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.1 Cg_exo -33.34 -75.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.023 1.815 . . . . 0.0 111.386 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.571 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -106.15 -47.07 3.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.71 -165.99 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.497 ' OE2' ' N ' ' A' ' 60' ' ' ALA . 62.2 tt0 -175.11 114.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -118.19 36.47 4.34 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.069 -1.019 . . . . 0.0 109.879 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 72.59 -21.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 0.0 109.042 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 55' ' ' THR . 40.9 mt -91.03 0.02 57.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CD2' HG21 ' A' ' 4' ' ' THR . 92.6 m-85 -128.51 -135.95 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -155.28 155.1 33.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.708 -1.245 . . . . 0.0 111.789 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.497 ' N ' ' OE2' ' A' ' 54' ' ' GLU . . . -86.37 177.44 7.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -139.51 150.77 45.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -115.77 173.16 6.7 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.228 -0.92 . . . . 0.0 108.995 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -168.41 111.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -48.42 155.1 0.55 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.08 -1.013 . . . . 0.0 109.068 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -56.82 -48.15 78.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.052 -1.03 . . . . 0.0 108.603 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.98 87.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.16 -1.588 . . . . 0.0 108.767 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -59.24 -28.11 66.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.866 -1.146 . . . . 0.0 108.32 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.692 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.2 tm? -59.83 -30.06 68.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -60.39 -37.14 79.85 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.09 -38.74 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.394 -0.816 . . . . 0.0 109.391 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.4 mp -58.35 -39.9 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 108.281 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.445 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -66.1 -40.03 90.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 111.096 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.13 -48.07 72.05 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.625 -1.297 . . . . 0.0 111.174 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -59.98 -52.67 64.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 112.029 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.587 HD11 HG13 ' A' ' 32' ' ' VAL . 4.4 mp -69.91 -42.1 73.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.302 -1.498 . . . . 0.0 110.459 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' OXT' ' O ' ' A' ' 72' ' ' ALA . 2.3 pp . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.7 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.16 -45.74 92.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.015 0.912 . . . . 0.0 108.78 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.4 m -61.2 -54.41 44.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 110.847 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.3 t -70.19 -48.34 57.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.834 -1.166 . . . . 0.0 112.067 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.15 -46.63 86.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.804 -1.185 . . . . 0.0 112.98 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.3 -48.12 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 112.155 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.4 mp -61.32 -47.78 91.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.667 -1.271 . . . . 0.0 109.934 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.3 -40.12 89.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.889 -1.132 . . . . 0.0 110.755 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.92 86.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.827 -1.171 . . . . 0.0 109.039 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 20' ' ' ILE . 35.2 m120 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 110.081 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -95.12 126.2 0.39 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.313 2.009 . . . . 0.0 110.595 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.66 136.86 54.27 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 110.942 -178.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.509 ' H ' ' CG ' ' A' ' 11' ' ' ASN . 27.7 mm -100.09 128.1 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.8 t -102.52 103.92 14.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.419 -0.8 . . . . 0.0 108.88 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.63 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -69.4 -7.28 36.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -47.55 91.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -128.73 11.59 6.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.99 83.27 0.04 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -150.36 139.72 21.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -1.014 . . . . 0.0 109.519 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -84.83 139.09 32.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 109.08 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 30' ' ' GLY . 71.0 mt -122.78 158.56 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -144.61 42.46 1.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -168.3 32.41 0.19 Allowed Glycine 0 C--N 1.294 -1.801 0 N-CA-C 106.313 -2.715 . . . . 0.0 106.313 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.463 ' OG1' HG21 ' A' ' 28' ' ' ILE . 12.7 m -136.79 142.64 42.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.784 0.802 . . . . 0.0 109.879 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.537 HG22 HD21 ' A' ' 75' ' ' LEU . 16.7 m -128.55 73.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 53.84 23.27 3.72 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.651 HD13 ' N ' ' A' ' 35' ' ' GLY . 1.7 tm? -73.75 123.71 24.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.651 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 78.64 158.49 12.22 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 10.2 m-20 93.94 7.09 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 C-N-CA 123.105 0.562 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 130.53 -3.77 5.81 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.473 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 10.1 p-90 -29.92 138.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.423 0.63 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.8 m -151.01 139.88 20.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.99 167.53 21.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.566 -1.334 . . . . 0.0 109.867 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -161.41 125.82 3.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -102.93 130.11 49.88 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.748 -1.22 . . . . 0.0 110.885 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -107.52 -11.31 15.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.645 -0.659 . . . . 0.0 109.716 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.03 2.32 89.5 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.97 -31.24 0.5 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -1.127 . . . . 0.0 109.433 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.4 m -157.22 118.66 3.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.18 122.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.346 -0.846 . . . . 0.0 111.535 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 t -95.61 99.16 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 142.32 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.407 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.1 p -117.11 149.57 44.55 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.56 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.408 1.405 . . . . 0.0 112.077 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -90.61 -45.85 8.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.884 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -167.44 1.17 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.273 -1.517 . . . . 0.0 111.486 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 28.2 mp0 -150.44 98.48 2.66 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 57' ' ' LEU . 4.1 p -129.99 144.29 51.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -25.13 -29.21 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.8 mp -83.61 -10.2 58.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.62 -1.3 . . . . 0.0 110.242 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 55' ' ' THR . 23.1 t80 -138.46 -164.55 1.65 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.282 -0.886 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -154.9 170.79 20.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.998 -1.064 . . . . 0.0 110.904 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.68 175.34 8.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.501 0.667 . . . . 0.0 110.404 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -128.77 141.77 51.21 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -86.71 169.29 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.046 -1.034 . . . . 0.0 110.592 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -162.91 127.87 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.8 m -61.19 154.9 22.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.277 -1.514 . . . . 0.0 108.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.75 68.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.654 -1.278 . . . . 0.0 109.401 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.93 87.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.695 -1.253 . . . . 0.0 109.153 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -55.04 -27.26 43.19 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.889 -1.132 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -59.91 -33.67 72.19 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -59.95 -35.4 74.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.0 mt -59.64 -39.75 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.91 . . . . 0.0 108.929 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.425 HG23 HG21 ' A' ' 32' ' ' VAL . 48.1 mt -58.88 -39.94 78.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.216 -0.927 . . . . 0.0 108.997 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.82 -41.56 99.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 111.106 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . 6.4 mtmp? -65.94 -50.04 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.047 -1.033 . . . . 0.0 111.011 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.87 -43.63 94.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.462 -0.773 . . . . 0.0 111.987 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 75' ' ' LEU . 5.7 mp -80.92 -22.51 39.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.43 -1.419 . . . . 0.0 110.326 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.11 -0.994 . . . . 0.0 109.96 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.222 0.534 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.99 -45.15 95.95 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.496 HG22 ' CE2' ' A' ' 58' ' ' PHE . 22.5 m -62.26 -54.88 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.855 -0.528 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -71.95 -48.65 43.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.574 -1.329 . . . . 0.0 112.0 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.81 -42.58 90.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.02 -1.05 . . . . 0.0 112.791 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 52' ' ' ALA . 96.7 t -69.81 -48.36 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.323 -1.486 . . . . 0.0 111.225 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.583 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.24 -47.91 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -63.71 -40.23 96.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.032 -1.042 . . . . 0.0 110.091 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.519 ' CB ' HD12 ' A' ' 22' ' ' LEU . . . -56.81 -38.22 72.28 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.093 -1.005 . . . . 0.0 108.384 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -95.95 129.7 0.4 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.001 1.8 . . . . 0.0 111.349 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 124.82 46.75 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -109.41 128.09 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.79 . . . . 0.0 109.037 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 23' ' ' VAL . 8.8 t -91.67 99.27 12.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.09 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -59.13 -8.59 1.59 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.59 ' N ' HD22 ' A' ' 22' ' ' LEU . 54.4 t -60.83 -41.12 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -123.28 -14.35 7.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.56 15.58 79.41 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -83.16 150.3 26.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -1.106 . . . . 0.0 111.776 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -91.66 130.99 37.37 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.73 74.39 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.53 -0.731 . . . . 0.0 109.864 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -68.5 108.48 3.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.853 -1.154 . . . . 0.0 108.925 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.91 21.77 0.87 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.3 p -143.62 150.92 39.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -1.068 . . . . 0.0 108.316 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 32' ' ' VAL . 32.7 m -127.1 89.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.448 -0.783 . . . . 0.0 109.178 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 57.78 19.94 6.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.112 -0.993 . . . . 0.0 109.918 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.1 tp -73.15 141.19 47.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 108.908 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.16 58.84 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.15 -138.51 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -102.22 24.32 31.5 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' GLY . 10.9 t90 -38.57 128.33 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.729 0.775 . . . . 0.0 110.891 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.5 t -151.09 137.71 18.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.11 173.12 17.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.304 -1.497 . . . . 0.0 110.208 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -151.97 153.79 34.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -101.26 120.79 40.78 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.707 -1.245 . . . . 0.0 109.131 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 49.1 t0 -100.69 -6.62 24.83 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.84 -117.33 0.97 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.029 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.9 17.94 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.961 . . . . 0.0 109.358 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.1 m -150.91 116.08 5.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.79 140.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 111.144 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.91 129.28 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.509 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -151.2 147.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.441 -1.412 . . . . 0.0 111.274 -178.036 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -112.3 121.32 39.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 177.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -36.06 -75.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.032 1.821 . . . . 0.0 111.731 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.583 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -104.83 -47.97 3.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.207 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.41 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 5.0 mt-10 -160.75 -166.48 1.62 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.361 -0.837 . . . . 0.0 109.953 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -173.14 116.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 4.9 p -89.88 -78.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.927 -1.108 . . . . 0.0 108.886 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.587 ' N ' ' OG1' ' A' ' 55' ' ' THR . . . -149.12 -76.03 0.16 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -64.86 22.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.394 -0.816 . . . . 0.0 109.871 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' H ' ' C ' ' A' ' 56' ' ' ALA . 22.7 m-85 -99.04 -175.67 3.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.783 -1.198 . . . . 0.0 108.366 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 138.94 53.89 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.964 0.888 . . . . 0.0 111.829 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.32 177.75 7.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -136.67 126.27 25.33 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.856 -1.153 . . . . 0.0 108.542 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -84.04 162.16 20.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.509 HD12 HG21 ' A' ' 49' ' ' ILE . 1.9 mt -151.08 112.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.7 p -62.81 152.18 36.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.755 -1.215 . . . . 0.0 108.358 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.59 69.17 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.773 -1.205 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.04 82.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.426 -1.422 . . . . 0.0 108.774 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -60.2 -35.34 75.18 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.841 -1.162 . . . . 0.0 109.507 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 71' ' ' ILE . 3.4 tm? -56.19 -34.45 66.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -60.53 -40.05 90.06 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mt -61.43 -32.01 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.667 HD12 HD22 ' A' ' 68' ' ' LEU . 79.7 mt -60.33 -39.72 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.047 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 76' ' ' LEU . . . -68.27 -36.23 79.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.994 -1.066 . . . . 0.0 109.732 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.07 -46.58 89.09 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.036 -1.04 . . . . 0.0 108.855 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -76.26 -74.19 0.24 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.7 -0.625 . . . . 0.0 110.835 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 75' ' ' LEU . 6.7 mp -60.22 -44.58 95.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.952 -1.093 . . . . 0.0 111.309 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 72' ' ' ALA . 21.9 mt . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.602 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.503 2.185 0 CA-C-O 121.051 0.453 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 3.8 tt -60.11 -48.34 82.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.836 -1.165 . . . . 0.0 109.253 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m -78.67 -50.52 11.3 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.494 0.664 . . . . 0.0 110.579 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -66.35 -52.86 42.69 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 112.561 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.55 -42.04 78.93 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.346 -1.471 . . . . 0.0 112.785 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 3' ' ' LEU . 95.7 t -61.15 -48.94 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.128 -0.983 . . . . 0.0 111.451 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.87 -40.34 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.411 -0.805 . . . . 0.0 109.905 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -58.68 -45.18 90.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.1 -1.0 . . . . 0.0 110.831 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 22' ' ' LEU . . . -60.12 -47.04 87.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.746 -1.221 . . . . 0.0 111.087 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 11' ' ' ASN . 5.3 p-10 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 120.672 -1.268 . . . . 0.0 110.681 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.539 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 15.8 mttt . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 111.013 0.005 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 75.5 Cg_endo -92.98 120.66 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.742 2.294 . . . . 0.0 113.513 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.0 tpt -121.5 123.41 41.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.542 -0.724 . . . . 0.0 110.544 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.2 mt -118.21 129.6 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLY . 29.9 t -91.13 99.14 12.2 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.136 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.19 -7.33 8.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.559 ' N ' HD22 ' A' ' 22' ' ' LEU . 78.2 t -61.11 -45.85 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -128.95 8.58 5.69 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.27 91.25 0.01 OUTLIER Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -143.56 137.15 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.372 -1.075 . . . . 0.0 109.042 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.491 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 57.9 mp0 -81.71 123.47 28.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.098 -1.001 . . . . 0.0 108.887 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' GLY . 50.1 mt -127.44 75.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.183 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -74.06 45.42 0.21 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.69 -1.256 . . . . 0.0 108.961 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -147.99 22.3 1.43 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -152.38 158.92 43.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 34' ' ' LEU . 14.4 m -133.44 112.6 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.321 -0.862 . . . . 0.0 108.974 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 32.5 p90 39.85 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.528 0.68 . . . . 0.0 109.369 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -81.93 129.01 34.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -178.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.65 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 127.35 -83.47 0.34 Allowed Glycine 0 N--CA 1.499 2.884 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 17.0 p-10 -32.92 -106.82 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.668 0.747 . . . . 0.0 111.895 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -123.23 30.11 5.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' GLY . 21.0 p-90 -31.71 132.68 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.872 0.844 . . . . 0.0 111.183 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -153.86 146.34 24.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 173.36 11.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.277 -1.514 . . . . 0.0 109.36 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -163.49 135.21 4.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -110.95 123.7 50.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.854 -1.154 . . . . 0.0 108.417 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 10.3 t70 -106.3 -10.05 16.55 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.362 -0.836 . . . . 0.0 111.305 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.45 -122.27 1.37 Allowed Glycine 0 N--CA 1.503 3.101 0 O-C-N 120.607 -1.308 . . . . 0.0 109.886 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.11 22.93 1.33 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -1.166 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 m -154.75 113.42 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mm -88.24 136.23 23.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.332 -0.855 . . . . 0.0 111.998 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.4 t -112.91 120.11 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.519 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -142.51 147.95 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.4 t -115.9 129.11 25.44 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.83 -76.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.597 1.531 . . . . 0.0 112.229 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.93 -49.99 4.58 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.023 -1.048 . . . . 0.0 112.318 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -165.51 -163.89 0.7 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.002 -1.686 . . . . 0.0 109.771 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -156.26 107.05 2.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.681 -0.637 . . . . 0.0 111.469 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.536 ' O ' ' C ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -110.81 118.02 35.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.621 -1.299 . . . . 0.0 108.288 178.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.27 -90.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.269 1.033 . . . . 0.0 110.287 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.28 43.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.305 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' A' ' 56' ' ' ALA . 54.9 p90 -91.88 -174.48 3.82 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.773 -1.204 . . . . 0.0 111.251 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.79 110.77 7.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.713 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.74 174.07 9.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.555 -1.34 . . . . 0.0 109.234 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -126.83 129.51 48.42 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -80.63 159.66 25.3 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.681 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.519 HD12 HG21 ' A' ' 49' ' ' ILE . 3.3 mt -153.34 114.57 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -66.87 159.84 27.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.29 -44.27 64.92 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.738 -1.185 . . . . 0.0 107.865 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.9 93.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.6 -0.688 . . . . 0.0 109.802 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -60.27 -24.79 65.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.17 -45.02 92.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.197 -1.564 . . . . 0.0 106.946 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -54.51 -29.71 51.3 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -0.965 . . . . 0.0 109.014 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.4 -39.67 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.727 -1.233 . . . . 0.0 108.507 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.92 -40.36 80.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.88 -31.49 69.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.363 -1.461 . . . . 0.0 110.528 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -69.84 -55.28 10.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.132 -1.605 . . . . 0.0 111.33 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 17' ' ' LYS . 28.0 t-20 -60.55 -44.66 95.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.229 -0.919 . . . . 0.0 111.334 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -63.78 -53.21 54.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 110.461 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 1.3 mm? . . . . . 0 C--N 1.294 -1.836 0 CA-C-O 117.892 -1.051 . . . . 0.0 108.374 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.36 -49.47 73.77 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 121.359 -0.838 . . . . 0.0 109.656 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.449 HG21 ' CE2' ' A' ' 58' ' ' PHE . 93.9 m -59.58 -48.79 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.072 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -69.01 -41.04 78.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.15 -1.594 . . . . 0.0 111.737 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -68.4 -50.32 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.042 -1.037 . . . . 0.0 112.329 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.495 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 97.6 t -69.37 -40.56 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.396 -0.815 . . . . 0.0 111.728 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 53' ' ' GLU . 7.0 mm -59.95 -47.37 91.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.843 -1.16 . . . . 0.0 109.8 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.24 -30.96 70.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.921 -1.112 . . . . 0.0 109.798 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 20' ' ' ILE . . . -66.78 -34.13 77.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.287 -0.883 . . . . 0.0 110.908 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 7' ' ' VAL . 21.7 p30 . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.084 -1.01 . . . . 0.0 111.079 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 ttmt . . . . . 0 N--CA 1.5 2.035 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 55.3 Cg_endo -98.47 136.29 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.109 2.54 . . . . 0.0 110.862 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.439 ' SD ' HG22 ' A' ' 31' ' ' THR . 11.8 ttt -122.96 136.95 55.05 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.904 -1.123 . . . . 0.0 111.32 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 10' ' ' ALA . 5.2 mm -105.26 133.15 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.4 t -109.28 102.81 11.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.746 . . . . 0.0 109.583 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.838 ' H ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.18 -19.38 65.29 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.556 -0.858 . . . . 0.0 108.829 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.01 -43.55 92.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -125.71 1.65 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.3 81.07 0.06 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -150.6 144.62 25.38 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.122 -1.223 . . . . 0.0 110.191 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -81.77 133.54 35.35 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -129.02 72.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.914 . . . . 0.0 110.853 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -65.57 115.52 5.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.678 -1.264 . . . . 0.0 109.296 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.36 21.05 2.32 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.439 HG22 ' SD ' ' A' ' 19' ' ' MET . 34.5 m -142.25 148.56 38.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.718 HG22 HD21 ' A' ' 75' ' ' LEU . 29.3 m -130.67 103.16 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.21 -0.931 . . . . 0.0 108.862 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.6 p90 33.31 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.616 -0.677 . . . . 0.0 110.93 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -93.18 129.96 39.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.606 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 96.41 40.82 3.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 77.4 m-20 -147.85 -40.12 0.18 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.745 -0.856 . . . . 0.0 108.703 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 153.63 33.26 0.03 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -49.86 145.51 5.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.911 -1.347 . . . . 0.0 111.41 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.2 p -145.64 133.24 20.92 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.53 171.04 17.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.063 -1.648 . . . . 0.0 109.821 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -165.63 132.88 2.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -93.04 120.77 33.69 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.675 -1.265 . . . . 0.0 109.479 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -99.07 -0.85 41.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 110.059 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.54 -118.93 1.49 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.67 -4.69 55.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.7 m -132.21 131.34 42.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.6 143.75 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.356 -0.84 . . . . 0.0 110.774 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.5 120.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.492 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -154.37 144.33 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.869 -1.144 . . . . 0.0 110.491 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.2 t -111.99 120.7 41.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -37.34 -78.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.019 0 C-N-CA 122.321 2.014 . . . . 0.0 113.508 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -84.05 -57.92 2.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.737 -1.227 . . . . 0.0 111.442 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' H ' HD11 ' A' ' 8' ' ' ILE . 92.7 mt-10 -158.58 -168.92 2.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.015 -1.053 . . . . 0.0 109.545 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -169.71 115.5 0.55 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.642 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 6.1 p -128.75 40.63 3.61 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.376 -0.828 . . . . 0.0 110.105 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 75.83 -24.88 0.21 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.682 -0.636 . . . . 0.0 110.386 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 57' ' ' LEU . 10.4 mp -92.53 1.02 57.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.6 -0.687 . . . . 0.0 109.556 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CE2' HG21 ' A' ' 4' ' ' THR . 98.1 m-85 -126.59 -160.98 1.03 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -134.97 149.67 50.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.084 -1.01 . . . . 0.0 111.555 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.08 175.64 8.89 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -132.76 141.95 48.78 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -101.94 107.8 19.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.2 -0.937 . . . . 0.0 109.721 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 49' ' ' ILE . 48.0 mt -100.82 104.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -51.37 164.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.849 -1.157 . . . . 0.0 108.899 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.01 82.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.071 . . . . 0.0 109.53 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.16 85.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.128 -1.608 . . . . 0.0 109.891 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -60.62 -38.18 83.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.389 -1.444 . . . . 0.0 108.679 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.637 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.4 tm? -55.96 -34.73 65.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.997 -1.064 . . . . 0.0 108.371 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -59.89 -33.82 72.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 108.817 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.47 HG22 ' ND2' ' A' ' 74' ' ' ASN . 77.2 mt -60.09 -40.57 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.58 -41.16 91.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.096 -1.003 . . . . 0.0 109.795 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.03 91.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 112.389 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -69.96 -36.95 75.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.868 -1.77 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.47 ' ND2' HG22 ' A' ' 70' ' ' ILE . 95.8 m-20 -63.53 -66.83 0.49 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 110.849 -178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.718 HD21 HG22 ' A' ' 32' ' ' VAL . 7.8 mp -66.77 -46.78 74.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.079 . . . . 0.0 111.323 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 120.881 -1.137 . . . . 0.0 109.865 -178.762 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.504 2.268 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.99 -41.59 92.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 m -77.79 -49.42 14.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.393 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.0 m -71.28 -57.11 4.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.927 -1.108 . . . . 0.0 111.647 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -60.32 -43.75 96.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.605 -1.309 . . . . 0.0 112.986 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 52' ' ' ALA . 94.5 t -67.19 -42.28 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.158 -1.589 . . . . 0.0 112.024 -177.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.56 -43.77 95.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.948 -1.095 . . . . 0.0 110.406 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -69.26 -49.31 57.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.738 -1.226 . . . . 0.0 111.204 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -18.87 65.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.871 -1.143 . . . . 0.0 109.759 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 -179.02 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.13 111.65 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.924 2.416 . . . . 0.0 113.645 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 19' ' ' MET . 0.9 OUTLIER -123.04 133.37 54.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.094 -1.004 . . . . 0.0 108.841 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -106.64 135.11 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.141 -0.974 . . . . 0.0 109.936 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -87.49 98.41 11.37 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -66.23 -13.5 60.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.12 -42.49 93.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.66 -17.4 5.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 82.94 74.44 1.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -138.59 131.86 30.13 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.209 -1.171 . . . . 0.0 109.468 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -82.06 122.57 27.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.869 -1.145 . . . . 0.0 109.824 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 30' ' ' GLY . 67.7 mt -108.66 166.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' N ' HG22 ' A' ' 28' ' ' ILE . 52.5 tttp -150.49 31.54 0.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.628 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -151.33 27.47 0.98 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 28' ' ' ILE . 6.1 p -137.82 144.27 41.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.887 -0.772 . . . . 0.0 109.461 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 32' ' ' VAL . 31.5 m -123.12 84.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER 58.9 39.15 24.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.561 -1.337 . . . . 0.0 109.489 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 36' ' ' ASP . 55.3 tp -80.38 137.32 36.52 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.12 -17.34 4.92 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 34' ' ' LEU . 83.9 m-20 -70.69 -32.23 69.39 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.345 -1.091 . . . . 0.0 108.663 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 129.13 19.73 1.53 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' GLY . 7.8 t90 -36.19 130.51 0.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.59 0.71 . . . . 0.0 110.955 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.9 t -150.56 131.99 14.69 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.37 179.97 7.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.012 -1.68 . . . . 0.0 111.079 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.93 157.75 43.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.06 -1.025 . . . . 0.0 108.297 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -96.72 113.51 25.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.528 -1.357 . . . . 0.0 108.827 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 46.1 t0 -100.62 -0.69 37.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.919 -1.113 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.99 -106.89 0.59 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.715 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -91.75 -14.04 30.59 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.491 -1.005 . . . . 0.0 110.279 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.7 m -120.7 125.36 47.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.775 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.7 135.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.551 -0.718 . . . . 0.0 110.46 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.61 106.58 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.46 140.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.567 -0.708 . . . . 0.0 111.634 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 51' ' ' PRO . 11.6 m -111.08 111.2 56.17 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.9 Cg_exo -33.49 -76.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 122.264 1.976 . . . . 0.0 112.07 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -97.87 -49.37 4.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.167 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -165.57 -163.85 0.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -167.91 117.1 0.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.146 -0.972 . . . . 0.0 109.508 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.605 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 8.6 p -88.15 -73.51 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.797 -1.189 . . . . 0.0 108.089 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.605 ' N ' ' OG1' ' A' ' 55' ' ' THR . . . -155.56 -77.28 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.45 26.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.505 -0.747 . . . . 0.0 111.092 -179.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.582 ' H ' ' C ' ' A' ' 56' ' ' ALA . 19.2 m-85 -103.71 -166.94 1.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 149.97 46.65 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.828 -1.17 . . . . 0.0 110.989 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.65 179.24 6.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -125.92 122.51 36.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -94.09 101.1 13.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.28 132.62 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.783 0.802 . . . . 0.0 109.421 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -65.9 149.44 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.83 -39.74 65.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 109.543 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.7 -41.39 90.65 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.426 -1.421 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -59.84 -34.74 73.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.435 -1.415 . . . . 0.0 108.567 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.772 HD22 HD12 ' A' ' 71' ' ' ILE . 3.2 tm? -58.33 -29.96 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -60.11 -37.19 79.25 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.56 -39.91 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.206 -0.934 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.772 HD12 HD22 ' A' ' 68' ' ' LEU . 78.7 mt -59.16 -39.72 79.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 108.679 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -66.28 -38.77 88.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 110.392 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -62.06 -40.8 97.03 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.595 -1.315 . . . . 0.0 110.42 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -73.99 -69.17 0.46 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.674 -0.641 . . . . 0.0 111.577 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.66 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.6 mp -60.03 -45.78 91.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.503 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.12 -43.84 95.33 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.486 HG22 ' CE1' ' A' ' 58' ' ' PHE . 24.8 m -60.13 -57.82 11.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.642 -0.661 . . . . 0.0 111.187 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 p -70.4 -45.79 65.25 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.788 -1.195 . . . . 0.0 111.771 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.86 -49.89 68.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.094 . . . . 0.0 112.733 -177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.8 t -69.82 -47.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 120.642 -1.286 . . . . 0.0 112.331 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.408 ' CD1' ' H ' ' A' ' 52' ' ' ALA . 47.3 mm -60.09 -48.58 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.876 -1.14 . . . . 0.0 109.547 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -60.05 -39.3 85.48 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.477 -0.764 . . . . 0.0 110.357 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.12 85.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.928 -1.108 . . . . 0.0 110.654 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.1 179.571 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.553 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 32.3 pttt . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 45.1 Cg_endo -95.56 108.75 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.657 1.571 . . . . 0.0 112.696 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.79 133.75 54.91 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.0 mt -110.6 130.67 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 t -90.39 100.73 13.51 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -65.45 -7.14 12.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 108.854 -179.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.493 ' N ' HD12 ' A' ' 22' ' ' LEU . 91.8 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 24' ' ' ASP . 42.8 t0 -135.34 3.54 3.1 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.31 86.72 0.04 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.19 134.61 29.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.375 -1.073 . . . . 0.0 109.724 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -82.82 121.99 27.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.3 mt -119.99 76.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 110.701 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -70.18 107.13 3.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.679 -1.263 . . . . 0.0 109.959 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.99 23.74 1.03 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -134.97 139.2 44.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.611 HG22 HD21 ' A' ' 75' ' ' LEU . 33.4 m -124.38 111.35 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.616 ' OH ' HD13 ' A' ' 71' ' ' ILE . 4.4 p90 32.0 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.002 -0.436 . . . . 0.0 111.405 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -92.82 135.92 33.7 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.874 -1.141 . . . . 0.0 109.926 -179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.599 ' H ' HD13 ' A' ' 34' ' ' LEU . . . 100.73 18.26 21.12 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -129.99 -99.94 0.32 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -1.062 . . . . 0.0 109.521 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -153.41 25.24 0.77 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -50.04 149.59 2.7 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.77 -0.841 . . . . 0.0 111.093 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.3 m -149.68 151.66 34.06 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.79 10.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.234 -1.542 . . . . 0.0 109.474 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -158.78 160.35 36.2 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -97.48 121.79 39.78 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.89 -1.131 . . . . 0.0 109.861 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.495 ' OD2' HG23 ' A' ' 48' ' ' VAL . 12.2 m-20 -100.04 -1.83 35.96 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.152 -0.967 . . . . 0.0 110.306 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.664 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 83.75 95.23 0.63 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.782 -1.199 . . . . 0.0 110.51 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 84.22 4.76 0.71 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.938 -0.742 . . . . 0.0 109.887 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -165.94 143.77 5.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.99 128.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.468 -0.77 . . . . 0.0 110.371 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' OD2' ' A' ' 43' ' ' ASP . 89.6 t -101.2 109.83 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.36 140.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 p -112.09 120.51 41.65 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -36.61 -79.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.006 1.804 . . . . 0.0 113.097 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -93.53 -48.85 6.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.794 -1.191 . . . . 0.0 109.203 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -160.85 -165.83 1.47 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.535 -1.353 . . . . 0.0 109.568 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.631 ' OE2' ' HB2' ' A' ' 60' ' ' ALA . 84.8 tt0 -157.5 100.86 1.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.152 -0.967 . . . . 0.0 109.607 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.651 ' O ' ' N ' ' A' ' 57' ' ' LEU . 26.7 p -131.22 145.57 51.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.849 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.82 -27.07 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.8 mp -79.61 -10.14 59.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.649 -1.282 . . . . 0.0 109.461 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 4' ' ' THR . 34.9 m-85 -137.5 -161.84 1.22 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.59 166.58 28.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.738 -1.227 . . . . 0.0 111.506 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.631 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -76.62 176.1 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -134.1 127.66 32.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -96.43 110.14 22.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.131 -0.981 . . . . 0.0 110.871 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -110.76 144.99 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.302 0.572 . . . . 0.0 109.812 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -73.4 163.59 27.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.099 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.9 95.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.405 -0.81 . . . . 0.0 111.345 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -49.98 72.62 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.267 -1.521 . . . . 0.0 111.426 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -60.21 -35.57 75.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.262 -1.524 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.659 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.1 tm? -59.7 -35.43 74.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 108.37 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -59.93 -34.48 73.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.969 -1.082 . . . . 0.0 109.296 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.2 mt -58.19 -38.7 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.88 -1.137 . . . . 0.0 108.77 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.63 HD12 HD22 ' A' ' 68' ' ' LEU . 82.6 mt -59.99 -39.92 81.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.759 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -62.45 -40.05 95.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.083 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -67.23 -50.56 60.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.736 -1.227 . . . . 0.0 110.53 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -59.97 -63.41 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.925 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.7 mp -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.884 -1.135 . . . . 0.0 111.028 -177.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.794 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 109.581 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.1 p -109.32 0.24 19.42 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.26 -49.81 76.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.603 HG21 ' CD1' ' A' ' 58' ' ' PHE . 56.3 m -60.38 -50.07 75.06 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.054 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -68.44 -49.19 61.71 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.312 -1.492 . . . . 0.0 111.019 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.12 -49.26 78.01 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.264 -0.897 . . . . 0.0 112.888 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.66 -45.81 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.554 -1.341 . . . . 0.0 111.892 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -59.93 -42.84 90.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.449 -1.407 . . . . 0.0 108.776 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -57.66 -39.26 76.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -55.19 19.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.835 -1.166 . . . . 0.0 109.005 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.424 ' ND2' ' CZ ' ' A' ' 14' ' ' ARG . 15.0 m120 -140.4 139.59 35.31 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -151.38 104.85 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.314 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.585 ' H ' ' HZ2' ' A' ' 61' ' ' LYS . . . 75.05 17.6 80.24 Favored Glycine 0 N--CA 1.496 2.64 0 O-C-N 121.274 -0.891 . . . . 0.0 111.099 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.424 ' CZ ' ' ND2' ' A' ' 11' ' ' ASN . 56.3 ttp180 -94.38 69.65 3.65 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.704 -1.468 . . . . 0.0 110.138 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 14' ' ' ARG . 99.0 mt-10 36.35 75.43 0.06 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.33 -0.856 . . . . 0.0 111.469 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' GLU . . . -36.25 102.16 0.01 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.631 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -162.52 -46.19 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.631 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 38.3 Cg_endo -101.1 128.03 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 123.364 2.71 . . . . 0.0 109.839 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.8 ttt -126.18 128.97 48.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.997 -1.064 . . . . 0.0 110.053 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -110.0 130.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.544 -0.723 . . . . 0.0 109.376 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 t -93.87 103.58 15.68 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.66 -7.83 12.12 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.12 -43.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -134.4 13.97 3.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.31 89.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -151.81 145.81 25.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.725 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.12 125.95 33.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.1 mt -123.11 73.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.728 -0.607 . . . . 0.0 109.398 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -69.22 109.37 4.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.007 -1.058 . . . . 0.0 109.361 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.2 21.64 0.95 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 p -140.83 147.82 39.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.51 101.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.321 -0.862 . . . . 0.0 108.708 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 51.4 28.46 4.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 109.138 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.5 tt -92.34 139.45 30.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.253 -0.904 . . . . 0.0 109.515 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.86 18.6 63.08 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -127.16 -54.51 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.72 -0.87 . . . . 0.0 109.187 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.97 33.05 0.02 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -50.31 138.99 15.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -1.222 . . . . 0.0 109.858 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.6 t -151.08 135.5 16.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.92 178.18 10.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.323 -1.486 . . . . 0.0 109.969 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -150.58 161.11 43.2 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -100.0 117.34 34.07 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.905 -1.122 . . . . 0.0 109.988 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 60.6 t0 -94.51 -12.49 27.54 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.128 -0.983 . . . . 0.0 109.373 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 93.81 98.24 1.55 Allowed Glycine 0 N--CA 1.499 2.851 0 O-C-N 121.175 -0.953 . . . . 0.0 110.814 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 85.55 1.1 0.7 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.983 -0.716 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.9 m -167.31 117.81 0.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -90.78 142.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.954 -1.091 . . . . 0.0 110.572 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -108.78 125.29 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -146.89 144.09 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.908 -1.12 . . . . 0.0 110.594 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.4 m -110.44 124.46 33.19 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -37.48 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.87 1.713 . . . . 0.0 111.7 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -101.82 -47.32 4.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.024 -1.048 . . . . 0.0 109.828 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 68.9 mt-10 -161.81 -165.84 1.34 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.692 . . . . 0.0 109.865 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -168.11 114.66 0.69 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.6 p -122.4 44.53 2.59 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.244 -0.91 . . . . 0.0 111.115 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 68.32 -16.74 0.19 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.024 -1.048 . . . . 0.0 110.38 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 55' ' ' THR . 12.6 mt -95.13 -0.77 53.08 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CD1' HG21 ' A' ' 4' ' ' THR . 89.3 m-85 -134.04 -156.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.09 164.19 35.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.828 -1.17 . . . . 0.0 111.381 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.33 174.96 9.56 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.449 0.642 . . . . 0.0 109.525 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.585 ' HZ2' ' H ' ' A' ' 13' ' ' GLY . 86.5 tttt -133.36 133.34 42.35 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -82.76 164.43 20.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.842 -1.161 . . . . 0.0 110.358 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -154.93 119.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.2 m -64.8 151.13 46.13 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.61 69.9 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.603 -1.31 . . . . 0.0 108.403 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.64 80.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.599 -1.313 . . . . 0.0 109.436 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -60.99 -34.21 74.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 108.981 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.584 ' O ' HD13 ' A' ' 68' ' ' LEU . 2.9 tm? -59.75 -33.1 71.22 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -60.6 -41.47 94.81 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.8 mt -60.15 -39.22 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.725 . . . . 0.0 110.727 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.59 ' O ' HD22 ' A' ' 75' ' ' LEU . 96.1 mt -59.72 -46.56 93.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 118.304 -1.359 . . . . 0.0 109.821 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.28 73.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.545 -1.347 . . . . 0.0 109.672 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -62.65 -40.01 95.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.833 -1.167 . . . . 0.0 109.607 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -59.94 -51.35 70.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.431 -0.793 . . . . 0.0 111.631 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.615 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.2 mm? -65.35 -46.82 78.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.177 . . . . 0.0 109.893 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.648 ' C ' HG22 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.571 0.7 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.652 HG23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER 167.99 -74.91 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.696 0.76 . . . . 0.0 109.088 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.652 ' H ' HG23 ' A' ' 2' ' ' THR . 8.6 tp -60.16 -45.43 93.1 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.4 m -70.04 -51.84 28.85 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.202 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -73.44 -57.56 3.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.31 -40.34 95.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.388 -1.445 . . . . 0.0 112.361 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.6 t -70.32 -47.95 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.589 -1.319 . . . . 0.0 112.341 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 11' ' ' ASN . 53.4 mt -68.24 -42.55 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.862 -1.149 . . . . 0.0 111.195 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -60.3 -41.7 93.96 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.789 -1.195 . . . . 0.0 110.343 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.47 91.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.886 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 8' ' ' ILE . 8.0 m120 -125.44 123.85 40.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -154.37 74.28 0.95 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 0.0 108.873 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.75 37.17 0.04 OUTLIER Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.474 HH21 ' HG2' ' A' ' 18' ' ' PRO . 17.8 mmm180 -81.73 159.96 23.75 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.514 -0.992 . . . . 0.0 110.03 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 tm-20 -70.43 -40.44 73.79 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.792 -0.567 . . . . 0.0 110.058 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.15 27.55 0.57 Allowed Glycine 0 N--CA 1.503 3.106 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.817 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 36.6 mtmt -151.33 -35.17 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.228 -1.16 . . . . 0.0 111.984 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.817 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 80.2 Cg_endo -96.46 123.68 0.25 Allowed 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.554 2.169 . . . . 0.0 113.629 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 19' ' ' MET . 0.3 OUTLIER -122.29 140.95 52.04 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.574 -0.704 . . . . 0.0 109.746 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 76.6 mt -110.53 131.39 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.412 -0.805 . . . . 0.0 110.296 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.6 m -94.59 101.11 12.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.025 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -8.44 22.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.372 -0.83 . . . . 0.0 109.528 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.97 -42.4 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 9.3 t70 -131.54 8.02 4.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.41 87.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -144.68 137.21 26.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -1.138 . . . . 0.0 109.233 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -83.43 122.97 29.21 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -120.06 76.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.376 -0.827 . . . . 0.0 110.319 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -66.01 107.53 1.91 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.837 -1.164 . . . . 0.0 109.011 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.4 19.16 0.77 Allowed Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 137.25 49.06 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 34' ' ' LEU . 3.1 m -118.03 98.89 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 44.6 17.07 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 32' ' ' VAL . 85.1 mt -72.12 142.01 49.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 108.473 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.5 -21.58 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -73.07 -35.45 66.66 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 123.53 31.8 0.94 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 106.818 -2.513 . . . . 0.0 106.818 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.45 ' HE1' HD12 ' A' ' 49' ' ' ILE . 16.3 t90 -47.52 139.54 6.77 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.285 1.04 . . . . 0.0 111.314 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -154.62 135.08 13.38 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.23 7.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.653 -1.28 . . . . 0.0 111.583 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -156.76 139.4 15.04 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -94.2 123.55 37.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.29 -1.506 . . . . 0.0 109.523 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 52.0 t0 -102.19 -5.6 24.19 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.354 -0.841 . . . . 0.0 110.201 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -112.07 0.54 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.752 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -90.9 -6.63 53.89 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -1.194 . . . . 0.0 109.956 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -125.1 119.95 30.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.981 -1.075 . . . . 0.0 108.88 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 mm -88.97 140.14 16.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.488 -0.758 . . . . 0.0 110.828 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.44 114.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.608 HD13 HD12 ' A' ' 63' ' ' ILE . 4.4 pt -118.78 172.35 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 121.023 -1.048 . . . . 0.0 109.917 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 51' ' ' PRO . 63.8 m -135.35 102.37 10.74 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 50' ' ' SER . 0.5 OUTLIER -28.9 -99.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.614 2.209 . . . . 0.0 112.083 -177.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -78.29 -44.29 25.77 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.41 ' OE2' HD23 ' A' ' 3' ' ' LEU . 68.2 mt-10 -160.92 -163.87 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' OE1' ' C ' ' A' ' 59' ' ' LYS . 10.0 tp10 -171.0 103.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.627 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 57' ' ' LEU . 73.1 p -130.81 152.59 49.98 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -26.8 -29.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.4 mp -84.11 -3.11 57.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.712 -1.243 . . . . 0.0 111.004 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 55' ' ' THR . 88.4 m-85 -129.27 -161.07 1.08 Allowed 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.461 -0.774 . . . . 0.0 109.702 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -140.08 155.68 46.92 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.156 -0.965 . . . . 0.0 111.197 -179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.71 175.5 10.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.688 -0.633 . . . . 0.0 109.819 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -132.17 153.82 50.16 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -109.28 161.09 15.59 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.331 -0.856 . . . . 0.0 109.978 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.608 HD12 HD13 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -153.06 117.45 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -61.74 149.26 40.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -49.61 -46.03 48.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.775 -1.203 . . . . 0.0 109.581 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.16 -41.73 65.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.186 -1.571 . . . . 0.0 110.241 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -65.75 -29.91 70.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.766 -1.209 . . . . 0.0 109.765 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 71' ' ' ILE . 3.2 tm? -59.63 -36.39 76.27 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -59.17 -39.23 81.85 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 mt -60.17 -32.65 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.053 -1.029 . . . . 0.0 110.184 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 68' ' ' LEU . 93.4 mt -62.14 -44.37 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.242 -1.536 . . . . 0.0 110.51 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.61 62.09 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.972 -1.08 . . . . 0.0 111.024 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -64.37 -56.54 13.67 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.142 -0.974 . . . . 0.0 110.224 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -51.92 -49.69 62.57 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.622 -0.674 . . . . 0.0 109.331 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -67.6 -23.94 65.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.052 -1.03 . . . . 0.0 110.626 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.825 -1.083 . . . . 0.0 108.962 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 1' ' ' ALA . 71.4 p 50.55 97.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 109.417 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.76 -40.13 94.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.671 -0.643 . . . . 0.0 111.022 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.428 ' OG1' ' OE2' ' A' ' 53' ' ' GLU . 41.7 m -59.94 -52.39 65.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.927 . . . . 0.0 110.642 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t -68.62 -41.27 79.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.702 -1.249 . . . . 0.0 111.744 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.77 -40.52 76.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.784 -1.197 . . . . 0.0 112.919 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 52' ' ' ALA . 70.7 t -71.21 -50.09 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.486 -1.383 . . . . 0.0 111.254 -178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.455 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.3 mp -60.27 -49.34 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.097 -1.002 . . . . 0.0 110.162 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -60.39 -40.02 89.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.058 -1.027 . . . . 0.0 110.596 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.64 80.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.961 -1.087 . . . . 0.0 109.459 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.425 HD21 HG13 ' A' ' 20' ' ' ILE . 9.5 m120 -144.64 115.61 7.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 109.439 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.569 ' C ' ' H ' ' A' ' 14' ' ' ARG . 72.6 tttt -78.3 169.88 17.54 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 15' ' ' GLU . . . -59.18 11.16 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 O-C-N 120.686 -1.259 . . . . 0.0 110.803 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.569 ' H ' ' C ' ' A' ' 12' ' ' LYS . 9.7 ptm180 -50.99 88.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.928 -1.337 . . . . 0.0 109.349 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 13' ' ' GLY . 46.3 tp10 47.93 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 0.0 109.562 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.04 101.41 0.31 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.674 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.3 tttm -154.85 -45.25 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.49 -1.006 . . . . 0.0 109.335 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 78.9 Cg_endo -95.54 130.25 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.748 2.299 . . . . 0.0 110.341 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.6 ttt -116.46 129.67 56.34 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.302 -0.874 . . . . 0.0 111.253 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.425 HG13 HD21 ' A' ' 11' ' ' ASN . 5.2 mm -106.14 119.85 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 25' ' ' GLY . 26.2 p -100.82 98.86 9.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 0.0 109.057 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.031 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.08 -10.71 59.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.374 -0.828 . . . . 0.0 109.825 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.557 ' N ' HD22 ' A' ' 22' ' ' LEU . 72.9 t -60.03 -41.73 87.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 108.493 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.48 1.29 4.53 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 60.04 82.55 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -145.28 137.69 25.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.359 -1.083 . . . . 0.0 109.472 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -84.56 128.97 34.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.92 77.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.714 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 44.4 pttt -71.94 109.99 6.14 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.68 20.36 0.54 Allowed Glycine 0 N--CA 1.497 2.736 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.4 p -142.33 149.08 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -1.124 . . . . 0.0 108.372 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.567 HG22 HD21 ' A' ' 75' ' ' LEU . 19.1 m -122.86 85.32 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.67 0.748 . . . . 0.0 109.301 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 53.54 34.29 18.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.435 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 tp -85.67 137.07 33.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.541 -0.724 . . . . 0.0 109.069 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.06 17.71 66.63 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -121.42 -41.98 2.47 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 145.71 26.69 0.1 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -51.26 136.99 23.69 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.163 -1.198 . . . . 0.0 109.294 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.6 p -152.42 142.31 22.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.13 178.96 9.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.229 -1.544 . . . . 0.0 110.461 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -158.65 146.59 18.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -96.66 123.28 40.29 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.644 -1.285 . . . . 0.0 109.155 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.6 -4.26 22.79 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -121.87 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -80.72 -9.96 59.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.217 . . . . 0.0 109.591 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.6 m -120.13 134.59 55.21 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 HD12 ' A' ' 68' ' ' LEU . 33.4 mm -104.69 130.02 56.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.676 -0.64 . . . . 0.0 109.873 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.82 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.064 -1.022 . . . . 0.0 108.354 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.63 141.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.188 -0.945 . . . . 0.0 110.601 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.0 m -109.9 118.69 49.38 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -36.77 -76.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 121.916 1.744 . . . . 0.0 112.211 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -94.96 -50.75 4.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 0.0 108.562 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' OE2' ' OG1' ' A' ' 4' ' ' THR . 15.5 pt-20 -173.22 -161.0 0.13 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.533 -0.729 . . . . 0.0 109.057 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -166.26 115.39 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.034 -1.041 . . . . 0.0 108.935 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 11.8 p -117.09 40.26 3.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.226 -0.921 . . . . 0.0 109.705 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 69.99 -16.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.663 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 55' ' ' THR . 4.6 mm? -90.0 -1.75 58.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 4' ' ' THR . 67.9 m-85 -136.27 -159.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -144.59 159.99 41.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.971 -1.081 . . . . 0.0 111.339 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 175.74 5.12 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -132.52 124.84 29.26 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -93.07 110.94 22.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.452 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 63' ' ' ILE . 14.4 tt -108.92 124.4 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.7 m -55.63 157.72 3.9 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.339 -0.85 . . . . 0.0 110.687 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.324 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.92 -41.37 61.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.551 -1.343 . . . . 0.0 108.748 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -63.04 -24.21 67.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -59.87 -38.79 83.18 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.07 -35.64 75.61 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.77 -39.86 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.859 -1.151 . . . . 0.0 108.888 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.45 -38.09 54.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.749 -1.22 . . . . 0.0 108.659 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -69.9 -38.13 76.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.158 -0.964 . . . . 0.0 111.529 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.91 -50.47 41.88 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.657 -1.277 . . . . 0.0 111.71 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -59.87 -47.37 86.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 111.457 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.567 HD21 HG22 ' A' ' 32' ' ' VAL . 5.3 mp -69.95 -44.3 69.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.922 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.0 p -105.02 -1.51 25.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.504 -0.748 . . . . 0.0 109.52 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 7' ' ' VAL . 3.0 tt -59.98 -49.32 78.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 109.739 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.415 ' OG1' ' OE1' ' A' ' 53' ' ' GLU . 89.5 m -64.92 -53.69 42.55 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.298 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.5 p -61.65 -45.26 94.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.718 -1.239 . . . . 0.0 111.751 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.99 -40.97 74.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.914 -1.117 . . . . 0.0 112.65 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 3' ' ' LEU . 80.8 t -68.6 -47.97 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.393 -1.442 . . . . 0.0 111.216 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.05 -49.16 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.877 -1.139 . . . . 0.0 110.437 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.97 -41.85 92.87 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.161 -0.962 . . . . 0.0 111.057 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.92 92.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.533 -1.354 . . . . 0.0 110.427 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -60.01 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.045 -1.034 . . . . 0.0 109.939 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.9 tptm 44.87 26.85 0.22 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.852 0.834 . . . . 0.0 109.342 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ARG . . . -167.84 55.63 0.22 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.506 ' NE ' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -37.57 -92.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.144 -0.621 . . . . 0.0 111.162 -178.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 17' ' ' LYS . 40.3 tp10 48.77 51.77 15.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.0 108.622 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.471 ' O ' ' ND2' ' A' ' 74' ' ' ASN . . . -16.46 73.81 0.0 OUTLIER Glycine 0 N--CA 1.505 3.247 0 C-N-CA 123.142 0.401 . . . . 0.0 113.399 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 15' ' ' GLU . 1.3 mmmt -167.01 -52.41 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.166 -1.196 . . . . 0.0 109.318 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HD2' ' H ' ' A' ' 17' ' ' LYS . 29.6 Cg_endo -95.46 113.31 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.659 2.239 . . . . 0.0 112.231 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.575 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.06 135.26 50.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.337 -0.852 . . . . 0.0 109.748 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.575 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.8 mm -106.22 129.08 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.754 . . . . 0.0 109.105 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' VAL . 79.5 p -113.58 100.24 8.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.521 -0.737 . . . . 0.0 109.629 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.97 -1.4 3.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' SER . 95.1 t -60.03 -44.2 94.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -140.81 15.76 2.31 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.11 85.27 0.03 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 106.63 -2.588 . . . . 0.0 106.63 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -145.7 134.3 22.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.459 -1.024 . . . . 0.0 109.729 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.63 128.67 34.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mt -127.56 75.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.87 109.25 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 109.248 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.89 26.4 1.13 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.8 m -141.74 148.45 39.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 32' ' ' VAL . 22.8 m -127.15 106.17 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 23.5 m-85 42.06 34.78 0.49 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.598 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -90.83 134.78 34.18 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 109.682 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.598 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 102.39 16.02 23.8 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.564 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 23.5 p30 -131.7 -100.97 0.29 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.38 -1.07 . . . . 0.0 109.276 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -143.72 30.48 1.94 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -46.97 140.02 5.14 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.248 -1.148 . . . . 0.0 110.959 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 t -146.66 149.08 32.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.78 169.92 18.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.084 -1.635 . . . . 0.0 109.184 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -158.94 143.67 15.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -98.92 120.07 38.75 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.606 -1.309 . . . . 0.0 110.584 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 32.3 t0 -97.81 -7.29 30.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.284 -0.885 . . . . 0.0 109.621 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.14 64.47 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -163.03 -57.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.121 . . . . 0.0 108.639 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 m -118.09 121.49 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.48 135.12 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 t -98.63 103.92 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.84 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.42 -0.8 . . . . 0.0 110.304 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -111.93 127.75 26.43 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.59 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.233 1.289 . . . . 0.0 111.455 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.73 -48.94 5.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 109.592 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.415 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 91.9 mt-10 -156.69 -169.98 3.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.122 -0.987 . . . . 0.0 109.882 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 15.6 tm-20 -155.62 96.72 1.79 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 58' ' ' PHE . 1.7 p -131.49 147.75 52.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.373 -0.83 . . . . 0.0 108.816 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -28.61 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.1 mp -85.4 0.57 51.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.605 -1.31 . . . . 0.0 110.222 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.5 m-85 -136.87 -160.88 1.1 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 108.935 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -150.08 160.19 43.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 0.0 111.612 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.28 173.5 12.53 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -136.18 128.7 30.49 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.32 109.51 22.12 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.969 -1.082 . . . . 0.0 110.789 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.83 138.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 m -74.43 162.61 28.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -0.94 . . . . 0.0 108.852 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -59.95 -48.05 83.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.883 -1.136 . . . . 0.0 109.44 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.0 -41.7 83.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.628 -1.295 . . . . 0.0 109.995 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -59.95 -32.61 70.96 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.787 -1.196 . . . . 0.0 108.633 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.762 ' O ' HD13 ' A' ' 68' ' ' LEU . 2.7 tm? -59.91 -34.77 73.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.86 -37.67 77.04 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.03 -1.044 . . . . 0.0 108.38 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.97 -39.85 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.975 . . . . 0.0 109.364 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.4 mp -59.92 -40.11 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 108.267 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.23 96.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 111.055 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.12 -40.0 95.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.672 -1.267 . . . . 0.0 109.489 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 16' ' ' GLY . 82.5 m-20 -66.7 -71.33 0.2 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.313 0.578 . . . . 0.0 111.883 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.697 ' N ' HD12 ' A' ' 75' ' ' LEU . 6.4 mp -63.01 -44.55 95.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 111.466 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 120.752 -1.217 . . . . 0.0 109.371 -179.757 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p -109.59 -9.08 14.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.395 -0.815 . . . . 0.0 109.044 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.05 -49.92 75.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 109.304 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.516 HG23 ' N ' ' A' ' 5' ' ' SER . 6.4 t -63.59 -48.46 77.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.311 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 4' ' ' THR . 14.5 p -65.19 -43.21 92.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.76 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -40.81 74.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.058 . . . . 0.0 112.122 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.96 -43.82 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.852 -1.155 . . . . 0.0 110.836 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 52' ' ' ALA . 1.3 mp -59.43 -49.11 84.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.821 . . . . 0.0 109.452 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.09 -36.15 76.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.808 -1.183 . . . . 0.0 109.755 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.24 -20.02 64.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.973 -1.079 . . . . 0.0 110.593 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -76.7 -119.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.772 -1.205 . . . . 0.0 110.715 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 59.26 30.16 19.85 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.757 -0.589 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 14' ' ' ARG . . . -160.35 58.73 0.31 Allowed Glycine 0 N--CA 1.483 1.798 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 13' ' ' GLY . 86.4 mtm-85 -48.99 -109.89 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.722 0.772 . . . . 0.0 110.37 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 48.19 50.11 16.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.86 -1.15 . . . . 0.0 108.819 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.36 -2.33 20.49 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 48.4 53.02 13.68 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.497 -1.002 . . . . 0.0 109.642 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 38.0 Cg_endo -66.52 156.13 66.93 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.02 1.813 . . . . 0.0 108.668 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.484 ' SD ' ' OD2' ' A' ' 36' ' ' ASP . 35.3 ttp -138.16 125.6 21.92 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.78 -1.2 . . . . 0.0 110.996 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.3 mt -102.38 128.96 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.7 p -86.61 99.18 11.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.012 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -62.66 -14.44 43.54 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' H ' HD22 ' A' ' 22' ' ' LEU . 71.6 t -60.86 -41.79 90.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -131.7 2.03 4.06 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 59.23 81.15 0.08 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -140.07 130.29 25.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.257 -1.143 . . . . 0.0 109.329 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 51.2 mp0 -77.44 134.91 38.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.289 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 30' ' ' GLY . 34.5 mt -130.8 60.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -71.94 47.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.862 0.839 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -153.51 26.05 0.76 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 106.846 -2.502 . . . . 0.0 106.846 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m -145.81 150.43 36.17 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 32' ' ' VAL . 18.6 m -114.81 94.62 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 32' ' ' VAL . 26.0 m-85 36.38 25.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.294 0.569 . . . . 0.0 110.538 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 35' ' ' GLY . 4.2 tt -97.68 129.12 44.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 109.207 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.711 ' N ' HD23 ' A' ' 34' ' ' LEU . . . 118.01 25.77 2.93 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' SD ' ' A' ' 19' ' ' MET . 90.9 m-20 -143.76 -61.84 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.302 -1.116 . . . . 0.0 109.638 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -170.96 23.79 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -35.23 135.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.021 0.915 . . . . 0.0 112.503 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 t -146.94 135.31 21.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.96 169.31 23.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.822 -1.798 . . . . 0.0 110.064 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -160.5 138.69 9.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -101.59 126.27 48.38 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.686 -1.259 . . . . 0.0 111.176 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 59.2 t0 -95.49 -12.47 25.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.735 -0.603 . . . . 0.0 109.491 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 94.87 105.05 1.95 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 84.63 -10.71 0.84 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.984 -0.715 . . . . 0.0 109.773 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.9 m -158.01 114.4 2.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -91.9 140.81 15.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 111.247 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.12 120.05 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.487 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -151.25 146.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.609 -1.307 . . . . 0.0 110.347 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 t -109.72 120.06 46.04 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -38.05 -77.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 122.082 1.854 . . . . 0.0 113.55 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -85.01 -58.8 2.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.862 -1.148 . . . . 0.0 111.082 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 40.5 mt-10 -161.25 -167.15 1.7 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.835 . . . . 0.0 109.616 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -167.43 113.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 1.4 p -127.87 45.12 2.8 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.36 -0.837 . . . . 0.0 110.198 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 71.8 -22.54 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 55' ' ' THR . 11.3 mt -90.09 -7.15 54.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.045 -1.034 . . . . 0.0 108.929 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -128.79 -160.53 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -145.8 158.96 43.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.724 -1.235 . . . . 0.0 111.075 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.15 173.52 8.43 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -127.98 140.27 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -85.05 155.54 21.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.912 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.487 HD12 HG21 ' A' ' 49' ' ' ILE . 8.0 mt -151.89 112.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.0 p -64.23 154.71 34.18 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.57 62.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.484 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.69 86.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.653 -1.279 . . . . 0.0 109.707 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -59.92 -39.16 84.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.108 -0.995 . . . . 0.0 109.331 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 68' ' ' LEU . 1.8 tm? -59.01 -37.09 76.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.877 -1.14 . . . . 0.0 108.757 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -58.97 -35.01 72.45 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.87 -38.65 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.5 mp -57.89 -40.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.63 -1.294 . . . . 0.0 108.796 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.0 96.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 110.904 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' O ' ' OXT' ' A' ' 76' ' ' LEU . 94.0 mttt -68.08 -44.47 76.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.874 -1.141 . . . . 0.0 110.501 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -59.74 -58.26 9.36 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 112.12 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 HG22 ' A' ' 32' ' ' VAL . 4.5 mp -68.01 -39.9 83.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.595 -1.316 . . . . 0.0 110.234 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.78 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.034 -1.041 . . . . 0.0 109.951 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.619 ' C ' HG22 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.19 0.519 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER 169.95 -82.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.794 . . . . 0.0 109.439 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.628 ' H ' HG23 ' A' ' 2' ' ' THR . 10.4 tp -59.95 -49.41 77.78 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 m -65.64 -49.09 69.92 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.956 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -72.36 -57.3 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 112.538 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 2' ' ' THR . 69.9 mm-40 -65.03 -44.33 89.49 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.569 -1.332 . . . . 0.0 113.129 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.0 -45.32 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.526 -1.359 . . . . 0.0 111.107 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.487 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.3 mp -60.1 -39.4 80.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.001 -1.062 . . . . 0.0 109.144 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.81 -44.0 94.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.802 -1.186 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.69 74.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.886 -1.133 . . . . 0.0 109.986 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.669 HD21 ' CG1' ' A' ' 20' ' ' ILE . 23.5 m120 -130.66 122.22 26.98 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.135 -0.978 . . . . 0.0 109.567 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -155.35 51.23 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 108.639 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.51 29.91 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.689 HH21 ' N ' ' A' ' 17' ' ' LYS . 14.9 ptm180 -81.76 165.2 21.14 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.467 -1.019 . . . . 0.0 108.785 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -70.35 -39.94 74.36 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.05 37.76 0.49 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.745 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 7.8 mtpt -142.77 -43.41 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.559 -0.965 . . . . 0.0 110.701 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.745 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 63.0 Cg_endo -101.14 130.18 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.151 2.568 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.7 ttp -112.2 143.26 43.56 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.669 ' CG1' HD21 ' A' ' 11' ' ' ASN . 4.5 mm -103.4 129.58 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.299 -0.876 . . . . 0.0 108.989 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 m -100.56 98.49 9.07 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -66.96 -3.04 6.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.563 ' N ' HD12 ' A' ' 22' ' ' LEU . 74.6 t -60.05 -44.27 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 49.8 t0 -125.01 -5.82 7.34 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.8 11.24 85.61 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -75.88 140.05 41.98 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.651 -0.911 . . . . 0.0 110.399 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.03 133.48 33.58 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.7 mt -123.45 73.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.223 -0.923 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -65.93 109.23 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.528 -1.357 . . . . 0.0 108.834 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.9 23.67 0.85 Allowed Glycine 0 N--CA 1.498 2.768 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 17' ' ' LYS . 87.8 m -133.26 137.26 45.99 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 34' ' ' LEU . 9.8 m -120.1 102.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 O-C-N 121.432 -0.792 . . . . 0.0 110.022 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.433 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.7 m-85 41.65 17.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.868 -0.52 . . . . 0.0 109.94 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 32' ' ' VAL . 43.7 tp -93.9 134.56 36.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.673 -1.267 . . . . 0.0 109.68 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.82 17.01 10.74 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 17.5 p-10 -139.37 -69.96 0.41 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -1.119 . . . . 0.0 110.121 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 173.1 32.08 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -51.54 155.65 1.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.434 -1.039 . . . . 0.0 110.324 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 t -153.39 131.97 12.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.86 177.32 10.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.339 -1.476 . . . . 0.0 109.57 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -159.7 160.05 33.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -99.48 114.76 27.91 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.88 -1.137 . . . . 0.0 109.649 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 38.4 t0 -96.74 -7.7 33.21 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.783 -1.198 . . . . 0.0 109.685 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.97 -113.56 0.66 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -88.84 -5.22 58.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.109 -1.23 . . . . 0.0 109.273 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 m -122.91 132.85 54.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.335 -0.853 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.1 mm -96.36 142.61 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.586 -0.696 . . . . 0.0 110.838 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -109.26 120.01 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.648 HD12 HD12 ' A' ' 63' ' ' ILE . 45.8 mt -131.73 144.16 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.583 -0.698 . . . . 0.0 110.518 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 51' ' ' PRO . 74.1 m -118.29 120.84 31.78 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' SER . 53.9 Cg_exo -33.34 -87.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.137 1.891 . . . . 0.0 111.961 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -99.9 -36.59 9.35 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -165.73 -163.21 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.708 0.766 . . . . 0.0 109.965 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -174.28 117.26 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.648 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 20.9 p -128.98 40.43 3.64 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 74.46 -26.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.373 -0.829 . . . . 0.0 110.283 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 55' ' ' THR . 8.8 mp -90.02 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.362 -0.836 . . . . 0.0 108.828 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.27 -157.19 0.75 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -140.46 158.36 44.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.001 -1.062 . . . . 0.0 111.075 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.04 173.77 9.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -138.99 120.03 14.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -84.76 171.32 12.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.648 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -161.69 118.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 177.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -60.18 153.89 21.0 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.694 -1.254 . . . . 0.0 108.13 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.95 -44.32 70.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.784 -1.197 . . . . 0.0 108.245 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.59 -44.05 69.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.041 -1.662 . . . . 0.0 109.309 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.88 -27.14 68.95 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.687 -1.258 . . . . 0.0 108.96 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.633 HD22 HD12 ' A' ' 71' ' ' ILE . 3.3 tm? -59.91 -32.88 71.17 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.92 -39.77 86.59 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.7 mt -58.28 -34.83 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.988 -1.07 . . . . 0.0 109.998 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.633 HD12 HD22 ' A' ' 68' ' ' LEU . 71.0 mt -60.02 -40.16 82.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.23 -1.544 . . . . 0.0 109.675 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -75.39 -28.81 59.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.879 -1.138 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' LEU . 1.6 tmtp? -69.77 -55.11 10.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -58.06 -50.06 74.74 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.857 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 75' ' ' LEU . 4.6 mp -68.11 -39.85 82.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.355 -1.466 . . . . 0.0 109.744 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 73' ' ' LYS . 1.5 pp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.138 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.731 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 154.55 -68.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 tp -59.83 -42.99 94.76 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -78.59 -50.01 12.26 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.857 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -65.72 -52.05 54.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.909 -1.119 . . . . 0.0 111.74 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.01 -47.12 63.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 112.836 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.81 -39.93 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.504 -1.372 . . . . 0.0 111.367 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.62 -45.47 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 108.372 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -59.05 -40.06 83.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.604 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 11' ' ' ASN . . . -59.97 -42.04 93.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.975 -1.078 . . . . 0.0 110.35 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' LYS . 89.7 m-20 -49.63 -99.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.94 . . . . 0.0 110.068 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 11' ' ' ASN . 8.4 mmmm 32.83 85.45 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.691 -0.631 . . . . 0.0 110.602 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.02 -7.63 4.79 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -61.07 147.23 44.49 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.745 -0.856 . . . . 0.0 109.146 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 12.0 tm-20 -133.57 -5.11 2.9 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' O ' ' OD1' ' A' ' 74' ' ' ASN . . . 113.13 31.23 2.5 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.674 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 32.2 ttpt -171.92 -37.19 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.481 -1.011 . . . . 0.0 111.345 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 98.2 Cg_endo -96.98 108.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 122.432 2.088 . . . . 0.0 113.836 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.439 ' C ' ' SD ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -122.74 131.63 53.87 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.574 -0.704 . . . . 0.0 109.101 178.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.19 131.89 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 110.154 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 23' ' ' VAL . 35.4 m -95.76 101.96 13.71 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -63.43 0.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.587 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.519 ' N ' HD12 ' A' ' 22' ' ' LEU . 71.3 t -60.03 -45.43 95.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.911 -1.118 . . . . 0.0 108.272 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -138.47 10.34 2.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.72 89.12 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mp0 -146.08 137.84 24.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.107 -1.231 . . . . 0.0 109.81 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.39 129.8 35.32 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 30' ' ' GLY . 53.6 mt -124.96 77.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.387 -0.821 . . . . 0.0 110.365 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -69.1 40.63 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 109.754 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -151.15 24.03 0.99 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 107.079 -2.409 . . . . 0.0 107.079 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 m -146.99 150.3 34.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 122.001 -0.705 . . . . 0.0 109.746 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 32' ' ' VAL . 35.5 m -134.67 104.71 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 41.0 p90 39.93 19.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.86 -0.525 . . . . 0.0 110.865 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.569 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 tt -103.33 118.45 36.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.127 -0.983 . . . . 0.0 108.484 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.546 ' N ' HD23 ' A' ' 34' ' ' LEU . . . 134.03 28.86 0.48 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 70.4 m-20 -155.74 -50.08 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.546 -0.973 . . . . 0.0 109.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 176.16 31.83 0.04 OUTLIER Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.4 ' C ' ' O ' ' A' ' 37' ' ' GLY . 55.4 p-90 -43.4 144.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.2 m -149.16 134.07 17.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.01 170.59 7.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.24 -1.538 . . . . 0.0 109.546 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -151.41 148.27 27.89 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -95.13 134.62 37.64 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.551 -1.343 . . . . 0.0 109.432 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -109.66 -8.51 14.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.476 -0.765 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.67 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 89.86 103.9 1.14 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 86.46 0.57 0.59 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.094 -0.651 . . . . 0.0 110.163 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 45' ' ' ALA . 72.2 m -171.59 116.33 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 108.365 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 47' ' ' ILE . 7.2 mm -91.17 136.28 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.097 -1.002 . . . . 0.0 110.395 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.02 120.7 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.655 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -148.3 147.8 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.651 -1.281 . . . . 0.0 111.559 -177.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.2 m -119.49 147.13 42.8 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.51 -84.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.631 1.554 . . . . 0.0 111.941 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -94.34 -39.44 10.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.011 -1.056 . . . . 0.0 109.921 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -159.4 -164.04 1.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 108.787 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.841 ' OE2' ' HB2' ' A' ' 60' ' ' ALA . 77.6 tt0 -165.82 100.1 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 110.354 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.629 ' O ' ' N ' ' A' ' 57' ' ' LEU . 23.6 p -130.27 151.15 51.1 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.88 -29.15 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.9 mp -84.17 1.29 45.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.701 -1.25 . . . . 0.0 110.041 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 97.7 m-85 -136.96 -161.03 1.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -151.18 169.29 22.25 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.839 -1.163 . . . . 0.0 111.58 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.841 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -93.92 175.58 6.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.43 0.633 . . . . 0.0 109.328 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -137.8 134.52 35.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -96.56 108.86 21.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.932 -1.105 . . . . 0.0 111.694 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.655 HD12 HG21 ' A' ' 49' ' ' ILE . 1.5 mt -89.84 131.41 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 p -72.63 159.32 34.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.998 -1.064 . . . . 0.0 108.357 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.89 -50.13 74.99 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.947 -1.095 . . . . 0.0 108.874 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.98 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.301 -1.499 . . . . 0.0 108.55 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -60.07 -33.69 72.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.967 -1.083 . . . . 0.0 108.988 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.688 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.3 tm? -60.03 -36.86 78.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.114 -0.991 . . . . 0.0 108.443 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -58.99 -37.38 76.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.85 -39.58 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 109.348 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.6 mt -59.89 -40.15 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.049 -1.032 . . . . 0.0 109.488 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -64.31 -40.0 95.05 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.659 -1.275 . . . . 0.0 109.74 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -59.9 -44.66 94.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.267 -1.52 . . . . 0.0 109.169 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 16' ' ' GLY . 8.1 m120 -76.28 -71.86 0.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 111.84 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.7 mp -61.9 -41.68 98.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.02 -1.05 . . . . 0.0 111.93 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ALA . 39.1 tp . . . . . 0 N--CA 1.502 2.135 0 O-C-N 120.913 -1.117 . . . . 0.0 109.434 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.389 0.614 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p -110.86 -0.88 16.72 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 tt -60.54 -50.11 74.85 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.054 0.93 . . . . 0.0 108.67 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.421 ' O ' HD13 ' A' ' 8' ' ' ILE . 97.8 m -61.02 -52.25 65.79 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.404 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.3 t -67.08 -43.35 82.8 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.853 -1.155 . . . . 0.0 111.786 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -69.73 -40.33 76.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 112.633 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.4 t -74.73 -43.08 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.352 -1.468 . . . . 0.0 111.81 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 4' ' ' THR . 1.5 mp -59.99 -52.63 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.864 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -63.61 -38.71 92.15 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.865 -1.147 . . . . 0.0 110.502 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.5 91.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.301 -0.874 . . . . 0.0 111.407 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' A' ' 8' ' ' ILE . 29.0 p30 -88.99 -9.12 52.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.53 -1.356 . . . . 0.0 111.287 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -66.29 131.99 47.37 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.963 -1.085 . . . . 0.0 109.09 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.94 -48.72 0.25 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' GLU . 34.5 ptt180 -169.0 177.46 4.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.016 -1.285 . . . . 0.0 110.226 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' ARG . 13.6 pt-20 -35.77 138.23 0.18 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.673 0.749 . . . . 0.0 109.945 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.05 97.07 0.1 OUTLIER Glycine 0 C--N 1.288 -2.083 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.6 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.681 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER -138.06 -46.81 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.7 -0.882 . . . . 0.0 109.045 178.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.681 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 27.3 Cg_endo -101.25 132.24 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.934 2.423 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.535 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 25.5 ttt -125.9 127.76 46.51 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.07 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.8 mt -109.31 133.58 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.825 0.822 . . . . 0.0 109.829 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.4 p -93.81 101.41 13.51 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.539 -0.726 . . . . 0.0 109.243 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.058 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.88 -10.89 23.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.76 -1.213 . . . . 0.0 109.676 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' N ' HD22 ' A' ' 22' ' ' LEU . 76.2 t -60.32 -40.25 83.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 108.641 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -137.16 5.18 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 57.23 88.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -143.68 137.35 28.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.46 -1.024 . . . . 0.0 108.772 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.23 128.61 33.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.22 74.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.346 -0.846 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -70.32 108.34 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.334 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.74 24.55 0.66 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p -143.64 148.43 35.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 75' ' ' LEU . 36.0 m -128.72 110.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.5 m-85 42.58 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.635 -0.665 . . . . 0.0 109.539 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 32' ' ' VAL . 49.0 tp -91.22 133.36 35.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.448 -0.783 . . . . 0.0 109.828 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.88 19.37 13.17 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.429 -1.869 . . . . 0.0 108.429 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -143.36 -65.05 0.38 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.063 . . . . 0.0 109.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 173.12 66.65 0.05 OUTLIER Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -74.33 154.15 39.01 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.286 -1.126 . . . . 0.0 109.633 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -156.36 150.13 24.91 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.89 170.68 15.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.764 -1.21 . . . . 0.0 109.831 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -165.62 109.06 0.82 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -89.95 126.27 35.67 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.546 -1.347 . . . . 0.0 110.364 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -109.2 0.73 19.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.594 -0.691 . . . . 0.0 110.724 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.06 -117.35 0.96 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -86.41 -8.6 57.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.312 . . . . 0.0 109.657 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.7 m -120.11 128.26 53.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.332 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -93.2 140.63 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.942 0.877 . . . . 0.0 111.315 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 t -109.37 120.13 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.614 HD12 HD12 ' A' ' 63' ' ' ILE . 56.2 mt -121.48 169.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.389 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 49' ' ' ILE . 54.8 m -142.33 99.53 5.87 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 104.518 -2.401 . . . . 0.0 104.518 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 50' ' ' SER . 9.3 Cg_exo -32.25 -79.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.307 2.004 . . . . 0.0 112.156 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -103.0 -41.57 6.08 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -155.55 -165.49 2.0 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -171.95 104.8 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.586 -0.696 . . . . 0.0 109.67 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 58' ' ' PHE . 19.2 p -129.65 148.48 51.54 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -33.15 -25.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.139 -0.35 . . . . 0.0 111.655 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 55' ' ' THR . 2.4 mt -81.47 2.09 30.37 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.634 -1.291 . . . . 0.0 109.187 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.617 ' N ' ' O ' ' A' ' 55' ' ' THR . 55.0 m-85 -139.73 -160.7 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 156.07 41.95 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.747 -1.221 . . . . 0.0 110.882 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.25 177.29 9.06 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 109.309 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -126.78 131.37 51.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -88.24 170.09 11.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.587 -1.32 . . . . 0.0 110.277 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.614 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -164.95 122.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.7 m -59.5 153.18 20.08 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.381 -1.449 . . . . 0.0 108.324 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -52.8 -48.63 66.75 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.811 -1.181 . . . . 0.0 109.058 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.94 84.23 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.347 -1.47 . . . . 0.0 108.775 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -59.78 -27.32 66.46 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.72 -1.192 . . . . 0.0 107.847 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.721 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.1 tm? -59.92 -31.32 69.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.445 -1.409 . . . . 0.0 107.641 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.34 -38.43 83.75 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.808 -1.183 . . . . 0.0 108.71 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.13 -38.88 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.016 -1.053 . . . . 0.0 109.236 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.62 -40.5 86.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.391 -0.818 . . . . 0.0 110.629 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -52.06 35.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.7 -1.25 . . . . 0.0 111.437 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.45 -37.74 81.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.085 -1.634 . . . . 0.0 111.069 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -62.96 -64.72 0.83 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.113 -0.992 . . . . 0.0 111.685 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 32' ' ' VAL . 5.9 mp -67.83 -47.1 69.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.101 -0.999 . . . . 0.0 110.821 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.695 HD22 ' N ' ' A' ' 76' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.597 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 t -97.75 -5.83 34.16 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.251 -0.906 . . . . 0.0 109.565 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.02 -41.59 92.51 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 5' ' ' SER . 6.5 t -79.66 -44.23 21.3 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.897 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 4' ' ' THR . 17.6 t -60.31 -53.68 54.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.034 . . . . 0.0 111.307 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.08 -43.16 71.71 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.098 -1.001 . . . . 0.0 112.545 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.99 -43.42 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.698 -1.251 . . . . 0.0 111.67 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.85 -52.24 63.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.773 -1.204 . . . . 0.0 109.201 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -56.18 -39.99 73.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 110.359 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.04 -47.36 85.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.685 -1.259 . . . . 0.0 109.694 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.504 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 77.6 m-20 -98.79 -69.91 0.75 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.918 -1.113 . . . . 0.0 109.212 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 8' ' ' ILE . 17.7 ttpp 60.26 77.67 0.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.796 -0.565 . . . . 0.0 111.568 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.56 26.74 72.49 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.391 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.504 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 36.8 ttm180 -60.83 -56.23 23.62 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.791 -1.417 . . . . 0.0 108.546 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.61 ' OE2' HD11 ' A' ' 63' ' ' ILE . 53.3 tp10 50.77 86.22 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.72 -113.25 0.3 Allowed Glycine 0 N--CA 1.48 1.614 0 C-N-CA 119.116 -1.516 . . . . 0.0 111.292 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.817 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 67.3 mttt -150.83 -34.58 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.768 -0.842 . . . . 0.0 112.039 -177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.817 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 66.9 Cg_endo -98.16 140.27 0.47 Allowed 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 122.272 1.981 . . . . 0.0 113.296 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 34' ' ' LEU . 4.6 ttt -121.32 138.4 54.27 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.9 mt -107.29 131.78 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.446 -0.784 . . . . 0.0 109.51 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.9 t -93.54 100.32 12.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -66.22 -10.05 38.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.43 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.545 ' N ' HD12 ' A' ' 22' ' ' LEU . 73.4 t -59.76 -40.69 83.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -132.22 -2.79 3.52 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 64.65 85.61 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -143.07 136.29 28.19 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.233 -1.157 . . . . 0.0 110.08 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 58.3 mp0 -82.6 124.63 30.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.1 mt -123.0 73.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.337 -0.852 . . . . 0.0 110.151 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.73 116.78 3.12 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.204 -0.935 . . . . 0.0 110.261 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.93 26.25 1.74 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.515 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.8 p -135.91 140.25 43.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.774 -0.839 . . . . 0.0 109.387 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.642 HG22 HD21 ' A' ' 75' ' ' LEU . 27.0 m -122.98 98.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 12.8 p90 40.1 26.57 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -96.22 135.24 38.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.661 -0.65 . . . . 0.0 110.692 -178.251 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.595 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 115.44 36.26 1.21 Allowed Glycine 0 N--CA 1.501 2.998 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.37 -85.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.185 . . . . 0.0 110.265 -178.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -147.37 26.28 1.54 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -44.54 148.13 0.52 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.378 -1.072 . . . . 0.0 110.471 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.0 m -148.24 146.95 28.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.07 165.35 27.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.239 -1.538 . . . . 0.0 109.543 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -154.16 130.88 10.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -101.69 125.56 48.37 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.227 -1.546 . . . . 0.0 110.057 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -99.39 -0.87 40.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 0.0 108.967 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.41 16.39 66.64 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.326 -0.94 . . . . 0.0 110.914 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -161.7 -57.08 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.3 m -122.32 131.73 54.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.7 mm -92.68 132.91 35.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.292 -0.88 . . . . 0.0 111.137 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.95 120.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 50' ' ' SER . 63.4 mt -128.19 155.41 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.432 -0.792 . . . . 0.0 109.794 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.8 m -124.97 120.57 25.46 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 22.4 Cg_exo -33.5 -85.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.096 1.864 . . . . 0.0 111.157 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -105.07 -36.97 7.11 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 73.7 mt-10 -164.52 -163.28 0.72 Allowed 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -169.14 114.78 0.58 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 7.4 p -127.67 41.98 3.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.083 -1.01 . . . . 0.0 109.492 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 70.65 -29.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.536 ' H ' ' C ' ' A' ' 55' ' ' THR . 7.2 mt -82.59 -4.87 58.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.3 -0.875 . . . . 0.0 108.726 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.73 -151.23 0.47 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -150.85 161.89 41.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.799 -1.188 . . . . 0.0 111.329 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.89 173.13 11.48 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' NZ ' ' CE2' ' A' ' 33' ' ' TYR . 36.5 ttpt -134.02 157.9 44.92 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.48 171.18 8.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.61 HD11 ' OE2' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -165.87 126.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.5 p -57.97 150.11 21.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.225 -1.547 . . . . 0.0 107.033 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.38 -44.9 68.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.746 -1.221 . . . . 0.0 109.131 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.4 -42.52 96.13 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.656 -1.277 . . . . 0.0 109.677 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 70' ' ' ILE . 12.9 m-70 -54.77 -27.01 38.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.548 -1.345 . . . . 0.0 107.798 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -59.4 -30.16 68.25 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 107.799 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.57 -33.17 75.07 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.982 -1.074 . . . . 0.0 109.057 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 67' ' ' HIS . 3.8 tt -59.92 -32.08 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.675 -1.266 . . . . 0.0 108.886 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.7 -41.16 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.9 -39.93 75.93 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.948 -1.095 . . . . 0.0 110.846 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -59.85 -50.2 74.74 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.046 -1.034 . . . . 0.0 109.445 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -68.25 -71.33 0.22 Allowed 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 111.309 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.687 ' N ' HD12 ' A' ' 75' ' ' LEU . 6.6 mp -61.18 -47.92 83.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.506 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 76' ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.505 2.308 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.293 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 p -103.91 -2.16 26.59 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.497 -0.752 . . . . 0.0 109.166 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 tp -60.15 -41.86 93.67 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.2 m -69.05 -51.44 38.91 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.667 -0.646 . . . . 0.0 110.657 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.0 m -69.59 -48.31 60.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.267 -1.52 . . . . 0.0 112.72 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.97 -44.5 72.8 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.595 -1.315 . . . . 0.0 113.115 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.24 -46.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.694 -1.254 . . . . 0.0 111.57 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.537 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -61.0 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 121.146 -0.971 . . . . 0.0 109.1 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.62 -39.49 80.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.77 -40.51 69.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.043 -1.036 . . . . 0.0 109.399 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.51 142.7 15.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -163.64 124.97 2.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.762 -1.211 . . . . 0.0 111.044 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 44.95 49.82 9.04 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -130.79 68.82 1.47 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.482 -1.01 . . . . 0.0 109.306 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 17' ' ' LYS . 97.2 mt-10 48.37 76.51 0.11 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.975 -1.078 . . . . 0.0 109.942 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -42.56 92.59 0.01 OUTLIER Glycine 0 N--CA 1.496 2.693 0 O-C-N 121.146 -0.971 . . . . 0.0 110.682 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.677 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 5.6 tttm -153.0 -46.38 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.417 -1.049 . . . . 0.0 108.31 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.677 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 86.3 Cg_endo -101.74 118.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 123.436 2.757 . . . . 0.0 112.068 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.6 ttt -121.65 130.44 53.47 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.205 -0.934 . . . . 0.0 109.741 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.4 mt -108.37 130.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.3 t -94.38 99.7 11.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 108.931 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -59.72 -12.57 7.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.6 -41.33 84.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -117.33 -16.11 10.32 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.67 8.72 87.56 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -78.98 158.03 28.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -1.033 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -94.91 128.72 41.9 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.95 78.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.599 -0.688 . . . . 0.0 109.539 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.5 101.46 3.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.861 -1.15 . . . . 0.0 108.977 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.4 24.47 0.3 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 p -141.61 147.09 37.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -1.022 . . . . 0.0 108.41 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.755 HG22 HD21 ' A' ' 75' ' ' LEU . 33.0 m -129.38 108.75 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 44.37 23.31 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.379 -0.826 . . . . 0.0 109.305 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' VAL . 29.2 tp -90.39 145.05 25.25 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.472 0.653 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.48 17.22 59.02 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -134.35 -48.06 0.77 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.508 -0.995 . . . . 0.0 110.127 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.81 37.39 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -51.36 139.73 18.74 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.133 -1.216 . . . . 0.0 109.92 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -146.52 137.69 24.32 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.58 166.82 13.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.116 -1.615 . . . . 0.0 108.982 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -141.34 154.51 45.72 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -103.11 134.84 45.87 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.73 -1.231 . . . . 0.0 109.514 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -104.77 -5.52 21.17 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.448 -0.782 . . . . 0.0 110.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.4 56.9 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -169.17 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -1.113 . . . . 0.0 109.409 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.9 m -143.62 119.0 10.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 mm -76.91 138.83 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.848 -1.157 . . . . 0.0 110.878 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.19 117.12 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 63' ' ' ILE . 53.7 mt -127.73 139.53 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 121.357 -0.84 . . . . 0.0 111.735 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.414 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 75.1 m -120.08 121.96 29.23 Favored Pre-proline 0 N--CA 1.48 1.028 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' SER . 49.6 Cg_exo -36.21 -78.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 121.886 1.724 . . . . 0.0 111.845 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.15 -40.9 5.71 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.194 -0.941 . . . . 0.0 110.073 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.59 -162.83 0.41 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.144 -0.973 . . . . 0.0 111.296 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' OE2' ' OG ' ' A' ' 50' ' ' SER . 80.7 mt-10 -152.09 104.63 2.99 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.896 -0.503 . . . . 0.0 111.198 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -107.67 114.34 28.25 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.626 -1.296 . . . . 0.0 109.222 178.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.66 -90.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.884 0.85 . . . . 0.0 110.05 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -64.62 43.39 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 111.025 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' A' ' 56' ' ' ALA . 55.4 p90 -93.41 -178.17 4.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.38 1.086 . . . . 0.0 111.698 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -137.51 119.75 15.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.895 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.27 177.26 8.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.098 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -131.2 127.27 37.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -101.09 108.04 19.63 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.935 -1.103 . . . . 0.0 110.966 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -104.03 140.68 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -69.89 157.98 36.4 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.383 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.36 83.8 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.049 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.81 85.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.44 -1.413 . . . . 0.0 110.516 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -59.5 -24.12 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.5 tm? -59.85 -39.14 84.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -55.75 -32.55 63.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.0 -41.26 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.692 -1.255 . . . . 0.0 108.392 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.6 mp -64.28 -40.31 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.79 93.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 111.236 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -37.72 58.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.453 -1.405 . . . . 0.0 111.559 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.86 -49.68 60.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.161 -0.962 . . . . 0.0 112.0 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.755 HD21 HG22 ' A' ' 32' ' ' VAL . 9.0 mp -80.33 -55.62 4.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.639 -1.288 . . . . 0.0 110.929 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--N 1.298 -1.67 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.777 -179.325 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.721 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER 157.69 -75.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.07 -47.74 84.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 m -61.02 -50.04 74.96 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.054 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m -75.0 -54.21 7.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.865 -1.147 . . . . 0.0 112.907 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.464 ' HB3' HD22 ' A' ' 22' ' ' LEU . 61.7 mm-40 -64.77 -41.21 96.03 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.624 -1.298 . . . . 0.0 112.928 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.562 ' CG1' ' CH2' ' A' ' 38' ' ' TRP . 94.0 t -69.91 -47.79 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.341 -1.474 . . . . 0.0 111.373 -177.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.2 mp -61.71 -42.91 96.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.283 -0.886 . . . . 0.0 110.626 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -65.78 -41.4 92.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.653 -1.279 . . . . 0.0 109.782 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.438 ' HB2' HD21 ' A' ' 22' ' ' LEU . . . -65.11 -22.43 66.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.36 99.26 3.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.055 -1.028 . . . . 0.0 109.329 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 14' ' ' ARG . 4.6 mmmm -93.45 169.91 10.0 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.89 39.88 0.11 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' LYS . 7.6 ptm180 -90.88 75.02 6.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.133 -1.216 . . . . 0.0 109.322 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ARG . 58.0 mp0 57.88 113.87 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.77 110.37 3.03 Favored Glycine 0 N--CA 1.481 1.656 0 O-C-N 120.994 -1.066 . . . . 0.0 110.613 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.668 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 7.5 tttp -167.12 -43.36 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.769 -0.842 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 80.5 Cg_endo -99.88 115.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 123.328 2.685 . . . . 0.0 111.714 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -111.46 141.88 44.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.378 -0.826 . . . . 0.0 109.696 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.602 ' N ' ' SD ' ' A' ' 19' ' ' MET . 4.5 mm -110.61 133.19 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 25' ' ' GLY . 20.3 m -105.92 100.48 10.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.449 -0.782 . . . . 0.0 109.067 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.652 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.84 -15.99 63.65 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.07 -46.5 94.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -124.9 2.21 8.07 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.627 -0.671 . . . . 0.0 109.228 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 56.47 78.99 0.1 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.33 135.4 28.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.267 -1.137 . . . . 0.0 109.283 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.45 126.81 32.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 0.0 108.637 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 30' ' ' GLY . 55.3 mt -113.02 162.6 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -147.7 36.19 0.87 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.513 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -155.42 30.03 0.63 Allowed Glycine 0 C--N 1.293 -1.818 0 N-CA-C 106.289 -2.724 . . . . 0.0 106.289 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.437 ' OG1' ' CG2' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -133.41 138.09 46.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.549 HG12 ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -131.87 102.65 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 179.09 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.549 ' CZ ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER 44.62 54.66 6.37 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.67 117.91 8.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.868 -1.145 . . . . 0.0 109.498 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' C ' ' HE1' ' A' ' 38' ' ' TRP . . . 142.21 22.18 0.23 Allowed Glycine 0 N--CA 1.501 3.016 0 O-C-N 120.995 -1.066 . . . . 0.0 110.887 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.719 ' N ' ' HE1' ' A' ' 38' ' ' TRP . 65.0 m-20 -157.81 -85.86 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.785 -1.421 . . . . 0.0 110.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -142.21 22.08 2.43 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.719 ' HE1' ' N ' ' A' ' 36' ' ' ASP . 2.3 m95 -57.6 147.59 26.7 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.586 0.707 . . . . 0.0 110.633 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 t -156.35 154.1 30.04 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.53 166.68 24.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.597 -1.315 . . . . 0.0 109.049 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -144.91 155.04 43.21 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -100.64 133.05 45.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.706 -1.246 . . . . 0.0 108.694 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.08 -11.86 15.54 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.418 -0.802 . . . . 0.0 109.98 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 95.89 107.35 2.27 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 80.3 -4.24 1.87 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.787 -0.831 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.2 m -166.16 120.59 1.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 mm -95.69 137.87 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.8 t -109.38 123.29 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.418 ' C ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.156 -0.965 . . . . 0.0 110.801 -179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.679 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -106.12 120.8 47.65 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 177.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.679 ' O ' ' O ' ' A' ' 50' ' ' SER . 31.1 Cg_exo -36.9 -112.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.144 1.896 . . . . 0.0 111.184 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -76.89 -31.61 56.86 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -171.79 -161.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.008 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -156.4 110.33 2.73 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.763 -0.585 . . . . 0.0 109.513 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.532 ' O ' ' C ' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -111.1 116.3 30.89 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.816 -1.177 . . . . 0.0 109.38 179.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.532 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 26.2 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.966 0.888 . . . . 0.0 110.497 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.2 43.61 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.871 -0.518 . . . . 0.0 111.247 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 56' ' ' ALA . 47.2 p90 -92.34 178.7 5.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.839 -1.163 . . . . 0.0 111.467 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.63 102.92 6.81 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.54 173.39 3.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 109.795 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -144.21 131.31 20.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -111.49 117.23 32.44 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.201 -0.937 . . . . 0.0 111.081 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.25 138.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -73.16 160.0 32.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.726 -1.233 . . . . 0.0 108.601 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.78 91.69 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.809 -1.182 . . . . 0.0 110.0 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.88 92.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.8 -1.188 . . . . 0.0 109.361 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -60.33 -25.21 65.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 68' ' ' LEU . 1.1 tt -57.35 -40.23 77.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -58.16 -28.63 64.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.597 -0.689 . . . . 0.0 109.227 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.06 -39.86 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.703 -1.248 . . . . 0.0 108.556 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.93 -39.94 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 108.997 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.53 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.986 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -60.0 -46.57 89.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.724 -1.235 . . . . 0.0 109.227 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.463 HD22 HG22 ' A' ' 32' ' ' VAL . 64.2 t30 -68.38 -74.22 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.866 -0.521 . . . . 0.0 111.166 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' A' ' 75' ' ' LEU . 2.8 mp -61.21 -46.59 89.8 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.705 -1.247 . . . . 0.0 111.226 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 76' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.014 -1.054 . . . . 0.0 109.127 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.733 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 156.89 -85.64 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.17 -50.15 74.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.0 m -61.42 -49.55 76.4 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.8 p -70.39 -48.04 58.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.911 -1.118 . . . . 0.0 112.384 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -69.6 -42.25 74.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 112.617 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 52' ' ' ALA . 95.4 t -66.76 -45.77 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.558 -1.338 . . . . 0.0 110.576 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mp -60.42 -45.31 96.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -60.64 -40.49 92.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.641 -1.287 . . . . 0.0 111.441 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -27.93 67.77 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.569 -1.332 . . . . 0.0 109.425 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.633 ' ND2' ' CZ ' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -160.28 140.26 11.36 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.026 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -160.27 118.6 2.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.1 -1.0 . . . . 0.0 110.227 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.72 35.57 24.9 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' O ' ' OH ' ' A' ' 33' ' ' TYR . 44.2 ttp180 -149.03 44.75 0.99 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.033 -1.275 . . . . 0.0 109.066 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -66.5 105.83 1.6 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.125 -0.984 . . . . 0.0 110.888 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.5 -68.19 0.04 OUTLIER Glycine 0 N--CA 1.498 2.775 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.849 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -174.56 -20.82 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.215 -1.168 . . . . 0.0 112.782 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.849 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 90.3 Cg_endo -88.8 110.21 0.54 Allowed 'Trans proline' 0 N--CA 1.485 1.02 0 CA-C-N 121.251 1.483 . . . . 0.0 112.203 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.563 ' SD ' HG21 ' A' ' 31' ' ' THR . 8.9 ttt -102.74 147.29 27.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.718 -0.614 . . . . 0.0 109.708 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.88 120.99 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.616 -0.678 . . . . 0.0 109.546 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 p -98.24 96.23 7.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.63 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.46 -17.84 64.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.2 t -59.68 -42.87 89.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -128.76 2.82 5.43 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.24 79.66 0.08 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.9 138.53 28.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.29 -1.123 . . . . 0.0 109.759 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 29' ' ' LYS . 4.1 tm-20 -81.31 120.93 25.56 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.95 67.99 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 109.71 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 46.0 pttt -60.24 102.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.442 1.115 . . . . 0.0 110.308 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.662 ' C ' HD21 ' A' ' 74' ' ' ASN . . . 136.45 25.49 0.46 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.563 HG21 ' SD ' ' A' ' 19' ' ' MET . 98.7 m -138.48 140.96 39.41 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.507 -0.996 . . . . 0.0 108.5 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -118.55 80.5 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CZ ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER 42.37 25.6 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' VAL . 54.9 tp -85.12 129.87 34.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.872 . . . . 0.0 109.79 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 36' ' ' ASP . . . 124.83 -75.24 0.4 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' GLY . 78.4 m-20 -31.59 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.866 -0.785 . . . . 0.0 111.498 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . -134.87 16.44 4.24 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.47 ' C ' ' O ' ' A' ' 37' ' ' GLY . 3.7 t90 -26.34 138.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.969 0.414 . . . . 0.0 111.793 -178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -159.46 144.51 15.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.852 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -170.05 168.59 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.525 -1.359 . . . . 0.0 109.195 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -153.73 159.54 42.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -104.97 120.97 42.77 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.026 -1.046 . . . . 0.0 110.409 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -100.9 -2.81 31.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.12 -0.988 . . . . 0.0 110.71 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.5 -114.56 1.24 Allowed Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.44 -9.8 59.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -1.027 . . . . 0.0 110.546 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.9 m -129.15 140.12 51.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.45 HG13 HD12 ' A' ' 68' ' ' LEU . 36.3 mm -108.09 139.85 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 110.104 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.2 120.28 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.557 -0.715 . . . . 0.0 109.278 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.66 141.29 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.817 -1.177 . . . . 0.0 110.802 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 51' ' ' PRO . 95.0 p -111.77 127.09 27.37 Favored Pre-proline 0 N--CA 1.482 1.129 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD3' ' HZ2' ' A' ' 61' ' ' LYS . 52.6 Cg_exo -34.83 -81.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.961 1.774 . . . . 0.0 112.619 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -106.03 -41.64 5.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 52' ' ' ALA . 79.3 mt-10 -158.62 -165.42 1.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.066 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -172.25 113.27 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.673 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 19.0 p -126.94 38.46 4.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.293 -0.879 . . . . 0.0 110.415 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 73.85 -24.92 0.2 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.93 -1.106 . . . . 0.0 109.57 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 55' ' ' THR . 6.4 mt -87.8 -3.29 58.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -132.47 -156.47 0.75 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -150.74 158.57 44.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.449 -1.407 . . . . 0.0 111.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.23 174.46 8.74 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HZ2' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -134.19 128.25 33.63 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -81.55 167.05 19.7 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.98 -1.075 . . . . 0.0 109.291 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 63' ' ' ILE . 19.2 tt -169.69 118.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.1 p -58.54 151.19 20.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 110.913 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -53.81 -41.44 67.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.381 -0.824 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.98 94.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.5 -1.375 . . . . 0.0 109.267 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.452 ' O ' HG22 ' A' ' 70' ' ' ILE . 18.6 m80 -61.52 -25.1 67.06 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.45 HD12 HG13 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -57.04 -28.45 62.55 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.34 -34.64 74.91 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.875 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 67' ' ' HIS . 4.6 tt -59.56 -36.51 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 118.479 -1.289 . . . . 0.0 108.427 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.516 ' O ' HD22 ' A' ' 75' ' ' LEU . 67.1 mt -60.32 -45.19 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.87 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.73 -28.82 67.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.055 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -62.26 -39.33 92.53 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.478 -1.389 . . . . 0.0 108.663 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.662 HD21 ' C ' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -69.59 -68.14 0.43 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.697 -0.627 . . . . 0.0 110.761 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.647 ' H ' HD22 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -60.1 -51.2 70.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.14 . . . . 0.0 111.221 -176.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 76' ' ' LEU . 6.3 mt . . . . . 0 C--N 1.3 -1.58 0 O-C-N 120.799 -1.188 . . . . 0.0 109.219 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER 162.05 -82.73 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.5 tp -59.92 -48.88 79.9 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.9 m -64.01 -51.82 62.45 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.329 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 t -70.95 -52.39 20.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.801 -1.187 . . . . 0.0 111.489 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' THR . 36.4 tp10 -61.01 -46.09 92.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.972 -1.08 . . . . 0.0 112.665 -177.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 52' ' ' ALA . 64.3 t -67.91 -49.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 112.078 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.586 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.01 -45.63 95.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 110.693 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.99 -40.11 88.03 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.981 -1.074 . . . . 0.0 110.931 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -19.93 65.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.83 -1.169 . . . . 0.0 111.769 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.549 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -124.77 52.5 1.55 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.996 -1.065 . . . . 0.0 111.263 -178.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -86.67 58.95 5.35 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.571 -1.33 . . . . 0.0 110.018 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.18 36.3 0.03 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.561 HH22 ' H ' ' A' ' 20' ' ' ILE . 5.6 tpp180 -74.19 138.89 44.06 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.403 -1.057 . . . . 0.0 109.508 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -70.44 -39.9 74.08 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 57.26 0.26 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.535 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -175.59 -46.05 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.412 -1.052 . . . . 0.0 109.463 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' ' H ' ' A' ' 17' ' ' LYS . 72.0 Cg_endo -90.57 128.6 1.42 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.31 2.007 . . . . 0.0 111.675 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -123.02 128.7 50.53 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.561 ' H ' HH22 ' A' ' 14' ' ' ARG . 87.1 mt -110.49 130.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.067 -1.021 . . . . 0.0 109.465 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' GLY . 67.6 m -88.72 99.78 12.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.015 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -61.95 -13.05 21.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.35 -0.844 . . . . 0.0 109.151 -179.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.575 ' N ' HD22 ' A' ' 22' ' ' LEU . 70.0 t -60.11 -47.64 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 108.604 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 52.7 t0 -123.42 7.56 9.0 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.93 84.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -142.39 135.5 28.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.476 -1.014 . . . . 0.0 109.936 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -77.13 121.08 23.09 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.8 mt -119.99 69.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -61.64 106.56 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.989 -1.069 . . . . 0.0 108.82 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.08 18.75 0.93 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.663 ' N ' HD21 ' A' ' 74' ' ' ASN . 0.5 OUTLIER -141.66 146.8 36.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -1.046 . . . . 0.0 108.437 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG2' HD21 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -131.23 111.46 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 44.63 21.63 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 0.0 109.224 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' VAL . 34.5 tp -85.82 149.34 25.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.83 79.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.47 -63.37 1.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.618 -0.93 . . . . 0.0 109.355 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 158.69 39.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -59.74 155.38 16.06 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.499 -1.0 . . . . 0.0 110.507 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -146.43 149.68 34.18 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.93 169.39 17.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.238 -1.539 . . . . 0.0 109.782 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -159.95 136.2 8.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -109.03 122.85 48.13 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.657 -1.277 . . . . 0.0 111.469 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 10.7 t70 -96.69 -6.84 35.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.658 -0.651 . . . . 0.0 110.687 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.61 15.66 42.49 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.743 -1.223 . . . . 0.0 110.813 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -171.12 -55.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.305 . . . . 0.0 108.647 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.3 m -120.12 129.99 54.42 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -91.34 140.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.419 -0.8 . . . . 0.0 111.959 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.6 t -103.61 111.58 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -129.67 140.17 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 51' ' ' PRO . 13.5 m -112.66 121.58 38.36 Favored Pre-proline 0 N--CA 1.483 1.222 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 50' ' ' SER . 30.8 Cg_exo -35.27 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 122.263 1.975 . . . . 0.0 112.154 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.586 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -107.98 -41.52 4.93 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -166.43 -163.41 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.609 0.719 . . . . 0.0 109.943 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 56' ' ' ALA . 3.9 tm-20 -172.05 116.27 0.36 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.667 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 6.6 p -122.15 38.1 4.22 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.155 -0.966 . . . . 0.0 110.338 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 73.66 -18.68 0.37 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.179 -0.95 . . . . 0.0 109.383 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 55' ' ' THR . 14.0 mt -93.51 0.09 56.56 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -130.13 -153.34 0.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -145.34 159.62 42.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.998 -1.064 . . . . 0.0 110.818 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.47 174.65 11.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -136.46 106.95 6.48 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -73.29 175.86 6.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -166.7 122.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.5 ' HG ' ' HD1' ' A' ' 67' ' ' HIS . 76.9 p -54.67 148.42 12.68 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.568 -1.332 . . . . 0.0 108.229 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -52.01 -44.92 64.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.99 -1.069 . . . . 0.0 109.158 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.11 79.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 119.992 -1.693 . . . . 0.0 109.967 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.5 ' HD1' ' HG ' ' A' ' 64' ' ' SER . 31.6 m80 -61.67 -23.57 66.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.558 -1.339 . . . . 0.0 108.668 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.95 -33.47 71.97 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -62.59 -37.18 85.23 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.03 -38.86 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.099 -1.001 . . . . 0.0 109.724 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.497 ' O ' HD22 ' A' ' 75' ' ' LEU . 57.9 mt -59.92 -44.08 93.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.824 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.14 -33.76 76.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.728 -1.232 . . . . 0.0 110.478 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -61.62 -41.91 98.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.448 -1.408 . . . . 0.0 109.597 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.663 HD21 ' N ' ' A' ' 31' ' ' THR . 57.1 t30 -60.71 -61.62 2.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.715 -0.616 . . . . 0.0 111.194 -177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.2 mm? -60.25 -40.04 88.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.629 -1.295 . . . . 0.0 110.361 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--N 1.297 -1.682 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.789 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.187 0.517 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p -102.56 -5.54 23.82 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.334 -0.854 . . . . 0.0 109.415 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.521 HD21 ' O ' ' A' ' 36' ' ' ASP . 10.6 tp -63.51 -54.71 31.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.441 HG21 ' CD2' ' A' ' 58' ' ' PHE . 33.3 m -62.49 -50.31 71.93 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -70.31 -43.67 69.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.123 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -70.05 -41.75 73.77 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.698 -1.252 . . . . 0.0 112.131 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.09 -50.3 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.531 -1.356 . . . . 0.0 111.087 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.571 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.05 -48.08 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.019 -1.051 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -60.01 -39.04 84.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.32 -22.18 63.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 109.416 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.2 t30 -152.56 126.92 9.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.732 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 14' ' ' ARG . 57.1 pttt -175.01 162.17 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.466 -0.771 . . . . 0.0 109.866 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.56 -27.54 1.56 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 12' ' ' LYS . 54.4 ttm-85 -95.02 127.0 40.75 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HA ' ' HZ1' ' A' ' 61' ' ' LYS . 91.3 mt-10 -43.95 -64.0 0.75 Allowed 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.17 0.509 . . . . 0.0 110.321 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.8 83.31 0.05 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.043 -1.551 . . . . 0.0 110.757 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.536 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -125.96 -52.2 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 18.4 Cg_endo -103.62 130.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.568 2.845 . . . . 0.0 110.678 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 ttt -132.06 126.23 33.33 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.878 -1.139 . . . . 0.0 110.012 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.79 129.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.717 0.77 . . . . 0.0 109.925 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 25' ' ' GLY . 13.6 p -87.82 100.7 13.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.049 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.39 -13.82 6.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' H ' HD22 ' A' ' 22' ' ' LEU . 65.9 t -59.99 -44.98 95.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -125.64 0.26 7.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 66.61 13.33 60.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -75.89 137.18 40.23 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.22 138.34 31.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.475 -0.766 . . . . 0.0 110.274 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 30' ' ' GLY . 63.8 mt -122.45 158.1 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -140.83 36.6 1.79 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.083 -1.636 . . . . 0.0 107.576 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -156.63 28.46 0.54 Allowed Glycine 0 C--N 1.297 -1.63 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.0 p -135.51 142.26 45.41 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.054 0.93 . . . . 0.0 110.146 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 32' ' ' VAL . 16.4 m -121.0 88.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 35.4 p90 40.08 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.538 0.685 . . . . 0.0 109.238 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 32' ' ' VAL . 47.1 tp -73.26 135.15 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.675 -0.64 . . . . 0.0 109.572 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . 73.1 147.28 0.85 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' HD21 ' A' ' 3' ' ' LEU . 6.5 m-20 95.92 19.95 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 123.295 0.638 . . . . 0.0 110.129 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 123.71 -11.38 8.38 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 37' ' ' GLY . 5.8 p-90 -32.26 126.14 0.28 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.39 0.614 . . . . 0.0 111.013 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 t -152.93 140.23 19.53 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.52 175.02 11.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.157 -1.589 . . . . 0.0 109.868 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -161.19 159.9 29.41 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -110.41 121.47 45.38 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.995 -1.066 . . . . 0.0 109.708 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.414 ' C ' ' OD1' ' A' ' 43' ' ' ASP . 4.4 p30 -100.66 -1.02 36.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.226 -0.921 . . . . 0.0 110.262 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.56 -120.04 1.36 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.736 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -81.41 -7.75 59.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -1.112 . . . . 0.0 110.317 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.7 m -123.47 130.82 53.25 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.82 141.93 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.14 119.63 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mt -131.66 146.96 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.287 -0.883 . . . . 0.0 110.917 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' PRO . 15.8 m -118.12 111.49 38.68 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 102.467 -3.161 . . . . 0.0 102.467 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.1 Cg_exo -33.34 -75.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.023 1.815 . . . . 0.0 111.386 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.571 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -106.15 -47.07 3.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.71 -165.99 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.497 ' OE2' ' N ' ' A' ' 60' ' ' ALA . 62.2 tt0 -175.11 114.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -118.19 36.47 4.34 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.069 -1.019 . . . . 0.0 109.879 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 72.59 -21.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 0.0 109.042 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 55' ' ' THR . 40.9 mt -91.03 0.02 57.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CD2' HG21 ' A' ' 4' ' ' THR . 92.6 m-85 -128.51 -135.95 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -155.28 155.1 33.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.708 -1.245 . . . . 0.0 111.789 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.497 ' N ' ' OE2' ' A' ' 54' ' ' GLU . . . -86.37 177.44 7.45 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HZ1' ' HA ' ' A' ' 15' ' ' GLU . 53.5 tttm -139.51 150.77 45.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -115.77 173.16 6.7 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.228 -0.92 . . . . 0.0 108.995 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -168.41 111.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -48.42 155.1 0.55 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.08 -1.013 . . . . 0.0 109.068 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -56.82 -48.15 78.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.052 -1.03 . . . . 0.0 108.603 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.98 87.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.16 -1.588 . . . . 0.0 108.767 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -59.24 -28.11 66.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.866 -1.146 . . . . 0.0 108.32 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.692 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.2 tm? -59.83 -30.06 68.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -60.39 -37.14 79.85 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.09 -38.74 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.394 -0.816 . . . . 0.0 109.391 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.4 mp -58.35 -39.9 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 108.281 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.445 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -66.1 -40.03 90.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 111.096 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.13 -48.07 72.05 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.625 -1.297 . . . . 0.0 111.174 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -59.98 -52.67 64.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 112.029 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.587 HD11 HG13 ' A' ' 32' ' ' VAL . 4.4 mp -69.91 -42.1 73.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.302 -1.498 . . . . 0.0 110.459 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' OXT' ' O ' ' A' ' 72' ' ' ALA . 2.3 pp . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.7 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p -97.23 -1.42 44.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.281 -0.887 . . . . 0.0 108.853 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.16 -45.74 92.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.015 0.912 . . . . 0.0 108.78 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.4 m -61.2 -54.41 44.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 110.847 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.3 t -70.19 -48.34 57.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.834 -1.166 . . . . 0.0 112.067 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.15 -46.63 86.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.804 -1.185 . . . . 0.0 112.98 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.3 -48.12 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 112.155 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.4 mp -61.32 -47.78 91.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.667 -1.271 . . . . 0.0 109.934 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.3 -40.12 89.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.889 -1.132 . . . . 0.0 110.755 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.92 86.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.827 -1.171 . . . . 0.0 109.039 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 20' ' ' ILE . 35.2 m120 -135.29 114.85 12.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 110.081 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 14' ' ' ARG . 52.5 tttm -89.71 169.67 11.1 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.79 27.29 0.14 Allowed Glycine 0 N--CA 1.488 2.141 0 O-C-N 120.536 -1.353 . . . . 0.0 110.81 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' LYS . 11.1 ptm180 -70.19 88.11 0.61 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.647 -1.502 . . . . 0.0 108.305 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 14' ' ' ARG . 44.5 mt-10 48.87 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.959 -1.088 . . . . 0.0 109.244 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.06 101.49 0.27 Allowed Glycine 0 N--CA 1.487 2.051 0 O-C-N 121.056 -1.027 . . . . 0.0 110.701 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 18' ' ' PRO . 2.0 mtmt -153.89 -52.73 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 17' ' ' LYS . 35.1 Cg_endo -95.12 126.2 0.39 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.313 2.009 . . . . 0.0 110.595 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.66 136.86 54.27 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 110.942 -178.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.509 ' H ' ' CG ' ' A' ' 11' ' ' ASN . 27.7 mm -100.09 128.1 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.8 t -102.52 103.92 14.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.419 -0.8 . . . . 0.0 108.88 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.63 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -69.4 -7.28 36.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -47.55 91.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -128.73 11.59 6.2 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.99 83.27 0.04 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -150.36 139.72 21.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.477 -1.014 . . . . 0.0 109.519 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -84.83 139.09 32.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 109.08 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 30' ' ' GLY . 71.0 mt -122.78 158.56 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -144.61 42.46 1.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -168.3 32.41 0.19 Allowed Glycine 0 C--N 1.294 -1.801 0 N-CA-C 106.313 -2.715 . . . . 0.0 106.313 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.463 ' OG1' HG21 ' A' ' 28' ' ' ILE . 12.7 m -136.79 142.64 42.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.784 0.802 . . . . 0.0 109.879 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.537 HG22 HD21 ' A' ' 75' ' ' LEU . 16.7 m -128.55 73.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.407 ' OH ' ' O ' ' A' ' 12' ' ' LYS . 14.5 m-85 53.84 23.27 3.72 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.651 HD13 ' N ' ' A' ' 35' ' ' GLY . 1.7 tm? -73.75 123.71 24.65 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.651 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 78.64 158.49 12.22 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 10.2 m-20 93.94 7.09 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 C-N-CA 123.105 0.562 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 130.53 -3.77 5.81 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.473 ' HB3' ' H ' ' A' ' 35' ' ' GLY . 10.1 p-90 -29.92 138.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.423 0.63 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.8 m -151.01 139.88 20.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.99 167.53 21.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.566 -1.334 . . . . 0.0 109.867 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -161.41 125.82 3.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -102.93 130.11 49.88 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.748 -1.22 . . . . 0.0 110.885 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -107.52 -11.31 15.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.645 -0.659 . . . . 0.0 109.716 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.03 2.32 89.5 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.97 -31.24 0.5 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -1.127 . . . . 0.0 109.433 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.4 m -157.22 118.66 3.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.18 122.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 121.346 -0.846 . . . . 0.0 111.535 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 t -95.61 99.16 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 142.32 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.407 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.1 p -117.11 149.57 44.55 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.56 -81.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.408 1.405 . . . . 0.0 112.077 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -90.61 -45.85 8.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.884 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -167.44 1.17 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.273 -1.517 . . . . 0.0 111.486 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 28.2 mp0 -150.44 98.48 2.66 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 57' ' ' LEU . 4.1 p -129.99 144.29 51.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -25.13 -29.21 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 55' ' ' THR . 6.8 mp -83.61 -10.2 58.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.62 -1.3 . . . . 0.0 110.242 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 55' ' ' THR . 23.1 t80 -138.46 -164.55 1.65 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.282 -0.886 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -154.9 170.79 20.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.998 -1.064 . . . . 0.0 110.904 -179.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.68 175.34 8.72 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.501 0.667 . . . . 0.0 110.404 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -128.77 141.77 51.21 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -86.71 169.29 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.046 -1.034 . . . . 0.0 110.592 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -162.91 127.87 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.8 m -61.19 154.9 22.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.277 -1.514 . . . . 0.0 108.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.44 -51.75 68.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.654 -1.278 . . . . 0.0 109.401 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.93 87.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.695 -1.253 . . . . 0.0 109.153 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -55.04 -27.26 43.19 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.889 -1.132 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -59.91 -33.67 72.19 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -59.95 -35.4 74.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.0 mt -59.64 -39.75 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.91 . . . . 0.0 108.929 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.425 HG23 HG21 ' A' ' 32' ' ' VAL . 48.1 mt -58.88 -39.94 78.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 O-C-N 121.216 -0.927 . . . . 0.0 108.997 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.82 -41.56 99.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 111.106 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' LEU . 6.4 mtmp? -65.94 -50.04 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.047 -1.033 . . . . 0.0 111.011 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.87 -43.63 94.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.462 -0.773 . . . . 0.0 111.987 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 75' ' ' LEU . 5.7 mp -80.92 -22.51 39.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.43 -1.419 . . . . 0.0 110.326 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.11 -0.994 . . . . 0.0 109.96 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.9 p -103.67 -6.82 21.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.612 -0.68 . . . . 0.0 109.755 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.99 -45.15 95.95 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.496 HG22 ' CE2' ' A' ' 58' ' ' PHE . 22.5 m -62.26 -54.88 34.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.855 -0.528 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -71.95 -48.65 43.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.574 -1.329 . . . . 0.0 112.0 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.81 -42.58 90.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.02 -1.05 . . . . 0.0 112.791 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 52' ' ' ALA . 96.7 t -69.81 -48.36 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.323 -1.486 . . . . 0.0 111.225 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.583 HD11 ' H ' ' A' ' 52' ' ' ALA . 1.4 mp -60.24 -47.91 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.0 111.058 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -63.71 -40.23 96.26 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.032 -1.042 . . . . 0.0 110.091 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.519 ' CB ' HD12 ' A' ' 22' ' ' LEU . . . -56.81 -38.22 72.28 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.093 -1.005 . . . . 0.0 108.384 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.26 109.45 5.08 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 14' ' ' ARG . 62.1 mttp -77.01 -179.73 5.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.65 40.25 0.95 Allowed Glycine 0 N--CA 1.491 2.304 0 O-C-N 120.877 -1.139 . . . . 0.0 110.375 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 15' ' ' GLU . 7.9 ptm180 -80.53 86.87 5.76 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.371 -1.076 . . . . 0.0 108.29 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' ARG . 52.4 tp10 53.24 105.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.51 -0.743 . . . . 0.0 109.61 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.32 93.71 0.45 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.517 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER -145.32 -51.85 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.346 -1.09 . . . . 0.0 108.996 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 61.2 Cg_endo -95.95 129.7 0.4 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.001 1.8 . . . . 0.0 111.349 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 124.82 46.75 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.4 mt -109.41 128.09 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.79 . . . . 0.0 109.037 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 23' ' ' VAL . 8.8 t -91.67 99.27 12.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.09 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -59.13 -8.59 1.59 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.59 ' N ' HD22 ' A' ' 22' ' ' LEU . 54.4 t -60.83 -41.12 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -123.28 -14.35 7.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.56 15.58 79.41 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -83.16 150.3 26.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -1.106 . . . . 0.0 111.776 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -91.66 130.99 37.37 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.73 74.39 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.53 -0.731 . . . . 0.0 109.864 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -68.5 108.48 3.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.853 -1.154 . . . . 0.0 108.925 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.91 21.77 0.87 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.3 p -143.62 150.92 39.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -1.068 . . . . 0.0 108.316 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 32' ' ' VAL . 32.7 m -127.1 89.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.448 -0.783 . . . . 0.0 109.178 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 57.78 19.94 6.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.112 -0.993 . . . . 0.0 109.918 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.1 tp -73.15 141.19 47.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 108.908 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.16 58.84 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.15 -138.51 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -102.22 24.32 31.5 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.427 ' C ' ' O ' ' A' ' 37' ' ' GLY . 10.9 t90 -38.57 128.33 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.729 0.775 . . . . 0.0 110.891 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.5 t -151.09 137.71 18.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.11 173.12 17.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.304 -1.497 . . . . 0.0 110.208 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -151.97 153.79 34.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -101.26 120.79 40.78 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.707 -1.245 . . . . 0.0 109.131 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 49.1 t0 -100.69 -6.62 24.83 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 110.414 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.84 -117.33 0.97 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.029 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.9 17.94 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.961 . . . . 0.0 109.358 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.1 m -150.91 116.08 5.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.79 140.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 111.144 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.91 129.28 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.509 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -151.2 147.17 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.441 -1.412 . . . . 0.0 111.274 -178.036 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -112.3 121.32 39.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 177.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -36.06 -75.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.032 1.821 . . . . 0.0 111.731 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.583 ' H ' HD11 ' A' ' 8' ' ' ILE . . . -104.83 -47.97 3.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.207 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.41 ' OE1' ' OG1' ' A' ' 4' ' ' THR . 5.0 mt-10 -160.75 -166.48 1.62 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.361 -0.837 . . . . 0.0 109.953 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -173.14 116.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 4.9 p -89.88 -78.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.927 -1.108 . . . . 0.0 108.886 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.587 ' N ' ' OG1' ' A' ' 55' ' ' THR . . . -149.12 -76.03 0.16 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -64.86 22.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.394 -0.816 . . . . 0.0 109.871 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' H ' ' C ' ' A' ' 56' ' ' ALA . 22.7 m-85 -99.04 -175.67 3.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.783 -1.198 . . . . 0.0 108.366 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 138.94 53.89 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.964 0.888 . . . . 0.0 111.829 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.32 177.75 7.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -136.67 126.27 25.33 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.856 -1.153 . . . . 0.0 108.542 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -84.04 162.16 20.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.509 HD12 HG21 ' A' ' 49' ' ' ILE . 1.9 mt -151.08 112.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.7 p -62.81 152.18 36.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.755 -1.215 . . . . 0.0 108.358 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.59 69.17 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.773 -1.205 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.04 82.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.426 -1.422 . . . . 0.0 108.774 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -60.2 -35.34 75.18 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.841 -1.162 . . . . 0.0 109.507 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 71' ' ' ILE . 3.4 tm? -56.19 -34.45 66.24 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -60.53 -40.05 90.06 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mt -61.43 -32.01 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.667 HD12 HD22 ' A' ' 68' ' ' LEU . 79.7 mt -60.33 -39.72 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.047 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 76' ' ' LEU . . . -68.27 -36.23 79.09 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.994 -1.066 . . . . 0.0 109.732 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.07 -46.58 89.09 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.036 -1.04 . . . . 0.0 108.855 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -76.26 -74.19 0.24 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.7 -0.625 . . . . 0.0 110.835 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 75' ' ' LEU . 6.7 mp -60.22 -44.58 95.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.952 -1.093 . . . . 0.0 111.309 -177.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 72' ' ' ALA . 21.9 mt . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.602 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p -102.33 -0.07 33.35 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.283 -0.886 . . . . 0.0 110.282 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 3.8 tt -60.11 -48.34 82.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.836 -1.165 . . . . 0.0 109.253 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m -78.67 -50.52 11.3 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.494 0.664 . . . . 0.0 110.579 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -66.35 -52.86 42.69 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 112.561 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.55 -42.04 78.93 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.346 -1.471 . . . . 0.0 112.785 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 3' ' ' LEU . 95.7 t -61.15 -48.94 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.128 -0.983 . . . . 0.0 111.451 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.87 -40.34 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.411 -0.805 . . . . 0.0 109.905 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -58.68 -45.18 90.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.1 -1.0 . . . . 0.0 110.831 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 22' ' ' LEU . . . -60.12 -47.04 87.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.746 -1.221 . . . . 0.0 111.087 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 11' ' ' ASN . 5.3 p-10 -88.81 -76.56 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.672 -1.268 . . . . 0.0 110.681 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt 49.61 48.69 21.14 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.546 -1.346 . . . . 0.0 108.545 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.37 40.32 0.02 OUTLIER Glycine 0 N--CA 1.487 2.039 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.551 ' CG ' ' HZ2' ' A' ' 61' ' ' LYS . 6.6 tpt180 -55.56 118.41 4.46 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.945 0.879 . . . . 0.0 109.632 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -76.79 -36.8 56.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.7 23.21 5.12 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.727 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 15.8 mttt -151.71 -41.6 0.01 OUTLIER Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.548 -0.972 . . . . 0.0 111.013 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.727 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 75.5 Cg_endo -92.98 120.66 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.742 2.294 . . . . 0.0 113.513 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.0 tpt -121.5 123.41 41.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.542 -0.724 . . . . 0.0 110.544 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.2 mt -118.21 129.6 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLY . 29.9 t -91.13 99.14 12.2 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.136 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.19 -7.33 8.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 -179.281 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.559 ' N ' HD22 ' A' ' 22' ' ' LEU . 78.2 t -61.11 -45.85 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -128.95 8.58 5.69 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 50.27 91.25 0.01 OUTLIER Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -143.56 137.15 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.372 -1.075 . . . . 0.0 109.042 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.491 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 57.9 mp0 -81.71 123.47 28.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.098 -1.001 . . . . 0.0 108.887 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' GLY . 50.1 mt -127.44 75.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.183 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -74.06 45.42 0.21 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.69 -1.256 . . . . 0.0 108.961 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' ILE . . . -147.99 22.3 1.43 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -152.38 158.92 43.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 34' ' ' LEU . 14.4 m -133.44 112.6 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.321 -0.862 . . . . 0.0 108.974 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.505 ' H ' ' NH1' ' A' ' 14' ' ' ARG . 32.5 p90 39.85 22.44 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.528 0.68 . . . . 0.0 109.369 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -81.93 129.01 34.64 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -178.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.65 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 127.35 -83.47 0.34 Allowed Glycine 0 N--CA 1.499 2.884 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 17.0 p-10 -32.92 -106.82 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.668 0.747 . . . . 0.0 111.895 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . -123.23 30.11 5.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.495 ' C ' ' O ' ' A' ' 37' ' ' GLY . 21.0 p-90 -31.71 132.68 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.872 0.844 . . . . 0.0 111.183 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.9 t -153.86 146.34 24.04 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 173.36 11.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.277 -1.514 . . . . 0.0 109.36 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -163.49 135.21 4.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -110.95 123.7 50.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.854 -1.154 . . . . 0.0 108.417 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 10.3 t70 -106.3 -10.05 16.55 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.362 -0.836 . . . . 0.0 111.305 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.45 -122.27 1.37 Allowed Glycine 0 N--CA 1.503 3.101 0 O-C-N 120.607 -1.308 . . . . 0.0 109.886 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.11 22.93 1.33 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -1.166 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 m -154.75 113.42 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mm -88.24 136.23 23.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.332 -0.855 . . . . 0.0 111.998 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.4 t -112.91 120.11 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.519 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -142.51 147.95 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.4 t -115.9 129.11 25.44 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -39.83 -76.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.597 1.531 . . . . 0.0 112.229 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -97.93 -49.99 4.58 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.023 -1.048 . . . . 0.0 112.318 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -165.51 -163.89 0.7 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.002 -1.686 . . . . 0.0 109.771 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -156.26 107.05 2.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.681 -0.637 . . . . 0.0 111.469 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.536 ' O ' ' C ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -110.81 118.02 35.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.621 -1.299 . . . . 0.0 108.288 178.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 55' ' ' THR . . . 25.27 -90.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.269 1.033 . . . . 0.0 110.287 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 55' ' ' THR . 0.3 OUTLIER -65.28 43.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.305 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' A' ' 56' ' ' ALA . 54.9 p90 -91.88 -174.48 3.82 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.773 -1.204 . . . . 0.0 111.251 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.79 110.77 7.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.713 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.74 174.07 9.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.555 -1.34 . . . . 0.0 109.234 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.551 ' HZ2' ' CG ' ' A' ' 14' ' ' ARG . 82.1 tttt -126.83 129.51 48.42 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -80.63 159.66 25.3 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.914 -1.116 . . . . 0.0 110.681 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.519 HD12 HG21 ' A' ' 49' ' ' ILE . 3.3 mt -153.34 114.57 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.2 m -66.87 159.84 27.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.29 -44.27 64.92 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.738 -1.185 . . . . 0.0 107.865 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.9 93.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.6 -0.688 . . . . 0.0 109.802 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -60.27 -24.79 65.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.17 -45.02 92.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.197 -1.564 . . . . 0.0 106.946 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -54.51 -29.71 51.3 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -0.965 . . . . 0.0 109.014 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.4 -39.67 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.727 -1.233 . . . . 0.0 108.507 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.92 -40.36 80.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.88 -31.49 69.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.363 -1.461 . . . . 0.0 110.528 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -69.84 -55.28 10.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.132 -1.605 . . . . 0.0 111.33 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 17' ' ' LYS . 28.0 t-20 -60.55 -44.66 95.89 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.229 -0.919 . . . . 0.0 111.334 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -63.78 -53.21 54.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.059 . . . . 0.0 110.461 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 1.3 mm? . . . . . 0 C--N 1.294 -1.836 0 CA-C-O 117.892 -1.051 . . . . 0.0 108.374 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.726 0.774 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.7 p -114.34 161.8 17.43 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.36 -49.47 73.77 Favored 'General case' 0 C--N 1.281 -2.381 0 O-C-N 121.359 -0.838 . . . . 0.0 109.656 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.449 HG21 ' CE2' ' A' ' 58' ' ' PHE . 93.9 m -59.58 -48.79 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.072 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -69.01 -41.04 78.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.15 -1.594 . . . . 0.0 111.737 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -68.4 -50.32 53.76 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.042 -1.037 . . . . 0.0 112.329 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.495 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 97.6 t -69.37 -40.56 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.396 -0.815 . . . . 0.0 111.728 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 53' ' ' GLU . 7.0 mm -59.95 -47.37 91.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.843 -1.16 . . . . 0.0 109.8 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.24 -30.96 70.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.921 -1.112 . . . . 0.0 109.798 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 20' ' ' ILE . . . -66.78 -34.13 77.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.287 -0.883 . . . . 0.0 110.908 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 7' ' ' VAL . 21.7 p30 -99.5 -17.33 17.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.084 -1.01 . . . . 0.0 111.079 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -69.33 134.67 49.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.575 -1.328 . . . . 0.0 108.953 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.42 -45.75 0.3 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' GLU . 16.2 ptm180 -168.47 -176.01 2.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.554 -0.968 . . . . 0.0 109.371 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 55.3 mp0 -36.93 138.26 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.602 0.715 . . . . 0.0 109.825 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.08 101.72 0.7 Allowed Glycine 0 C--N 1.291 -1.934 0 C-N-CA 119.46 -1.353 . . . . 0.0 110.239 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.658 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 3.5 ttmt -141.75 -48.03 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.52 -0.988 . . . . 0.0 108.991 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.658 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 55.3 Cg_endo -98.47 136.29 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.109 2.54 . . . . 0.0 110.862 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.439 ' SD ' HG22 ' A' ' 31' ' ' THR . 11.8 ttt -122.96 136.95 55.05 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 120.904 -1.123 . . . . 0.0 111.32 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 10' ' ' ALA . 5.2 mm -105.26 133.15 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.4 t -109.28 102.81 11.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.746 . . . . 0.0 109.583 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.838 ' H ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.18 -19.38 65.29 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.556 -0.858 . . . . 0.0 108.829 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.01 -43.55 92.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -125.71 1.65 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 53.3 81.07 0.06 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -150.6 144.62 25.38 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.122 -1.223 . . . . 0.0 110.191 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -81.77 133.54 35.35 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -129.02 72.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.914 . . . . 0.0 110.853 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -65.57 115.52 5.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.678 -1.264 . . . . 0.0 109.296 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.36 21.05 2.32 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.439 HG22 ' SD ' ' A' ' 19' ' ' MET . 34.5 m -142.25 148.56 38.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.718 HG22 HD21 ' A' ' 75' ' ' LEU . 29.3 m -130.67 103.16 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.21 -0.931 . . . . 0.0 108.862 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 32' ' ' VAL . 13.6 p90 33.31 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.616 -0.677 . . . . 0.0 110.93 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -93.18 129.96 39.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.606 ' N ' HD13 ' A' ' 34' ' ' LEU . . . 96.41 40.82 3.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 77.4 m-20 -147.85 -40.12 0.18 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.745 -0.856 . . . . 0.0 108.703 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . 153.63 33.26 0.03 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -49.86 145.51 5.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.911 -1.347 . . . . 0.0 111.41 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.2 p -145.64 133.24 20.92 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.53 171.04 17.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.063 -1.648 . . . . 0.0 109.821 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -165.63 132.88 2.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -93.04 120.77 33.69 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.675 -1.265 . . . . 0.0 109.479 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -99.07 -0.85 41.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 110.059 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.54 -118.93 1.49 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.67 -4.69 55.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.7 m -132.21 131.34 42.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.6 143.75 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.356 -0.84 . . . . 0.0 110.774 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.5 120.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.492 HG21 HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -154.37 144.33 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.869 -1.144 . . . . 0.0 110.491 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.2 t -111.99 120.7 41.36 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -37.34 -78.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.019 0 C-N-CA 122.321 2.014 . . . . 0.0 113.508 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -84.05 -57.92 2.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.737 -1.227 . . . . 0.0 111.442 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' H ' HD11 ' A' ' 8' ' ' ILE . 92.7 mt-10 -158.58 -168.92 2.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.015 -1.053 . . . . 0.0 109.545 -177.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -169.71 115.5 0.55 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.642 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 6.1 p -128.75 40.63 3.61 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.376 -0.828 . . . . 0.0 110.105 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 55' ' ' THR . . . 75.83 -24.88 0.21 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.682 -0.636 . . . . 0.0 110.386 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 57' ' ' LEU . 10.4 mp -92.53 1.02 57.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.6 -0.687 . . . . 0.0 109.556 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CE2' HG21 ' A' ' 4' ' ' THR . 98.1 m-85 -126.59 -160.98 1.03 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -134.97 149.67 50.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.084 -1.01 . . . . 0.0 111.555 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.08 175.64 8.89 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -132.76 141.95 48.78 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -101.94 107.8 19.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.2 -0.937 . . . . 0.0 109.721 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 49' ' ' ILE . 48.0 mt -100.82 104.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -51.37 164.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.849 -1.157 . . . . 0.0 108.899 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.01 82.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.071 . . . . 0.0 109.53 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.16 85.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.128 -1.608 . . . . 0.0 109.891 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -60.62 -38.18 83.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.389 -1.444 . . . . 0.0 108.679 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.637 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.4 tm? -55.96 -34.73 65.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.997 -1.064 . . . . 0.0 108.371 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -59.89 -33.82 72.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 108.817 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.47 HG22 ' ND2' ' A' ' 74' ' ' ASN . 77.2 mt -60.09 -40.57 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.58 -41.16 91.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.096 -1.003 . . . . 0.0 109.795 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.03 91.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 112.389 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -69.96 -36.95 75.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.868 -1.77 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.47 ' ND2' HG22 ' A' ' 70' ' ' ILE . 95.8 m-20 -63.53 -66.83 0.49 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 110.849 -178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.718 HD21 HG22 ' A' ' 32' ' ' VAL . 7.8 mp -66.77 -46.78 74.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.079 . . . . 0.0 111.323 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 120.881 -1.137 . . . . 0.0 109.865 -178.762 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.688 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER 160.43 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.99 -41.59 92.37 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.6 m -77.79 -49.42 14.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.393 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.0 m -71.28 -57.11 4.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.927 -1.108 . . . . 0.0 111.647 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -60.32 -43.75 96.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.605 -1.309 . . . . 0.0 112.986 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 52' ' ' ALA . 94.5 t -67.19 -42.28 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.158 -1.589 . . . . 0.0 112.024 -177.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.56 -43.77 95.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 120.948 -1.095 . . . . 0.0 110.406 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -69.26 -49.31 57.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.738 -1.226 . . . . 0.0 111.204 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -18.87 65.31 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.871 -1.143 . . . . 0.0 109.759 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -146.2 123.2 11.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.66 ' N ' HH11 ' A' ' 14' ' ' ARG . 16.7 ttmm -151.02 103.4 3.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.277 -0.889 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.572 ' N ' ' NH1' ' A' ' 14' ' ' ARG . . . 72.95 45.34 33.28 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.66 HH11 ' N ' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -62.69 -95.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -1.115 . . . . 0.0 110.852 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 17' ' ' LYS . 78.4 tt0 170.68 83.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 15' ' ' GLU . . . -4.82 70.0 0.0 OUTLIER Glycine 0 N--CA 1.511 3.661 0 C-N-CA 123.464 0.554 . . . . 0.0 113.831 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 15' ' ' GLU . 1.2 mtpp -174.01 -52.51 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.288 . . . . 0.0 109.944 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.13 111.65 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.924 2.416 . . . . 0.0 113.645 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 19' ' ' MET . 0.9 OUTLIER -123.04 133.37 54.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.094 -1.004 . . . . 0.0 108.841 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -106.64 135.11 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.141 -0.974 . . . . 0.0 109.936 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -87.49 98.41 11.37 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -66.23 -13.5 60.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.12 -42.49 93.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.66 -17.4 5.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' SER . . . 82.94 74.44 1.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -138.59 131.86 30.13 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.209 -1.171 . . . . 0.0 109.468 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -82.06 122.57 27.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.869 -1.145 . . . . 0.0 109.824 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 30' ' ' GLY . 67.7 mt -108.66 166.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' N ' HG22 ' A' ' 28' ' ' ILE . 52.5 tttp -150.49 31.54 0.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.628 ' H ' HG22 ' A' ' 28' ' ' ILE . . . -151.33 27.47 0.98 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 28' ' ' ILE . 6.1 p -137.82 144.27 41.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.887 -0.772 . . . . 0.0 109.461 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 32' ' ' VAL . 31.5 m -123.12 84.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER 58.9 39.15 24.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.561 -1.337 . . . . 0.0 109.489 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 36' ' ' ASP . 55.3 tp -80.38 137.32 36.52 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.12 -17.34 4.92 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 34' ' ' LEU . 83.9 m-20 -70.69 -32.23 69.39 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.345 -1.091 . . . . 0.0 108.663 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 38' ' ' TRP . . . 129.13 19.73 1.53 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 37' ' ' GLY . 7.8 t90 -36.19 130.51 0.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.59 0.71 . . . . 0.0 110.955 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.9 t -150.56 131.99 14.69 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.37 179.97 7.86 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.012 -1.68 . . . . 0.0 111.079 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.93 157.75 43.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.06 -1.025 . . . . 0.0 108.297 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -96.72 113.51 25.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.528 -1.357 . . . . 0.0 108.827 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 46.1 t0 -100.62 -0.69 37.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.919 -1.113 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.99 -106.89 0.59 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.715 ' O ' ' HB2' ' A' ' 65' ' ' ALA . . . -91.75 -14.04 30.59 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.491 -1.005 . . . . 0.0 110.279 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.7 m -120.7 125.36 47.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.775 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.7 135.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.551 -0.718 . . . . 0.0 110.46 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.61 106.58 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.46 140.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.567 -0.708 . . . . 0.0 111.634 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 51' ' ' PRO . 11.6 m -111.08 111.2 56.17 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' SER . 29.9 Cg_exo -33.49 -76.73 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 122.264 1.976 . . . . 0.0 112.07 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 7' ' ' VAL . . . -97.87 -49.37 4.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.167 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -165.57 -163.85 0.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -167.91 117.1 0.78 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.146 -0.972 . . . . 0.0 109.508 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.605 ' OG1' ' N ' ' A' ' 56' ' ' ALA . 8.6 p -88.15 -73.51 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.797 -1.189 . . . . 0.0 108.089 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.605 ' N ' ' OG1' ' A' ' 55' ' ' THR . . . -155.56 -77.28 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.45 26.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.505 -0.747 . . . . 0.0 111.092 -179.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.582 ' H ' ' C ' ' A' ' 56' ' ' ALA . 19.2 m-85 -103.71 -166.94 1.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 149.97 46.65 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.828 -1.17 . . . . 0.0 110.989 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.65 179.24 6.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -125.92 122.51 36.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -94.09 101.1 13.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.28 132.62 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.783 0.802 . . . . 0.0 109.421 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -65.9 149.44 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 45' ' ' ALA . . . -53.83 -39.74 65.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 109.543 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.7 -41.39 90.65 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.426 -1.421 . . . . 0.0 110.388 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -59.84 -34.74 73.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.435 -1.415 . . . . 0.0 108.567 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.772 HD22 HD12 ' A' ' 71' ' ' ILE . 3.2 tm? -58.33 -29.96 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -60.11 -37.19 79.25 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.0 mt -60.56 -39.91 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.206 -0.934 . . . . 0.0 109.472 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.772 HD12 HD22 ' A' ' 68' ' ' LEU . 78.7 mt -59.16 -39.72 79.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 108.679 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 76' ' ' LEU . . . -66.28 -38.77 88.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 110.392 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -62.06 -40.8 97.03 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.595 -1.315 . . . . 0.0 110.42 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -73.99 -69.17 0.46 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.674 -0.641 . . . . 0.0 111.577 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.66 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.6 mp -60.03 -45.78 91.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.503 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.753 0.787 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -133.85 170.9 14.91 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.12 -43.84 95.33 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.486 HG22 ' CE1' ' A' ' 58' ' ' PHE . 24.8 m -60.13 -57.82 11.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.642 -0.661 . . . . 0.0 111.187 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 p -70.4 -45.79 65.25 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.788 -1.195 . . . . 0.0 111.771 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.86 -49.89 68.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.094 . . . . 0.0 112.733 -177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.8 t -69.82 -47.76 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 120.642 -1.286 . . . . 0.0 112.331 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.408 ' CD1' ' H ' ' A' ' 52' ' ' ALA . 47.3 mm -60.09 -48.58 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.876 -1.14 . . . . 0.0 109.547 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -60.05 -39.3 85.48 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.477 -0.764 . . . . 0.0 110.357 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.12 85.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.928 -1.108 . . . . 0.0 110.654 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.9 m-20 -71.08 -79.0 0.07 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.1 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 tptp 40.96 26.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.599 -0.688 . . . . 0.0 110.874 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' ASN . . . 171.85 39.05 0.03 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -69.77 110.8 5.12 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.748 -0.854 . . . . 0.0 110.21 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.91 -40.0 72.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 109.101 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.13 25.93 0.25 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.795 ' H ' ' CD ' ' A' ' 18' ' ' PRO . 32.3 pttt -178.42 -22.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.278 -1.13 . . . . 0.0 112.875 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.795 ' CD ' ' H ' ' A' ' 17' ' ' LYS . 45.1 Cg_endo -95.56 108.75 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.657 1.571 . . . . 0.0 112.696 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.79 133.75 54.91 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.0 mt -110.6 130.67 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 t -90.39 100.73 13.51 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -65.45 -7.14 12.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 108.854 -179.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.493 ' N ' HD12 ' A' ' 22' ' ' LEU . 91.8 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 24' ' ' ASP . 42.8 t0 -135.34 3.54 3.1 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.31 86.72 0.04 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.19 134.61 29.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.375 -1.073 . . . . 0.0 109.724 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -82.82 121.99 27.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.3 mt -119.99 76.4 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 110.701 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -70.18 107.13 3.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.679 -1.263 . . . . 0.0 109.959 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.99 23.74 1.03 Allowed Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -134.97 139.2 44.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.611 HG22 HD21 ' A' ' 75' ' ' LEU . 33.4 m -124.38 111.35 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.616 ' OH ' HD13 ' A' ' 71' ' ' ILE . 4.4 p90 32.0 32.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.002 -0.436 . . . . 0.0 111.405 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -92.82 135.92 33.7 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.874 -1.141 . . . . 0.0 109.926 -179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.599 ' H ' HD13 ' A' ' 34' ' ' LEU . . . 100.73 18.26 21.12 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -129.99 -99.94 0.32 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -1.062 . . . . 0.0 109.521 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -153.41 25.24 0.77 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -50.04 149.59 2.7 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.77 -0.841 . . . . 0.0 111.093 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.3 m -149.68 151.66 34.06 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -169.09 167.79 10.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.234 -1.542 . . . . 0.0 109.474 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -158.78 160.35 36.2 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -97.48 121.79 39.78 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.89 -1.131 . . . . 0.0 109.861 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.495 ' OD2' HG23 ' A' ' 48' ' ' VAL . 12.2 m-20 -100.04 -1.83 35.96 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.152 -0.967 . . . . 0.0 110.306 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.664 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 83.75 95.23 0.63 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.782 -1.199 . . . . 0.0 110.51 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 84.22 4.76 0.71 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.938 -0.742 . . . . 0.0 109.887 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.1 m -165.94 143.77 5.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.99 128.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.468 -0.77 . . . . 0.0 110.371 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.495 HG23 ' OD2' ' A' ' 43' ' ' ASP . 89.6 t -101.2 109.83 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.36 140.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.4 p -112.09 120.51 41.65 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -36.61 -79.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.006 1.804 . . . . 0.0 113.097 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 37' ' ' GLY . . . -93.53 -48.85 6.18 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.794 -1.191 . . . . 0.0 109.203 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -160.85 -165.83 1.47 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.535 -1.353 . . . . 0.0 109.568 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.631 ' OE2' ' HB2' ' A' ' 60' ' ' ALA . 84.8 tt0 -157.5 100.86 1.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.152 -0.967 . . . . 0.0 109.607 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.651 ' O ' ' N ' ' A' ' 57' ' ' LEU . 26.7 p -131.22 145.57 51.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.849 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -27.82 -27.07 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 55' ' ' THR . 5.8 mp -79.61 -10.14 59.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.649 -1.282 . . . . 0.0 109.461 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 4' ' ' THR . 34.9 m-85 -137.5 -161.84 1.22 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.59 166.58 28.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.738 -1.227 . . . . 0.0 111.506 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.631 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . . . -76.62 176.1 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -134.1 127.66 32.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -96.43 110.14 22.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.131 -0.981 . . . . 0.0 110.871 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -110.76 144.99 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.302 0.572 . . . . 0.0 109.812 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -73.4 163.59 27.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.099 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.9 95.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.405 -0.81 . . . . 0.0 111.345 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -49.98 72.62 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.267 -1.521 . . . . 0.0 111.426 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -60.21 -35.57 75.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.262 -1.524 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.659 ' O ' HD13 ' A' ' 68' ' ' LEU . 3.1 tm? -59.7 -35.43 74.48 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 108.37 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -59.93 -34.48 73.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.969 -1.082 . . . . 0.0 109.296 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.2 mt -58.19 -38.7 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.88 -1.137 . . . . 0.0 108.77 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.63 HD12 HD22 ' A' ' 68' ' ' LEU . 82.6 mt -59.99 -39.92 81.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.759 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' OXT' ' A' ' 76' ' ' LEU . . . -62.45 -40.05 95.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.083 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -67.23 -50.56 60.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.736 -1.227 . . . . 0.0 110.53 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -59.97 -63.41 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.925 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.7 mp -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.884 -1.135 . . . . 0.0 111.028 -177.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.794 HD23 ' N ' ' A' ' 76' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 109.581 179.889 . . . . . . . . 1 1 . 1 stop_ save_